data_1aw0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1aw0 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 . . . . . 0 CA--C 1.528 0.12 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.85 153.97 21.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.162 0.985 . . . . 0.0 110.232 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.2 t -149.94 143.39 25.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.896 0.879 . . . . 0.0 109.149 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.0 t -108.66 124.69 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 173.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.9 mt -121.95 119.53 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -73.5 126.36 30.04 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.2 mt -120.86 110.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.086 1.355 . . . . 0.0 107.675 -176.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -99.9 145.57 27.65 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.438 0.695 . . . . 0.0 109.146 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.08 13.01 47.47 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.648 1.118 . . . . 0.0 113.497 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 C--N 1.343 0.291 0 CA-C-N 118.558 1.179 . . . . 0.0 109.257 177.034 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.6 p . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.203 0.049 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.4 m -63.86 -46.55 84.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.695 0.798 . . . . 0.0 110.598 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -53.4 -53.69 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.293 1.037 . . . . 0.0 110.059 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -60.97 -46.14 91.92 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.858 1.263 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.1 t -57.44 -53.59 56.47 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.534 0.733 . . . . 0.0 110.754 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.6 mt -55.98 -55.27 19.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 C-N-CA 124.083 0.953 . . . . 0.0 109.424 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.89 -53.08 54.26 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.569 0.748 . . . . 0.0 110.932 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.22 -53.37 46.18 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.383 0.992 . . . . 0.0 112.552 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.82 -53.56 46.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 117.579 0.689 . . . . 0.0 110.485 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.3 mm -62.21 -36.64 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 118.814 -0.612 . . . . 0.0 111.024 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.7 t -51.3 -37.12 45.75 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.829 0.741 . . . . 0.0 111.933 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -89.21 -3.62 58.5 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.709 0.804 . . . . 0.0 112.455 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -71.78 142.53 85.9 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 119.352 0.978 . . . . 0.0 109.322 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -46.55 134.41 16.58 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.921 3.081 . . . . 0.0 112.801 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.93 -40.33 2.85 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-O 118.802 -0.999 . . . . 0.0 112.644 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.45 135.42 28.5 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.178 0.989 . . . . 0.0 109.704 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -114.29 -88.42 0.56 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.7 p -90.82 149.85 21.81 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.581 0.752 . . . . 0.0 109.949 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.52 138.19 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 124.035 0.934 . . . . 0.0 109.041 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -130.84 109.09 10.32 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.778 1.231 . . . . 0.0 108.287 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.9 t -98.21 114.61 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 124.002 0.921 . . . . 0.0 108.748 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.1 t -100.61 123.56 44.99 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 124.388 1.075 . . . . 0.0 109.452 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.0 tp -71.93 -44.08 64.21 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.688 0.795 . . . . 0.0 110.019 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.87 -46.88 74.79 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.892 1.277 . . . . 0.0 111.732 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -89.23 -7.06 56.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.209 0.604 . . . . 0.0 111.352 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.3 m 53.05 54.88 9.69 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.774 1.63 . . . . 0.0 111.019 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -155.54 163.58 39.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.986 0.422 . . . . 0.0 111.803 -175.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.24 116.16 3.54 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 126.402 1.954 . . . . 0.0 108.365 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.1 m -99.24 101.56 12.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.5 t -108.38 131.72 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 124.499 1.12 . . . . 0.0 109.521 -170.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -102.24 125.41 48.93 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -146.59 164.82 31.39 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.587 0.755 . . . . 0.0 111.405 -171.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -97.49 115.68 65.77 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.476 1.111 . . . . 0.0 109.277 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -45.94 -38.48 18.48 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 125.255 3.97 . . . . 0.0 115.175 175.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.8 mt -65.59 -28.13 68.92 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.456 0.702 . . . . 0.0 111.839 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.64 -44.09 6.25 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.219 1.007 . . . . 0.0 110.854 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.1 t -144.9 176.21 9.64 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.483 0.713 . . . . 0.0 110.403 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.8 p -149.99 164.63 19.97 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 124.209 1.004 . . . . 0.0 109.864 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.24 -47.08 28.7 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.605 2.87 . . . . 0.0 113.009 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.65 -36.0 82.39 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.468 0.707 . . . . 0.0 112.118 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 m -67.18 -45.65 76.3 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.963 0.505 . . . . 0.0 110.154 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.1 mt -62.21 -46.52 88.5 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.07 0.948 . . . . 0.0 110.443 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -52.5 -47.24 66.73 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.172 0.989 . . . . 0.0 110.052 170.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.75 -45.2 86.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.257 0.932 . . . . 0.0 112.288 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.85 77.43 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 117.677 0.739 . . . . 0.0 111.262 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.8 mt -60.98 -41.99 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.759 0.824 . . . . 0.0 110.076 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.93 -41.32 99.44 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.089 0.956 . . . . 0.0 110.799 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.68 -42.05 99.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.856 0.862 . . . . 0.0 111.094 177.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -58.68 -46.82 86.39 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.98 0.354 . . . . 0.0 110.09 173.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.06 59.13 0.13 Allowed Glycine 0 C--N 1.341 0.815 0 C-N-CA 123.882 0.754 . . . . 0.0 111.735 170.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -140.21 146.55 38.84 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.874 0.87 . . . . 0.0 109.124 174.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -76.13 92.32 3.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.5 131.82 45.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.928 1.291 . . . . 0.0 110.166 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.3 m -143.51 134.01 24.84 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.825 1.25 . . . . 0.0 108.414 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.5 mt . . . . . 0 CA--C 1.53 0.193 0 C-N-CA 123.154 0.582 . . . . 0.0 109.904 -178.708 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 . . . . . 0 CA--C 1.527 0.081 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -122.77 155.83 35.74 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.034 0.934 . . . . 0.0 110.076 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.3 t -150.08 144.71 25.92 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.115 0.966 . . . . 0.0 109.303 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.7 t -107.11 127.67 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 172.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.4 mt -125.65 124.33 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -66.17 132.5 48.61 Favored 'General case' 0 C--N 1.337 0.045 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 172.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.6 mt -127.66 95.36 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -99.82 156.63 17.01 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.363 0.665 . . . . 0.0 109.938 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.41 32.43 34.55 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.913 0.768 . . . . 0.0 112.036 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 96.7 mtp . . . . . 0 N--CA 1.455 -0.19 0 C-N-CA 123.965 0.906 . . . . 0.0 108.585 175.161 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 111.3 0.111 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.1 m -65.91 -48.41 71.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.159 0.584 . . . . 0.0 110.103 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -51.87 -54.42 13.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 123.419 0.688 . . . . 0.0 109.881 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -59.16 -52.9 63.73 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.66 1.184 . . . . 0.0 111.408 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 p -61.15 -53.46 56.72 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.854 0.462 . . . . 0.0 111.387 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 85.0 mt -55.85 -54.79 22.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 123.815 0.846 . . . . 0.0 109.657 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -59.45 -47.01 87.14 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.526 0.33 . . . . 0.0 110.677 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.43 -51.94 53.1 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.314 0.959 . . . . 0.0 112.256 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.73 -55.21 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 117.631 0.716 . . . . 0.0 110.503 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.23 -37.65 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.087 0.555 . . . . 0.0 111.564 -173.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 92.7 p -54.9 -30.48 58.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.786 0.721 . . . . 0.0 112.694 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -89.51 -4.41 57.93 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.906 0.882 . . . . 0.0 112.256 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -70.73 144.84 91.48 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 118.936 0.789 . . . . 0.0 109.205 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -63.71 128.59 22.54 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.019 2.479 . . . . 0.0 110.444 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.56 -32.44 7.57 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-O 118.817 -0.99 . . . . 0.0 112.491 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.8 t -68.62 132.59 32.79 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 CA-C-N 118.276 1.038 . . . . 0.0 109.914 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -106.34 -99.96 0.34 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.999 1.32 . . . . 0.0 108.009 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.5 p -88.64 151.06 22.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.795 0.838 . . . . 0.0 109.365 173.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.7 tt -150.48 131.9 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.293 0.637 . . . . 0.0 109.302 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.94 94.79 4.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.567 1.547 . . . . 0.0 107.747 -175.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.9 t -90.38 125.66 43.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.3 t -118.96 126.93 52.91 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.733 1.213 . . . . 0.0 110.235 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.6 tp -72.45 -47.91 45.19 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.728 1.211 . . . . 0.0 109.455 170.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.99 -46.49 68.31 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.769 1.227 . . . . 0.0 111.591 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -89.42 -11.57 42.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.306 0.642 . . . . 0.0 111.605 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.9 m 53.42 57.65 5.97 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.125 1.37 . . . . 0.0 110.372 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.7 p30 -157.85 171.04 21.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.402 0.681 . . . . 0.0 111.201 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.88 115.84 1.86 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.1 m -99.46 101.99 13.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.9 t -106.73 139.02 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.918 1.287 . . . . 0.0 109.755 -169.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -108.13 130.28 55.12 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 168.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -150.62 169.0 22.6 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.933 0.493 . . . . 0.0 112.05 -170.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.66 112.86 65.29 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.469 1.507 . . . . 0.0 109.531 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -43.29 -42.74 10.33 Favored 'Trans proline' 0 C--N 1.347 0.456 1 C-N-CA 125.696 4.264 . . . . 0.0 115.872 176.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.0 mt -68.26 -28.85 67.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.645 0.378 . . . . 0.0 111.956 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.9 mt -99.71 -33.91 10.4 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.204 1.002 . . . . 0.0 111.801 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -151.69 170.97 18.41 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.273 0.629 . . . . 0.0 110.088 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.8 p -144.04 164.22 30.73 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.602 1.161 . . . . 0.0 109.747 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -52.72 -38.08 76.5 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.377 2.718 . . . . 0.0 112.55 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -66.05 -45.99 79.4 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.331 1.052 . . . . 0.0 110.349 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.8 m -62.45 -46.57 87.92 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.182 0.593 . . . . 0.0 110.545 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.7 mt -60.23 -49.78 76.26 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.03 0.932 . . . . 0.0 110.566 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.2 ttp85 -52.25 -48.54 65.17 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.323 1.049 . . . . 0.0 110.33 173.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.31 -45.79 87.9 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.287 0.946 . . . . 0.0 112.316 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.34 -48.32 78.49 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.559 0.743 . . . . 0.0 111.189 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.7 mt -59.25 -42.1 86.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.777 0.831 . . . . 0.0 110.045 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -63.11 -42.22 99.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.393 0.677 . . . . 0.0 110.982 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -62.11 -41.82 98.61 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.082 0.953 . . . . 0.0 111.103 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.0 mtp -58.75 -45.89 88.67 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.542 0.337 . . . . 0.0 110.32 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.33 58.45 0.13 Allowed Glycine 0 C--N 1.339 0.749 0 C-N-CA 123.618 0.628 . . . . 0.0 111.719 169.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -140.32 140.31 35.61 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -68.44 96.6 0.69 Allowed 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.9 127.75 46.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.887 1.275 . . . . 0.0 109.646 -172.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.5 m -149.16 130.41 14.61 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.0 mt . . . . . 0 CA--C 1.532 0.272 0 C-N-CA 123.367 0.667 . . . . 0.0 110.597 -177.33 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 . . . . . 0 CA--C 1.529 0.145 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -140.18 141.58 35.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.215 1.006 . . . . 0.0 109.041 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -135.65 146.24 47.63 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.564 1.146 . . . . 0.0 109.588 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.92 124.18 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.3 mt -120.72 120.27 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -68.45 134.44 50.15 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.9 mt -131.67 106.49 11.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.117 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.92 142.63 31.13 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.64 19.4 20.3 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.792 1.187 . . . . 0.0 113.155 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.1 mtm . . . . . 0 C--N 1.342 0.26 0 CA-C-N 118.425 1.113 . . . . 0.0 109.393 176.445 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 120.222 0.058 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.7 m -67.15 -44.49 79.67 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.244 0.618 . . . . 0.0 110.647 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.2 t -54.71 -49.67 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.015 0.926 . . . . 0.0 109.893 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.08 -45.34 93.95 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.582 1.553 . . . . 0.0 111.033 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 m -58.6 -53.16 61.51 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 122.951 0.5 . . . . 0.0 110.852 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.59 -50.83 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 123.744 0.818 . . . . 0.0 109.789 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -49.95 -58.45 5.42 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.839 1.256 . . . . 0.0 110.345 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.78 -57.76 17.73 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.789 0.709 . . . . 0.0 112.155 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.9 t -59.67 -56.88 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.302 0.641 . . . . 0.0 110.872 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.6 mm -64.64 -38.49 82.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 118.747 -0.644 . . . . 0.0 111.212 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.2 t -52.94 -35.2 58.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.864 0.756 . . . . 0.0 111.971 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -89.41 -2.6 58.46 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.799 0.84 . . . . 0.0 112.49 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -71.21 145.16 90.65 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 119.448 1.022 . . . . 0.0 109.267 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.97 131.24 30.08 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.94 2.427 . . . . 0.0 109.895 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.71 -36.18 4.41 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-O 118.934 -0.926 . . . . 0.0 112.047 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.7 t -73.57 143.85 13.28 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 CA-C-N 118.044 0.922 . . . . 0.0 110.105 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -118.18 -103.69 0.41 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.078 1.351 . . . . 0.0 107.411 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.0 p -90.37 109.41 20.52 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.164 0.986 . . . . 0.0 110.414 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.0 tt -97.66 141.68 15.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 168.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -126.3 94.46 4.09 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -175.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -89.38 98.37 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.9 t -89.84 109.41 20.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.843 0.857 . . . . 0.0 109.32 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.2 -43.17 95.84 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.468 0.707 . . . . 0.0 109.878 171.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.6 -49.29 68.11 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.609 1.164 . . . . 0.0 111.742 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -89.8 1.02 56.65 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.033 0.533 . . . . 0.0 112.301 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.9 m 49.36 52.72 13.94 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.419 1.488 . . . . 0.0 111.574 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -155.5 166.25 34.1 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.106 0.479 . . . . 0.0 111.762 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.33 118.3 3.82 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.0 m -98.96 99.62 10.69 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.63 121.46 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 125.281 1.433 . . . . 0.0 109.516 -169.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -89.48 128.21 35.95 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 169.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -150.23 168.91 22.64 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -169.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -106.13 113.24 63.73 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 125.447 1.499 . . . . 0.0 108.979 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -48.27 -35.32 26.86 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 124.807 3.671 . . . . 0.0 114.615 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.0 mt -63.42 -31.46 72.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.509 0.723 . . . . 0.0 111.861 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.8 mt -106.79 -31.35 8.43 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.295 1.038 . . . . 0.0 112.368 -171.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 t -149.71 175.45 11.57 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.746 0.703 . . . . 0.0 110.177 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.2 p -146.46 160.86 40.64 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 124.2 1.0 . . . . 0.0 109.839 -176.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.62 -40.93 54.98 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.402 2.734 . . . . 0.0 112.747 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.97 -44.38 85.09 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.068 0.947 . . . . 0.0 111.148 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.7 m -61.95 -46.71 88.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.153 0.581 . . . . 0.0 110.462 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.4 mt -61.82 -49.72 75.16 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.306 1.042 . . . . 0.0 110.411 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -51.89 -44.48 63.78 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.81 0.844 . . . . 0.0 110.2 171.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.22 -48.0 77.75 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.523 1.058 . . . . 0.0 112.128 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.26 -45.58 90.83 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.657 0.729 . . . . 0.0 111.479 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.0 mt -62.01 -45.32 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.873 0.869 . . . . 0.0 109.914 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -61.71 -42.03 98.4 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.586 1.154 . . . . 0.0 110.775 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.39 -43.64 98.53 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.349 1.06 . . . . 0.0 111.338 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 69.0 mtm -57.11 -48.21 79.2 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 117.908 0.322 . . . . 0.0 110.481 173.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.2 65.8 0.1 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -140.24 152.03 45.63 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.158 0.983 . . . . 0.0 108.717 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -78.21 90.19 4.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.77 133.71 43.73 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.823 1.249 . . . . 0.0 110.464 -174.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.7 m -150.11 146.45 26.92 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.169 0.988 . . . . 0.0 108.459 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 CA--C 1.533 0.314 0 CA-C-N 118.276 0.489 . . . . 0.0 110.001 179.13 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 . . . . . 0 CA--C 1.529 0.154 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -140.28 146.0 38.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.777 0.831 . . . . 0.0 109.609 177.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -137.2 137.31 38.99 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.319 1.048 . . . . 0.0 109.692 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.8 t -99.84 109.11 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 172.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.1 mt -99.82 119.97 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -71.83 123.59 23.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.9 mt -123.53 119.49 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -118.14 158.01 25.85 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.188 0.595 . . . . 0.0 109.746 173.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.9 16.41 51.44 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.621 1.105 . . . . 0.0 112.052 -170.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 89.3 mtp . . . . . 0 CA--C 1.532 0.266 0 C-N-CA 124.458 1.103 . . . . 0.0 108.504 178.852 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.1 t . . . . . 0 CA--C 1.532 0.284 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.1 m -62.35 -49.22 76.46 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -54.16 -52.77 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.144 0.978 . . . . 0.0 109.916 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -55.14 -51.33 66.8 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.81 1.244 . . . . 0.0 110.883 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -60.06 -56.4 22.14 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.235 0.614 . . . . 0.0 110.967 -177.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 93.5 mt -53.78 -52.69 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.483 1.113 . . . . 0.0 109.749 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -56.02 -55.5 32.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.324 1.049 . . . . 0.0 110.502 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.57 -50.26 64.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.715 1.15 . . . . 0.0 112.286 -176.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.9 t -63.12 -55.34 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 117.368 0.584 . . . . 0.0 110.394 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 84.3 mt -65.06 -40.91 90.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 119.222 -0.418 . . . . 0.0 111.607 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.8 p -53.73 -28.64 35.41 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -89.43 -8.3 53.33 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.888 0.875 . . . . 0.0 112.523 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -71.88 124.62 91.15 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 119.08 0.854 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.12 121.98 7.72 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.699 2.933 . . . . 0.0 112.135 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.13 -37.35 3.45 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.0 0.81 . . . . 0.0 111.76 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.39 126.97 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 117.827 0.814 . . . . 0.0 109.761 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -94.38 -101.35 0.15 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.924 1.29 . . . . 0.0 107.83 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 91.4 p -90.01 163.04 15.08 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.529 0.732 . . . . 0.0 110.186 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.3 tt -150.63 147.85 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.747 0.819 . . . . 0.0 109.73 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.97 109.06 6.77 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.616 1.166 . . . . 0.0 107.884 172.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.42 102.2 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 124.171 0.988 . . . . 0.0 108.467 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -93.65 112.99 24.98 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.969 0.908 . . . . 0.0 110.372 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tt -66.42 -51.37 57.65 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.22 -51.09 57.16 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.09 1.356 . . . . 0.0 112.209 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -89.86 6.56 41.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.963 0.505 . . . . 0.0 111.939 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 m 49.23 57.02 6.93 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 125.654 1.582 . . . . 0.0 112.047 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -157.19 164.11 38.12 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.519 0.676 . . . . 0.0 112.728 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.45 110.11 2.09 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 106.186 -2.766 . . . . 0.0 106.186 169.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -98.81 97.2 8.44 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.5 t -106.87 124.27 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 124.387 1.075 . . . . 0.0 109.099 -170.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -89.81 130.82 36.01 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 169.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -150.31 165.98 31.4 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.072 0.549 . . . . 0.0 112.191 -169.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -104.37 113.19 65.36 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.098 1.359 . . . . 0.0 109.189 173.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -44.65 -36.65 10.52 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 125.286 3.991 . . . . 0.0 114.846 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.6 mt -66.06 -28.61 68.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.617 0.767 . . . . 0.0 112.12 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.7 mt -109.83 -35.29 6.21 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.314 1.046 . . . . 0.0 112.051 -171.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -145.26 179.32 7.46 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.869 0.868 . . . . 0.0 109.396 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.0 p -150.07 162.63 27.31 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 123.207 0.603 . . . . 0.0 110.56 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.03 -38.82 87.03 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.32 2.68 . . . . 0.0 111.782 172.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.45 -49.72 75.66 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.858 0.863 . . . . 0.0 110.677 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -58.37 -48.35 80.88 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.319 0.647 . . . . 0.0 110.549 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.3 mt -60.65 -47.84 84.45 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.219 1.008 . . . . 0.0 110.87 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -56.55 -44.61 81.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.679 0.792 . . . . 0.0 110.555 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.27 -45.94 87.33 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.095 0.855 . . . . 0.0 111.87 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.39 -49.83 73.95 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.378 0.671 . . . . 0.0 111.091 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.8 mt -60.08 -45.28 95.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.32 0.648 . . . . 0.0 110.212 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -57.56 -48.97 77.88 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.102 0.961 . . . . 0.0 110.048 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.78 -43.58 90.48 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.114 0.965 . . . . 0.0 111.454 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.4 mtp -59.44 -44.53 92.91 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.928 0.491 . . . . 0.0 110.631 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.04 62.21 0.2 Allowed Glycine 0 C--N 1.339 0.725 0 C-N-CA 123.795 0.712 . . . . 0.0 111.598 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -140.31 155.4 46.84 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.789 0.836 . . . . 0.0 109.29 172.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -78.37 91.12 4.43 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.703 0.801 . . . . 0.0 108.996 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.67 129.68 45.83 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.618 1.167 . . . . 0.0 110.816 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.7 m -150.07 132.42 15.57 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.897 0.879 . . . . 0.0 108.818 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 43.5 mt . . . . . 0 CA--C 1.534 0.33 0 C-N-CA 123.054 0.542 . . . . 0.0 111.094 -178.171 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -124.14 144.14 50.08 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.461 1.105 . . . . 0.0 108.886 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -137.7 146.78 44.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.33 1.052 . . . . 0.0 109.326 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.99 125.59 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.9 mt -120.32 121.06 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -72.37 132.07 43.47 Favored 'General case' 0 C--O 1.228 -0.044 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 174.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.5 mt -127.97 106.42 14.8 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -99.56 149.57 23.11 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.427 0.691 . . . . 0.0 109.195 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.27 16.27 47.64 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.441 1.02 . . . . 0.0 113.005 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.8 mtm . . . . . 0 C--N 1.343 0.293 0 CA-C-N 118.58 1.19 . . . . 0.0 109.252 175.227 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.8 m -60.76 -57.2 13.71 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.4 0.68 . . . . 0.0 109.603 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.7 t -49.89 -51.55 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.06 1.344 . . . . 0.0 111.067 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -59.87 -52.48 65.27 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.009 1.324 . . . . 0.0 111.103 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.3 p -61.12 -48.98 79.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.122 0.569 . . . . 0.0 111.3 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.8 mt -53.76 -55.31 14.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.805 0.842 . . . . 0.0 109.397 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -54.18 -55.06 31.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.113 0.565 . . . . 0.0 110.712 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.43 -50.45 59.94 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.315 0.959 . . . . 0.0 112.779 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.38 -49.68 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.409 0.683 . . . . 0.0 110.699 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.6 mm -66.28 -33.53 64.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.46 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.7 m -50.87 -30.88 15.72 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.872 0.76 . . . . 0.0 112.734 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -89.07 -3.35 58.7 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.58 0.752 . . . . 0.0 112.167 -173.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -77.12 143.01 69.27 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 118.87 0.759 . . . . 0.0 109.903 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.92 135.37 17.82 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.91 3.073 . . . . 0.0 112.608 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.17 -34.9 3.95 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.674 -1.07 . . . . 0.0 113.045 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.1 124.22 20.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-N 118.448 1.124 . . . . 0.0 109.918 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -89.84 -102.59 0.09 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.0 p -90.49 158.02 17.25 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.336 1.054 . . . . 0.0 109.676 171.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.5 tt -150.23 127.37 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -116.19 107.13 14.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.465 1.106 . . . . 0.0 108.497 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.62 124.38 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.0 t -106.8 129.48 54.65 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.636 1.174 . . . . 0.0 110.17 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.5 tp -68.35 -53.61 22.93 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.709 0.803 . . . . 0.0 109.09 171.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.16 -47.48 71.93 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 125.265 1.426 . . . . 0.0 112.086 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -89.25 -9.63 49.95 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.403 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.5 m 52.79 56.08 8.1 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 125.016 1.326 . . . . 0.0 111.02 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -157.17 168.31 27.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.419 0.688 . . . . 0.0 110.853 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.55 116.83 2.89 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 126.215 1.864 . . . . 0.0 108.783 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.0 m -99.12 100.56 11.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 176.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.6 t -106.3 125.52 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.502 1.121 . . . . 0.0 109.537 -170.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -95.53 127.93 41.98 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 168.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -150.26 164.36 35.93 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.17 0.588 . . . . 0.0 111.779 -169.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -98.36 114.25 65.02 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.737 1.215 . . . . 0.0 109.013 172.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -47.74 -34.35 21.07 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.741 3.627 . . . . 0.0 114.93 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.5 mt -65.92 -33.9 76.89 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.457 0.703 . . . . 0.0 111.584 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.75 -35.3 9.84 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.895 0.878 . . . . 0.0 111.578 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.3 t -147.4 178.37 8.48 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.698 0.681 . . . . 0.0 110.539 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.3 p -148.88 159.85 36.73 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 124.624 1.17 . . . . 0.0 109.714 -174.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.41 -40.42 62.47 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.511 2.807 . . . . 0.0 112.814 176.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -66.79 -41.05 88.28 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.555 1.142 . . . . 0.0 110.927 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.8 m -67.55 -45.65 75.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.1 0.56 . . . . 0.0 110.326 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.0 mt -60.73 -49.55 77.05 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.241 1.016 . . . . 0.0 110.253 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.9 ttp85 -52.1 -47.24 65.38 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.164 0.986 . . . . 0.0 109.988 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.19 -45.23 83.22 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.569 1.08 . . . . 0.0 112.293 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.59 -48.24 75.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.635 0.717 . . . . 0.0 111.099 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.93 -42.45 89.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.92 0.888 . . . . 0.0 109.981 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -63.51 -41.04 98.52 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.628 1.171 . . . . 0.0 110.568 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.36 -41.48 98.83 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.01 0.924 . . . . 0.0 111.182 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.9 mtp -57.83 -44.27 86.36 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.097 0.408 . . . . 0.0 110.203 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.13 61.76 0.16 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 123.651 0.643 . . . . 0.0 111.702 169.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -140.33 152.43 45.82 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.999 0.919 . . . . 0.0 109.414 175.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -79.74 86.24 5.35 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.57 128.99 45.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.626 1.171 . . . . 0.0 110.461 -173.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.9 p -142.34 151.19 41.68 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.154 1.382 . . . . 0.0 109.039 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.414 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 CA--C 1.528 0.097 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -134.76 141.27 46.42 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.061 0.945 . . . . 0.0 108.969 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -131.56 144.8 51.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.406 1.082 . . . . 0.0 109.49 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.97 123.75 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.2 mt -116.37 121.76 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -69.94 118.19 12.47 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.3 mt -110.8 102.34 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -99.65 149.03 23.71 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.562 0.745 . . . . 0.0 109.27 176.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.67 26.04 16.28 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.667 1.127 . . . . 0.0 112.359 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 88.8 mtp . . . . . 0 CA--C 1.53 0.206 0 C-N-CA 124.107 0.963 . . . . 0.0 108.413 175.589 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 p . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.31 -40.51 96.54 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.939 0.895 . . . . 0.0 109.239 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.5 t -49.86 -59.3 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.358 1.063 . . . . 0.0 109.928 173.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.89 -45.5 94.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.609 1.164 . . . . 0.0 111.037 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.8 t -59.55 -57.88 11.04 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.956 0.902 . . . . 0.0 110.828 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.3 mt -55.42 -54.4 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.964 0.906 . . . . 0.0 109.587 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -55.38 -49.02 73.4 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.144 0.578 . . . . 0.0 110.791 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.39 -37.27 91.75 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.002 1.287 . . . . 0.0 113.284 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.6 t -77.84 -57.81 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.253 1.026 . . . . 0.0 110.17 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.38 -37.63 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.452 0.701 . . . . 0.0 111.404 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.9 p -51.6 -30.78 22.44 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -89.42 -8.29 53.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.815 0.846 . . . . 0.0 112.434 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -72.56 143.62 85.3 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 118.751 0.705 . . . . 0.0 109.816 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -47.51 134.27 21.0 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.791 2.994 . . . . 0.0 112.655 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.56 -31.76 5.64 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-O 118.724 -1.042 . . . . 0.0 113.457 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.5 t -67.12 134.02 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.341 1.071 . . . . 0.0 110.146 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -113.88 -102.94 0.41 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.192 1.397 . . . . 0.0 108.297 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.4 p -82.44 154.05 25.35 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.161 0.584 . . . . 0.0 109.79 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.5 tt -150.33 145.32 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.326 0.65 . . . . 0.0 110.1 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -139.97 103.47 4.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.5 t -91.67 108.6 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.2 t -89.52 129.23 36.03 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.145 0.578 . . . . 0.0 110.111 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tt -73.96 -57.01 4.25 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.813 1.245 . . . . 0.0 108.152 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.79 -45.7 78.13 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.524 1.53 . . . . 0.0 112.356 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -89.12 -10.54 46.91 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.893 0.477 . . . . 0.0 111.013 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.2 m 56.23 58.15 4.5 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.057 1.343 . . . . 0.0 110.614 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -146.03 163.59 34.75 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.86 0.464 . . . . 0.0 111.618 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.04 107.59 1.8 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.9 m -99.13 99.84 10.9 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.3 t -114.91 126.01 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 124.791 1.236 . . . . 0.0 109.608 -169.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -89.92 131.61 35.74 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -150.51 156.96 42.44 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.274 0.629 . . . . 0.0 112.256 -170.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -93.53 120.08 66.67 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.703 1.201 . . . . 0.0 110.117 173.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.53 -41.79 29.51 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 125.069 3.846 . . . . 0.0 115.785 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -68.47 -29.74 68.43 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.614 0.365 . . . . 0.0 111.73 -173.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.2 mt -99.64 -32.66 10.96 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.227 1.011 . . . . 0.0 111.893 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -153.23 176.22 12.19 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.677 0.671 . . . . 0.0 110.05 173.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.9 p -150.09 162.6 27.39 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.039 0.936 . . . . 0.0 109.993 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.3 -44.34 49.77 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.439 2.759 . . . . 0.0 112.755 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.05 -34.12 77.3 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.502 0.721 . . . . 0.0 112.571 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.1 m -70.93 -47.67 57.79 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 122.944 0.498 . . . . 0.0 109.732 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.9 mt -58.36 -50.31 74.12 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.943 0.897 . . . . 0.0 110.05 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -52.29 -47.4 65.91 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.791 1.236 . . . . 0.0 110.533 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.82 -47.87 76.0 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.32 0.962 . . . . 0.0 112.156 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.5 -46.77 86.95 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.561 0.744 . . . . 0.0 111.401 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.7 mt -60.97 -43.99 97.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.56 0.744 . . . . 0.0 109.938 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -63.14 -41.67 99.34 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.712 0.805 . . . . 0.0 110.945 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.13 -43.49 98.81 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.253 1.021 . . . . 0.0 111.184 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 69.5 mtm -58.46 -50.04 75.14 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 117.842 0.292 . . . . 0.0 110.382 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.39 63.01 0.09 OUTLIER Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 171.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -140.25 142.98 35.74 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.27 93.51 1.11 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.9 120.7 40.19 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.219 1.407 . . . . 0.0 109.425 -174.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 47.1 p -138.27 140.26 39.55 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.356 1.062 . . . . 0.0 108.617 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 CA--C 1.53 0.201 0 C-N-CA 122.596 0.358 . . . . 0.0 110.31 -176.409 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 . . . . . 0 CA--C 1.527 0.088 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -128.5 151.81 48.99 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.554 1.142 . . . . 0.0 109.438 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -145.44 148.68 33.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.298 1.039 . . . . 0.0 109.394 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.93 123.54 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.4 mt -119.06 128.86 75.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -70.28 121.47 17.69 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 171.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.7 mt -125.95 95.01 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.75 151.74 20.9 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.31 15.79 56.64 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.31 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 54.8 mtt . . . . . 0 C--N 1.344 0.344 0 CA-C-N 118.755 1.277 . . . . 0.0 109.764 174.6 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.3 m -63.8 -44.26 93.83 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.736 0.814 . . . . 0.0 110.679 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.3 t -51.92 -54.7 12.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 C-N-CA 123.302 0.641 . . . . 0.0 109.641 176.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -61.51 -42.65 99.13 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.668 0.787 . . . . 0.0 111.432 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -59.24 -55.43 35.01 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.131 0.572 . . . . 0.0 110.663 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.2 mt -54.25 -55.8 12.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 123.873 0.869 . . . . 0.0 109.155 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -54.44 -54.67 37.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.85 0.86 . . . . 0.0 111.091 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.09 -53.57 44.64 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.281 0.943 . . . . 0.0 112.364 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.61 -54.24 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 117.382 0.591 . . . . 0.0 110.438 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.9 mm -61.78 -40.6 87.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.699 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.1 t -51.2 -36.21 40.27 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.427 0.691 . . . . 0.0 112.089 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -88.97 -11.06 45.41 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.464 0.705 . . . . 0.0 112.131 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -73.08 139.43 79.5 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 119.466 1.03 . . . . 0.0 109.962 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -45.22 137.81 10.09 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.354 3.369 . . . . 0.0 113.665 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.34 -38.79 3.01 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-O 118.841 -0.977 . . . . 0.0 112.49 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.34 134.02 30.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 CA-C-N 118.254 1.027 . . . . 0.0 110.088 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -104.61 -102.09 0.31 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.849 1.259 . . . . 0.0 107.926 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.8 p -87.31 152.83 21.96 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.464 0.706 . . . . 0.0 109.849 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 tt -150.69 140.23 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.645 0.778 . . . . 0.0 109.676 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -129.84 110.95 12.13 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.924 1.29 . . . . 0.0 108.659 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.34 122.79 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.363 1.065 . . . . 0.0 108.572 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.7 t -115.63 123.66 48.98 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.823 1.249 . . . . 0.0 110.588 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.6 tp -69.83 -48.24 59.71 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.745 1.218 . . . . 0.0 109.823 170.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.12 -46.74 65.46 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.691 1.197 . . . . 0.0 111.639 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -89.51 -15.03 33.91 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.419 0.688 . . . . 0.0 111.7 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.2 m 54.52 54.68 8.97 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 125.14 1.376 . . . . 0.0 110.415 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -154.32 163.42 40.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.454 0.702 . . . . 0.0 110.928 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.54 119.6 3.74 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.4 m -99.2 104.52 16.49 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 t -112.86 127.75 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 124.655 1.182 . . . . 0.0 109.575 -170.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -96.73 133.07 41.76 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 169.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -150.38 169.79 20.58 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.773 0.429 . . . . 0.0 111.865 -171.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -103.67 110.76 64.47 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 125.133 1.373 . . . . 0.0 109.268 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -41.66 -38.73 4.47 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 125.268 3.979 . . . . 0.0 115.227 170.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.9 mt -62.51 -35.12 78.36 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.25 0.62 . . . . 0.0 111.955 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.9 mt -104.4 -31.57 9.45 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.299 1.04 . . . . 0.0 112.344 -170.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 t -150.1 176.76 10.52 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.408 0.683 . . . . 0.0 110.173 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.3 p -147.45 163.43 27.91 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.36 1.064 . . . . 0.0 109.929 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.92 -41.87 67.92 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.326 2.684 . . . . 0.0 112.443 176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -66.47 -40.85 89.6 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.786 0.834 . . . . 0.0 111.39 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.9 m -62.66 -47.24 84.56 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.779 0.432 . . . . 0.0 110.242 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.6 mt -62.07 -47.53 84.25 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.106 0.963 . . . . 0.0 110.606 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -51.66 -48.54 63.37 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.495 1.118 . . . . 0.0 109.954 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.86 -45.01 92.09 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.485 1.04 . . . . 0.0 112.255 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.43 -49.29 76.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.477 0.711 . . . . 0.0 111.159 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.59 -41.81 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.707 0.803 . . . . 0.0 110.164 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -61.42 -43.0 99.63 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.942 0.897 . . . . 0.0 110.707 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.4 -42.27 99.31 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.917 0.887 . . . . 0.0 111.091 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mtp -58.67 -44.84 90.32 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.973 0.352 . . . . 0.0 110.379 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.39 59.92 0.17 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 123.756 0.693 . . . . 0.0 111.976 169.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -140.31 152.31 45.75 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.051 0.94 . . . . 0.0 108.95 174.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -75.9 91.5 3.02 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.31 122.47 42.5 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.54 1.136 . . . . 0.0 109.95 -172.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.6 m -148.54 132.59 17.24 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.54 1.136 . . . . 0.0 108.304 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.2 mt . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 123.147 0.579 . . . . 0.0 111.477 -175.115 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.1 mm100 . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -108.94 145.11 35.97 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.388 1.075 . . . . 0.0 109.385 176.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 t -134.99 133.7 39.74 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.028 0.931 . . . . 0.0 109.336 172.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.93 108.32 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.7 mt -99.55 120.6 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -82.93 109.84 17.39 Favored 'General case' 0 C--N 1.334 -0.072 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.8 mt -111.73 106.19 20.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.403 1.081 . . . . 0.0 108.278 -172.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -99.6 145.4 27.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.07 -5.71 46.32 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.553 -1.137 . . . . 0.0 113.584 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 C--N 1.344 0.337 0 CA-C-N 119.069 1.434 . . . . 0.0 110.296 179.93 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.7 m . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -63.33 -45.04 93.09 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.667 0.787 . . . . 0.0 110.569 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.0 t -54.8 -53.86 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.625 0.77 . . . . 0.0 110.318 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -58.23 -46.72 85.39 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.588 1.155 . . . . 0.0 111.22 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.6 t -57.18 -52.67 64.37 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.313 0.645 . . . . 0.0 110.684 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.5 mt -55.01 -61.21 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 124.461 1.104 . . . . 0.0 110.075 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -59.3 -41.08 88.16 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.985 0.357 . . . . 0.0 111.386 -174.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.39 -56.08 27.0 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.24 -52.51 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.673 0.789 . . . . 0.0 110.726 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.5 mm -62.52 -37.58 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.434 0.693 . . . . 0.0 111.56 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.1 m -54.32 -29.51 47.98 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.698 0.681 . . . . 0.0 112.738 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -89.31 -6.38 56.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.288 0.635 . . . . 0.0 112.222 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -72.81 139.75 80.55 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 119.104 0.865 . . . . 0.0 109.251 177.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.05 131.56 29.13 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.004 2.469 . . . . 0.0 110.065 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.33 -36.19 4.54 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-O 118.872 -0.96 . . . . 0.0 111.795 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.53 131.65 32.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-N 118.141 0.971 . . . . 0.0 109.866 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -104.07 -101.63 0.31 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.943 1.297 . . . . 0.0 107.81 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.3 p -90.06 160.35 16.36 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.873 0.869 . . . . 0.0 110.079 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.7 tt -150.39 146.58 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 123.861 0.864 . . . . 0.0 109.488 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.94 109.78 7.6 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 173.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -98.67 103.71 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.0 t -89.78 118.98 29.78 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.602 0.761 . . . . 0.0 109.132 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.0 tp -70.56 -44.26 67.81 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.693 0.797 . . . . 0.0 109.656 172.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.12 -48.78 67.58 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.775 1.23 . . . . 0.0 111.666 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -89.39 -5.91 57.04 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.105 0.562 . . . . 0.0 111.534 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.8 m 52.07 55.78 8.72 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.52 1.528 . . . . 0.0 111.255 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -155.3 151.29 27.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.127 0.489 . . . . 0.0 111.815 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.67 113.56 4.27 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 126.242 1.877 . . . . 0.0 108.621 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.6 m -98.78 97.14 8.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 t -104.64 126.91 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.348 1.059 . . . . 0.0 109.399 -170.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -92.67 131.07 38.07 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -149.96 164.14 36.26 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.242 0.617 . . . . 0.0 110.971 -171.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -101.38 114.4 65.71 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.408 1.083 . . . . 0.0 109.151 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.52 -35.35 16.4 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 125.002 3.801 . . . . 0.0 115.069 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.27 -29.69 69.37 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.515 0.726 . . . . 0.0 111.833 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.8 -46.92 5.23 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.054 0.942 . . . . 0.0 110.725 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 t -138.56 -178.95 5.53 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.965 0.906 . . . . 0.0 110.107 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.9 p -148.35 161.69 33.01 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.872 0.869 . . . . 0.0 110.287 -173.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -51.43 -50.01 15.33 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.494 2.796 . . . . 0.0 112.73 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.95 -33.21 75.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.897 0.479 . . . . 0.0 112.115 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.5 m -64.81 -48.75 73.29 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.9 mt -61.86 -46.98 87.07 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.497 0.719 . . . . 0.0 110.601 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.8 ttp85 -53.78 -46.47 71.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.043 0.937 . . . . 0.0 109.88 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.99 -42.71 93.03 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.521 1.058 . . . . 0.0 112.309 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.21 -47.13 83.82 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.999 0.899 . . . . 0.0 111.03 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mm -58.59 -44.76 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 122.73 0.412 . . . . 0.0 110.108 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -61.7 -38.99 89.9 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.25 0.62 . . . . 0.0 111.011 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.59 -43.42 93.91 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.315 1.046 . . . . 0.0 110.94 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.5 mtp -58.7 -41.51 86.43 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.958 0.344 . . . . 0.0 110.472 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.7 57.92 0.23 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 123.959 0.79 . . . . 0.0 111.919 169.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -140.27 145.53 37.42 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -73.92 91.13 1.98 Allowed 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.662 0.785 . . . . 0.0 109.565 -174.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.84 127.72 45.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.04 1.336 . . . . 0.0 110.374 -174.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.1 m -144.76 130.99 19.55 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.363 1.065 . . . . 0.0 108.515 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 CA--C 1.531 0.216 0 C-N-CA 123.426 0.69 . . . . 0.0 111.627 -178.323 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 . . . . . 0 CA--C 1.529 0.173 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -128.27 151.46 49.27 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.51 1.124 . . . . 0.0 109.429 175.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 t -150.13 140.94 22.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.589 0.755 . . . . 0.0 110.025 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.1 t -99.73 129.49 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 171.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.4 mt -121.47 123.66 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -78.66 120.47 23.38 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.0 mt -119.73 103.32 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 125.917 1.687 . . . . 0.0 106.708 -173.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -99.97 144.85 28.53 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.923 0.489 . . . . 0.0 110.23 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.47 34.76 7.77 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.788 1.185 . . . . 0.0 112.852 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.9 mtm . . . . . 0 C--N 1.34 0.182 0 CA-C-N 117.794 0.797 . . . . 0.0 109.563 177.791 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.7 p . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.685 0.278 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.0 m -64.57 -47.36 79.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.476 0.71 . . . . 0.0 110.285 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -51.16 -56.56 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.151 0.98 . . . . 0.0 110.445 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -62.38 -49.06 77.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.308 1.043 . . . . 0.0 111.494 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.3 p -61.52 -50.12 73.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.004 0.365 . . . . 0.0 111.568 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.8 mt -55.16 -55.07 18.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 C-N-CA 123.769 0.828 . . . . 0.0 109.343 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.3 -49.62 71.67 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.25 0.62 . . . . 0.0 110.999 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.4 -51.33 59.76 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.633 1.111 . . . . 0.0 112.347 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.73 -54.29 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 117.75 0.775 . . . . 0.0 110.311 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.8 mm -64.3 -38.27 82.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 118.911 -0.566 . . . . 0.0 111.638 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.4 p -53.74 -31.73 49.5 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.85 0.75 . . . . 0.0 112.721 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -89.58 -3.65 58.2 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.049 0.939 . . . . 0.0 112.395 -174.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -72.03 143.26 86.15 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 119.071 0.851 . . . . 0.0 109.64 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -46.82 128.47 13.4 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.894 3.063 . . . . 0.0 112.665 176.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.01 -30.86 7.09 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.391 177.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.5 t -69.66 125.45 27.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 CA-C-N 118.694 1.247 . . . . 0.0 109.832 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -95.9 -103.04 0.16 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.7 p -86.58 155.62 20.38 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.415 0.686 . . . . 0.0 110.213 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tt -150.66 139.06 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.922 0.889 . . . . 0.0 109.208 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -128.91 103.8 7.24 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.655 1.182 . . . . 0.0 108.77 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -93.25 121.91 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 123.967 0.907 . . . . 0.0 108.769 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.7 t -118.09 124.44 48.07 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.911 1.284 . . . . 0.0 109.725 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tt -71.09 -46.97 60.81 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.273 1.029 . . . . 0.0 109.487 172.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.36 -47.46 56.04 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.732 1.213 . . . . 0.0 111.778 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -89.57 -8.72 52.06 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.365 0.666 . . . . 0.0 111.774 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.1 m 51.87 55.64 8.99 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.779 1.632 . . . . 0.0 110.709 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -155.77 170.41 22.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.005 0.522 . . . . 0.0 111.765 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.7 118.31 2.58 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.4 m -98.98 100.49 11.66 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 t -106.72 128.33 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.556 1.142 . . . . 0.0 109.757 -169.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -96.52 130.54 43.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 168.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -150.22 163.39 38.39 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.009 0.523 . . . . 0.0 111.881 -171.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -97.08 113.98 63.95 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.916 1.286 . . . . 0.0 109.381 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -45.69 -37.41 15.8 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 124.942 3.762 . . . . 0.0 114.777 172.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -64.61 -34.35 78.07 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.505 0.722 . . . . 0.0 111.811 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.4 mt -104.09 -30.47 10.22 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.121 0.969 . . . . 0.0 112.279 -172.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.0 t -151.78 177.96 9.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.302 0.641 . . . . 0.0 110.107 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.3 p -149.21 162.05 30.16 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 125.106 1.363 . . . . 0.0 109.549 -172.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.14 -38.43 80.95 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.934 2.422 . . . . 0.0 112.03 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.28 -48.92 71.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.587 1.155 . . . . 0.0 111.44 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.4 p -62.56 -42.49 99.58 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.503 0.321 . . . . 0.0 111.096 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.5 mt -64.83 -47.8 76.68 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.385 0.674 . . . . 0.0 110.365 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.5 ttp85 -51.99 -48.03 64.62 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.166 0.986 . . . . 0.0 110.219 171.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.63 -46.69 81.13 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.294 0.95 . . . . 0.0 112.246 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.42 -48.64 78.79 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.638 0.775 . . . . 0.0 111.169 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.0 mt -60.16 -42.42 90.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.71 0.804 . . . . 0.0 110.059 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.62 -39.94 95.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.579 0.751 . . . . 0.0 110.831 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.69 -41.66 98.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.022 0.929 . . . . 0.0 111.003 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.9 mtp -58.31 -43.4 88.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.984 0.356 . . . . 0.0 110.268 172.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.26 58.39 0.18 Allowed Glycine 0 C--N 1.34 0.778 0 C-N-CA 123.827 0.727 . . . . 0.0 111.975 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -140.29 142.48 35.68 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.004 0.922 . . . . 0.0 108.935 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -69.75 92.36 0.67 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.67 123.95 44.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.232 1.413 . . . . 0.0 109.302 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.1 p -138.66 136.74 36.2 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.703 1.201 . . . . 0.0 108.872 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 61.6 mt . . . . . 0 CA--C 1.529 0.171 0 C-N-CA 122.615 0.366 . . . . 0.0 110.215 -177.471 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -125.02 152.97 43.55 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.428 1.091 . . . . 0.0 109.567 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -149.75 138.29 20.76 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.447 0.699 . . . . 0.0 110.115 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.83 124.18 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 172.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.4 mt -119.81 120.17 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -75.86 126.87 31.84 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.8 mt -122.13 111.41 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.639 1.176 . . . . 0.0 108.014 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -99.61 147.61 25.19 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.21 2.02 51.19 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.279 0.942 . . . . 0.0 112.885 -177.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.8 mtm . . . . . 0 C--N 1.342 0.261 0 CA-C-N 118.688 1.244 . . . . 0.0 108.624 174.813 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.9 p . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 111.222 0.082 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -59.07 -50.3 74.59 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.755 0.822 . . . . 0.0 110.281 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -53.85 -52.51 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 124.87 1.268 . . . . 0.0 110.922 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -59.22 -46.12 89.31 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.5 1.12 . . . . 0.0 111.142 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.6 m -58.53 -52.87 63.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.177 0.591 . . . . 0.0 110.792 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.1 mt -56.55 -53.65 38.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 123.599 0.76 . . . . 0.0 109.689 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -52.82 -55.51 22.51 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.193 0.997 . . . . 0.0 110.739 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.43 -52.07 53.92 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.161 0.886 . . . . 0.0 112.186 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.8 t -61.01 -56.18 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.268 0.627 . . . . 0.0 110.907 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.7 mm -62.01 -37.11 77.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.259 0.624 . . . . 0.0 111.39 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.0 t -49.45 -40.7 37.88 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 123.763 0.825 . . . . 0.0 112.673 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -89.47 -6.08 56.78 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -171.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -75.07 148.39 84.27 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 119.165 0.893 . . . . 0.0 110.459 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -44.14 133.86 8.72 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.494 3.463 . . . . 0.0 113.707 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.66 -40.57 2.92 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-O 118.959 -0.911 . . . . 0.0 112.674 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.7 t -68.31 134.91 29.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 CA-C-N 117.983 0.892 . . . . 0.0 110.168 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -109.29 -98.67 0.39 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.602 1.161 . . . . 0.0 107.88 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.7 p -87.59 152.41 22.2 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.634 0.774 . . . . 0.0 109.509 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.0 tt -150.56 136.65 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 123.499 0.719 . . . . 0.0 109.224 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.23 101.47 6.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.869 1.267 . . . . 0.0 108.39 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.8 t -96.88 122.93 48.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.9 t -107.02 130.67 54.62 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.793 1.237 . . . . 0.0 110.332 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.3 tp -69.62 -52.39 26.36 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.705 0.802 . . . . 0.0 109.119 170.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.53 -47.51 69.88 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 125.22 1.408 . . . . 0.0 112.114 -176.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -89.25 -9.69 49.74 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.888 0.475 . . . . 0.0 111.457 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.1 m 52.52 56.43 7.68 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.107 1.363 . . . . 0.0 110.783 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -155.65 166.35 33.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.095 0.558 . . . . 0.0 111.191 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.67 115.03 2.49 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.507 2.003 . . . . 0.0 108.707 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.9 m -99.28 98.82 9.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 t -106.24 131.3 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 124.453 1.101 . . . . 0.0 109.693 -170.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -99.04 130.34 45.36 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -150.19 163.27 38.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.119 0.568 . . . . 0.0 111.825 -169.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -98.13 113.84 64.4 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.686 1.195 . . . . 0.0 109.293 172.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -44.45 -36.96 10.26 Favored 'Trans proline' 0 C--N 1.349 0.556 1 C-N-CA 125.356 4.037 . . . . 0.0 115.024 173.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.2 mt -64.5 -36.39 84.06 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.109 0.564 . . . . 0.0 111.789 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.2 mt -100.0 -32.96 10.7 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.12 0.968 . . . . 0.0 112.244 -171.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.3 t -149.35 178.86 8.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.29 0.636 . . . . 0.0 110.093 176.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.9 p -150.21 162.9 26.34 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 124.172 0.989 . . . . 0.0 109.759 -174.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -53.07 -46.94 30.33 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.191 2.594 . . . . 0.0 112.372 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.42 -33.9 76.75 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.016 0.526 . . . . 0.0 112.287 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 98.3 m -67.73 -45.32 75.35 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.376 0.535 . . . . 0.0 110.096 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.5 mt -61.19 -47.33 86.67 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.65 0.78 . . . . 0.0 110.461 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -52.64 -47.04 67.34 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.052 0.941 . . . . 0.0 110.269 171.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.48 -45.82 82.85 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.303 0.954 . . . . 0.0 112.313 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.34 -46.36 83.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.785 0.834 . . . . 0.0 111.35 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.4 mt -62.43 -43.46 98.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.758 0.823 . . . . 0.0 110.08 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.35 -41.7 98.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.293 1.037 . . . . 0.0 110.938 176.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.57 -43.91 97.99 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.968 0.907 . . . . 0.0 111.132 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.9 mtm -59.32 -50.88 72.28 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 117.911 0.323 . . . . 0.0 110.213 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.71 60.84 0.09 OUTLIER Glycine 0 C--N 1.34 0.802 0 C-N-CA 123.519 0.581 . . . . 0.0 111.789 171.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -140.09 141.94 36.12 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 171.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -75.7 91.07 2.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.661 0.784 . . . . 0.0 109.49 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.36 134.8 41.69 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.632 1.173 . . . . 0.0 110.362 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 95.0 m -144.07 133.8 23.71 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.983 1.313 . . . . 0.0 108.369 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.0 mt . . . . . 0 CA--C 1.53 0.173 0 C-N-CA 123.215 0.606 . . . . 0.0 109.872 -178.635 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -101.13 142.31 32.76 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.81 0.444 . . . . 0.0 110.244 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -135.81 137.72 41.84 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.418 1.087 . . . . 0.0 109.127 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.3 t -99.96 129.58 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.516 -1.291 . . . . 0.0 107.516 174.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.1 mt -126.04 122.01 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -76.99 124.18 27.4 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.5 mt -117.37 109.14 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 124.989 1.315 . . . . 0.0 107.874 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -99.97 149.81 23.07 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 174.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.35 1.82 56.74 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.072 0.844 . . . . 0.0 113.232 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.0 mtm . . . . . 0 C--N 1.342 0.262 0 CA-C-N 118.719 1.26 . . . . 0.0 108.329 173.725 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.1 p . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.4 m -58.87 -49.04 79.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.544 1.137 . . . . 0.0 108.73 169.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -49.87 -52.23 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 125.549 1.54 . . . . 0.0 110.331 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -62.48 -45.74 91.65 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.676 0.79 . . . . 0.0 111.009 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -58.69 -53.26 60.38 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.667 0.787 . . . . 0.0 110.774 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.0 mt -55.78 -54.8 22.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 C-N-CA 124.064 0.946 . . . . 0.0 109.402 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.63 -54.49 32.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.73 0.812 . . . . 0.0 110.86 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.68 -53.65 43.51 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.234 0.921 . . . . 0.0 112.514 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.9 t -63.69 -54.75 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 117.41 0.605 . . . . 0.0 110.813 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.78 -37.31 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 118.844 -0.598 . . . . 0.0 110.929 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.4 t -50.14 -34.8 23.45 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.637 0.653 . . . . 0.0 112.564 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -89.64 -10.52 45.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.128 0.971 . . . . 0.0 112.472 -174.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -69.96 146.29 95.04 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 119.011 0.823 . . . . 0.0 110.062 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -46.34 135.6 15.52 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 124.033 3.156 . . . . 0.0 113.101 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.08 -37.32 3.34 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 118.856 -0.969 . . . . 0.0 112.763 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 52.1 t -67.17 141.21 18.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-N 118.302 1.051 . . . . 0.0 110.216 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -116.72 -98.67 0.45 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.895 1.278 . . . . 0.0 108.011 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.4 p -90.2 154.96 19.35 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.535 0.734 . . . . 0.0 109.796 174.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.1 tt -150.85 139.79 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.519 0.727 . . . . 0.0 109.88 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.71 109.49 12.11 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.841 1.256 . . . . 0.0 108.399 174.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.6 125.97 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.9 t -115.57 127.97 55.63 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.86 1.264 . . . . 0.0 110.151 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.8 tp -70.73 -50.47 35.81 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.098 0.959 . . . . 0.0 109.65 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.76 -43.76 69.43 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.019 1.328 . . . . 0.0 111.832 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -89.18 -16.52 31.15 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.162 0.585 . . . . 0.0 111.122 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.0 m 55.21 56.29 6.63 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 125.141 1.376 . . . . 0.0 110.223 -177.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -154.84 168.8 25.69 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.062 0.545 . . . . 0.0 111.475 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.04 115.79 2.41 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 126.101 1.81 . . . . 0.0 108.6 176.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.7 m -99.22 99.1 10.03 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.5 t -106.9 126.71 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 124.791 1.236 . . . . 0.0 109.374 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -90.04 131.57 35.84 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -150.18 165.16 33.72 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.196 0.599 . . . . 0.0 112.022 -172.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -100.69 113.83 65.68 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.348 1.459 . . . . 0.0 108.688 172.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.65 -35.79 17.77 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 125.188 3.925 . . . . 0.0 114.798 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.26 -34.27 77.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.383 0.673 . . . . 0.0 111.73 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.75 -36.22 9.53 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.846 0.858 . . . . 0.0 111.557 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.1 t -147.22 176.74 9.74 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.62 0.645 . . . . 0.0 110.655 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.7 p -148.46 161.25 34.27 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.62 1.168 . . . . 0.0 109.729 -175.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.97 -38.74 59.38 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.42 2.747 . . . . 0.0 112.914 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -65.77 -44.32 86.19 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.482 1.113 . . . . 0.0 110.432 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.4 m -64.54 -45.4 87.31 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.056 0.543 . . . . 0.0 110.374 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.3 mt -63.22 -46.35 87.38 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.025 0.93 . . . . 0.0 110.775 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -52.21 -48.93 64.83 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.885 0.874 . . . . 0.0 109.805 170.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.15 -44.92 83.86 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.301 0.953 . . . . 0.0 112.582 176.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.96 -48.13 77.71 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.728 0.811 . . . . 0.0 111.287 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.6 mt -60.08 -41.43 86.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.916 0.886 . . . . 0.0 109.897 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -64.29 -40.19 95.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.382 0.673 . . . . 0.0 111.008 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.56 -41.9 98.37 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.027 0.931 . . . . 0.0 111.017 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.8 mtp -58.31 -45.3 88.3 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 172.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.39 57.04 0.14 Allowed Glycine 0 C--N 1.34 0.764 0 C-N-CA 123.807 0.718 . . . . 0.0 111.747 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -140.35 139.35 35.36 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.792 0.837 . . . . 0.0 108.763 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -70.64 93.05 0.89 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.726 0.81 . . . . 0.0 109.497 -176.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.5 131.44 45.5 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.75 1.22 . . . . 0.0 109.751 -173.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.0 p -139.25 139.19 37.34 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.857 1.263 . . . . 0.0 108.603 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 CA--C 1.53 0.204 0 C-N-CA 122.83 0.452 . . . . 0.0 110.467 -178.648 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 . . . . . 0 CA--C 1.528 0.126 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -120.03 142.7 48.59 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.099 0.96 . . . . 0.0 109.273 176.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.6 t -135.42 140.77 45.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.315 1.046 . . . . 0.0 109.712 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.9 t -103.54 111.2 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 175.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.6 mt -99.57 123.9 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -82.28 111.85 18.73 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.9 mt -116.48 106.42 20.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 C-N-CA 124.447 1.099 . . . . 0.0 108.071 -171.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -99.92 151.63 21.09 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.035 0.534 . . . . 0.0 109.59 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.52 12.11 56.26 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.489 1.043 . . . . 0.0 113.259 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.4 mtm . . . . . 0 C--N 1.343 0.296 0 CA-C-N 118.676 1.238 . . . . 0.0 109.43 177.176 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.5 m . . . . . 0 N--CA 1.457 -0.086 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.7 m -57.54 -47.03 83.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 168.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.5 t -49.59 -51.29 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.386 1.474 . . . . 0.0 110.595 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -62.87 -48.27 79.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.259 0.624 . . . . 0.0 111.232 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.4 p -61.2 -48.29 82.19 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.87 0.468 . . . . 0.0 111.274 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.2 mt -54.23 -59.03 2.38 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 C-N-CA 124.383 1.073 . . . . 0.0 109.488 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -54.63 -48.84 71.77 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.66 0.784 . . . . 0.0 110.642 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.95 -52.87 43.64 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.635 1.112 . . . . 0.0 112.303 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.2 t -67.69 -55.12 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 117.777 0.788 . . . . 0.0 110.697 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.14 -36.71 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.404 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.6 p -54.36 -29.66 49.12 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.127 0.876 . . . . 0.0 112.832 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.47 -7.93 53.98 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.983 0.913 . . . . 0.0 112.269 -176.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -70.7 142.4 88.5 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 119.022 0.828 . . . . 0.0 109.586 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.09 130.9 26.95 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.955 2.437 . . . . 0.0 109.987 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.93 -32.21 7.75 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 118.923 -0.932 . . . . 0.0 112.111 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.8 t -72.08 138.72 21.0 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 CA-C-N 118.396 1.098 . . . . 0.0 109.365 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -108.68 -101.83 0.37 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.7 p -90.29 153.83 20.17 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.566 0.747 . . . . 0.0 109.394 172.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.1 tt -150.18 129.83 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 123.511 0.724 . . . . 0.0 109.235 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -120.86 105.06 10.34 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 125.139 1.376 . . . . 0.0 108.65 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.44 122.49 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.1 t -110.03 128.25 55.31 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.643 1.177 . . . . 0.0 110.284 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.2 tp -67.25 -53.5 29.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.95 0.9 . . . . 0.0 109.277 171.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.34 -47.39 69.41 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.277 1.431 . . . . 0.0 112.039 -175.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -89.19 -8.03 54.42 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 119.043 -0.504 . . . . 0.0 111.605 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.8 m 51.57 56.25 8.17 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.168 1.387 . . . . 0.0 110.932 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.7 p30 -155.22 163.98 39.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.966 0.506 . . . . 0.0 111.217 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.84 113.32 2.44 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.1 m -98.65 94.66 6.78 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 t -101.03 123.81 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 124.362 1.065 . . . . 0.0 109.064 -170.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -95.07 128.93 42.28 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -150.24 174.19 13.11 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.145 0.578 . . . . 0.0 111.702 -170.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -108.41 110.24 61.64 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.541 1.536 . . . . 0.0 109.157 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -42.8 -40.47 8.13 Favored 'Trans proline' 0 C--N 1.348 0.545 1 C-N-CA 125.444 4.096 . . . . 0.0 114.995 173.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.4 mt -63.34 -31.79 73.04 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.753 0.821 . . . . 0.0 111.774 -176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.45 -34.53 9.12 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.426 1.09 . . . . 0.0 111.981 -173.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 t -149.57 158.25 44.0 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.551 0.74 . . . . 0.0 109.762 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 62.2 p -123.04 160.24 50.5 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.553 1.141 . . . . 0.0 110.068 -178.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -48.45 -39.61 36.37 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.54 2.827 . . . . 0.0 112.839 171.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -65.58 -45.14 84.41 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.139 0.975 . . . . 0.0 110.407 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.9 m -60.12 -46.64 88.96 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.219 0.608 . . . . 0.0 110.476 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.6 mt -62.35 -48.15 81.05 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.828 0.851 . . . . 0.0 110.518 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -53.94 -42.1 68.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.642 0.777 . . . . 0.0 110.469 172.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.72 -43.77 86.58 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.311 0.958 . . . . 0.0 112.171 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.88 -44.64 92.43 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.871 0.835 . . . . 0.0 111.429 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.7 mm -63.07 -41.84 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 122.861 0.464 . . . . 0.0 110.567 176.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.53 -41.92 98.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.836 0.854 . . . . 0.0 110.461 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -62.61 -45.72 91.56 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.014 0.926 . . . . 0.0 110.876 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.2 mmm -58.95 -34.74 72.12 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.302 0.641 . . . . 0.0 111.056 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.44 59.11 0.57 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 124.209 0.909 . . . . 0.0 111.655 169.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -140.2 154.57 46.96 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.911 0.884 . . . . 0.0 109.861 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -81.0 88.68 5.92 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.838 0.855 . . . . 0.0 109.558 -174.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.41 129.5 45.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.956 1.302 . . . . 0.0 110.948 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 89.5 m -144.28 128.72 17.96 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.586 1.154 . . . . 0.0 108.547 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.8 mt . . . . . 0 CA--C 1.532 0.274 0 C-N-CA 123.519 0.728 . . . . 0.0 111.127 -178.174 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 . . . . . 0 CA--C 1.531 0.217 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -140.06 142.74 36.14 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.178 0.991 . . . . 0.0 108.943 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 t -137.24 149.64 47.3 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.507 1.123 . . . . 0.0 109.316 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.0 t -110.87 138.12 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 172.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.0 mt -133.27 125.54 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -70.17 130.17 41.35 Favored 'General case' 0 C--N 1.337 0.061 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.2 mt -130.1 113.6 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -117.18 153.76 32.27 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.656 0.782 . . . . 0.0 109.907 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.39 20.44 48.58 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.403 1.001 . . . . 0.0 112.565 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.6 mtm . . . . . 0 N--CA 1.455 -0.19 0 CA-C-N 117.901 0.85 . . . . 0.0 108.911 177.596 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.9 m . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.2 m -65.73 -43.51 88.79 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.226 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -52.22 -54.19 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.111 0.564 . . . . 0.0 109.927 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -61.22 -45.76 93.24 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.158 0.983 . . . . 0.0 111.18 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.6 m -58.35 -53.68 55.56 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.876 0.47 . . . . 0.0 110.99 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.03 -55.53 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.351 1.06 . . . . 0.0 109.722 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -56.81 -50.34 72.66 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.139 0.975 . . . . 0.0 110.937 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.93 -51.96 56.12 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.902 1.239 . . . . 0.0 112.161 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.16 -54.47 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 117.746 0.773 . . . . 0.0 110.223 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.9 mt -65.44 -35.53 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.796 -172.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.0 p -54.2 -30.55 50.18 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.01 0.823 . . . . 0.0 112.519 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -89.58 -11.23 43.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.077 0.951 . . . . 0.0 112.617 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -68.27 144.46 96.71 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 119.193 0.906 . . . . 0.0 109.918 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.75 132.23 34.28 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.054 2.502 . . . . 0.0 110.31 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.17 -35.85 4.6 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-O 119.02 -0.878 . . . . 0.0 112.223 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.76 127.74 31.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 118.09 0.945 . . . . 0.0 109.881 -177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -94.56 -101.41 0.15 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.7 p -90.07 155.75 18.85 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.608 0.763 . . . . 0.0 110.363 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.2 tt -150.62 145.72 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 123.975 0.91 . . . . 0.0 109.772 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.12 141.98 44.21 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.0 t -125.52 117.37 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.691 1.197 . . . . 0.0 108.324 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.7 t -104.62 123.96 48.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.809 1.244 . . . . 0.0 109.818 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.9 tp -73.94 -44.12 56.03 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 124.165 0.986 . . . . 0.0 110.107 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.86 -45.88 74.62 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.582 1.153 . . . . 0.0 111.406 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -89.5 -7.61 54.63 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.607 0.763 . . . . 0.0 111.591 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.3 m 54.49 53.79 10.26 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.949 1.699 . . . . 0.0 111.474 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -160.02 167.23 28.36 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.198 0.599 . . . . 0.0 111.185 -175.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.59 121.84 3.96 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.8 m -99.68 112.94 25.12 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 173.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 t -117.81 122.27 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.701 1.2 . . . . 0.0 108.737 -172.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -89.68 132.51 35.12 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 169.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -150.36 168.31 24.48 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.905 0.482 . . . . 0.0 112.103 -170.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -103.97 111.4 65.14 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 125.181 1.392 . . . . 0.0 109.048 173.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -41.75 -38.28 4.41 Favored 'Trans proline' 0 C--N 1.347 0.495 1 C-N-CA 125.432 4.088 . . . . 0.0 115.312 171.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.8 mt -64.25 -34.03 77.18 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.162 0.585 . . . . 0.0 111.952 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.5 mt -103.82 -33.65 8.82 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.264 1.025 . . . . 0.0 112.333 -171.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.9 t -148.72 176.27 10.51 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.56 0.744 . . . . 0.0 109.801 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.9 p -150.25 163.5 24.12 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 123.891 0.877 . . . . 0.0 110.323 -174.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.42 -46.92 30.33 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.401 2.734 . . . . 0.0 112.986 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -65.73 -35.8 81.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.305 0.642 . . . . 0.0 112.123 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.8 m -67.16 -46.04 75.19 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.165 0.439 . . . . 0.0 110.296 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.7 mt -60.55 -47.11 87.61 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.544 0.737 . . . . 0.0 110.418 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.5 ttp85 -54.77 -46.5 74.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.134 0.973 . . . . 0.0 110.055 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.43 -43.99 93.77 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.503 1.049 . . . . 0.0 112.309 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.44 -46.22 87.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.926 0.863 . . . . 0.0 111.099 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.0 mt -59.92 -45.69 94.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 123.411 0.685 . . . . 0.0 109.639 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -61.28 -41.56 97.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.672 0.789 . . . . 0.0 111.039 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.97 -44.35 96.28 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.499 1.12 . . . . 0.0 111.032 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.6 mtm -57.84 -43.62 85.97 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.513 0.325 . . . . 0.0 110.595 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.67 61.54 0.19 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 123.531 0.586 . . . . 0.0 111.651 169.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -140.08 147.35 40.16 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 173.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -70.13 95.92 1.03 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.5 123.5 47.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.016 1.326 . . . . 0.0 109.937 -173.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.9 p -142.35 142.88 32.52 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.234 1.014 . . . . 0.0 108.542 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.5 mt . . . . . 0 CA--C 1.53 0.209 0 C-N-CA 122.776 0.43 . . . . 0.0 110.959 -176.38 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 . . . . . 0 C--O 1.231 0.128 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.79 140.91 52.52 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.824 1.249 . . . . 0.0 108.44 173.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 t -136.27 135.64 39.14 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.181 0.992 . . . . 0.0 109.529 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.5 t -99.65 124.1 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 171.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.9 mt -120.44 120.14 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -73.74 129.21 37.45 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.7 mt -122.19 108.65 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -99.61 145.87 27.09 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.56 -7.09 53.26 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 118.855 -0.97 . . . . 0.0 113.36 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.9 mtm . . . . . 0 C--N 1.344 0.358 0 CA-C-N 118.938 1.369 . . . . 0.0 110.09 177.729 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 119.811 -0.138 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.6 m -61.97 -50.04 73.71 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.932 0.493 . . . . 0.0 110.297 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.1 t -51.24 -50.26 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.229 1.012 . . . . 0.0 110.85 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -58.17 -50.25 74.19 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.403 1.081 . . . . 0.0 110.681 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.4 m -57.92 -48.34 80.18 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.142 0.577 . . . . 0.0 111.152 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -59.07 -50.46 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.611 0.764 . . . . 0.0 109.548 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -51.52 -56.4 13.59 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.022 0.929 . . . . 0.0 110.106 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.34 -55.0 32.74 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.206 0.908 . . . . 0.0 112.335 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.09 -56.35 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.317 0.647 . . . . 0.0 110.767 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.3 mm -61.41 -37.86 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.215 -175.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.0 t -50.31 -38.21 40.4 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.618 0.645 . . . . 0.0 112.285 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.41 -1.45 58.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.664 0.785 . . . . 0.0 112.717 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -69.94 145.07 93.86 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 119.424 1.011 . . . . 0.0 109.485 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.37 127.8 20.93 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.88 2.387 . . . . 0.0 109.911 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.92 -38.2 3.37 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.126 -0.819 . . . . 0.0 111.713 -176.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.81 140.15 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 118.046 0.923 . . . . 0.0 109.805 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -106.22 -98.79 0.34 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 172.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 53.0 p -90.63 160.07 16.09 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.035 0.934 . . . . 0.0 110.234 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.9 tt -150.27 138.93 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 124.288 1.035 . . . . 0.0 108.454 172.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.57 104.69 10.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.498 1.119 . . . . 0.0 109.205 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -94.8 122.69 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.8 t -109.7 127.01 54.3 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.463 1.105 . . . . 0.0 109.933 -177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.67 -55.92 14.87 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.137 0.975 . . . . 0.0 108.528 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.69 -47.16 63.99 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.414 1.486 . . . . 0.0 112.341 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -89.26 -10.91 45.15 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.954 0.501 . . . . 0.0 111.634 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m 52.87 56.46 7.56 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.188 1.395 . . . . 0.0 110.906 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.1 p30 -155.44 169.73 23.58 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.166 0.587 . . . . 0.0 111.175 -176.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.08 115.43 2.19 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 126.269 1.89 . . . . 0.0 108.714 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.5 m -99.04 96.48 7.84 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.81 129.4 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.516 1.127 . . . . 0.0 109.283 -170.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -99.37 124.12 44.22 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -150.3 172.46 15.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.943 0.497 . . . . 0.0 112.288 -169.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -105.88 110.33 64.0 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.29 1.436 . . . . 0.0 109.468 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -40.84 -41.79 4.1 Favored 'Trans proline' 0 C--N 1.348 0.518 1 C-N-CA 125.432 4.088 . . . . 0.0 115.294 171.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.1 mt -60.56 -35.55 76.31 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.465 0.706 . . . . 0.0 111.866 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.0 -32.18 11.09 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.232 1.013 . . . . 0.0 112.1 -172.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.1 t -150.42 152.73 34.77 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.603 0.638 . . . . 0.0 109.891 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 p -116.36 162.53 25.95 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.535 1.134 . . . . 0.0 109.936 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.09 -39.59 50.92 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.329 2.686 . . . . 0.0 112.65 170.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.2 -39.11 89.42 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.929 0.892 . . . . 0.0 111.596 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 m -63.73 -47.34 81.46 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.927 0.491 . . . . 0.0 110.202 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.2 mt -62.14 -49.17 76.91 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.125 0.97 . . . . 0.0 110.36 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -49.88 -48.12 51.56 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.795 1.238 . . . . 0.0 109.943 170.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.32 -46.95 85.68 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.528 1.061 . . . . 0.0 112.413 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.65 91.55 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.835 0.817 . . . . 0.0 111.29 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -60.62 -44.16 96.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.804 0.842 . . . . 0.0 109.912 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.01 -38.94 92.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.853 0.861 . . . . 0.0 111.153 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.55 -44.08 97.22 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.26 1.024 . . . . 0.0 110.816 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.7 mtm -58.81 -48.84 79.89 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.3 59.76 0.1 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 170.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -140.24 137.59 34.39 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 172.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.33 97.94 1.01 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.542 0.737 . . . . 0.0 109.798 -176.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.86 133.14 44.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.792 1.237 . . . . 0.0 110.184 -174.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.2 m -144.49 138.57 27.7 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.603 1.161 . . . . 0.0 108.369 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 mm? . . . . . 0 CA--C 1.531 0.232 0 C-N-CA 122.732 0.413 . . . . 0.0 110.178 -177.883 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.88 149.24 43.67 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.738 0.815 . . . . 0.0 110.428 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -143.85 146.17 32.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.459 1.104 . . . . 0.0 108.999 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 51.2 t -113.3 124.5 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.8 mt -120.32 125.79 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -177.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -70.13 126.86 30.91 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 172.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.4 mt -123.11 95.15 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -99.33 132.48 44.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.32 -27.81 4.41 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -170.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 48.4 mtm . . . . . 0 C--N 1.342 0.241 0 CA-C-N 117.717 0.758 . . . . 0.0 109.161 174.838 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.1 p . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 111.316 0.117 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.2 m -62.41 -49.65 74.63 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.674 0.789 . . . . 0.0 109.661 177.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.8 t -54.6 -58.08 4.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.332 1.053 . . . . 0.0 110.224 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -61.69 -41.76 98.01 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.285 0.634 . . . . 0.0 111.382 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -58.98 -59.13 5.95 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.104 0.561 . . . . 0.0 110.633 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.4 mt -57.78 -55.61 20.55 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 123.52 0.728 . . . . 0.0 109.69 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -55.67 -48.49 74.97 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.572 0.749 . . . . 0.0 110.706 -176.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.94 -53.45 45.35 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.329 0.966 . . . . 0.0 112.225 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.22 -55.63 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 117.709 0.754 . . . . 0.0 110.683 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.5 mm -63.7 -38.22 81.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.514 0.725 . . . . 0.0 111.559 -173.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.5 p -54.98 -30.65 59.76 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.069 0.85 . . . . 0.0 112.553 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.35 -5.98 57.04 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.932 0.893 . . . . 0.0 112.187 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -70.71 142.67 88.76 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 119.017 0.826 . . . . 0.0 109.136 176.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.16 132.49 34.29 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.823 2.349 . . . . 0.0 110.093 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.48 -35.78 4.73 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 118.919 -0.934 . . . . 0.0 112.088 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.27 129.32 33.71 Favored 'Isoleucine or valine' 0 C--N 1.341 0.214 0 CA-C-N 118.074 0.937 . . . . 0.0 109.735 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -100.66 -101.87 0.25 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.55 1.14 . . . . 0.0 108.03 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 74.0 p -87.01 151.62 23.11 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.288 0.635 . . . . 0.0 109.744 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.1 tt -150.4 131.05 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.462 0.705 . . . . 0.0 109.421 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -120.81 105.78 11.05 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.429 1.492 . . . . 0.0 108.717 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.72 125.89 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.2 t -116.16 118.71 33.59 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.685 1.194 . . . . 0.0 110.023 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.59 -49.1 74.68 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.991 0.916 . . . . 0.0 109.834 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.1 -48.55 67.72 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.7 1.2 . . . . 0.0 111.994 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -89.7 -1.86 58.12 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.232 0.613 . . . . 0.0 112.201 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.1 m 49.71 52.0 15.41 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.318 1.447 . . . . 0.0 111.579 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -156.21 170.22 22.74 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 120.968 0.413 . . . . 0.0 111.664 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.58 119.28 2.55 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 125.607 1.575 . . . . 0.0 109.232 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.5 m -99.32 104.49 16.4 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.6 t -112.04 128.57 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.532 1.133 . . . . 0.0 109.574 -170.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -98.79 133.33 43.26 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -150.43 164.87 34.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.66 0.784 . . . . 0.0 111.844 -170.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -102.27 116.57 62.82 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.337 1.055 . . . . 0.0 109.498 173.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.71 -40.29 18.88 Favored 'Trans proline' 0 C--N 1.349 0.586 1 C-N-CA 125.348 4.032 . . . . 0.0 115.468 177.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.9 mt -67.11 -27.72 67.56 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.197 0.599 . . . . 0.0 111.949 -174.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.68 -42.05 7.04 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.078 0.951 . . . . 0.0 110.707 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.4 t -148.73 174.81 11.79 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.62 0.768 . . . . 0.0 110.001 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.3 p -150.56 164.37 20.7 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 124.563 1.145 . . . . 0.0 110.439 -170.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.25 -45.58 38.39 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.134 2.556 . . . . 0.0 112.79 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -67.32 -38.78 85.49 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.396 0.679 . . . . 0.0 112.806 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.3 p -66.0 -46.37 78.24 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.724 0.693 . . . . 0.0 110.438 176.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.6 mt -62.1 -46.43 89.08 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.752 0.821 . . . . 0.0 110.428 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -53.5 -45.36 69.64 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.159 0.984 . . . . 0.0 110.47 171.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.4 -47.04 91.0 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.076 0.846 . . . . 0.0 112.114 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.05 -51.95 65.92 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.473 0.709 . . . . 0.0 111.059 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.8 mt -57.57 -41.84 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.016 0.926 . . . . 0.0 109.9 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -59.0 -50.52 73.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.355 0.662 . . . . 0.0 109.749 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -58.25 -38.74 77.5 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.772 1.229 . . . . 0.0 112.0 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mtp -60.81 -20.95 62.59 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.98 57.12 0.52 Allowed Glycine 0 C--N 1.34 0.784 0 C-N-CA 124.306 0.955 . . . . 0.0 111.151 170.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -140.6 155.47 46.56 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.27 1.028 . . . . 0.0 109.46 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -80.39 93.75 6.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 169.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.42 117.57 34.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.698 1.199 . . . . 0.0 108.862 -176.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.4 p -140.06 136.52 33.72 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.21 1.004 . . . . 0.0 109.054 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.6 mt . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 122.84 0.456 . . . . 0.0 110.813 -175.998 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -123.98 154.65 39.52 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.873 1.269 . . . . 0.0 109.652 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 t -150.14 144.74 25.89 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.779 0.832 . . . . 0.0 109.981 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.7 t -109.27 115.75 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.3 mt -110.51 118.13 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -76.04 121.89 23.43 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.1 mt -118.15 110.11 29.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 124.747 1.219 . . . . 0.0 108.097 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -99.8 148.04 24.84 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.58 3.67 56.2 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.511 1.053 . . . . 0.0 113.531 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.6 mtm . . . . . 0 C--N 1.344 0.362 0 CA-C-N 118.825 1.313 . . . . 0.0 109.767 178.547 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.5 m . . . . . 0 N--CA 1.456 -0.168 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.0 m -61.03 -49.17 78.47 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 168.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 82.7 t -49.71 -51.64 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.221 1.408 . . . . 0.0 110.279 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -60.33 -48.66 80.77 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.092 0.957 . . . . 0.0 111.125 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.7 p -62.19 -47.81 82.84 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 122.848 0.459 . . . . 0.0 111.371 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.2 mt -55.35 -60.58 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 123.715 0.806 . . . . 0.0 108.953 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -53.24 -48.5 68.17 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.772 0.829 . . . . 0.0 110.959 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.08 -57.78 16.79 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.241 0.925 . . . . 0.0 111.925 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.49 -53.13 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 117.624 0.712 . . . . 0.0 110.929 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.9 -45.76 91.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.618 0.767 . . . . 0.0 110.738 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 88.0 p -57.73 -27.46 63.0 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -88.9 -5.51 57.95 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.43 0.692 . . . . 0.0 111.891 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -78.83 123.18 85.3 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 119.084 0.856 . . . . 0.0 109.026 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.74 116.94 2.64 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.696 2.931 . . . . 0.0 112.075 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.47 -44.51 1.15 Allowed Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.9 t -70.8 130.4 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 117.453 0.626 . . . . 0.0 109.718 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -96.82 -100.79 0.18 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.974 1.31 . . . . 0.0 107.529 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.4 p -90.23 156.83 18.03 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.38 0.672 . . . . 0.0 110.004 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.6 tt -150.58 145.52 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.7 0.8 . . . . 0.0 110.217 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -133.97 104.92 6.47 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.923 1.289 . . . . 0.0 107.571 169.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.2 t -89.8 97.86 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.8 t -89.75 123.08 33.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.835 0.854 . . . . 0.0 109.469 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.1 tp -70.82 -49.34 47.4 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.792 0.837 . . . . 0.0 110.092 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.69 -46.17 74.07 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.0 1.32 . . . . 0.0 112.054 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -89.22 -6.79 56.6 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.745 0.818 . . . . 0.0 111.319 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 m 52.55 54.25 10.94 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.85 1.66 . . . . 0.0 111.389 176.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -156.52 150.08 24.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.342 0.592 . . . . 0.0 112.282 -175.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -94.7 108.71 3.72 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 170.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -98.76 95.74 7.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 175.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 t -108.81 134.19 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.517 1.127 . . . . 0.0 109.879 -169.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -105.27 132.71 51.13 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 168.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -150.36 170.9 17.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.079 0.552 . . . . 0.0 111.384 -169.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -102.8 111.43 64.88 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.056 1.342 . . . . 0.0 109.241 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -41.75 -40.03 5.37 Favored 'Trans proline' 0 C--N 1.347 0.454 1 C-N-CA 125.618 4.212 . . . . 0.0 115.047 172.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.1 mt -61.93 -33.38 74.16 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.612 0.765 . . . . 0.0 111.829 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.0 mt -102.87 -38.13 7.53 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.478 1.111 . . . . 0.0 111.919 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 t -147.12 174.16 11.83 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.592 0.757 . . . . 0.0 110.1 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.7 p -150.21 162.89 26.37 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.113 0.965 . . . . 0.0 110.02 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -52.62 -43.55 54.36 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.659 2.906 . . . . 0.0 113.186 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -64.29 -36.83 85.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.551 0.74 . . . . 0.0 112.103 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.0 m -68.57 -46.41 69.48 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.019 0.527 . . . . 0.0 109.884 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.3 mt -61.0 -46.83 89.17 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.166 0.986 . . . . 0.0 110.307 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -54.63 -44.7 73.39 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.171 0.988 . . . . 0.0 110.296 172.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.13 -44.64 93.07 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.247 0.927 . . . . 0.0 112.245 175.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.06 -49.31 75.02 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.542 0.737 . . . . 0.0 111.229 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.4 mt -61.85 -39.39 83.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.913 0.885 . . . . 0.0 110.028 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.46 -48.52 80.75 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.6 0.76 . . . . 0.0 109.859 176.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.27 -40.67 86.8 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.561 1.144 . . . . 0.0 111.43 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.8 mmm -60.98 -19.63 61.4 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.607 0.763 . . . . 0.0 112.163 173.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.15 53.53 0.95 Allowed Glycine 0 C--N 1.34 0.796 0 C-N-CA 124.411 1.005 . . . . 0.0 111.699 169.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -140.52 156.2 46.39 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.86 0.864 . . . . 0.0 110.273 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -82.88 87.14 6.84 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.23 124.74 44.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.606 1.162 . . . . 0.0 109.936 -173.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.9 p -139.99 140.18 36.21 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.685 1.194 . . . . 0.0 108.79 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 CA--C 1.531 0.213 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.103 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -102.58 143.27 32.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.211 1.004 . . . . 0.0 109.354 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -137.26 142.44 41.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.46 124.83 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.0 mt -121.09 120.5 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -77.29 120.76 22.77 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.3 mt -122.35 106.85 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.745 1.218 . . . . 0.0 107.881 -173.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -99.6 146.91 25.93 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.83 -12.61 17.7 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.55 1.071 . . . . 0.0 112.108 -172.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 44.6 mtm . . . . . 0 C--N 1.343 0.325 0 CA-C-N 118.382 1.091 . . . . 0.0 109.56 178.64 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.3 m -61.24 -59.1 5.83 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.375 0.67 . . . . 0.0 109.394 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -50.01 -51.3 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.23 1.412 . . . . 0.0 111.194 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -59.79 -53.19 60.81 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.272 1.429 . . . . 0.0 111.079 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.3 p -60.24 -49.34 77.99 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.026 0.53 . . . . 0.0 111.072 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.3 mt -53.46 -57.21 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.195 0.998 . . . . 0.0 109.943 177.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -53.39 -52.38 59.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.921 0.888 . . . . 0.0 110.844 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.08 -54.2 38.74 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.844 0.735 . . . . 0.0 112.312 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.16 -54.71 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.373 1.069 . . . . 0.0 110.876 -176.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.2 mm -61.75 -34.72 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.874 0.87 . . . . 0.0 111.262 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t -53.73 -19.47 4.23 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -89.25 -12.67 40.07 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.929 0.786 . . . . 0.0 112.392 -175.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -74.58 143.55 79.17 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 118.783 0.719 . . . . 0.0 110.131 -172.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.27 130.35 25.2 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.061 2.508 . . . . 0.0 109.772 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.04 -39.61 2.8 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 118.926 -0.93 . . . . 0.0 111.419 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.59 123.65 20.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 CA-C-N 118.069 0.935 . . . . 0.0 109.139 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -93.26 -102.65 0.13 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.4 p -90.26 155.99 18.6 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.907 0.883 . . . . 0.0 109.706 171.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.1 tt -150.32 141.08 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.652 0.781 . . . . 0.0 109.586 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -135.52 131.78 36.46 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.91 0.884 . . . . 0.0 108.769 169.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -115.82 133.73 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.9 t -112.56 133.46 54.6 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.932 1.293 . . . . 0.0 110.702 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.18 -56.7 5.54 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 170.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.55 -47.78 63.31 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.339 1.456 . . . . 0.0 112.335 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -89.25 -10.36 47.24 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.577 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m 52.03 56.29 7.99 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.02 1.328 . . . . 0.0 110.867 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -156.5 164.39 38.28 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.054 0.542 . . . . 0.0 111.102 -176.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.75 113.57 2.41 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 126.18 1.847 . . . . 0.0 108.825 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.9 m -99.4 107.88 20.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.34 130.22 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.453 1.101 . . . . 0.0 109.583 -170.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -93.65 127.73 39.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 168.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -149.1 155.48 40.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.827 0.451 . . . . 0.0 110.959 -169.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -95.15 115.22 65.21 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.282 1.033 . . . . 0.0 109.288 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.26 -36.38 17.02 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.861 3.708 . . . . 0.0 114.653 172.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.6 mt -66.06 -29.28 69.59 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.472 0.709 . . . . 0.0 112.099 -176.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.0 mt -108.73 -33.27 7.03 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.23 1.012 . . . . 0.0 112.26 -172.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.0 t -147.32 -179.83 7.12 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.566 0.746 . . . . 0.0 109.849 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.6 p -149.82 162.09 29.3 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 123.732 0.813 . . . . 0.0 110.125 -176.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -51.9 -40.0 67.51 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.402 2.734 . . . . 0.0 112.18 173.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.92 -46.91 79.67 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.288 1.035 . . . . 0.0 110.949 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.8 m -60.02 -47.32 86.34 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.052 0.541 . . . . 0.0 110.406 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.96 -50.45 73.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.843 0.857 . . . . 0.0 110.52 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.1 ttp85 -50.72 -46.76 59.18 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.149 0.98 . . . . 0.0 110.487 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.69 -46.77 81.34 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.137 0.875 . . . . 0.0 112.114 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.24 -47.01 86.3 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.664 0.732 . . . . 0.0 111.486 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 mm -58.51 -44.51 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.222 0.609 . . . . 0.0 110.24 175.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.51 -38.28 90.53 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.143 0.577 . . . . 0.0 110.927 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.27 -43.67 94.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.016 0.926 . . . . 0.0 110.947 176.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 90.6 mtp -59.0 -41.42 87.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 117.978 0.354 . . . . 0.0 110.441 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.26 56.45 0.22 Allowed Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.092 0.853 . . . . 0.0 111.862 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -140.27 139.75 35.6 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -74.02 96.33 2.66 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.467 0.707 . . . . 0.0 109.447 -175.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.95 132.72 45.14 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.96 1.304 . . . . 0.0 110.582 -173.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.9 p -138.24 134.95 35.05 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.079 1.352 . . . . 0.0 108.795 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.6 mt . . . . . 0 CA--C 1.528 0.133 0 C-N-CA 122.701 0.4 . . . . 0.0 110.401 -177.404 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.52 143.1 34.16 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.749 0.82 . . . . 0.0 109.258 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -139.46 144.66 38.11 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.009 0.924 . . . . 0.0 108.913 172.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.4 t -110.54 115.68 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.8 mm -99.84 126.81 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -77.51 113.89 15.79 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 170.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.9 mt -116.35 98.0 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -176.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -99.85 158.38 15.84 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.03 13.82 60.05 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.818 0.723 . . . . 0.0 112.902 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 68.0 mtm . . . . . 0 C--N 1.341 0.236 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 171.122 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 110.713 -0.106 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.3 m -60.22 -50.34 74.06 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.807 0.843 . . . . 0.0 110.006 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.3 t -52.76 -54.86 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.74 1.216 . . . . 0.0 110.347 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -60.11 -46.27 90.18 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.301 1.041 . . . . 0.0 111.586 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -57.88 -48.86 78.6 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.675 0.39 . . . . 0.0 111.199 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.0 mt -59.81 -59.41 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.19 0.596 . . . . 0.0 109.948 -177.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.95 -43.52 86.42 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.102 0.41 . . . . 0.0 111.166 -176.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.31 -54.82 29.82 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.814 0.721 . . . . 0.0 112.023 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.21 -53.89 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.322 0.649 . . . . 0.0 110.792 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.4 mm -62.79 -35.42 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.729 -172.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.0 m -53.3 -30.25 37.77 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.86 0.754 . . . . 0.0 112.77 174.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 -6.7 56.24 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.498 0.719 . . . . 0.0 112.052 -175.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -72.82 143.13 84.07 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 118.859 0.754 . . . . 0.0 109.314 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.84 135.9 54.43 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.931 2.421 . . . . 0.0 110.025 -176.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.39 -40.07 2.62 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-O 118.888 -0.951 . . . . 0.0 111.525 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -67.66 134.83 29.59 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 CA-C-N 118.068 0.934 . . . . 0.0 109.797 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -112.8 -89.5 0.52 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.8 p -90.75 154.49 19.49 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.884 0.874 . . . . 0.0 110.38 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.5 tt -150.61 148.8 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.666 1.186 . . . . 0.0 108.744 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -135.65 106.3 6.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.781 0.833 . . . . 0.0 109.201 174.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.8 t -94.49 100.49 11.21 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 C-N-CA 124.015 0.926 . . . . 0.0 109.307 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.4 t -89.54 120.19 30.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.974 0.91 . . . . 0.0 109.7 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.9 tp -69.98 -47.11 63.54 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.474 1.109 . . . . 0.0 110.042 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.01 -44.47 67.32 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.768 1.227 . . . . 0.0 111.682 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -89.29 -14.73 35.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.404 0.681 . . . . 0.0 111.3 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.1 m 55.52 54.76 8.05 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 125.403 1.481 . . . . 0.0 110.665 -177.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.5 p30 -153.17 158.47 41.84 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.028 0.531 . . . . 0.0 111.619 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.58 114.55 3.17 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 126.052 1.787 . . . . 0.0 108.92 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.3 m -98.9 97.14 8.35 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.67 134.14 44.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 C-N-CA 124.829 1.252 . . . . 0.0 109.704 -170.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -105.19 116.99 32.88 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 172.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -145.9 153.17 40.55 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.602 0.761 . . . . 0.0 111.842 -169.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -88.16 120.49 70.62 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 123.673 0.789 . . . . 0.0 110.163 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -47.8 -39.33 31.23 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.997 3.798 . . . . 0.0 115.457 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.4 mt -67.67 -28.77 67.98 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.882 0.473 . . . . 0.0 111.809 -174.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.61 -34.76 10.09 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.797 0.839 . . . . 0.0 111.091 -174.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 t -151.83 171.03 18.38 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.631 0.65 . . . . 0.0 110.2 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.6 p -138.89 162.68 51.3 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.757 1.223 . . . . 0.0 109.996 -175.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -50.99 -43.12 49.6 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.492 2.795 . . . . 0.0 112.573 174.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -62.48 -43.3 99.15 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.891 0.876 . . . . 0.0 111.739 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.5 m -64.15 -47.55 79.44 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.991 0.359 . . . . 0.0 110.299 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.8 mt -59.46 -50.61 73.25 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.985 0.914 . . . . 0.0 110.318 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 -51.5 -46.69 63.29 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.54 1.136 . . . . 0.0 110.297 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.75 -47.04 91.34 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.6 1.095 . . . . 0.0 112.184 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.57 -45.35 93.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.507 0.723 . . . . 0.0 111.273 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -62.75 -43.69 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.714 0.806 . . . . 0.0 109.876 178.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -59.47 -46.59 88.36 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.683 0.793 . . . . 0.0 110.035 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -59.24 -42.83 92.0 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.494 1.118 . . . . 0.0 111.562 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 71.7 mtm -57.66 -45.81 85.07 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 118.025 0.375 . . . . 0.0 110.687 173.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.47 63.05 0.12 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 170.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -140.28 158.5 43.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.902 0.881 . . . . 0.0 109.385 174.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -79.33 87.21 5.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.28 118.72 36.57 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.552 1.141 . . . . 0.0 109.835 -173.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.2 p -138.19 149.87 46.23 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.783 1.233 . . . . 0.0 108.683 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 29.3 mt . . . . . 0 CA--C 1.529 0.136 0 CA-C-N 118.159 0.436 . . . . 0.0 110.056 179.932 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 . . . . . 0 CA--C 1.528 0.115 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -140.27 147.08 39.43 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.511 0.724 . . . . 0.0 109.975 -177.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.8 t -142.23 153.11 43.71 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.371 1.068 . . . . 0.0 109.918 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.35 115.81 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 173.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.4 mt -106.12 124.94 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -80.14 118.67 22.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.6 mt -116.06 102.53 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -174.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -99.55 142.65 30.74 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.21 19.55 27.94 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.554 1.073 . . . . 0.0 113.142 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 68.5 mtm . . . . . 0 C--N 1.342 0.269 0 CA-C-N 118.618 1.209 . . . . 0.0 109.261 174.652 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.5 m -62.58 -50.87 69.56 Favored 'General case' 0 C--N 1.338 0.104 0 C-N-CA 123.689 0.796 . . . . 0.0 110.287 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.1 t -53.44 -49.86 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.188 0.995 . . . . 0.0 110.706 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -57.74 -45.54 85.71 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.958 0.903 . . . . 0.0 111.406 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.7 m -59.67 -53.81 53.73 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.822 0.449 . . . . 0.0 110.856 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -57.73 -51.33 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.604 1.162 . . . . 0.0 109.797 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -49.8 -58.52 5.19 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.859 1.664 . . . . 0.0 110.232 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.95 -55.05 32.68 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.063 0.839 . . . . 0.0 112.141 -177.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.22 -55.3 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.428 0.691 . . . . 0.0 110.79 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.6 mt -68.09 -34.68 68.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 119.145 -0.455 . . . . 0.0 111.344 -173.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -54.72 -27.42 40.63 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 174.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -89.69 -8.3 52.68 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.441 0.697 . . . . 0.0 112.522 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -72.91 141.54 81.95 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 119.171 0.896 . . . . 0.0 110.019 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.95 131.05 27.6 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.146 2.564 . . . . 0.0 110.265 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.67 -34.28 5.91 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-O 118.897 -0.946 . . . . 0.0 112.137 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.07 121.55 16.39 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 CA-C-N 118.178 0.989 . . . . 0.0 109.536 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -91.58 -101.5 0.11 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.366 1.066 . . . . 0.0 108.221 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.1 p -88.57 141.46 28.51 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.6 tt -141.69 138.31 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.04 111.07 6.95 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.042 1.337 . . . . 0.0 108.017 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.5 t -104.48 120.99 55.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 124.778 1.231 . . . . 0.0 108.462 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.8 t -103.08 129.03 49.78 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.749 1.22 . . . . 0.0 110.806 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.57 -56.7 9.54 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.369 1.067 . . . . 0.0 108.131 169.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.42 -48.72 62.59 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.452 1.501 . . . . 0.0 112.466 -175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -89.23 -5.03 57.97 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.883 0.473 . . . . 0.0 111.662 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.2 m 51.3 54.63 10.79 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.244 1.418 . . . . 0.0 111.341 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -156.78 160.09 38.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.017 0.437 . . . . 0.0 111.363 -176.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.06 114.23 3.15 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 126.307 1.908 . . . . 0.0 108.391 174.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.1 m -99.0 109.61 22.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 t -118.53 123.12 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.477 1.111 . . . . 0.0 109.198 -169.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -96.74 132.3 42.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 168.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -150.33 169.87 20.36 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.967 0.507 . . . . 0.0 112.155 -169.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.25 113.43 65.87 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.334 1.454 . . . . 0.0 109.68 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -45.67 -41.13 19.19 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 125.292 3.994 . . . . 0.0 115.637 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.5 mt -68.27 -29.0 67.69 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.836 0.454 . . . . 0.0 111.752 -174.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.2 mt -99.78 -35.31 9.83 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.385 1.074 . . . . 0.0 111.647 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -152.03 171.27 18.11 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.607 0.763 . . . . 0.0 109.76 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.3 p -148.15 164.71 20.84 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.739 1.216 . . . . 0.0 109.952 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.18 -38.91 81.77 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.298 2.665 . . . . 0.0 112.196 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -59.86 -52.4 65.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.236 1.014 . . . . 0.0 110.804 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.1 p -63.77 -40.78 97.5 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 122.882 0.473 . . . . 0.0 111.426 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.1 mt -66.26 -45.99 78.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.185 0.594 . . . . 0.0 110.391 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -54.77 -48.46 72.62 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.805 0.842 . . . . 0.0 109.608 171.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.36 -44.98 58.74 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.461 1.029 . . . . 0.0 112.628 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.56 -48.06 76.44 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.635 0.774 . . . . 0.0 111.057 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.5 mt -59.7 -45.03 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.556 0.743 . . . . 0.0 109.906 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.7 -42.82 97.97 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.39 1.076 . . . . 0.0 110.861 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.35 -43.97 97.57 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.034 0.934 . . . . 0.0 111.111 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.4 mtp -59.17 -40.56 86.01 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.797 0.439 . . . . 0.0 110.601 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.23 58.06 0.24 Allowed Glycine 0 C--N 1.34 0.792 0 C-N-CA 123.913 0.768 . . . . 0.0 111.856 169.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -140.26 148.7 41.85 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 124.018 0.927 . . . . 0.0 108.993 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -74.48 95.61 2.77 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -177.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 130.09 45.99 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.107 1.363 . . . . 0.0 110.218 -175.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 t -150.02 135.5 18.23 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.157 0.583 . . . . 0.0 109.765 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.7 mt . . . . . 0 CA--C 1.531 0.231 0 C-N-CA 123.266 0.626 . . . . 0.0 110.246 -177.582 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -122.11 155.57 35.44 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.837 1.255 . . . . 0.0 109.007 173.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 t -150.17 133.73 16.6 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 122.795 0.438 . . . . 0.0 109.825 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.8 t -99.71 99.01 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 124.825 1.25 . . . . 0.0 107.714 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.7 mt -99.85 114.45 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -75.22 132.68 41.27 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.2 mt -126.7 108.27 18.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 125.026 1.33 . . . . 0.0 107.773 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.89 139.87 34.94 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.69 7.09 26.17 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.023 1.297 . . . . 0.0 113.416 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.2 mtm . . . . . 0 C--N 1.341 0.232 0 CA-C-N 118.845 1.322 . . . . 0.0 109.921 -179.663 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 p . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.164 0.507 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.9 m -68.05 -43.9 77.61 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.811 1.245 . . . . 0.0 111.267 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.7 t -53.29 -50.7 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.039 0.936 . . . . 0.0 110.013 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -61.72 -50.08 73.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.777 1.231 . . . . 0.0 111.355 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.8 p -62.33 -46.27 89.45 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.959 0.345 . . . . 0.0 111.52 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.8 mt -58.13 -53.75 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 C-N-CA 123.748 0.819 . . . . 0.0 109.106 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -50.56 -57.7 7.54 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.873 0.869 . . . . 0.0 110.188 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.91 -56.8 23.02 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.992 0.806 . . . . 0.0 112.281 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.5 t -62.05 -53.82 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 117.305 0.552 . . . . 0.0 111.086 -174.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.8 mm -61.66 -36.97 76.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.915 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.8 t -54.25 -29.29 46.27 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.779 0.718 . . . . 0.0 112.611 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.1 mtmt -89.61 -14.89 33.97 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.848 0.859 . . . . 0.0 112.852 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -64.28 143.52 98.41 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 119.577 1.081 . . . . 0.0 110.228 174.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.24 142.13 78.5 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.153 2.568 . . . . 0.0 110.276 -175.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.67 -30.45 6.51 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.694 -1.059 . . . . 0.0 112.41 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.73 131.78 34.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 118.629 1.215 . . . . 0.0 109.739 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -90.05 -105.09 0.09 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 172.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.3 p -91.08 165.8 13.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.873 1.269 . . . . 0.0 110.382 169.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -147.96 132.6 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.472 1.109 . . . . 0.0 108.024 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.3 105.9 13.06 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.7 t -98.24 119.24 46.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.812 0.845 . . . . 0.0 108.926 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.4 t -109.47 125.49 52.5 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.851 1.26 . . . . 0.0 110.089 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.52 -52.25 41.2 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.327 1.051 . . . . 0.0 109.007 171.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.97 -46.07 68.08 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.3 1.44 . . . . 0.0 112.2 -176.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -89.25 -7.69 54.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.128 0.571 . . . . 0.0 111.425 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 m 52.76 54.22 10.88 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.8 1.64 . . . . 0.0 110.868 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -156.21 168.06 28.48 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.132 0.491 . . . . 0.0 111.502 -175.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.93 117.33 2.98 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 107.537 -2.225 . . . . 0.0 107.537 172.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.7 p -98.74 102.43 14.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.3 t -99.21 127.26 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -169.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -94.2 127.24 39.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 170.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -150.71 170.76 18.43 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -169.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -105.97 112.04 64.35 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.21 1.404 . . . . 0.0 109.183 173.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -42.74 -39.61 7.42 Favored 'Trans proline' 0 C--N 1.348 0.519 1 C-N-CA 125.443 4.095 . . . . 0.0 115.181 172.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.35 -35.79 80.24 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.334 0.654 . . . . 0.0 111.78 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.6 mt -99.96 -32.76 10.81 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.301 1.041 . . . . 0.0 112.181 -171.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.1 t -150.77 168.5 24.21 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.637 0.653 . . . . 0.0 110.28 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.3 p -136.07 159.49 70.79 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.746 1.218 . . . . 0.0 110.103 -176.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.42 -39.91 44.52 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.674 2.916 . . . . 0.0 113.163 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.01 -39.42 83.18 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.806 0.842 . . . . 0.0 111.78 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.8 m -65.26 -46.67 79.59 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.672 0.389 . . . . 0.0 109.985 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.6 mt -62.6 -46.67 87.22 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.325 1.05 . . . . 0.0 110.577 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -51.89 -47.02 64.74 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.568 1.147 . . . . 0.0 109.869 170.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.54 -44.61 90.64 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.321 0.962 . . . . 0.0 112.328 176.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.23 -43.59 90.94 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.742 0.771 . . . . 0.0 111.389 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.6 mt -64.82 -38.65 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.744 0.818 . . . . 0.0 110.004 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.95 -40.86 95.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.618 0.767 . . . . 0.0 110.53 176.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.08 -42.93 99.73 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.995 0.918 . . . . 0.0 110.862 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.5 mmm -56.22 -39.66 72.83 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.214 0.606 . . . . 0.0 110.637 172.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.7 58.37 0.27 Allowed Glycine 0 C--N 1.341 0.816 0 C-N-CA 123.867 0.746 . . . . 0.0 111.967 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -140.41 155.11 46.84 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.896 0.878 . . . . 0.0 109.957 175.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -77.24 94.37 4.12 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.62 124.0 44.42 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.917 1.287 . . . . 0.0 109.526 -175.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 48.0 p -141.87 143.77 33.51 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.415 1.086 . . . . 0.0 109.124 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 mm? . . . . . 0 CA--C 1.529 0.153 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.482 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 39.0 tp . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 110.634 -0.136 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.7 p -136.54 125.57 24.4 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.484 1.113 . . . . 0.0 109.785 -174.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -138.71 149.22 44.86 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.568 1.547 . . . . 0.0 108.366 170.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.85 153.97 21.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.162 0.985 . . . . 0.0 110.232 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.2 t -149.94 143.39 25.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.896 0.879 . . . . 0.0 109.149 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.0 t -108.66 124.69 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 173.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.9 mt -121.95 119.53 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -73.5 126.36 30.04 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.2 mt -120.86 110.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.086 1.355 . . . . 0.0 107.675 -176.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -99.9 145.57 27.65 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.438 0.695 . . . . 0.0 109.146 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.08 13.01 47.47 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.648 1.118 . . . . 0.0 113.497 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 67.4 mtm -72.7 82.71 1.15 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.558 1.179 . . . . 0.0 109.257 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.5 m -76.33 93.14 3.4 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.556 1.142 . . . . 0.0 109.937 -171.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.6 t 77.0 163.37 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.765 1.626 . . . . 0.0 111.225 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -53.3 -25.1 13.51 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.707 1.603 . . . . 0.0 113.075 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.6 p -54.47 -51.67 64.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.92 0.888 . . . . 0.0 110.931 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.4 m -63.86 -46.55 84.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.695 0.798 . . . . 0.0 110.598 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -53.4 -53.69 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.293 1.037 . . . . 0.0 110.059 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -60.97 -46.14 91.92 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.858 1.263 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.1 t -57.44 -53.59 56.47 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.534 0.733 . . . . 0.0 110.754 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.6 mt -55.98 -55.27 19.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 C-N-CA 124.083 0.953 . . . . 0.0 109.424 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.89 -53.08 54.26 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.569 0.748 . . . . 0.0 110.932 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.22 -53.37 46.18 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.383 0.992 . . . . 0.0 112.552 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.82 -53.56 46.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 117.579 0.689 . . . . 0.0 110.485 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.3 mm -62.21 -36.64 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 118.814 -0.612 . . . . 0.0 111.024 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.7 t -51.3 -37.12 45.75 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.829 0.741 . . . . 0.0 111.933 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -89.21 -3.62 58.5 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.709 0.804 . . . . 0.0 112.455 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -71.78 142.53 85.9 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 119.352 0.978 . . . . 0.0 109.322 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -46.55 134.41 16.58 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.921 3.081 . . . . 0.0 112.801 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.93 -40.33 2.85 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-O 118.802 -0.999 . . . . 0.0 112.644 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.45 135.42 28.5 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.178 0.989 . . . . 0.0 109.704 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -114.29 -88.42 0.56 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.7 p -90.82 149.85 21.81 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.581 0.752 . . . . 0.0 109.949 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.52 138.19 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 124.035 0.934 . . . . 0.0 109.041 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -130.84 109.09 10.32 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.778 1.231 . . . . 0.0 108.287 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.9 t -98.21 114.61 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 124.002 0.921 . . . . 0.0 108.748 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.1 t -100.61 123.56 44.99 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 124.388 1.075 . . . . 0.0 109.452 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.0 tp -71.93 -44.08 64.21 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.688 0.795 . . . . 0.0 110.019 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.87 -46.88 74.79 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.892 1.277 . . . . 0.0 111.732 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -89.23 -7.06 56.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.209 0.604 . . . . 0.0 111.352 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.3 m 53.05 54.88 9.69 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.774 1.63 . . . . 0.0 111.019 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -155.54 163.58 39.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.986 0.422 . . . . 0.0 111.803 -175.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.24 116.16 3.54 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 126.402 1.954 . . . . 0.0 108.365 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.1 m -99.24 101.56 12.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.5 t -108.38 131.72 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 124.499 1.12 . . . . 0.0 109.521 -170.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -102.24 125.41 48.93 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -146.59 164.82 31.39 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.587 0.755 . . . . 0.0 111.405 -171.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -97.49 115.68 65.77 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.476 1.111 . . . . 0.0 109.277 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -45.94 -38.48 18.48 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 125.255 3.97 . . . . 0.0 115.175 175.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.8 mt -65.59 -28.13 68.92 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.456 0.702 . . . . 0.0 111.839 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.64 -44.09 6.25 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.219 1.007 . . . . 0.0 110.854 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.1 t -144.9 176.21 9.64 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.483 0.713 . . . . 0.0 110.403 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.8 p -149.99 164.63 19.97 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 124.209 1.004 . . . . 0.0 109.864 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.24 -47.08 28.7 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.605 2.87 . . . . 0.0 113.009 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.65 -36.0 82.39 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.468 0.707 . . . . 0.0 112.118 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 m -67.18 -45.65 76.3 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.963 0.505 . . . . 0.0 110.154 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.1 mt -62.21 -46.52 88.5 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.07 0.948 . . . . 0.0 110.443 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -52.5 -47.24 66.73 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.172 0.989 . . . . 0.0 110.052 170.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.75 -45.2 86.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.257 0.932 . . . . 0.0 112.288 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.85 77.43 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 117.677 0.739 . . . . 0.0 111.262 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.8 mt -60.98 -41.99 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.759 0.824 . . . . 0.0 110.076 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.93 -41.32 99.44 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.089 0.956 . . . . 0.0 110.799 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.68 -42.05 99.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.856 0.862 . . . . 0.0 111.094 177.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -58.68 -46.82 86.39 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.98 0.354 . . . . 0.0 110.09 173.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.06 59.13 0.13 Allowed Glycine 0 C--N 1.341 0.815 0 C-N-CA 123.882 0.754 . . . . 0.0 111.735 170.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -140.21 146.55 38.84 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.874 0.87 . . . . 0.0 109.124 174.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -76.13 92.32 3.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.5 131.82 45.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.928 1.291 . . . . 0.0 110.166 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.3 m -143.51 134.01 24.84 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.825 1.25 . . . . 0.0 108.414 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.5 mt -64.12 127.68 32.48 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.154 0.582 . . . . 0.0 109.904 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.9 t -98.42 -51.41 3.97 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.01 0.924 . . . . 0.0 109.77 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.6 t70 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 116.906 -1.521 . . . . 0.0 108.831 -179.824 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.1 p -134.69 115.89 14.3 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.84 1.256 . . . . 0.0 109.137 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -134.92 156.83 48.29 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 124.571 1.148 . . . . 0.0 108.612 171.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -122.77 155.83 35.74 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.034 0.934 . . . . 0.0 110.076 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.3 t -150.08 144.71 25.92 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.115 0.966 . . . . 0.0 109.303 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.7 t -107.11 127.67 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 172.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.4 mt -125.65 124.33 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -66.17 132.5 48.61 Favored 'General case' 0 C--N 1.337 0.045 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 172.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.6 mt -127.66 95.36 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -99.82 156.63 17.01 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.363 0.665 . . . . 0.0 109.938 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.41 32.43 34.55 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.913 0.768 . . . . 0.0 112.036 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 96.7 mtp -87.82 112.14 22.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.965 0.906 . . . . 0.0 108.585 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.8 m -64.6 -56.2 15.44 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.165 0.986 . . . . 0.0 111.445 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.3 p -162.96 -171.61 2.74 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.072 0.549 . . . . 0.0 111.264 -169.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -50.98 -35.36 33.37 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.949 1.7 . . . . 0.0 113.163 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -55.21 -38.46 68.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.172 0.589 . . . . 0.0 111.3 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.1 m -65.91 -48.41 71.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.159 0.584 . . . . 0.0 110.103 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -51.87 -54.42 13.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 123.419 0.688 . . . . 0.0 109.881 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -59.16 -52.9 63.73 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.66 1.184 . . . . 0.0 111.408 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 p -61.15 -53.46 56.72 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.854 0.462 . . . . 0.0 111.387 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 85.0 mt -55.85 -54.79 22.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 123.815 0.846 . . . . 0.0 109.657 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -59.45 -47.01 87.14 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.526 0.33 . . . . 0.0 110.677 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.43 -51.94 53.1 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.314 0.959 . . . . 0.0 112.256 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.73 -55.21 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 117.631 0.716 . . . . 0.0 110.503 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.23 -37.65 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.087 0.555 . . . . 0.0 111.564 -173.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 92.7 p -54.9 -30.48 58.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.786 0.721 . . . . 0.0 112.694 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -89.51 -4.41 57.93 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.906 0.882 . . . . 0.0 112.256 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -70.73 144.84 91.48 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 118.936 0.789 . . . . 0.0 109.205 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -63.71 128.59 22.54 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.019 2.479 . . . . 0.0 110.444 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.56 -32.44 7.57 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-O 118.817 -0.99 . . . . 0.0 112.491 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.8 t -68.62 132.59 32.79 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 CA-C-N 118.276 1.038 . . . . 0.0 109.914 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -106.34 -99.96 0.34 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.999 1.32 . . . . 0.0 108.009 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.5 p -88.64 151.06 22.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.795 0.838 . . . . 0.0 109.365 173.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.7 tt -150.48 131.9 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.293 0.637 . . . . 0.0 109.302 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.94 94.79 4.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.567 1.547 . . . . 0.0 107.747 -175.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.9 t -90.38 125.66 43.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.3 t -118.96 126.93 52.91 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.733 1.213 . . . . 0.0 110.235 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.6 tp -72.45 -47.91 45.19 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.728 1.211 . . . . 0.0 109.455 170.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.99 -46.49 68.31 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.769 1.227 . . . . 0.0 111.591 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -89.42 -11.57 42.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.306 0.642 . . . . 0.0 111.605 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.9 m 53.42 57.65 5.97 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.125 1.37 . . . . 0.0 110.372 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.7 p30 -157.85 171.04 21.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.402 0.681 . . . . 0.0 111.201 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.88 115.84 1.86 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.1 m -99.46 101.99 13.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.9 t -106.73 139.02 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.918 1.287 . . . . 0.0 109.755 -169.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -108.13 130.28 55.12 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 168.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -150.62 169.0 22.6 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.933 0.493 . . . . 0.0 112.05 -170.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.66 112.86 65.29 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.469 1.507 . . . . 0.0 109.531 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -43.29 -42.74 10.33 Favored 'Trans proline' 0 C--N 1.347 0.456 1 C-N-CA 125.696 4.264 . . . . 0.0 115.872 176.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.0 mt -68.26 -28.85 67.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.645 0.378 . . . . 0.0 111.956 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.9 mt -99.71 -33.91 10.4 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.204 1.002 . . . . 0.0 111.801 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -151.69 170.97 18.41 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.273 0.629 . . . . 0.0 110.088 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.8 p -144.04 164.22 30.73 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.602 1.161 . . . . 0.0 109.747 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -52.72 -38.08 76.5 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.377 2.718 . . . . 0.0 112.55 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -66.05 -45.99 79.4 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.331 1.052 . . . . 0.0 110.349 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.8 m -62.45 -46.57 87.92 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.182 0.593 . . . . 0.0 110.545 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.7 mt -60.23 -49.78 76.26 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.03 0.932 . . . . 0.0 110.566 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.2 ttp85 -52.25 -48.54 65.17 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.323 1.049 . . . . 0.0 110.33 173.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.31 -45.79 87.9 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.287 0.946 . . . . 0.0 112.316 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.34 -48.32 78.49 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.559 0.743 . . . . 0.0 111.189 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.7 mt -59.25 -42.1 86.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.777 0.831 . . . . 0.0 110.045 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -63.11 -42.22 99.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.393 0.677 . . . . 0.0 110.982 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -62.11 -41.82 98.61 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.082 0.953 . . . . 0.0 111.103 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.0 mtp -58.75 -45.89 88.67 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.542 0.337 . . . . 0.0 110.32 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.33 58.45 0.13 Allowed Glycine 0 C--N 1.339 0.749 0 C-N-CA 123.618 0.628 . . . . 0.0 111.719 169.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -140.32 140.31 35.61 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -68.44 96.6 0.69 Allowed 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.9 127.75 46.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.887 1.275 . . . . 0.0 109.646 -172.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.5 m -149.16 130.41 14.61 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.0 mt -58.45 134.91 57.07 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.367 0.667 . . . . 0.0 110.597 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 t -101.08 -52.99 3.14 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.076 0.95 . . . . 0.0 109.557 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 116.841 -1.552 . . . . 0.0 108.833 -178.583 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 57.3 tp . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 53.8 p -99.55 80.72 2.41 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.951 0.901 . . . . 0.0 109.473 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -94.14 165.16 12.75 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.972 0.909 . . . . 0.0 109.758 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -140.18 141.58 35.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.215 1.006 . . . . 0.0 109.041 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -135.65 146.24 47.63 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.564 1.146 . . . . 0.0 109.588 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.92 124.18 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.3 mt -120.72 120.27 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -68.45 134.44 50.15 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.9 mt -131.67 106.49 11.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.117 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.92 142.63 31.13 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.64 19.4 20.3 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.792 1.187 . . . . 0.0 113.155 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.1 mtm -78.66 75.41 5.17 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.425 1.113 . . . . 0.0 109.393 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.4 p -72.45 99.3 2.44 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.942 0.897 . . . . 0.0 110.842 -175.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.1 t 75.77 164.54 0.26 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.618 1.567 . . . . 0.0 111.501 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -50.14 -27.05 5.18 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.548 1.539 . . . . 0.0 113.31 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m -53.63 -49.79 67.11 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.075 0.95 . . . . 0.0 111.107 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.7 m -67.15 -44.49 79.67 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.244 0.618 . . . . 0.0 110.647 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.2 t -54.71 -49.67 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.015 0.926 . . . . 0.0 109.893 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.08 -45.34 93.95 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.582 1.553 . . . . 0.0 111.033 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 m -58.6 -53.16 61.51 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 122.951 0.5 . . . . 0.0 110.852 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.59 -50.83 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 123.744 0.818 . . . . 0.0 109.789 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -49.95 -58.45 5.42 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.839 1.256 . . . . 0.0 110.345 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.78 -57.76 17.73 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.789 0.709 . . . . 0.0 112.155 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.9 t -59.67 -56.88 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.302 0.641 . . . . 0.0 110.872 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.6 mm -64.64 -38.49 82.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 118.747 -0.644 . . . . 0.0 111.212 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.2 t -52.94 -35.2 58.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.864 0.756 . . . . 0.0 111.971 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -89.41 -2.6 58.46 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.799 0.84 . . . . 0.0 112.49 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -71.21 145.16 90.65 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 119.448 1.022 . . . . 0.0 109.267 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.97 131.24 30.08 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.94 2.427 . . . . 0.0 109.895 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.71 -36.18 4.41 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-O 118.934 -0.926 . . . . 0.0 112.047 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.7 t -73.57 143.85 13.28 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 CA-C-N 118.044 0.922 . . . . 0.0 110.105 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -118.18 -103.69 0.41 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.078 1.351 . . . . 0.0 107.411 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.0 p -90.37 109.41 20.52 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.164 0.986 . . . . 0.0 110.414 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.0 tt -97.66 141.68 15.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 168.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -126.3 94.46 4.09 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -175.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -89.38 98.37 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.9 t -89.84 109.41 20.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.843 0.857 . . . . 0.0 109.32 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.2 -43.17 95.84 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.468 0.707 . . . . 0.0 109.878 171.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.6 -49.29 68.11 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.609 1.164 . . . . 0.0 111.742 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -89.8 1.02 56.65 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.033 0.533 . . . . 0.0 112.301 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.9 m 49.36 52.72 13.94 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.419 1.488 . . . . 0.0 111.574 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -155.5 166.25 34.1 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.106 0.479 . . . . 0.0 111.762 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.33 118.3 3.82 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.0 m -98.96 99.62 10.69 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.63 121.46 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 125.281 1.433 . . . . 0.0 109.516 -169.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -89.48 128.21 35.95 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 169.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -150.23 168.91 22.64 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -169.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -106.13 113.24 63.73 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 125.447 1.499 . . . . 0.0 108.979 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -48.27 -35.32 26.86 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 124.807 3.671 . . . . 0.0 114.615 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.0 mt -63.42 -31.46 72.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.509 0.723 . . . . 0.0 111.861 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.8 mt -106.79 -31.35 8.43 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.295 1.038 . . . . 0.0 112.368 -171.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 t -149.71 175.45 11.57 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.746 0.703 . . . . 0.0 110.177 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.2 p -146.46 160.86 40.64 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 124.2 1.0 . . . . 0.0 109.839 -176.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.62 -40.93 54.98 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.402 2.734 . . . . 0.0 112.747 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.97 -44.38 85.09 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.068 0.947 . . . . 0.0 111.148 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.7 m -61.95 -46.71 88.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.153 0.581 . . . . 0.0 110.462 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.4 mt -61.82 -49.72 75.16 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.306 1.042 . . . . 0.0 110.411 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -51.89 -44.48 63.78 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.81 0.844 . . . . 0.0 110.2 171.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.22 -48.0 77.75 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.523 1.058 . . . . 0.0 112.128 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.26 -45.58 90.83 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.657 0.729 . . . . 0.0 111.479 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.0 mt -62.01 -45.32 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.873 0.869 . . . . 0.0 109.914 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -61.71 -42.03 98.4 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.586 1.154 . . . . 0.0 110.775 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.39 -43.64 98.53 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.349 1.06 . . . . 0.0 111.338 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 69.0 mtm -57.11 -48.21 79.2 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 117.908 0.322 . . . . 0.0 110.481 173.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.2 65.8 0.1 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -140.24 152.03 45.63 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.158 0.983 . . . . 0.0 108.717 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -78.21 90.19 4.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.77 133.71 43.73 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.823 1.249 . . . . 0.0 110.464 -174.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.7 m -150.11 146.45 26.92 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.169 0.988 . . . . 0.0 108.459 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -64.95 150.73 47.42 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.276 0.489 . . . . 0.0 110.001 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 t -121.13 -50.84 2.13 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.349 1.06 . . . . 0.0 109.372 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 t70 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 117.085 -1.436 . . . . 0.0 108.699 177.751 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 44.1 mt . . . . . 0 N--CA 1.476 0.874 0 CA-C-O 120.296 0.093 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 53.7 p -134.67 84.7 2.12 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.597 1.159 . . . . 0.0 108.171 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -105.06 173.9 6.1 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.432 1.093 . . . . 0.0 109.982 -176.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -140.28 146.0 38.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.777 0.831 . . . . 0.0 109.609 177.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -137.2 137.31 38.99 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.319 1.048 . . . . 0.0 109.692 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.8 t -99.84 109.11 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 172.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.1 mt -99.82 119.97 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -71.83 123.59 23.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.9 mt -123.53 119.49 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -118.14 158.01 25.85 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.188 0.595 . . . . 0.0 109.746 173.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.9 16.41 51.44 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.621 1.105 . . . . 0.0 112.052 -170.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 89.3 mtp -81.06 70.88 7.99 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.458 1.103 . . . . 0.0 108.504 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -62.94 -29.37 70.75 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -169.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.2 p -154.54 176.06 12.86 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.974 0.806 . . . . 0.0 111.821 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -66.42 -22.66 66.23 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.299 1.039 . . . . 0.0 112.543 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.1 t -62.34 -35.96 80.73 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.296 0.498 . . . . 0.0 110.281 172.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.1 m -62.35 -49.22 76.46 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -54.16 -52.77 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.144 0.978 . . . . 0.0 109.916 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -55.14 -51.33 66.8 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.81 1.244 . . . . 0.0 110.883 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -60.06 -56.4 22.14 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.235 0.614 . . . . 0.0 110.967 -177.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 93.5 mt -53.78 -52.69 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.483 1.113 . . . . 0.0 109.749 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -56.02 -55.5 32.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.324 1.049 . . . . 0.0 110.502 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.57 -50.26 64.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.715 1.15 . . . . 0.0 112.286 -176.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.9 t -63.12 -55.34 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 117.368 0.584 . . . . 0.0 110.394 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 84.3 mt -65.06 -40.91 90.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 119.222 -0.418 . . . . 0.0 111.607 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.8 p -53.73 -28.64 35.41 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -89.43 -8.3 53.33 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.888 0.875 . . . . 0.0 112.523 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -71.88 124.62 91.15 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 119.08 0.854 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.12 121.98 7.72 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.699 2.933 . . . . 0.0 112.135 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.13 -37.35 3.45 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.0 0.81 . . . . 0.0 111.76 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.39 126.97 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 117.827 0.814 . . . . 0.0 109.761 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -94.38 -101.35 0.15 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.924 1.29 . . . . 0.0 107.83 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 91.4 p -90.01 163.04 15.08 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.529 0.732 . . . . 0.0 110.186 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.3 tt -150.63 147.85 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.747 0.819 . . . . 0.0 109.73 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.97 109.06 6.77 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.616 1.166 . . . . 0.0 107.884 172.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.42 102.2 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 124.171 0.988 . . . . 0.0 108.467 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -93.65 112.99 24.98 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.969 0.908 . . . . 0.0 110.372 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tt -66.42 -51.37 57.65 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.22 -51.09 57.16 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.09 1.356 . . . . 0.0 112.209 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -89.86 6.56 41.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.963 0.505 . . . . 0.0 111.939 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 m 49.23 57.02 6.93 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 125.654 1.582 . . . . 0.0 112.047 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -157.19 164.11 38.12 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.519 0.676 . . . . 0.0 112.728 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.45 110.11 2.09 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 106.186 -2.766 . . . . 0.0 106.186 169.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -98.81 97.2 8.44 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.5 t -106.87 124.27 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 124.387 1.075 . . . . 0.0 109.099 -170.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -89.81 130.82 36.01 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 169.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -150.31 165.98 31.4 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.072 0.549 . . . . 0.0 112.191 -169.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -104.37 113.19 65.36 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.098 1.359 . . . . 0.0 109.189 173.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -44.65 -36.65 10.52 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 125.286 3.991 . . . . 0.0 114.846 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.6 mt -66.06 -28.61 68.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.617 0.767 . . . . 0.0 112.12 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.7 mt -109.83 -35.29 6.21 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.314 1.046 . . . . 0.0 112.051 -171.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -145.26 179.32 7.46 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.869 0.868 . . . . 0.0 109.396 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.0 p -150.07 162.63 27.31 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 123.207 0.603 . . . . 0.0 110.56 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.03 -38.82 87.03 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.32 2.68 . . . . 0.0 111.782 172.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.45 -49.72 75.66 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.858 0.863 . . . . 0.0 110.677 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -58.37 -48.35 80.88 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.319 0.647 . . . . 0.0 110.549 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.3 mt -60.65 -47.84 84.45 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.219 1.008 . . . . 0.0 110.87 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -56.55 -44.61 81.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.679 0.792 . . . . 0.0 110.555 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.27 -45.94 87.33 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.095 0.855 . . . . 0.0 111.87 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.39 -49.83 73.95 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.378 0.671 . . . . 0.0 111.091 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.8 mt -60.08 -45.28 95.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.32 0.648 . . . . 0.0 110.212 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -57.56 -48.97 77.88 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.102 0.961 . . . . 0.0 110.048 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.78 -43.58 90.48 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.114 0.965 . . . . 0.0 111.454 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.4 mtp -59.44 -44.53 92.91 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.928 0.491 . . . . 0.0 110.631 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.04 62.21 0.2 Allowed Glycine 0 C--N 1.339 0.725 0 C-N-CA 123.795 0.712 . . . . 0.0 111.598 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -140.31 155.4 46.84 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.789 0.836 . . . . 0.0 109.29 172.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -78.37 91.12 4.43 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.703 0.801 . . . . 0.0 108.996 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.67 129.68 45.83 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.618 1.167 . . . . 0.0 110.816 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.7 m -150.07 132.42 15.57 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.897 0.879 . . . . 0.0 108.818 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 43.5 mt -63.64 163.85 10.66 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.054 0.542 . . . . 0.0 111.094 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.7 p -74.32 82.8 1.89 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.339 0.656 . . . . 0.0 109.29 170.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 116.953 -1.499 . . . . 0.0 109.948 177.687 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 51.5 tp . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 110.691 -0.115 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -139.05 126.25 21.35 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.461 1.104 . . . . 0.0 108.773 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 -130.19 167.98 17.54 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.196 1.398 . . . . 0.0 109.302 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -124.14 144.14 50.08 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.461 1.105 . . . . 0.0 108.886 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -137.7 146.78 44.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.33 1.052 . . . . 0.0 109.326 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.99 125.59 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.9 mt -120.32 121.06 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -72.37 132.07 43.47 Favored 'General case' 0 C--O 1.228 -0.044 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 174.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.5 mt -127.97 106.42 14.8 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -99.56 149.57 23.11 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.427 0.691 . . . . 0.0 109.195 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.27 16.27 47.64 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.441 1.02 . . . . 0.0 113.005 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.8 mtm -81.1 64.47 5.85 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.58 1.19 . . . . 0.0 109.252 175.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.6 m -79.4 84.52 5.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.438 1.095 . . . . 0.0 109.788 -173.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.3 t 118.85 148.78 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 129.511 3.124 . . . . 0.0 109.579 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -54.88 -29.95 56.8 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.44 1.096 . . . . 0.0 111.922 175.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.9 m -50.59 -43.43 56.64 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.416 1.086 . . . . 0.0 111.562 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.8 m -60.76 -57.2 13.71 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.4 0.68 . . . . 0.0 109.603 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.7 t -49.89 -51.55 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.06 1.344 . . . . 0.0 111.067 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -59.87 -52.48 65.27 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.009 1.324 . . . . 0.0 111.103 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.3 p -61.12 -48.98 79.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.122 0.569 . . . . 0.0 111.3 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.8 mt -53.76 -55.31 14.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.805 0.842 . . . . 0.0 109.397 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -54.18 -55.06 31.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.113 0.565 . . . . 0.0 110.712 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.43 -50.45 59.94 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.315 0.959 . . . . 0.0 112.779 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.38 -49.68 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.409 0.683 . . . . 0.0 110.699 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.6 mm -66.28 -33.53 64.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.46 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.7 m -50.87 -30.88 15.72 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.872 0.76 . . . . 0.0 112.734 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -89.07 -3.35 58.7 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.58 0.752 . . . . 0.0 112.167 -173.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -77.12 143.01 69.27 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 118.87 0.759 . . . . 0.0 109.903 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.92 135.37 17.82 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.91 3.073 . . . . 0.0 112.608 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.17 -34.9 3.95 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.674 -1.07 . . . . 0.0 113.045 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.1 124.22 20.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-N 118.448 1.124 . . . . 0.0 109.918 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -89.84 -102.59 0.09 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.0 p -90.49 158.02 17.25 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.336 1.054 . . . . 0.0 109.676 171.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.5 tt -150.23 127.37 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -116.19 107.13 14.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.465 1.106 . . . . 0.0 108.497 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.62 124.38 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.0 t -106.8 129.48 54.65 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.636 1.174 . . . . 0.0 110.17 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.5 tp -68.35 -53.61 22.93 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.709 0.803 . . . . 0.0 109.09 171.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.16 -47.48 71.93 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 125.265 1.426 . . . . 0.0 112.086 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -89.25 -9.63 49.95 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.403 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.5 m 52.79 56.08 8.1 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 125.016 1.326 . . . . 0.0 111.02 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -157.17 168.31 27.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.419 0.688 . . . . 0.0 110.853 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.55 116.83 2.89 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 126.215 1.864 . . . . 0.0 108.783 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.0 m -99.12 100.56 11.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 176.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.6 t -106.3 125.52 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.502 1.121 . . . . 0.0 109.537 -170.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -95.53 127.93 41.98 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 168.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -150.26 164.36 35.93 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.17 0.588 . . . . 0.0 111.779 -169.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -98.36 114.25 65.02 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.737 1.215 . . . . 0.0 109.013 172.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -47.74 -34.35 21.07 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.741 3.627 . . . . 0.0 114.93 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.5 mt -65.92 -33.9 76.89 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.457 0.703 . . . . 0.0 111.584 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.75 -35.3 9.84 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.895 0.878 . . . . 0.0 111.578 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.3 t -147.4 178.37 8.48 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.698 0.681 . . . . 0.0 110.539 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.3 p -148.88 159.85 36.73 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 124.624 1.17 . . . . 0.0 109.714 -174.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.41 -40.42 62.47 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.511 2.807 . . . . 0.0 112.814 176.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -66.79 -41.05 88.28 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.555 1.142 . . . . 0.0 110.927 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.8 m -67.55 -45.65 75.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.1 0.56 . . . . 0.0 110.326 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.0 mt -60.73 -49.55 77.05 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.241 1.016 . . . . 0.0 110.253 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.9 ttp85 -52.1 -47.24 65.38 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.164 0.986 . . . . 0.0 109.988 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.19 -45.23 83.22 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.569 1.08 . . . . 0.0 112.293 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.59 -48.24 75.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.635 0.717 . . . . 0.0 111.099 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.93 -42.45 89.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.92 0.888 . . . . 0.0 109.981 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -63.51 -41.04 98.52 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.628 1.171 . . . . 0.0 110.568 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.36 -41.48 98.83 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.01 0.924 . . . . 0.0 111.182 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.9 mtp -57.83 -44.27 86.36 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.097 0.408 . . . . 0.0 110.203 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.13 61.76 0.16 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 123.651 0.643 . . . . 0.0 111.702 169.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -140.33 152.43 45.82 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.999 0.919 . . . . 0.0 109.414 175.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -79.74 86.24 5.35 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.57 128.99 45.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.626 1.171 . . . . 0.0 110.461 -173.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.9 p -142.34 151.19 41.68 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.154 1.382 . . . . 0.0 109.039 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -69.29 137.69 53.24 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.6 t -87.63 55.97 3.72 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.043 0.537 . . . . 0.0 110.146 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.618 -1.182 . . . . 0.0 110.662 179.404 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.9 p -99.32 153.0 19.31 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.248 1.019 . . . . 0.0 110.516 -171.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -114.72 172.09 7.25 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 125.485 1.514 . . . . 0.0 109.166 -174.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -134.76 141.27 46.42 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.061 0.945 . . . . 0.0 108.969 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -131.56 144.8 51.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.406 1.082 . . . . 0.0 109.49 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.97 123.75 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.2 mt -116.37 121.76 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -69.94 118.19 12.47 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.3 mt -110.8 102.34 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -99.65 149.03 23.71 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.562 0.745 . . . . 0.0 109.27 176.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.67 26.04 16.28 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.667 1.127 . . . . 0.0 112.359 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 88.8 mtp -86.45 129.71 34.76 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.107 0.963 . . . . 0.0 108.413 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.9 p -73.2 -67.72 0.55 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.013 0.525 . . . . 0.0 110.521 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -161.0 -157.07 0.49 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.04 0.936 . . . . 0.0 108.911 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -73.99 77.88 1.68 Allowed 'General case' 0 C--N 1.343 0.287 0 C-N-CA 124.158 0.983 . . . . 0.0 109.174 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 p -165.86 -57.25 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.366 1.867 . . . . 0.0 106.553 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.31 -40.51 96.54 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.939 0.895 . . . . 0.0 109.239 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.5 t -49.86 -59.3 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.358 1.063 . . . . 0.0 109.928 173.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.89 -45.5 94.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.609 1.164 . . . . 0.0 111.037 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.8 t -59.55 -57.88 11.04 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.956 0.902 . . . . 0.0 110.828 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.3 mt -55.42 -54.4 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.964 0.906 . . . . 0.0 109.587 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -55.38 -49.02 73.4 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.144 0.578 . . . . 0.0 110.791 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.39 -37.27 91.75 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.002 1.287 . . . . 0.0 113.284 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.6 t -77.84 -57.81 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.253 1.026 . . . . 0.0 110.17 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.38 -37.63 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.452 0.701 . . . . 0.0 111.404 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.9 p -51.6 -30.78 22.44 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -89.42 -8.29 53.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.815 0.846 . . . . 0.0 112.434 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -72.56 143.62 85.3 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 118.751 0.705 . . . . 0.0 109.816 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -47.51 134.27 21.0 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.791 2.994 . . . . 0.0 112.655 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.56 -31.76 5.64 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-O 118.724 -1.042 . . . . 0.0 113.457 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.5 t -67.12 134.02 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.341 1.071 . . . . 0.0 110.146 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -113.88 -102.94 0.41 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.192 1.397 . . . . 0.0 108.297 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.4 p -82.44 154.05 25.35 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.161 0.584 . . . . 0.0 109.79 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.5 tt -150.33 145.32 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.326 0.65 . . . . 0.0 110.1 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -139.97 103.47 4.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.5 t -91.67 108.6 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.2 t -89.52 129.23 36.03 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.145 0.578 . . . . 0.0 110.111 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tt -73.96 -57.01 4.25 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.813 1.245 . . . . 0.0 108.152 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.79 -45.7 78.13 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.524 1.53 . . . . 0.0 112.356 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -89.12 -10.54 46.91 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.893 0.477 . . . . 0.0 111.013 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.2 m 56.23 58.15 4.5 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.057 1.343 . . . . 0.0 110.614 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -146.03 163.59 34.75 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.86 0.464 . . . . 0.0 111.618 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.04 107.59 1.8 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.9 m -99.13 99.84 10.9 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.3 t -114.91 126.01 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 124.791 1.236 . . . . 0.0 109.608 -169.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -89.92 131.61 35.74 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -150.51 156.96 42.44 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.274 0.629 . . . . 0.0 112.256 -170.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -93.53 120.08 66.67 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.703 1.201 . . . . 0.0 110.117 173.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.53 -41.79 29.51 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 125.069 3.846 . . . . 0.0 115.785 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -68.47 -29.74 68.43 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.614 0.365 . . . . 0.0 111.73 -173.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.2 mt -99.64 -32.66 10.96 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.227 1.011 . . . . 0.0 111.893 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -153.23 176.22 12.19 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.677 0.671 . . . . 0.0 110.05 173.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.9 p -150.09 162.6 27.39 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.039 0.936 . . . . 0.0 109.993 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.3 -44.34 49.77 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.439 2.759 . . . . 0.0 112.755 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.05 -34.12 77.3 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.502 0.721 . . . . 0.0 112.571 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.1 m -70.93 -47.67 57.79 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 122.944 0.498 . . . . 0.0 109.732 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.9 mt -58.36 -50.31 74.12 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.943 0.897 . . . . 0.0 110.05 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -52.29 -47.4 65.91 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.791 1.236 . . . . 0.0 110.533 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.82 -47.87 76.0 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.32 0.962 . . . . 0.0 112.156 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.5 -46.77 86.95 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.561 0.744 . . . . 0.0 111.401 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.7 mt -60.97 -43.99 97.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.56 0.744 . . . . 0.0 109.938 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -63.14 -41.67 99.34 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.712 0.805 . . . . 0.0 110.945 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.13 -43.49 98.81 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.253 1.021 . . . . 0.0 111.184 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 69.5 mtm -58.46 -50.04 75.14 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 117.842 0.292 . . . . 0.0 110.382 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.39 63.01 0.09 OUTLIER Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 171.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -140.25 142.98 35.74 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.27 93.51 1.11 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.9 120.7 40.19 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.219 1.407 . . . . 0.0 109.425 -174.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 47.1 p -138.27 140.26 39.55 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.356 1.062 . . . . 0.0 108.617 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 68.3 mt -68.1 123.83 21.74 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.596 0.358 . . . . 0.0 110.31 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.0 t -85.87 -49.65 7.73 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.832 0.853 . . . . 0.0 108.824 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.5 t70 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 116.928 -1.511 . . . . 0.0 108.305 -179.941 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 120.542 0.21 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.1 p -139.55 118.05 12.17 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.926 1.29 . . . . 0.0 109.3 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -139.58 164.99 28.44 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.518 1.127 . . . . 0.0 109.196 172.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -128.5 151.81 48.99 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.554 1.142 . . . . 0.0 109.438 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -145.44 148.68 33.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.298 1.039 . . . . 0.0 109.394 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.93 123.54 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.4 mt -119.06 128.86 75.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -70.28 121.47 17.69 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 171.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.7 mt -125.95 95.01 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.75 151.74 20.9 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.31 15.79 56.64 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.31 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 54.8 mtt -55.9 -57.65 11.2 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 118.755 1.277 . . . . 0.0 109.764 174.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 m 77.45 -63.06 0.36 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.165 1.786 . . . . 0.0 112.106 174.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.7 t -117.78 151.63 36.92 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.364 1.065 . . . . 0.0 111.228 -169.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -58.56 -29.39 66.34 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.603 1.161 . . . . 0.0 112.03 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.0 m -55.11 -48.52 73.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.858 0.863 . . . . 0.0 110.18 172.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.3 m -63.8 -44.26 93.83 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.736 0.814 . . . . 0.0 110.679 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.3 t -51.92 -54.7 12.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 C-N-CA 123.302 0.641 . . . . 0.0 109.641 176.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -61.51 -42.65 99.13 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.668 0.787 . . . . 0.0 111.432 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -59.24 -55.43 35.01 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.131 0.572 . . . . 0.0 110.663 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.2 mt -54.25 -55.8 12.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 123.873 0.869 . . . . 0.0 109.155 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -54.44 -54.67 37.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.85 0.86 . . . . 0.0 111.091 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.09 -53.57 44.64 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.281 0.943 . . . . 0.0 112.364 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.61 -54.24 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 117.382 0.591 . . . . 0.0 110.438 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.9 mm -61.78 -40.6 87.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.699 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.1 t -51.2 -36.21 40.27 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.427 0.691 . . . . 0.0 112.089 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -88.97 -11.06 45.41 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.464 0.705 . . . . 0.0 112.131 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -73.08 139.43 79.5 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 119.466 1.03 . . . . 0.0 109.962 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -45.22 137.81 10.09 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.354 3.369 . . . . 0.0 113.665 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.34 -38.79 3.01 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-O 118.841 -0.977 . . . . 0.0 112.49 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.34 134.02 30.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 CA-C-N 118.254 1.027 . . . . 0.0 110.088 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -104.61 -102.09 0.31 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.849 1.259 . . . . 0.0 107.926 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.8 p -87.31 152.83 21.96 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.464 0.706 . . . . 0.0 109.849 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 tt -150.69 140.23 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.645 0.778 . . . . 0.0 109.676 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -129.84 110.95 12.13 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.924 1.29 . . . . 0.0 108.659 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.34 122.79 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.363 1.065 . . . . 0.0 108.572 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.7 t -115.63 123.66 48.98 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.823 1.249 . . . . 0.0 110.588 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.6 tp -69.83 -48.24 59.71 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.745 1.218 . . . . 0.0 109.823 170.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.12 -46.74 65.46 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.691 1.197 . . . . 0.0 111.639 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -89.51 -15.03 33.91 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.419 0.688 . . . . 0.0 111.7 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.2 m 54.52 54.68 8.97 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 125.14 1.376 . . . . 0.0 110.415 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -154.32 163.42 40.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.454 0.702 . . . . 0.0 110.928 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.54 119.6 3.74 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.4 m -99.2 104.52 16.49 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 t -112.86 127.75 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 124.655 1.182 . . . . 0.0 109.575 -170.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -96.73 133.07 41.76 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 169.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -150.38 169.79 20.58 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.773 0.429 . . . . 0.0 111.865 -171.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -103.67 110.76 64.47 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 125.133 1.373 . . . . 0.0 109.268 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -41.66 -38.73 4.47 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 125.268 3.979 . . . . 0.0 115.227 170.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.9 mt -62.51 -35.12 78.36 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.25 0.62 . . . . 0.0 111.955 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.9 mt -104.4 -31.57 9.45 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.299 1.04 . . . . 0.0 112.344 -170.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 t -150.1 176.76 10.52 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.408 0.683 . . . . 0.0 110.173 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.3 p -147.45 163.43 27.91 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.36 1.064 . . . . 0.0 109.929 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.92 -41.87 67.92 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.326 2.684 . . . . 0.0 112.443 176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -66.47 -40.85 89.6 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.786 0.834 . . . . 0.0 111.39 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.9 m -62.66 -47.24 84.56 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.779 0.432 . . . . 0.0 110.242 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.6 mt -62.07 -47.53 84.25 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.106 0.963 . . . . 0.0 110.606 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -51.66 -48.54 63.37 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.495 1.118 . . . . 0.0 109.954 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.86 -45.01 92.09 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.485 1.04 . . . . 0.0 112.255 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.43 -49.29 76.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.477 0.711 . . . . 0.0 111.159 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.59 -41.81 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.707 0.803 . . . . 0.0 110.164 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -61.42 -43.0 99.63 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.942 0.897 . . . . 0.0 110.707 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.4 -42.27 99.31 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.917 0.887 . . . . 0.0 111.091 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mtp -58.67 -44.84 90.32 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.973 0.352 . . . . 0.0 110.379 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.39 59.92 0.17 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 123.756 0.693 . . . . 0.0 111.976 169.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -140.31 152.31 45.75 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.051 0.94 . . . . 0.0 108.95 174.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -75.9 91.5 3.02 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.31 122.47 42.5 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.54 1.136 . . . . 0.0 109.95 -172.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.6 m -148.54 132.59 17.24 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.54 1.136 . . . . 0.0 108.304 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.2 mt -60.73 142.01 56.3 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.147 0.579 . . . . 0.0 111.477 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.68 -54.52 2.56 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.945 1.298 . . . . 0.0 108.197 172.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 . . . . . 0 C--O 1.249 1.077 0 C-N-CA 125.473 1.509 . . . . 0.0 107.981 -178.94 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 64.6 tp . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 119.838 -0.125 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.4 p -139.47 137.11 35.27 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.142 0.977 . . . . 0.0 108.839 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.1 mm100 -126.33 162.08 26.34 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.78 1.632 . . . . 0.0 109.355 -177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -108.94 145.11 35.97 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.388 1.075 . . . . 0.0 109.385 176.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 t -134.99 133.7 39.74 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.028 0.931 . . . . 0.0 109.336 172.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.93 108.32 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.7 mt -99.55 120.6 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -82.93 109.84 17.39 Favored 'General case' 0 C--N 1.334 -0.072 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.8 mt -111.73 106.19 20.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.403 1.081 . . . . 0.0 108.278 -172.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -99.6 145.4 27.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.07 -5.71 46.32 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.553 -1.137 . . . . 0.0 113.584 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.2 mtm -55.21 -60.44 3.39 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-N 119.069 1.434 . . . . 0.0 110.296 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 m 75.15 -63.33 0.42 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.754 1.622 . . . . 0.0 112.517 170.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.1 m -108.27 154.52 21.67 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.401 1.081 . . . . 0.0 111.142 -170.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -62.58 -27.72 69.39 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.808 0.843 . . . . 0.0 111.608 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.7 m -56.62 -48.02 78.39 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.364 0.665 . . . . 0.0 110.333 173.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -63.33 -45.04 93.09 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.667 0.787 . . . . 0.0 110.569 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.0 t -54.8 -53.86 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.625 0.77 . . . . 0.0 110.318 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -58.23 -46.72 85.39 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.588 1.155 . . . . 0.0 111.22 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.6 t -57.18 -52.67 64.37 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.313 0.645 . . . . 0.0 110.684 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.5 mt -55.01 -61.21 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 124.461 1.104 . . . . 0.0 110.075 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -59.3 -41.08 88.16 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.985 0.357 . . . . 0.0 111.386 -174.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.39 -56.08 27.0 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.24 -52.51 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.673 0.789 . . . . 0.0 110.726 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.5 mm -62.52 -37.58 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.434 0.693 . . . . 0.0 111.56 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.1 m -54.32 -29.51 47.98 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.698 0.681 . . . . 0.0 112.738 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -89.31 -6.38 56.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.288 0.635 . . . . 0.0 112.222 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -72.81 139.75 80.55 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 119.104 0.865 . . . . 0.0 109.251 177.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.05 131.56 29.13 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.004 2.469 . . . . 0.0 110.065 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.33 -36.19 4.54 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-O 118.872 -0.96 . . . . 0.0 111.795 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.53 131.65 32.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-N 118.141 0.971 . . . . 0.0 109.866 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -104.07 -101.63 0.31 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.943 1.297 . . . . 0.0 107.81 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.3 p -90.06 160.35 16.36 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.873 0.869 . . . . 0.0 110.079 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.7 tt -150.39 146.58 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 123.861 0.864 . . . . 0.0 109.488 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.94 109.78 7.6 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 173.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -98.67 103.71 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.0 t -89.78 118.98 29.78 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.602 0.761 . . . . 0.0 109.132 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.0 tp -70.56 -44.26 67.81 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.693 0.797 . . . . 0.0 109.656 172.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.12 -48.78 67.58 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.775 1.23 . . . . 0.0 111.666 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -89.39 -5.91 57.04 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.105 0.562 . . . . 0.0 111.534 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.8 m 52.07 55.78 8.72 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.52 1.528 . . . . 0.0 111.255 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -155.3 151.29 27.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.127 0.489 . . . . 0.0 111.815 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.67 113.56 4.27 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 126.242 1.877 . . . . 0.0 108.621 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.6 m -98.78 97.14 8.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 t -104.64 126.91 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.348 1.059 . . . . 0.0 109.399 -170.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -92.67 131.07 38.07 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -149.96 164.14 36.26 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.242 0.617 . . . . 0.0 110.971 -171.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -101.38 114.4 65.71 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.408 1.083 . . . . 0.0 109.151 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.52 -35.35 16.4 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 125.002 3.801 . . . . 0.0 115.069 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.27 -29.69 69.37 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.515 0.726 . . . . 0.0 111.833 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.8 -46.92 5.23 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.054 0.942 . . . . 0.0 110.725 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 t -138.56 -178.95 5.53 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.965 0.906 . . . . 0.0 110.107 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.9 p -148.35 161.69 33.01 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.872 0.869 . . . . 0.0 110.287 -173.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -51.43 -50.01 15.33 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.494 2.796 . . . . 0.0 112.73 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.95 -33.21 75.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.897 0.479 . . . . 0.0 112.115 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.5 m -64.81 -48.75 73.29 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.9 mt -61.86 -46.98 87.07 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.497 0.719 . . . . 0.0 110.601 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.8 ttp85 -53.78 -46.47 71.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.043 0.937 . . . . 0.0 109.88 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.99 -42.71 93.03 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.521 1.058 . . . . 0.0 112.309 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.21 -47.13 83.82 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.999 0.899 . . . . 0.0 111.03 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mm -58.59 -44.76 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 122.73 0.412 . . . . 0.0 110.108 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -61.7 -38.99 89.9 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.25 0.62 . . . . 0.0 111.011 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.59 -43.42 93.91 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.315 1.046 . . . . 0.0 110.94 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.5 mtp -58.7 -41.51 86.43 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.958 0.344 . . . . 0.0 110.472 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.7 57.92 0.23 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 123.959 0.79 . . . . 0.0 111.919 169.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -140.27 145.53 37.42 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -73.92 91.13 1.98 Allowed 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.662 0.785 . . . . 0.0 109.565 -174.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.84 127.72 45.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.04 1.336 . . . . 0.0 110.374 -174.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.1 m -144.76 130.99 19.55 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.363 1.065 . . . . 0.0 108.515 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.6 mt -64.06 158.41 22.72 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.426 0.69 . . . . 0.0 111.627 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.2 p -77.33 66.71 3.14 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.008 0.923 . . . . 0.0 109.489 172.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.02 -1.466 . . . . 0.0 108.806 -176.962 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 49.1 tp . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.2 p -140.11 126.46 20.07 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.74 1.216 . . . . 0.0 108.466 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -142.18 167.11 22.9 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.349 1.46 . . . . 0.0 108.9 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -128.27 151.46 49.27 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.51 1.124 . . . . 0.0 109.429 175.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 t -150.13 140.94 22.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.589 0.755 . . . . 0.0 110.025 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.1 t -99.73 129.49 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 171.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.4 mt -121.47 123.66 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -78.66 120.47 23.38 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.0 mt -119.73 103.32 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 125.917 1.687 . . . . 0.0 106.708 -173.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -99.97 144.85 28.53 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.923 0.489 . . . . 0.0 110.23 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.47 34.76 7.77 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.788 1.185 . . . . 0.0 112.852 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.9 mtm -93.45 102.24 14.46 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 117.794 0.797 . . . . 0.0 109.563 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.8 m -60.12 147.05 40.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.859 0.863 . . . . 0.0 110.683 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.7 t -48.59 124.49 8.34 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.281 1.432 . . . . 0.0 112.381 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.289 5.7 p30 64.85 -54.05 0.3 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 129.061 2.944 . . . . 0.0 115.486 174.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.7 p -55.67 -57.69 10.91 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.46 1.104 . . . . 0.0 111.316 -175.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.0 m -64.57 -47.36 79.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.476 0.71 . . . . 0.0 110.285 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -51.16 -56.56 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.151 0.98 . . . . 0.0 110.445 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -62.38 -49.06 77.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.308 1.043 . . . . 0.0 111.494 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.3 p -61.52 -50.12 73.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.004 0.365 . . . . 0.0 111.568 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.8 mt -55.16 -55.07 18.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 C-N-CA 123.769 0.828 . . . . 0.0 109.343 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.3 -49.62 71.67 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.25 0.62 . . . . 0.0 110.999 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.4 -51.33 59.76 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.633 1.111 . . . . 0.0 112.347 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.73 -54.29 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 117.75 0.775 . . . . 0.0 110.311 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.8 mm -64.3 -38.27 82.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 118.911 -0.566 . . . . 0.0 111.638 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.4 p -53.74 -31.73 49.5 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.85 0.75 . . . . 0.0 112.721 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -89.58 -3.65 58.2 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.049 0.939 . . . . 0.0 112.395 -174.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -72.03 143.26 86.15 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 119.071 0.851 . . . . 0.0 109.64 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -46.82 128.47 13.4 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.894 3.063 . . . . 0.0 112.665 176.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.01 -30.86 7.09 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.391 177.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.5 t -69.66 125.45 27.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 CA-C-N 118.694 1.247 . . . . 0.0 109.832 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -95.9 -103.04 0.16 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.7 p -86.58 155.62 20.38 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.415 0.686 . . . . 0.0 110.213 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tt -150.66 139.06 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.922 0.889 . . . . 0.0 109.208 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -128.91 103.8 7.24 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.655 1.182 . . . . 0.0 108.77 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -93.25 121.91 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 123.967 0.907 . . . . 0.0 108.769 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.7 t -118.09 124.44 48.07 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.911 1.284 . . . . 0.0 109.725 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tt -71.09 -46.97 60.81 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.273 1.029 . . . . 0.0 109.487 172.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.36 -47.46 56.04 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.732 1.213 . . . . 0.0 111.778 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -89.57 -8.72 52.06 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.365 0.666 . . . . 0.0 111.774 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.1 m 51.87 55.64 8.99 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.779 1.632 . . . . 0.0 110.709 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -155.77 170.41 22.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.005 0.522 . . . . 0.0 111.765 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.7 118.31 2.58 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.4 m -98.98 100.49 11.66 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 t -106.72 128.33 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.556 1.142 . . . . 0.0 109.757 -169.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -96.52 130.54 43.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 168.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -150.22 163.39 38.39 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.009 0.523 . . . . 0.0 111.881 -171.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -97.08 113.98 63.95 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.916 1.286 . . . . 0.0 109.381 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -45.69 -37.41 15.8 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 124.942 3.762 . . . . 0.0 114.777 172.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -64.61 -34.35 78.07 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.505 0.722 . . . . 0.0 111.811 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.4 mt -104.09 -30.47 10.22 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.121 0.969 . . . . 0.0 112.279 -172.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.0 t -151.78 177.96 9.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.302 0.641 . . . . 0.0 110.107 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.3 p -149.21 162.05 30.16 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 125.106 1.363 . . . . 0.0 109.549 -172.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.14 -38.43 80.95 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.934 2.422 . . . . 0.0 112.03 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.28 -48.92 71.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.587 1.155 . . . . 0.0 111.44 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.4 p -62.56 -42.49 99.58 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.503 0.321 . . . . 0.0 111.096 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.5 mt -64.83 -47.8 76.68 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.385 0.674 . . . . 0.0 110.365 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.5 ttp85 -51.99 -48.03 64.62 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.166 0.986 . . . . 0.0 110.219 171.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.63 -46.69 81.13 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.294 0.95 . . . . 0.0 112.246 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.42 -48.64 78.79 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.638 0.775 . . . . 0.0 111.169 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.0 mt -60.16 -42.42 90.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.71 0.804 . . . . 0.0 110.059 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.62 -39.94 95.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.579 0.751 . . . . 0.0 110.831 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.69 -41.66 98.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.022 0.929 . . . . 0.0 111.003 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.9 mtp -58.31 -43.4 88.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.984 0.356 . . . . 0.0 110.268 172.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.26 58.39 0.18 Allowed Glycine 0 C--N 1.34 0.778 0 C-N-CA 123.827 0.727 . . . . 0.0 111.975 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -140.29 142.48 35.68 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.004 0.922 . . . . 0.0 108.935 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -69.75 92.36 0.67 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.67 123.95 44.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.232 1.413 . . . . 0.0 109.302 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.1 p -138.66 136.74 36.2 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.703 1.201 . . . . 0.0 108.872 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 61.6 mt -68.73 126.9 31.19 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.615 0.366 . . . . 0.0 110.215 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.3 t -104.44 -34.89 8.1 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.455 1.102 . . . . 0.0 110.263 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 C--O 1.25 1.116 0 C-N-CA 128.094 2.558 . . . . 0.0 109.931 -175.903 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 66.0 tp . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.7 p -98.76 156.58 16.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.906 0.882 . . . . 0.0 110.297 -169.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -131.22 169.31 16.12 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.724 1.61 . . . . 0.0 109.21 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -125.02 152.97 43.55 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.428 1.091 . . . . 0.0 109.567 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -149.75 138.29 20.76 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.447 0.699 . . . . 0.0 110.115 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.83 124.18 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 172.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.4 mt -119.81 120.17 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -75.86 126.87 31.84 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.8 mt -122.13 111.41 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.639 1.176 . . . . 0.0 108.014 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -99.61 147.61 25.19 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.21 2.02 51.19 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.279 0.942 . . . . 0.0 112.885 -177.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.8 mtm -76.59 81.25 3.25 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.688 1.244 . . . . 0.0 108.624 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.8 m -50.74 -50.99 54.34 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.606 1.562 . . . . 0.0 112.6 -170.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.5 m -141.34 179.32 6.85 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.105 0.962 . . . . 0.0 110.107 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -54.98 -32.14 61.38 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.549 1.14 . . . . 0.0 111.656 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.9 p -54.06 -50.26 67.14 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.786 0.834 . . . . 0.0 111.222 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -59.07 -50.3 74.59 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.755 0.822 . . . . 0.0 110.281 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -53.85 -52.51 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 124.87 1.268 . . . . 0.0 110.922 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -59.22 -46.12 89.31 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.5 1.12 . . . . 0.0 111.142 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.6 m -58.53 -52.87 63.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.177 0.591 . . . . 0.0 110.792 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.1 mt -56.55 -53.65 38.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 123.599 0.76 . . . . 0.0 109.689 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -52.82 -55.51 22.51 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.193 0.997 . . . . 0.0 110.739 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.43 -52.07 53.92 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.161 0.886 . . . . 0.0 112.186 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.8 t -61.01 -56.18 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.268 0.627 . . . . 0.0 110.907 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.7 mm -62.01 -37.11 77.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.259 0.624 . . . . 0.0 111.39 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.0 t -49.45 -40.7 37.88 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 123.763 0.825 . . . . 0.0 112.673 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -89.47 -6.08 56.78 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -171.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -75.07 148.39 84.27 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 119.165 0.893 . . . . 0.0 110.459 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -44.14 133.86 8.72 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.494 3.463 . . . . 0.0 113.707 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.66 -40.57 2.92 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-O 118.959 -0.911 . . . . 0.0 112.674 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.7 t -68.31 134.91 29.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 CA-C-N 117.983 0.892 . . . . 0.0 110.168 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -109.29 -98.67 0.39 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.602 1.161 . . . . 0.0 107.88 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.7 p -87.59 152.41 22.2 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.634 0.774 . . . . 0.0 109.509 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.0 tt -150.56 136.65 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 123.499 0.719 . . . . 0.0 109.224 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.23 101.47 6.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.869 1.267 . . . . 0.0 108.39 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.8 t -96.88 122.93 48.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.9 t -107.02 130.67 54.62 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.793 1.237 . . . . 0.0 110.332 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.3 tp -69.62 -52.39 26.36 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.705 0.802 . . . . 0.0 109.119 170.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.53 -47.51 69.88 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 125.22 1.408 . . . . 0.0 112.114 -176.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -89.25 -9.69 49.74 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.888 0.475 . . . . 0.0 111.457 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.1 m 52.52 56.43 7.68 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.107 1.363 . . . . 0.0 110.783 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -155.65 166.35 33.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.095 0.558 . . . . 0.0 111.191 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.67 115.03 2.49 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.507 2.003 . . . . 0.0 108.707 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.9 m -99.28 98.82 9.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 t -106.24 131.3 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 124.453 1.101 . . . . 0.0 109.693 -170.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -99.04 130.34 45.36 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -150.19 163.27 38.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.119 0.568 . . . . 0.0 111.825 -169.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -98.13 113.84 64.4 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.686 1.195 . . . . 0.0 109.293 172.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -44.45 -36.96 10.26 Favored 'Trans proline' 0 C--N 1.349 0.556 1 C-N-CA 125.356 4.037 . . . . 0.0 115.024 173.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.2 mt -64.5 -36.39 84.06 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.109 0.564 . . . . 0.0 111.789 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.2 mt -100.0 -32.96 10.7 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.12 0.968 . . . . 0.0 112.244 -171.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.3 t -149.35 178.86 8.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.29 0.636 . . . . 0.0 110.093 176.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.9 p -150.21 162.9 26.34 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 124.172 0.989 . . . . 0.0 109.759 -174.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -53.07 -46.94 30.33 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.191 2.594 . . . . 0.0 112.372 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.42 -33.9 76.75 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.016 0.526 . . . . 0.0 112.287 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 98.3 m -67.73 -45.32 75.35 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.376 0.535 . . . . 0.0 110.096 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.5 mt -61.19 -47.33 86.67 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.65 0.78 . . . . 0.0 110.461 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -52.64 -47.04 67.34 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.052 0.941 . . . . 0.0 110.269 171.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.48 -45.82 82.85 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.303 0.954 . . . . 0.0 112.313 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.34 -46.36 83.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.785 0.834 . . . . 0.0 111.35 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.4 mt -62.43 -43.46 98.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.758 0.823 . . . . 0.0 110.08 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.35 -41.7 98.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.293 1.037 . . . . 0.0 110.938 176.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.57 -43.91 97.99 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.968 0.907 . . . . 0.0 111.132 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.9 mtm -59.32 -50.88 72.28 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 117.911 0.323 . . . . 0.0 110.213 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.71 60.84 0.09 OUTLIER Glycine 0 C--N 1.34 0.802 0 C-N-CA 123.519 0.581 . . . . 0.0 111.789 171.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -140.09 141.94 36.12 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 171.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -75.7 91.07 2.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.661 0.784 . . . . 0.0 109.49 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.36 134.8 41.69 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.632 1.173 . . . . 0.0 110.362 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 95.0 m -144.07 133.8 23.71 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.983 1.313 . . . . 0.0 108.369 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.0 mt -64.95 128.48 35.95 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.215 0.606 . . . . 0.0 109.872 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.9 t -99.24 -58.66 1.88 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.9 t70 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 124.932 1.293 . . . . 0.0 107.798 178.39 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 62.6 p -130.3 60.32 1.62 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.614 1.166 . . . . 0.0 107.953 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -95.47 139.6 31.51 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -101.13 142.31 32.76 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.81 0.444 . . . . 0.0 110.244 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -135.81 137.72 41.84 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.418 1.087 . . . . 0.0 109.127 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.3 t -99.96 129.58 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.516 -1.291 . . . . 0.0 107.516 174.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.1 mt -126.04 122.01 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -76.99 124.18 27.4 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.5 mt -117.37 109.14 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 124.989 1.315 . . . . 0.0 107.874 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -99.97 149.81 23.07 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 174.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.35 1.82 56.74 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.072 0.844 . . . . 0.0 113.232 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.0 mtm -74.74 104.58 5.44 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.719 1.26 . . . . 0.0 108.329 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.4 m -55.48 -57.81 10.34 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.268 1.027 . . . . 0.0 111.286 -174.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.6 p -164.0 -164.96 0.93 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.1 0.96 . . . . 0.0 109.395 -176.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -72.44 77.35 1.04 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.504 1.122 . . . . 0.0 110.052 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.1 p -168.72 -54.94 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 126.983 2.113 . . . . 0.0 107.027 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.4 m -58.87 -49.04 79.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.544 1.137 . . . . 0.0 108.73 169.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -49.87 -52.23 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 125.549 1.54 . . . . 0.0 110.331 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -62.48 -45.74 91.65 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.676 0.79 . . . . 0.0 111.009 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -58.69 -53.26 60.38 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.667 0.787 . . . . 0.0 110.774 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.0 mt -55.78 -54.8 22.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 C-N-CA 124.064 0.946 . . . . 0.0 109.402 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.63 -54.49 32.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.73 0.812 . . . . 0.0 110.86 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.68 -53.65 43.51 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.234 0.921 . . . . 0.0 112.514 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.9 t -63.69 -54.75 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 117.41 0.605 . . . . 0.0 110.813 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.78 -37.31 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 118.844 -0.598 . . . . 0.0 110.929 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.4 t -50.14 -34.8 23.45 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.637 0.653 . . . . 0.0 112.564 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -89.64 -10.52 45.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.128 0.971 . . . . 0.0 112.472 -174.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -69.96 146.29 95.04 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 119.011 0.823 . . . . 0.0 110.062 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -46.34 135.6 15.52 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 124.033 3.156 . . . . 0.0 113.101 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.08 -37.32 3.34 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 118.856 -0.969 . . . . 0.0 112.763 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 52.1 t -67.17 141.21 18.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-N 118.302 1.051 . . . . 0.0 110.216 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -116.72 -98.67 0.45 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.895 1.278 . . . . 0.0 108.011 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.4 p -90.2 154.96 19.35 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.535 0.734 . . . . 0.0 109.796 174.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.1 tt -150.85 139.79 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.519 0.727 . . . . 0.0 109.88 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.71 109.49 12.11 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.841 1.256 . . . . 0.0 108.399 174.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.6 125.97 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.9 t -115.57 127.97 55.63 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.86 1.264 . . . . 0.0 110.151 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.8 tp -70.73 -50.47 35.81 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.098 0.959 . . . . 0.0 109.65 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.76 -43.76 69.43 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.019 1.328 . . . . 0.0 111.832 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -89.18 -16.52 31.15 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.162 0.585 . . . . 0.0 111.122 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.0 m 55.21 56.29 6.63 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 125.141 1.376 . . . . 0.0 110.223 -177.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -154.84 168.8 25.69 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.062 0.545 . . . . 0.0 111.475 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.04 115.79 2.41 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 126.101 1.81 . . . . 0.0 108.6 176.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.7 m -99.22 99.1 10.03 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.5 t -106.9 126.71 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 124.791 1.236 . . . . 0.0 109.374 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -90.04 131.57 35.84 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -150.18 165.16 33.72 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.196 0.599 . . . . 0.0 112.022 -172.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -100.69 113.83 65.68 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.348 1.459 . . . . 0.0 108.688 172.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.65 -35.79 17.77 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 125.188 3.925 . . . . 0.0 114.798 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.26 -34.27 77.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.383 0.673 . . . . 0.0 111.73 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.75 -36.22 9.53 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.846 0.858 . . . . 0.0 111.557 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.1 t -147.22 176.74 9.74 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.62 0.645 . . . . 0.0 110.655 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.7 p -148.46 161.25 34.27 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.62 1.168 . . . . 0.0 109.729 -175.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.97 -38.74 59.38 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.42 2.747 . . . . 0.0 112.914 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -65.77 -44.32 86.19 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.482 1.113 . . . . 0.0 110.432 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.4 m -64.54 -45.4 87.31 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.056 0.543 . . . . 0.0 110.374 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.3 mt -63.22 -46.35 87.38 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.025 0.93 . . . . 0.0 110.775 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -52.21 -48.93 64.83 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.885 0.874 . . . . 0.0 109.805 170.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.15 -44.92 83.86 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.301 0.953 . . . . 0.0 112.582 176.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.96 -48.13 77.71 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.728 0.811 . . . . 0.0 111.287 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.6 mt -60.08 -41.43 86.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.916 0.886 . . . . 0.0 109.897 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -64.29 -40.19 95.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.382 0.673 . . . . 0.0 111.008 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.56 -41.9 98.37 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.027 0.931 . . . . 0.0 111.017 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.8 mtp -58.31 -45.3 88.3 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 172.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.39 57.04 0.14 Allowed Glycine 0 C--N 1.34 0.764 0 C-N-CA 123.807 0.718 . . . . 0.0 111.747 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -140.35 139.35 35.36 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.792 0.837 . . . . 0.0 108.763 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -70.64 93.05 0.89 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.726 0.81 . . . . 0.0 109.497 -176.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.5 131.44 45.5 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.75 1.22 . . . . 0.0 109.751 -173.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.0 p -139.25 139.19 37.34 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.857 1.263 . . . . 0.0 108.603 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.61 143.97 57.39 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.83 0.452 . . . . 0.0 110.467 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.3 t -135.87 51.26 2.05 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 116.986 -1.483 . . . . 0.0 109.162 -169.678 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 66.3 tp . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 119.866 -0.112 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.8 p -140.08 152.19 45.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.192 0.997 . . . . 0.0 109.239 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -143.53 160.14 41.16 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.922 1.689 . . . . 0.0 108.554 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -120.03 142.7 48.59 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.099 0.96 . . . . 0.0 109.273 176.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.6 t -135.42 140.77 45.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.315 1.046 . . . . 0.0 109.712 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.9 t -103.54 111.2 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 175.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.6 mt -99.57 123.9 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -82.28 111.85 18.73 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.9 mt -116.48 106.42 20.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 C-N-CA 124.447 1.099 . . . . 0.0 108.071 -171.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -99.92 151.63 21.09 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.035 0.534 . . . . 0.0 109.59 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.52 12.11 56.26 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.489 1.043 . . . . 0.0 113.259 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.4 mtm -78.26 81.13 4.64 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.676 1.238 . . . . 0.0 109.43 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.5 m -63.74 98.34 0.19 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.642 1.177 . . . . 0.0 111.045 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.5 t 71.27 169.27 0.32 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.323 1.449 . . . . 0.0 111.271 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -75.09 74.81 2.27 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.5 m -156.92 -54.24 0.08 Allowed 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 126.771 2.028 . . . . 0.0 106.754 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.7 m -57.54 -47.03 83.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 168.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.5 t -49.59 -51.29 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.386 1.474 . . . . 0.0 110.595 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -62.87 -48.27 79.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.259 0.624 . . . . 0.0 111.232 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.4 p -61.2 -48.29 82.19 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.87 0.468 . . . . 0.0 111.274 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.2 mt -54.23 -59.03 2.38 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 C-N-CA 124.383 1.073 . . . . 0.0 109.488 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -54.63 -48.84 71.77 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.66 0.784 . . . . 0.0 110.642 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.95 -52.87 43.64 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.635 1.112 . . . . 0.0 112.303 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.2 t -67.69 -55.12 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 117.777 0.788 . . . . 0.0 110.697 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.14 -36.71 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.404 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.6 p -54.36 -29.66 49.12 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.127 0.876 . . . . 0.0 112.832 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.47 -7.93 53.98 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.983 0.913 . . . . 0.0 112.269 -176.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -70.7 142.4 88.5 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 119.022 0.828 . . . . 0.0 109.586 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.09 130.9 26.95 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.955 2.437 . . . . 0.0 109.987 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.93 -32.21 7.75 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 118.923 -0.932 . . . . 0.0 112.111 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.8 t -72.08 138.72 21.0 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 CA-C-N 118.396 1.098 . . . . 0.0 109.365 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -108.68 -101.83 0.37 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.7 p -90.29 153.83 20.17 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.566 0.747 . . . . 0.0 109.394 172.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.1 tt -150.18 129.83 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 123.511 0.724 . . . . 0.0 109.235 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -120.86 105.06 10.34 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 125.139 1.376 . . . . 0.0 108.65 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.44 122.49 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.1 t -110.03 128.25 55.31 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.643 1.177 . . . . 0.0 110.284 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.2 tp -67.25 -53.5 29.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.95 0.9 . . . . 0.0 109.277 171.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.34 -47.39 69.41 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.277 1.431 . . . . 0.0 112.039 -175.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -89.19 -8.03 54.42 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 119.043 -0.504 . . . . 0.0 111.605 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.8 m 51.57 56.25 8.17 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.168 1.387 . . . . 0.0 110.932 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.7 p30 -155.22 163.98 39.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.966 0.506 . . . . 0.0 111.217 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.84 113.32 2.44 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.1 m -98.65 94.66 6.78 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 t -101.03 123.81 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 124.362 1.065 . . . . 0.0 109.064 -170.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -95.07 128.93 42.28 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -150.24 174.19 13.11 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.145 0.578 . . . . 0.0 111.702 -170.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -108.41 110.24 61.64 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.541 1.536 . . . . 0.0 109.157 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -42.8 -40.47 8.13 Favored 'Trans proline' 0 C--N 1.348 0.545 1 C-N-CA 125.444 4.096 . . . . 0.0 114.995 173.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.4 mt -63.34 -31.79 73.04 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.753 0.821 . . . . 0.0 111.774 -176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.45 -34.53 9.12 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.426 1.09 . . . . 0.0 111.981 -173.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 t -149.57 158.25 44.0 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.551 0.74 . . . . 0.0 109.762 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 62.2 p -123.04 160.24 50.5 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.553 1.141 . . . . 0.0 110.068 -178.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -48.45 -39.61 36.37 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.54 2.827 . . . . 0.0 112.839 171.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -65.58 -45.14 84.41 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.139 0.975 . . . . 0.0 110.407 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.9 m -60.12 -46.64 88.96 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.219 0.608 . . . . 0.0 110.476 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.6 mt -62.35 -48.15 81.05 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.828 0.851 . . . . 0.0 110.518 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -53.94 -42.1 68.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.642 0.777 . . . . 0.0 110.469 172.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.72 -43.77 86.58 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.311 0.958 . . . . 0.0 112.171 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.88 -44.64 92.43 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.871 0.835 . . . . 0.0 111.429 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.7 mm -63.07 -41.84 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 122.861 0.464 . . . . 0.0 110.567 176.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.53 -41.92 98.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.836 0.854 . . . . 0.0 110.461 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -62.61 -45.72 91.56 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.014 0.926 . . . . 0.0 110.876 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.2 mmm -58.95 -34.74 72.12 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.302 0.641 . . . . 0.0 111.056 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.44 59.11 0.57 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 124.209 0.909 . . . . 0.0 111.655 169.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -140.2 154.57 46.96 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.911 0.884 . . . . 0.0 109.861 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -81.0 88.68 5.92 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.838 0.855 . . . . 0.0 109.558 -174.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.41 129.5 45.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.956 1.302 . . . . 0.0 110.948 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 89.5 m -144.28 128.72 17.96 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.586 1.154 . . . . 0.0 108.547 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.8 mt -62.41 155.5 25.16 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.519 0.728 . . . . 0.0 111.127 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.7 p -77.33 67.79 3.33 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.444 0.698 . . . . 0.0 109.461 171.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 C--O 1.25 1.13 0 CA-C-O 117.181 -1.39 . . . . 0.0 108.801 -177.193 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.369 0.128 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 45.7 p -140.37 120.64 13.92 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.377 1.071 . . . . 0.0 109.259 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -139.37 172.38 12.9 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.219 1.408 . . . . 0.0 109.131 175.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -140.06 142.74 36.14 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.178 0.991 . . . . 0.0 108.943 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 t -137.24 149.64 47.3 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.507 1.123 . . . . 0.0 109.316 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.0 t -110.87 138.12 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 172.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.0 mt -133.27 125.54 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -70.17 130.17 41.35 Favored 'General case' 0 C--N 1.337 0.061 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.2 mt -130.1 113.6 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -117.18 153.76 32.27 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.656 0.782 . . . . 0.0 109.907 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.39 20.44 48.58 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.403 1.001 . . . . 0.0 112.565 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.6 mtm -82.55 96.7 8.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 117.901 0.85 . . . . 0.0 108.911 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.9 p -71.49 100.19 2.18 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 110.091 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 p 55.26 -171.11 0.07 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.805 2.442 . . . . 0.0 114.614 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -52.97 -30.0 32.27 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.9 1.68 . . . . 0.0 112.949 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.9 m -55.22 -55.05 35.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.124 0.97 . . . . 0.0 110.554 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.2 m -65.73 -43.51 88.79 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.226 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -52.22 -54.19 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.111 0.564 . . . . 0.0 109.927 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -61.22 -45.76 93.24 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.158 0.983 . . . . 0.0 111.18 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.6 m -58.35 -53.68 55.56 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.876 0.47 . . . . 0.0 110.99 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.03 -55.53 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.351 1.06 . . . . 0.0 109.722 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -56.81 -50.34 72.66 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.139 0.975 . . . . 0.0 110.937 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.93 -51.96 56.12 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.902 1.239 . . . . 0.0 112.161 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.16 -54.47 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 117.746 0.773 . . . . 0.0 110.223 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.9 mt -65.44 -35.53 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.796 -172.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.0 p -54.2 -30.55 50.18 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.01 0.823 . . . . 0.0 112.519 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -89.58 -11.23 43.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.077 0.951 . . . . 0.0 112.617 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -68.27 144.46 96.71 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 119.193 0.906 . . . . 0.0 109.918 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.75 132.23 34.28 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.054 2.502 . . . . 0.0 110.31 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.17 -35.85 4.6 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-O 119.02 -0.878 . . . . 0.0 112.223 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.76 127.74 31.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 118.09 0.945 . . . . 0.0 109.881 -177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -94.56 -101.41 0.15 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.7 p -90.07 155.75 18.85 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.608 0.763 . . . . 0.0 110.363 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.2 tt -150.62 145.72 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 123.975 0.91 . . . . 0.0 109.772 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.12 141.98 44.21 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.0 t -125.52 117.37 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.691 1.197 . . . . 0.0 108.324 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.7 t -104.62 123.96 48.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.809 1.244 . . . . 0.0 109.818 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.9 tp -73.94 -44.12 56.03 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 124.165 0.986 . . . . 0.0 110.107 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.86 -45.88 74.62 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.582 1.153 . . . . 0.0 111.406 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -89.5 -7.61 54.63 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.607 0.763 . . . . 0.0 111.591 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.3 m 54.49 53.79 10.26 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.949 1.699 . . . . 0.0 111.474 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -160.02 167.23 28.36 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.198 0.599 . . . . 0.0 111.185 -175.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.59 121.84 3.96 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.8 m -99.68 112.94 25.12 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 173.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 t -117.81 122.27 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.701 1.2 . . . . 0.0 108.737 -172.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -89.68 132.51 35.12 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 169.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -150.36 168.31 24.48 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.905 0.482 . . . . 0.0 112.103 -170.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -103.97 111.4 65.14 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 125.181 1.392 . . . . 0.0 109.048 173.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -41.75 -38.28 4.41 Favored 'Trans proline' 0 C--N 1.347 0.495 1 C-N-CA 125.432 4.088 . . . . 0.0 115.312 171.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.8 mt -64.25 -34.03 77.18 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.162 0.585 . . . . 0.0 111.952 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.5 mt -103.82 -33.65 8.82 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.264 1.025 . . . . 0.0 112.333 -171.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.9 t -148.72 176.27 10.51 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.56 0.744 . . . . 0.0 109.801 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.9 p -150.25 163.5 24.12 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 123.891 0.877 . . . . 0.0 110.323 -174.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.42 -46.92 30.33 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.401 2.734 . . . . 0.0 112.986 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -65.73 -35.8 81.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.305 0.642 . . . . 0.0 112.123 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.8 m -67.16 -46.04 75.19 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.165 0.439 . . . . 0.0 110.296 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.7 mt -60.55 -47.11 87.61 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.544 0.737 . . . . 0.0 110.418 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.5 ttp85 -54.77 -46.5 74.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.134 0.973 . . . . 0.0 110.055 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.43 -43.99 93.77 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.503 1.049 . . . . 0.0 112.309 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.44 -46.22 87.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.926 0.863 . . . . 0.0 111.099 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.0 mt -59.92 -45.69 94.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 123.411 0.685 . . . . 0.0 109.639 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -61.28 -41.56 97.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.672 0.789 . . . . 0.0 111.039 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.97 -44.35 96.28 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.499 1.12 . . . . 0.0 111.032 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.6 mtm -57.84 -43.62 85.97 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.513 0.325 . . . . 0.0 110.595 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.67 61.54 0.19 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 123.531 0.586 . . . . 0.0 111.651 169.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -140.08 147.35 40.16 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 173.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -70.13 95.92 1.03 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.5 123.5 47.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.016 1.326 . . . . 0.0 109.937 -173.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.9 p -142.35 142.88 32.52 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.234 1.014 . . . . 0.0 108.542 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.5 mt -64.63 143.06 58.19 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.776 0.43 . . . . 0.0 110.959 -176.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.3 t -122.93 27.85 7.5 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.192 1.397 . . . . 0.0 109.701 175.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.6 t70 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 117.278 -1.344 . . . . 0.0 108.361 -172.191 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 120.389 0.138 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.6 p -140.49 122.21 15.33 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.363 1.065 . . . . 0.0 109.022 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -139.5 163.88 31.36 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.791 1.236 . . . . 0.0 109.307 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.79 140.91 52.52 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.824 1.249 . . . . 0.0 108.44 173.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 t -136.27 135.64 39.14 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.181 0.992 . . . . 0.0 109.529 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.5 t -99.65 124.1 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 171.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.9 mt -120.44 120.14 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -73.74 129.21 37.45 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.7 mt -122.19 108.65 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -99.61 145.87 27.09 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.56 -7.09 53.26 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 118.855 -0.97 . . . . 0.0 113.36 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.9 mtm -57.59 -53.06 62.45 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.938 1.369 . . . . 0.0 110.09 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 m 76.47 -42.23 0.43 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.708 1.603 . . . . 0.0 113.467 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.5 p -144.67 168.29 20.52 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.782 0.833 . . . . 0.0 112.16 -170.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -66.68 -33.06 74.81 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.984 1.314 . . . . 0.0 112.598 -173.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.8 p -66.42 -41.69 88.86 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.508 0.594 . . . . 0.0 110.728 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.6 m -61.97 -50.04 73.71 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.932 0.493 . . . . 0.0 110.297 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.1 t -51.24 -50.26 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.229 1.012 . . . . 0.0 110.85 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -58.17 -50.25 74.19 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.403 1.081 . . . . 0.0 110.681 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.4 m -57.92 -48.34 80.18 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.142 0.577 . . . . 0.0 111.152 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -59.07 -50.46 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.611 0.764 . . . . 0.0 109.548 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -51.52 -56.4 13.59 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.022 0.929 . . . . 0.0 110.106 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.34 -55.0 32.74 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.206 0.908 . . . . 0.0 112.335 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.09 -56.35 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.317 0.647 . . . . 0.0 110.767 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.3 mm -61.41 -37.86 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.215 -175.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.0 t -50.31 -38.21 40.4 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.618 0.645 . . . . 0.0 112.285 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.41 -1.45 58.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.664 0.785 . . . . 0.0 112.717 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -69.94 145.07 93.86 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 119.424 1.011 . . . . 0.0 109.485 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.37 127.8 20.93 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.88 2.387 . . . . 0.0 109.911 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.92 -38.2 3.37 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.126 -0.819 . . . . 0.0 111.713 -176.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.81 140.15 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 118.046 0.923 . . . . 0.0 109.805 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -106.22 -98.79 0.34 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 172.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 53.0 p -90.63 160.07 16.09 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.035 0.934 . . . . 0.0 110.234 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.9 tt -150.27 138.93 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 124.288 1.035 . . . . 0.0 108.454 172.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.57 104.69 10.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.498 1.119 . . . . 0.0 109.205 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -94.8 122.69 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.8 t -109.7 127.01 54.3 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.463 1.105 . . . . 0.0 109.933 -177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.67 -55.92 14.87 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.137 0.975 . . . . 0.0 108.528 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.69 -47.16 63.99 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.414 1.486 . . . . 0.0 112.341 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -89.26 -10.91 45.15 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.954 0.501 . . . . 0.0 111.634 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m 52.87 56.46 7.56 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.188 1.395 . . . . 0.0 110.906 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.1 p30 -155.44 169.73 23.58 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.166 0.587 . . . . 0.0 111.175 -176.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.08 115.43 2.19 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 126.269 1.89 . . . . 0.0 108.714 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.5 m -99.04 96.48 7.84 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.81 129.4 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.516 1.127 . . . . 0.0 109.283 -170.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -99.37 124.12 44.22 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -150.3 172.46 15.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.943 0.497 . . . . 0.0 112.288 -169.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -105.88 110.33 64.0 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.29 1.436 . . . . 0.0 109.468 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -40.84 -41.79 4.1 Favored 'Trans proline' 0 C--N 1.348 0.518 1 C-N-CA 125.432 4.088 . . . . 0.0 115.294 171.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.1 mt -60.56 -35.55 76.31 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.465 0.706 . . . . 0.0 111.866 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.0 -32.18 11.09 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.232 1.013 . . . . 0.0 112.1 -172.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.1 t -150.42 152.73 34.77 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.603 0.638 . . . . 0.0 109.891 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 p -116.36 162.53 25.95 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.535 1.134 . . . . 0.0 109.936 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.09 -39.59 50.92 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.329 2.686 . . . . 0.0 112.65 170.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.2 -39.11 89.42 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.929 0.892 . . . . 0.0 111.596 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 m -63.73 -47.34 81.46 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.927 0.491 . . . . 0.0 110.202 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.2 mt -62.14 -49.17 76.91 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.125 0.97 . . . . 0.0 110.36 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -49.88 -48.12 51.56 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.795 1.238 . . . . 0.0 109.943 170.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.32 -46.95 85.68 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.528 1.061 . . . . 0.0 112.413 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.65 91.55 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.835 0.817 . . . . 0.0 111.29 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -60.62 -44.16 96.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.804 0.842 . . . . 0.0 109.912 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.01 -38.94 92.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.853 0.861 . . . . 0.0 111.153 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.55 -44.08 97.22 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.26 1.024 . . . . 0.0 110.816 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.7 mtm -58.81 -48.84 79.89 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.3 59.76 0.1 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 170.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -140.24 137.59 34.39 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 172.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.33 97.94 1.01 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.542 0.737 . . . . 0.0 109.798 -176.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.86 133.14 44.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.792 1.237 . . . . 0.0 110.184 -174.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.2 m -144.49 138.57 27.7 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.603 1.161 . . . . 0.0 108.369 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -65.4 148.41 51.77 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.732 0.413 . . . . 0.0 110.178 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 t -148.34 46.72 1.05 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.998 0.919 . . . . 0.0 109.566 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.8 t70 . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.251 1.821 . . . . 0.0 110.038 -171.736 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 86.9 mt . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.6 p -98.76 77.91 2.29 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -89.49 151.39 22.01 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.794 0.838 . . . . 0.0 109.302 -174.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.88 149.24 43.67 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.738 0.815 . . . . 0.0 110.428 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -143.85 146.17 32.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.459 1.104 . . . . 0.0 108.999 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 51.2 t -113.3 124.5 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.8 mt -120.32 125.79 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -177.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -70.13 126.86 30.91 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 172.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.4 mt -123.11 95.15 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -99.33 132.48 44.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.32 -27.81 4.41 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -170.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 48.4 mtm -60.99 123.37 17.4 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 117.717 0.758 . . . . 0.0 109.161 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t -141.58 10.87 2.07 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.778 0.831 . . . . 0.0 111.911 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.0 t -165.64 151.59 9.41 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -56.14 -30.91 62.81 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.646 0.778 . . . . 0.0 111.903 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.1 p -50.49 -41.9 53.9 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.469 0.707 . . . . 0.0 111.316 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.2 m -62.41 -49.65 74.63 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.674 0.789 . . . . 0.0 109.661 177.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.8 t -54.6 -58.08 4.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.332 1.053 . . . . 0.0 110.224 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -61.69 -41.76 98.01 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.285 0.634 . . . . 0.0 111.382 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -58.98 -59.13 5.95 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.104 0.561 . . . . 0.0 110.633 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.4 mt -57.78 -55.61 20.55 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 123.52 0.728 . . . . 0.0 109.69 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -55.67 -48.49 74.97 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.572 0.749 . . . . 0.0 110.706 -176.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.94 -53.45 45.35 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.329 0.966 . . . . 0.0 112.225 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.22 -55.63 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 117.709 0.754 . . . . 0.0 110.683 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.5 mm -63.7 -38.22 81.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.514 0.725 . . . . 0.0 111.559 -173.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.5 p -54.98 -30.65 59.76 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.069 0.85 . . . . 0.0 112.553 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.35 -5.98 57.04 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.932 0.893 . . . . 0.0 112.187 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -70.71 142.67 88.76 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 119.017 0.826 . . . . 0.0 109.136 176.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.16 132.49 34.29 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.823 2.349 . . . . 0.0 110.093 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.48 -35.78 4.73 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 118.919 -0.934 . . . . 0.0 112.088 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.27 129.32 33.71 Favored 'Isoleucine or valine' 0 C--N 1.341 0.214 0 CA-C-N 118.074 0.937 . . . . 0.0 109.735 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -100.66 -101.87 0.25 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.55 1.14 . . . . 0.0 108.03 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 74.0 p -87.01 151.62 23.11 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.288 0.635 . . . . 0.0 109.744 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.1 tt -150.4 131.05 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.462 0.705 . . . . 0.0 109.421 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -120.81 105.78 11.05 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.429 1.492 . . . . 0.0 108.717 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.72 125.89 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.2 t -116.16 118.71 33.59 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.685 1.194 . . . . 0.0 110.023 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.59 -49.1 74.68 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.991 0.916 . . . . 0.0 109.834 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.1 -48.55 67.72 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.7 1.2 . . . . 0.0 111.994 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -89.7 -1.86 58.12 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.232 0.613 . . . . 0.0 112.201 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.1 m 49.71 52.0 15.41 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.318 1.447 . . . . 0.0 111.579 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -156.21 170.22 22.74 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 120.968 0.413 . . . . 0.0 111.664 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.58 119.28 2.55 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 125.607 1.575 . . . . 0.0 109.232 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.5 m -99.32 104.49 16.4 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.6 t -112.04 128.57 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.532 1.133 . . . . 0.0 109.574 -170.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -98.79 133.33 43.26 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -150.43 164.87 34.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.66 0.784 . . . . 0.0 111.844 -170.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -102.27 116.57 62.82 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.337 1.055 . . . . 0.0 109.498 173.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.71 -40.29 18.88 Favored 'Trans proline' 0 C--N 1.349 0.586 1 C-N-CA 125.348 4.032 . . . . 0.0 115.468 177.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.9 mt -67.11 -27.72 67.56 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.197 0.599 . . . . 0.0 111.949 -174.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.68 -42.05 7.04 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.078 0.951 . . . . 0.0 110.707 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.4 t -148.73 174.81 11.79 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.62 0.768 . . . . 0.0 110.001 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.3 p -150.56 164.37 20.7 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 124.563 1.145 . . . . 0.0 110.439 -170.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.25 -45.58 38.39 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.134 2.556 . . . . 0.0 112.79 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -67.32 -38.78 85.49 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.396 0.679 . . . . 0.0 112.806 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.3 p -66.0 -46.37 78.24 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.724 0.693 . . . . 0.0 110.438 176.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.6 mt -62.1 -46.43 89.08 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.752 0.821 . . . . 0.0 110.428 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -53.5 -45.36 69.64 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.159 0.984 . . . . 0.0 110.47 171.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.4 -47.04 91.0 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.076 0.846 . . . . 0.0 112.114 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.05 -51.95 65.92 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.473 0.709 . . . . 0.0 111.059 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.8 mt -57.57 -41.84 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.016 0.926 . . . . 0.0 109.9 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -59.0 -50.52 73.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.355 0.662 . . . . 0.0 109.749 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -58.25 -38.74 77.5 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.772 1.229 . . . . 0.0 112.0 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mtp -60.81 -20.95 62.59 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.98 57.12 0.52 Allowed Glycine 0 C--N 1.34 0.784 0 C-N-CA 124.306 0.955 . . . . 0.0 111.151 170.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -140.6 155.47 46.56 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.27 1.028 . . . . 0.0 109.46 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -80.39 93.75 6.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 169.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.42 117.57 34.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.698 1.199 . . . . 0.0 108.862 -176.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.4 p -140.06 136.52 33.72 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.21 1.004 . . . . 0.0 109.054 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.69 138.85 58.63 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.84 0.456 . . . . 0.0 110.813 -175.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.24 -52.25 3.73 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.549 1.139 . . . . 0.0 108.206 171.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 116.931 -1.509 . . . . 0.0 108.335 -179.664 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 111.213 0.079 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.6 p -140.52 130.87 25.18 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.408 1.083 . . . . 0.0 109.618 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -143.4 164.37 30.48 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.535 1.134 . . . . 0.0 109.454 171.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -123.98 154.65 39.52 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.873 1.269 . . . . 0.0 109.652 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 t -150.14 144.74 25.89 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.779 0.832 . . . . 0.0 109.981 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.7 t -109.27 115.75 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.3 mt -110.51 118.13 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -76.04 121.89 23.43 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.1 mt -118.15 110.11 29.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 124.747 1.219 . . . . 0.0 108.097 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -99.8 148.04 24.84 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.58 3.67 56.2 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.511 1.053 . . . . 0.0 113.531 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.6 mtm -71.13 87.0 0.77 Allowed 'General case' 0 C--N 1.344 0.362 0 CA-C-N 118.825 1.313 . . . . 0.0 109.767 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.1 m -79.54 99.0 7.08 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.217 1.007 . . . . 0.0 109.58 -174.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 t 73.74 163.45 0.27 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.728 1.611 . . . . 0.0 111.712 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -71.07 73.33 0.62 Allowed 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.703 1.201 . . . . 0.0 109.708 173.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.5 m -162.33 -52.13 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 127.654 2.381 . . . . 0.0 106.477 -176.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.0 m -61.03 -49.17 78.47 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 168.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 82.7 t -49.71 -51.64 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.221 1.408 . . . . 0.0 110.279 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -60.33 -48.66 80.77 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.092 0.957 . . . . 0.0 111.125 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.7 p -62.19 -47.81 82.84 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 122.848 0.459 . . . . 0.0 111.371 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.2 mt -55.35 -60.58 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 123.715 0.806 . . . . 0.0 108.953 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -53.24 -48.5 68.17 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.772 0.829 . . . . 0.0 110.959 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.08 -57.78 16.79 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.241 0.925 . . . . 0.0 111.925 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.49 -53.13 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 117.624 0.712 . . . . 0.0 110.929 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.9 -45.76 91.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.618 0.767 . . . . 0.0 110.738 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 88.0 p -57.73 -27.46 63.0 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -88.9 -5.51 57.95 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.43 0.692 . . . . 0.0 111.891 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -78.83 123.18 85.3 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 119.084 0.856 . . . . 0.0 109.026 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.74 116.94 2.64 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.696 2.931 . . . . 0.0 112.075 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.47 -44.51 1.15 Allowed Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.9 t -70.8 130.4 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 117.453 0.626 . . . . 0.0 109.718 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -96.82 -100.79 0.18 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.974 1.31 . . . . 0.0 107.529 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.4 p -90.23 156.83 18.03 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.38 0.672 . . . . 0.0 110.004 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.6 tt -150.58 145.52 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.7 0.8 . . . . 0.0 110.217 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -133.97 104.92 6.47 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.923 1.289 . . . . 0.0 107.571 169.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.2 t -89.8 97.86 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.8 t -89.75 123.08 33.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.835 0.854 . . . . 0.0 109.469 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.1 tp -70.82 -49.34 47.4 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.792 0.837 . . . . 0.0 110.092 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.69 -46.17 74.07 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.0 1.32 . . . . 0.0 112.054 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -89.22 -6.79 56.6 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.745 0.818 . . . . 0.0 111.319 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 m 52.55 54.25 10.94 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.85 1.66 . . . . 0.0 111.389 176.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -156.52 150.08 24.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.342 0.592 . . . . 0.0 112.282 -175.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -94.7 108.71 3.72 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 170.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -98.76 95.74 7.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 175.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 t -108.81 134.19 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.517 1.127 . . . . 0.0 109.879 -169.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -105.27 132.71 51.13 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 168.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -150.36 170.9 17.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.079 0.552 . . . . 0.0 111.384 -169.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -102.8 111.43 64.88 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.056 1.342 . . . . 0.0 109.241 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -41.75 -40.03 5.37 Favored 'Trans proline' 0 C--N 1.347 0.454 1 C-N-CA 125.618 4.212 . . . . 0.0 115.047 172.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.1 mt -61.93 -33.38 74.16 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.612 0.765 . . . . 0.0 111.829 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.0 mt -102.87 -38.13 7.53 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.478 1.111 . . . . 0.0 111.919 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 t -147.12 174.16 11.83 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.592 0.757 . . . . 0.0 110.1 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.7 p -150.21 162.89 26.37 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.113 0.965 . . . . 0.0 110.02 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -52.62 -43.55 54.36 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.659 2.906 . . . . 0.0 113.186 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -64.29 -36.83 85.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.551 0.74 . . . . 0.0 112.103 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.0 m -68.57 -46.41 69.48 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.019 0.527 . . . . 0.0 109.884 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.3 mt -61.0 -46.83 89.17 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.166 0.986 . . . . 0.0 110.307 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -54.63 -44.7 73.39 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.171 0.988 . . . . 0.0 110.296 172.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.13 -44.64 93.07 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.247 0.927 . . . . 0.0 112.245 175.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.06 -49.31 75.02 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.542 0.737 . . . . 0.0 111.229 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.4 mt -61.85 -39.39 83.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.913 0.885 . . . . 0.0 110.028 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.46 -48.52 80.75 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.6 0.76 . . . . 0.0 109.859 176.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.27 -40.67 86.8 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.561 1.144 . . . . 0.0 111.43 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.8 mmm -60.98 -19.63 61.4 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.607 0.763 . . . . 0.0 112.163 173.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.15 53.53 0.95 Allowed Glycine 0 C--N 1.34 0.796 0 C-N-CA 124.411 1.005 . . . . 0.0 111.699 169.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -140.52 156.2 46.39 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.86 0.864 . . . . 0.0 110.273 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -82.88 87.14 6.84 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.23 124.74 44.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.606 1.162 . . . . 0.0 109.936 -173.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.9 p -139.99 140.18 36.21 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.685 1.194 . . . . 0.0 108.79 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.9 mt -67.58 135.11 52.4 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 t -80.91 70.29 7.68 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 116.894 -1.527 . . . . 0.0 110.505 -174.476 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 57.9 tp . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 110.725 -0.102 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 87.9 m -140.32 143.32 35.75 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.463 1.105 . . . . 0.0 108.444 172.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -137.1 164.77 27.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.695 1.598 . . . . 0.0 108.294 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -102.58 143.27 32.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.211 1.004 . . . . 0.0 109.354 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -137.26 142.44 41.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.46 124.83 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.0 mt -121.09 120.5 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -77.29 120.76 22.77 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.3 mt -122.35 106.85 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.745 1.218 . . . . 0.0 107.881 -173.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -99.6 146.91 25.93 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.83 -12.61 17.7 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.55 1.071 . . . . 0.0 112.108 -172.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 44.6 mtm -77.28 76.63 3.82 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 118.382 1.091 . . . . 0.0 109.56 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.4 m -65.28 -48.82 71.84 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.02 0.928 . . . . 0.0 111.601 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.2 t -117.14 157.25 26.25 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.806 1.242 . . . . 0.0 110.409 -171.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -48.95 -36.91 18.55 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.663 1.185 . . . . 0.0 111.644 171.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -50.05 -42.74 50.31 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.433 1.093 . . . . 0.0 112.004 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.3 m -61.24 -59.1 5.83 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.375 0.67 . . . . 0.0 109.394 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -50.01 -51.3 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.23 1.412 . . . . 0.0 111.194 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -59.79 -53.19 60.81 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.272 1.429 . . . . 0.0 111.079 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.3 p -60.24 -49.34 77.99 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.026 0.53 . . . . 0.0 111.072 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.3 mt -53.46 -57.21 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.195 0.998 . . . . 0.0 109.943 177.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -53.39 -52.38 59.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.921 0.888 . . . . 0.0 110.844 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.08 -54.2 38.74 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.844 0.735 . . . . 0.0 112.312 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.16 -54.71 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.373 1.069 . . . . 0.0 110.876 -176.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.2 mm -61.75 -34.72 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.874 0.87 . . . . 0.0 111.262 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t -53.73 -19.47 4.23 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -89.25 -12.67 40.07 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.929 0.786 . . . . 0.0 112.392 -175.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -74.58 143.55 79.17 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 118.783 0.719 . . . . 0.0 110.131 -172.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.27 130.35 25.2 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.061 2.508 . . . . 0.0 109.772 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.04 -39.61 2.8 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 118.926 -0.93 . . . . 0.0 111.419 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.59 123.65 20.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 CA-C-N 118.069 0.935 . . . . 0.0 109.139 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -93.26 -102.65 0.13 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.4 p -90.26 155.99 18.6 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.907 0.883 . . . . 0.0 109.706 171.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.1 tt -150.32 141.08 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.652 0.781 . . . . 0.0 109.586 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -135.52 131.78 36.46 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.91 0.884 . . . . 0.0 108.769 169.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -115.82 133.73 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.9 t -112.56 133.46 54.6 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.932 1.293 . . . . 0.0 110.702 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.18 -56.7 5.54 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 170.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.55 -47.78 63.31 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.339 1.456 . . . . 0.0 112.335 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -89.25 -10.36 47.24 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.577 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m 52.03 56.29 7.99 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.02 1.328 . . . . 0.0 110.867 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -156.5 164.39 38.28 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.054 0.542 . . . . 0.0 111.102 -176.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.75 113.57 2.41 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 126.18 1.847 . . . . 0.0 108.825 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.9 m -99.4 107.88 20.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.34 130.22 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.453 1.101 . . . . 0.0 109.583 -170.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -93.65 127.73 39.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 168.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -149.1 155.48 40.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.827 0.451 . . . . 0.0 110.959 -169.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -95.15 115.22 65.21 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.282 1.033 . . . . 0.0 109.288 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.26 -36.38 17.02 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.861 3.708 . . . . 0.0 114.653 172.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.6 mt -66.06 -29.28 69.59 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.472 0.709 . . . . 0.0 112.099 -176.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.0 mt -108.73 -33.27 7.03 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.23 1.012 . . . . 0.0 112.26 -172.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.0 t -147.32 -179.83 7.12 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.566 0.746 . . . . 0.0 109.849 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.6 p -149.82 162.09 29.3 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 123.732 0.813 . . . . 0.0 110.125 -176.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -51.9 -40.0 67.51 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.402 2.734 . . . . 0.0 112.18 173.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.92 -46.91 79.67 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.288 1.035 . . . . 0.0 110.949 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.8 m -60.02 -47.32 86.34 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.052 0.541 . . . . 0.0 110.406 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.96 -50.45 73.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.843 0.857 . . . . 0.0 110.52 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.1 ttp85 -50.72 -46.76 59.18 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.149 0.98 . . . . 0.0 110.487 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.69 -46.77 81.34 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.137 0.875 . . . . 0.0 112.114 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.24 -47.01 86.3 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.664 0.732 . . . . 0.0 111.486 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 mm -58.51 -44.51 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.222 0.609 . . . . 0.0 110.24 175.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.51 -38.28 90.53 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.143 0.577 . . . . 0.0 110.927 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.27 -43.67 94.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.016 0.926 . . . . 0.0 110.947 176.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 90.6 mtp -59.0 -41.42 87.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 117.978 0.354 . . . . 0.0 110.441 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.26 56.45 0.22 Allowed Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.092 0.853 . . . . 0.0 111.862 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -140.27 139.75 35.6 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -74.02 96.33 2.66 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.467 0.707 . . . . 0.0 109.447 -175.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.95 132.72 45.14 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.96 1.304 . . . . 0.0 110.582 -173.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.9 p -138.24 134.95 35.05 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.079 1.352 . . . . 0.0 108.795 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.6 mt -69.14 132.51 46.67 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.701 0.4 . . . . 0.0 110.401 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.43 -51.72 4.05 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 172.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 p30 . . . . . 0 C--O 1.25 1.12 0 C-N-CA 125.475 1.51 . . . . 0.0 108.854 176.344 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 58.7 tp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 110.783 -0.08 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.7 p -99.66 131.88 45.36 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.647 0.779 . . . . 0.0 110.252 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -93.06 157.32 16.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.638 1.575 . . . . 0.0 107.986 170.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.52 143.1 34.16 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.749 0.82 . . . . 0.0 109.258 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -139.46 144.66 38.11 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.009 0.924 . . . . 0.0 108.913 172.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.4 t -110.54 115.68 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.8 mm -99.84 126.81 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -77.51 113.89 15.79 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 170.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.9 mt -116.35 98.0 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -176.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -99.85 158.38 15.84 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.03 13.82 60.05 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.818 0.723 . . . . 0.0 112.902 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 68.0 mtm -79.17 85.37 5.06 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 171.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.6 p -59.48 -50.99 71.79 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.688 0.795 . . . . 0.0 112.001 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.3 m -133.35 171.4 14.1 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.337 1.055 . . . . 0.0 110.322 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -58.34 -25.19 61.68 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.186 0.994 . . . . 0.0 111.968 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -50.47 -47.37 57.07 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.608 0.763 . . . . 0.0 110.713 171.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.3 m -60.22 -50.34 74.06 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.807 0.843 . . . . 0.0 110.006 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.3 t -52.76 -54.86 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.74 1.216 . . . . 0.0 110.347 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -60.11 -46.27 90.18 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.301 1.041 . . . . 0.0 111.586 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -57.88 -48.86 78.6 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.675 0.39 . . . . 0.0 111.199 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.0 mt -59.81 -59.41 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.19 0.596 . . . . 0.0 109.948 -177.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.95 -43.52 86.42 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.102 0.41 . . . . 0.0 111.166 -176.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.31 -54.82 29.82 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.814 0.721 . . . . 0.0 112.023 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.21 -53.89 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.322 0.649 . . . . 0.0 110.792 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.4 mm -62.79 -35.42 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.729 -172.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.0 m -53.3 -30.25 37.77 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.86 0.754 . . . . 0.0 112.77 174.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 -6.7 56.24 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.498 0.719 . . . . 0.0 112.052 -175.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -72.82 143.13 84.07 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 118.859 0.754 . . . . 0.0 109.314 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.84 135.9 54.43 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.931 2.421 . . . . 0.0 110.025 -176.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.39 -40.07 2.62 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-O 118.888 -0.951 . . . . 0.0 111.525 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -67.66 134.83 29.59 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 CA-C-N 118.068 0.934 . . . . 0.0 109.797 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -112.8 -89.5 0.52 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.8 p -90.75 154.49 19.49 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.884 0.874 . . . . 0.0 110.38 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.5 tt -150.61 148.8 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.666 1.186 . . . . 0.0 108.744 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -135.65 106.3 6.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.781 0.833 . . . . 0.0 109.201 174.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.8 t -94.49 100.49 11.21 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 C-N-CA 124.015 0.926 . . . . 0.0 109.307 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.4 t -89.54 120.19 30.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.974 0.91 . . . . 0.0 109.7 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.9 tp -69.98 -47.11 63.54 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.474 1.109 . . . . 0.0 110.042 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.01 -44.47 67.32 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.768 1.227 . . . . 0.0 111.682 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -89.29 -14.73 35.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.404 0.681 . . . . 0.0 111.3 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.1 m 55.52 54.76 8.05 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 125.403 1.481 . . . . 0.0 110.665 -177.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.5 p30 -153.17 158.47 41.84 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.028 0.531 . . . . 0.0 111.619 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.58 114.55 3.17 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 126.052 1.787 . . . . 0.0 108.92 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.3 m -98.9 97.14 8.35 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.67 134.14 44.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 C-N-CA 124.829 1.252 . . . . 0.0 109.704 -170.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -105.19 116.99 32.88 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 172.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -145.9 153.17 40.55 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.602 0.761 . . . . 0.0 111.842 -169.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -88.16 120.49 70.62 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 123.673 0.789 . . . . 0.0 110.163 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -47.8 -39.33 31.23 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.997 3.798 . . . . 0.0 115.457 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.4 mt -67.67 -28.77 67.98 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.882 0.473 . . . . 0.0 111.809 -174.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.61 -34.76 10.09 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.797 0.839 . . . . 0.0 111.091 -174.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 t -151.83 171.03 18.38 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.631 0.65 . . . . 0.0 110.2 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.6 p -138.89 162.68 51.3 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.757 1.223 . . . . 0.0 109.996 -175.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -50.99 -43.12 49.6 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.492 2.795 . . . . 0.0 112.573 174.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -62.48 -43.3 99.15 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.891 0.876 . . . . 0.0 111.739 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.5 m -64.15 -47.55 79.44 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.991 0.359 . . . . 0.0 110.299 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.8 mt -59.46 -50.61 73.25 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.985 0.914 . . . . 0.0 110.318 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 -51.5 -46.69 63.29 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.54 1.136 . . . . 0.0 110.297 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.75 -47.04 91.34 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.6 1.095 . . . . 0.0 112.184 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.57 -45.35 93.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.507 0.723 . . . . 0.0 111.273 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -62.75 -43.69 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.714 0.806 . . . . 0.0 109.876 178.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -59.47 -46.59 88.36 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.683 0.793 . . . . 0.0 110.035 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -59.24 -42.83 92.0 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.494 1.118 . . . . 0.0 111.562 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 71.7 mtm -57.66 -45.81 85.07 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 118.025 0.375 . . . . 0.0 110.687 173.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.47 63.05 0.12 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 170.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -140.28 158.5 43.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.902 0.881 . . . . 0.0 109.385 174.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -79.33 87.21 5.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.28 118.72 36.57 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.552 1.141 . . . . 0.0 109.835 -173.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.2 p -138.19 149.87 46.23 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.783 1.233 . . . . 0.0 108.683 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 29.3 mt -73.78 129.61 38.28 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.159 0.436 . . . . 0.0 110.056 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 t -89.49 -51.85 5.33 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--O 1.251 1.146 0 C-N-CA 125.311 1.444 . . . . 0.0 109.186 177.912 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 61.0 tp . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.8 p -106.02 123.78 48.53 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.52 1.128 . . . . 0.0 110.266 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -136.5 159.14 42.67 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.108 1.363 . . . . 0.0 107.646 169.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -140.27 147.08 39.43 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.511 0.724 . . . . 0.0 109.975 -177.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.8 t -142.23 153.11 43.71 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.371 1.068 . . . . 0.0 109.918 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.35 115.81 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 173.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.4 mt -106.12 124.94 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -80.14 118.67 22.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.6 mt -116.06 102.53 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -174.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -99.55 142.65 30.74 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.21 19.55 27.94 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.554 1.073 . . . . 0.0 113.142 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 68.5 mtm -79.58 69.04 5.79 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.618 1.209 . . . . 0.0 109.261 174.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.9 m -67.43 104.07 1.45 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.171 0.988 . . . . 0.0 109.607 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.5 t 79.92 148.47 0.09 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.725 2.01 . . . . 0.0 111.386 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -51.31 -24.7 4.85 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.005 1.722 . . . . 0.0 113.441 176.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.3 m -50.67 -44.69 57.81 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.816 0.846 . . . . 0.0 111.601 173.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.5 m -62.58 -50.87 69.56 Favored 'General case' 0 C--N 1.338 0.104 0 C-N-CA 123.689 0.796 . . . . 0.0 110.287 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.1 t -53.44 -49.86 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.188 0.995 . . . . 0.0 110.706 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -57.74 -45.54 85.71 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.958 0.903 . . . . 0.0 111.406 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.7 m -59.67 -53.81 53.73 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.822 0.449 . . . . 0.0 110.856 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -57.73 -51.33 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.604 1.162 . . . . 0.0 109.797 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -49.8 -58.52 5.19 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.859 1.664 . . . . 0.0 110.232 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.95 -55.05 32.68 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.063 0.839 . . . . 0.0 112.141 -177.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.22 -55.3 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.428 0.691 . . . . 0.0 110.79 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.6 mt -68.09 -34.68 68.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 119.145 -0.455 . . . . 0.0 111.344 -173.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -54.72 -27.42 40.63 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 174.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -89.69 -8.3 52.68 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.441 0.697 . . . . 0.0 112.522 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -72.91 141.54 81.95 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 119.171 0.896 . . . . 0.0 110.019 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.95 131.05 27.6 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.146 2.564 . . . . 0.0 110.265 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.67 -34.28 5.91 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-O 118.897 -0.946 . . . . 0.0 112.137 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.07 121.55 16.39 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 CA-C-N 118.178 0.989 . . . . 0.0 109.536 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -91.58 -101.5 0.11 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.366 1.066 . . . . 0.0 108.221 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.1 p -88.57 141.46 28.51 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.6 tt -141.69 138.31 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.04 111.07 6.95 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.042 1.337 . . . . 0.0 108.017 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.5 t -104.48 120.99 55.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 124.778 1.231 . . . . 0.0 108.462 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.8 t -103.08 129.03 49.78 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.749 1.22 . . . . 0.0 110.806 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.57 -56.7 9.54 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.369 1.067 . . . . 0.0 108.131 169.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.42 -48.72 62.59 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.452 1.501 . . . . 0.0 112.466 -175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -89.23 -5.03 57.97 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.883 0.473 . . . . 0.0 111.662 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.2 m 51.3 54.63 10.79 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.244 1.418 . . . . 0.0 111.341 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -156.78 160.09 38.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.017 0.437 . . . . 0.0 111.363 -176.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.06 114.23 3.15 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 126.307 1.908 . . . . 0.0 108.391 174.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.1 m -99.0 109.61 22.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 t -118.53 123.12 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.477 1.111 . . . . 0.0 109.198 -169.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -96.74 132.3 42.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 168.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -150.33 169.87 20.36 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.967 0.507 . . . . 0.0 112.155 -169.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.25 113.43 65.87 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.334 1.454 . . . . 0.0 109.68 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -45.67 -41.13 19.19 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 125.292 3.994 . . . . 0.0 115.637 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.5 mt -68.27 -29.0 67.69 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.836 0.454 . . . . 0.0 111.752 -174.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.2 mt -99.78 -35.31 9.83 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.385 1.074 . . . . 0.0 111.647 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -152.03 171.27 18.11 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.607 0.763 . . . . 0.0 109.76 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.3 p -148.15 164.71 20.84 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.739 1.216 . . . . 0.0 109.952 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.18 -38.91 81.77 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.298 2.665 . . . . 0.0 112.196 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -59.86 -52.4 65.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.236 1.014 . . . . 0.0 110.804 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.1 p -63.77 -40.78 97.5 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 122.882 0.473 . . . . 0.0 111.426 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.1 mt -66.26 -45.99 78.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.185 0.594 . . . . 0.0 110.391 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -54.77 -48.46 72.62 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.805 0.842 . . . . 0.0 109.608 171.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.36 -44.98 58.74 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.461 1.029 . . . . 0.0 112.628 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.56 -48.06 76.44 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.635 0.774 . . . . 0.0 111.057 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.5 mt -59.7 -45.03 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.556 0.743 . . . . 0.0 109.906 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.7 -42.82 97.97 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.39 1.076 . . . . 0.0 110.861 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.35 -43.97 97.57 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.034 0.934 . . . . 0.0 111.111 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.4 mtp -59.17 -40.56 86.01 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.797 0.439 . . . . 0.0 110.601 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.23 58.06 0.24 Allowed Glycine 0 C--N 1.34 0.792 0 C-N-CA 123.913 0.768 . . . . 0.0 111.856 169.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -140.26 148.7 41.85 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 124.018 0.927 . . . . 0.0 108.993 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -74.48 95.61 2.77 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -177.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 130.09 45.99 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.107 1.363 . . . . 0.0 110.218 -175.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 t -150.02 135.5 18.23 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.157 0.583 . . . . 0.0 109.765 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.7 mt -64.86 150.2 48.11 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.266 0.626 . . . . 0.0 110.246 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.9 m -79.93 63.14 4.37 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 170.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.0 t70 . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.963 -1.494 . . . . 0.0 108.705 -176.46 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 N--CA 1.476 0.856 0 CA-C-O 120.565 0.221 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 42.9 p -140.12 126.13 19.67 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.475 1.11 . . . . 0.0 108.467 176.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -143.12 166.12 25.55 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.004 1.321 . . . . 0.0 109.381 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -122.11 155.57 35.44 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.837 1.255 . . . . 0.0 109.007 173.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 t -150.17 133.73 16.6 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 122.795 0.438 . . . . 0.0 109.825 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.8 t -99.71 99.01 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 124.825 1.25 . . . . 0.0 107.714 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.7 mt -99.85 114.45 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -75.22 132.68 41.27 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.2 mt -126.7 108.27 18.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 125.026 1.33 . . . . 0.0 107.773 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.89 139.87 34.94 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.69 7.09 26.17 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.023 1.297 . . . . 0.0 113.416 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.2 mtm -78.77 106.17 10.58 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.845 1.322 . . . . 0.0 109.921 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.5 p -78.88 90.2 4.71 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.26 0.624 . . . . 0.0 111.21 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.7 t 69.29 -81.09 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.798 2.039 . . . . 0.0 113.778 169.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -138.7 -38.73 0.52 Allowed 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.85 0.86 . . . . 0.0 111.814 -169.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 p -50.01 -54.58 19.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.312 1.045 . . . . 0.0 111.065 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.9 m -68.05 -43.9 77.61 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.811 1.245 . . . . 0.0 111.267 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.7 t -53.29 -50.7 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.039 0.936 . . . . 0.0 110.013 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -61.72 -50.08 73.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.777 1.231 . . . . 0.0 111.355 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.8 p -62.33 -46.27 89.45 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.959 0.345 . . . . 0.0 111.52 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.8 mt -58.13 -53.75 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 C-N-CA 123.748 0.819 . . . . 0.0 109.106 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -50.56 -57.7 7.54 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.873 0.869 . . . . 0.0 110.188 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.91 -56.8 23.02 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.992 0.806 . . . . 0.0 112.281 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.5 t -62.05 -53.82 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 117.305 0.552 . . . . 0.0 111.086 -174.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.8 mm -61.66 -36.97 76.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.915 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.8 t -54.25 -29.29 46.27 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.779 0.718 . . . . 0.0 112.611 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.1 mtmt -89.61 -14.89 33.97 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.848 0.859 . . . . 0.0 112.852 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -64.28 143.52 98.41 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 119.577 1.081 . . . . 0.0 110.228 174.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.24 142.13 78.5 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.153 2.568 . . . . 0.0 110.276 -175.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.67 -30.45 6.51 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.694 -1.059 . . . . 0.0 112.41 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.73 131.78 34.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 118.629 1.215 . . . . 0.0 109.739 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -90.05 -105.09 0.09 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 172.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.3 p -91.08 165.8 13.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.873 1.269 . . . . 0.0 110.382 169.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -147.96 132.6 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.472 1.109 . . . . 0.0 108.024 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.3 105.9 13.06 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.7 t -98.24 119.24 46.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.812 0.845 . . . . 0.0 108.926 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.4 t -109.47 125.49 52.5 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.851 1.26 . . . . 0.0 110.089 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.52 -52.25 41.2 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.327 1.051 . . . . 0.0 109.007 171.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.97 -46.07 68.08 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.3 1.44 . . . . 0.0 112.2 -176.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -89.25 -7.69 54.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.128 0.571 . . . . 0.0 111.425 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 m 52.76 54.22 10.88 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.8 1.64 . . . . 0.0 110.868 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -156.21 168.06 28.48 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.132 0.491 . . . . 0.0 111.502 -175.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.93 117.33 2.98 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 107.537 -2.225 . . . . 0.0 107.537 172.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.7 p -98.74 102.43 14.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.3 t -99.21 127.26 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -169.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -94.2 127.24 39.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 170.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -150.71 170.76 18.43 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -169.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -105.97 112.04 64.35 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.21 1.404 . . . . 0.0 109.183 173.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -42.74 -39.61 7.42 Favored 'Trans proline' 0 C--N 1.348 0.519 1 C-N-CA 125.443 4.095 . . . . 0.0 115.181 172.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.35 -35.79 80.24 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.334 0.654 . . . . 0.0 111.78 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.6 mt -99.96 -32.76 10.81 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.301 1.041 . . . . 0.0 112.181 -171.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.1 t -150.77 168.5 24.21 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.637 0.653 . . . . 0.0 110.28 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.3 p -136.07 159.49 70.79 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.746 1.218 . . . . 0.0 110.103 -176.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.42 -39.91 44.52 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.674 2.916 . . . . 0.0 113.163 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.01 -39.42 83.18 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.806 0.842 . . . . 0.0 111.78 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.8 m -65.26 -46.67 79.59 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.672 0.389 . . . . 0.0 109.985 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.6 mt -62.6 -46.67 87.22 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.325 1.05 . . . . 0.0 110.577 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -51.89 -47.02 64.74 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.568 1.147 . . . . 0.0 109.869 170.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.54 -44.61 90.64 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.321 0.962 . . . . 0.0 112.328 176.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.23 -43.59 90.94 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.742 0.771 . . . . 0.0 111.389 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.6 mt -64.82 -38.65 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.744 0.818 . . . . 0.0 110.004 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.95 -40.86 95.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.618 0.767 . . . . 0.0 110.53 176.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.08 -42.93 99.73 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.995 0.918 . . . . 0.0 110.862 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.5 mmm -56.22 -39.66 72.83 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.214 0.606 . . . . 0.0 110.637 172.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.7 58.37 0.27 Allowed Glycine 0 C--N 1.341 0.816 0 C-N-CA 123.867 0.746 . . . . 0.0 111.967 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -140.41 155.11 46.84 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.896 0.878 . . . . 0.0 109.957 175.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -77.24 94.37 4.12 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.62 124.0 44.42 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.917 1.287 . . . . 0.0 109.526 -175.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 48.0 p -141.87 143.77 33.51 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.415 1.086 . . . . 0.0 109.124 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -68.71 133.35 48.27 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.7 t -69.08 -42.01 76.75 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.46 0.304 . . . . 0.0 110.861 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.209 -1.377 . . . . 0.0 108.524 179.085 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 . . . . . 0 CA--C 1.528 0.12 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.85 153.97 21.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.162 0.985 . . . . 0.0 110.232 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.2 t -149.94 143.39 25.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.896 0.879 . . . . 0.0 109.149 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.0 t -108.66 124.69 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 173.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.9 mt -121.95 119.53 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -73.5 126.36 30.04 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.2 mt -120.86 110.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.086 1.355 . . . . 0.0 107.675 -176.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -99.9 145.57 27.65 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.438 0.695 . . . . 0.0 109.146 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.08 13.01 47.47 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.648 1.118 . . . . 0.0 113.497 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 C--N 1.343 0.291 0 CA-C-N 118.558 1.179 . . . . 0.0 109.257 177.034 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.6 p . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.203 0.049 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.4 m -63.86 -46.55 84.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.695 0.798 . . . . 0.0 110.598 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -53.4 -53.69 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.293 1.037 . . . . 0.0 110.059 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -60.97 -46.14 91.92 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.858 1.263 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.1 t -57.44 -53.59 56.47 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.534 0.733 . . . . 0.0 110.754 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.6 mt -55.98 -55.27 19.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 C-N-CA 124.083 0.953 . . . . 0.0 109.424 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.89 -53.08 54.26 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.569 0.748 . . . . 0.0 110.932 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.22 -53.37 46.18 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.383 0.992 . . . . 0.0 112.552 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.82 -53.56 46.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 117.579 0.689 . . . . 0.0 110.485 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.3 mm -62.21 -36.64 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 118.814 -0.612 . . . . 0.0 111.024 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.7 t -51.3 -37.12 45.75 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.829 0.741 . . . . 0.0 111.933 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -89.21 -3.62 58.5 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.709 0.804 . . . . 0.0 112.455 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -71.78 142.53 85.9 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 119.352 0.978 . . . . 0.0 109.322 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -46.55 134.41 16.58 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.921 3.081 . . . . 0.0 112.801 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.93 -40.33 2.85 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-O 118.802 -0.999 . . . . 0.0 112.644 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.45 135.42 28.5 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.178 0.989 . . . . 0.0 109.704 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -114.29 -88.42 0.56 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.7 p -90.82 149.85 21.81 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.581 0.752 . . . . 0.0 109.949 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.52 138.19 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 124.035 0.934 . . . . 0.0 109.041 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -130.84 109.09 10.32 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.778 1.231 . . . . 0.0 108.287 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.9 t -98.21 114.61 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 124.002 0.921 . . . . 0.0 108.748 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.1 t -100.61 123.56 44.99 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 124.388 1.075 . . . . 0.0 109.452 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.0 tp -71.93 -44.08 64.21 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.688 0.795 . . . . 0.0 110.019 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.87 -46.88 74.79 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.892 1.277 . . . . 0.0 111.732 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -89.23 -7.06 56.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.209 0.604 . . . . 0.0 111.352 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.3 m 53.05 54.88 9.69 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.774 1.63 . . . . 0.0 111.019 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -155.54 163.58 39.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.986 0.422 . . . . 0.0 111.803 -175.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.24 116.16 3.54 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 126.402 1.954 . . . . 0.0 108.365 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.1 m -99.24 101.56 12.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.5 t -108.38 131.72 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 124.499 1.12 . . . . 0.0 109.521 -170.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -102.24 125.41 48.93 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -146.59 164.82 31.39 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.587 0.755 . . . . 0.0 111.405 -171.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -97.49 115.68 65.77 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.476 1.111 . . . . 0.0 109.277 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -45.94 -38.48 18.48 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 125.255 3.97 . . . . 0.0 115.175 175.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.8 mt -65.59 -28.13 68.92 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.456 0.702 . . . . 0.0 111.839 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.64 -44.09 6.25 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.219 1.007 . . . . 0.0 110.854 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.1 t -144.9 176.21 9.64 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.483 0.713 . . . . 0.0 110.403 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.8 p -149.99 164.63 19.97 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 124.209 1.004 . . . . 0.0 109.864 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.24 -47.08 28.7 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.605 2.87 . . . . 0.0 113.009 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.65 -36.0 82.39 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.468 0.707 . . . . 0.0 112.118 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 m -67.18 -45.65 76.3 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.963 0.505 . . . . 0.0 110.154 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.1 mt -62.21 -46.52 88.5 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.07 0.948 . . . . 0.0 110.443 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -52.5 -47.24 66.73 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.172 0.989 . . . . 0.0 110.052 170.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.75 -45.2 86.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.257 0.932 . . . . 0.0 112.288 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.85 77.43 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 117.677 0.739 . . . . 0.0 111.262 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.8 mt -60.98 -41.99 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.759 0.824 . . . . 0.0 110.076 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.93 -41.32 99.44 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.089 0.956 . . . . 0.0 110.799 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.68 -42.05 99.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.856 0.862 . . . . 0.0 111.094 177.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -58.68 -46.82 86.39 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.98 0.354 . . . . 0.0 110.09 173.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.06 59.13 0.13 Allowed Glycine 0 C--N 1.341 0.815 0 C-N-CA 123.882 0.754 . . . . 0.0 111.735 170.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -140.21 146.55 38.84 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.874 0.87 . . . . 0.0 109.124 174.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -76.13 92.32 3.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.5 131.82 45.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.928 1.291 . . . . 0.0 110.166 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.3 m -143.51 134.01 24.84 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.825 1.25 . . . . 0.0 108.414 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.5 mt . . . . . 0 CA--C 1.53 0.193 0 C-N-CA 123.154 0.582 . . . . 0.0 109.904 -178.708 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 . . . . . 0 CA--C 1.527 0.081 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -122.77 155.83 35.74 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.034 0.934 . . . . 0.0 110.076 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.3 t -150.08 144.71 25.92 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.115 0.966 . . . . 0.0 109.303 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.7 t -107.11 127.67 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 172.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.4 mt -125.65 124.33 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -66.17 132.5 48.61 Favored 'General case' 0 C--N 1.337 0.045 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 172.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.6 mt -127.66 95.36 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -99.82 156.63 17.01 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.363 0.665 . . . . 0.0 109.938 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.41 32.43 34.55 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.913 0.768 . . . . 0.0 112.036 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 96.7 mtp . . . . . 0 N--CA 1.455 -0.19 0 C-N-CA 123.965 0.906 . . . . 0.0 108.585 175.161 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 111.3 0.111 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.1 m -65.91 -48.41 71.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.159 0.584 . . . . 0.0 110.103 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -51.87 -54.42 13.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 123.419 0.688 . . . . 0.0 109.881 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -59.16 -52.9 63.73 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.66 1.184 . . . . 0.0 111.408 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 p -61.15 -53.46 56.72 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.854 0.462 . . . . 0.0 111.387 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 85.0 mt -55.85 -54.79 22.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 123.815 0.846 . . . . 0.0 109.657 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -59.45 -47.01 87.14 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.526 0.33 . . . . 0.0 110.677 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.43 -51.94 53.1 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.314 0.959 . . . . 0.0 112.256 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.73 -55.21 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 117.631 0.716 . . . . 0.0 110.503 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.23 -37.65 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.087 0.555 . . . . 0.0 111.564 -173.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 92.7 p -54.9 -30.48 58.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.786 0.721 . . . . 0.0 112.694 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -89.51 -4.41 57.93 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.906 0.882 . . . . 0.0 112.256 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -70.73 144.84 91.48 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 118.936 0.789 . . . . 0.0 109.205 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -63.71 128.59 22.54 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.019 2.479 . . . . 0.0 110.444 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.56 -32.44 7.57 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-O 118.817 -0.99 . . . . 0.0 112.491 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.8 t -68.62 132.59 32.79 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 CA-C-N 118.276 1.038 . . . . 0.0 109.914 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -106.34 -99.96 0.34 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.999 1.32 . . . . 0.0 108.009 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.5 p -88.64 151.06 22.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.795 0.838 . . . . 0.0 109.365 173.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.7 tt -150.48 131.9 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.293 0.637 . . . . 0.0 109.302 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.94 94.79 4.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.567 1.547 . . . . 0.0 107.747 -175.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.9 t -90.38 125.66 43.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.3 t -118.96 126.93 52.91 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.733 1.213 . . . . 0.0 110.235 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.6 tp -72.45 -47.91 45.19 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.728 1.211 . . . . 0.0 109.455 170.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.99 -46.49 68.31 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.769 1.227 . . . . 0.0 111.591 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -89.42 -11.57 42.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.306 0.642 . . . . 0.0 111.605 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.9 m 53.42 57.65 5.97 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.125 1.37 . . . . 0.0 110.372 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.7 p30 -157.85 171.04 21.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.402 0.681 . . . . 0.0 111.201 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.88 115.84 1.86 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.1 m -99.46 101.99 13.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.9 t -106.73 139.02 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.918 1.287 . . . . 0.0 109.755 -169.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -108.13 130.28 55.12 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 168.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -150.62 169.0 22.6 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.933 0.493 . . . . 0.0 112.05 -170.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.66 112.86 65.29 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.469 1.507 . . . . 0.0 109.531 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -43.29 -42.74 10.33 Favored 'Trans proline' 0 C--N 1.347 0.456 1 C-N-CA 125.696 4.264 . . . . 0.0 115.872 176.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.0 mt -68.26 -28.85 67.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.645 0.378 . . . . 0.0 111.956 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.9 mt -99.71 -33.91 10.4 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.204 1.002 . . . . 0.0 111.801 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -151.69 170.97 18.41 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.273 0.629 . . . . 0.0 110.088 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.8 p -144.04 164.22 30.73 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.602 1.161 . . . . 0.0 109.747 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -52.72 -38.08 76.5 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.377 2.718 . . . . 0.0 112.55 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -66.05 -45.99 79.4 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.331 1.052 . . . . 0.0 110.349 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.8 m -62.45 -46.57 87.92 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.182 0.593 . . . . 0.0 110.545 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.7 mt -60.23 -49.78 76.26 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.03 0.932 . . . . 0.0 110.566 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.2 ttp85 -52.25 -48.54 65.17 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.323 1.049 . . . . 0.0 110.33 173.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.31 -45.79 87.9 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.287 0.946 . . . . 0.0 112.316 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.34 -48.32 78.49 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.559 0.743 . . . . 0.0 111.189 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.7 mt -59.25 -42.1 86.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.777 0.831 . . . . 0.0 110.045 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -63.11 -42.22 99.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.393 0.677 . . . . 0.0 110.982 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -62.11 -41.82 98.61 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.082 0.953 . . . . 0.0 111.103 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.0 mtp -58.75 -45.89 88.67 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.542 0.337 . . . . 0.0 110.32 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.33 58.45 0.13 Allowed Glycine 0 C--N 1.339 0.749 0 C-N-CA 123.618 0.628 . . . . 0.0 111.719 169.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -140.32 140.31 35.61 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -68.44 96.6 0.69 Allowed 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.9 127.75 46.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.887 1.275 . . . . 0.0 109.646 -172.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.5 m -149.16 130.41 14.61 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.0 mt . . . . . 0 CA--C 1.532 0.272 0 C-N-CA 123.367 0.667 . . . . 0.0 110.597 -177.33 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 . . . . . 0 CA--C 1.529 0.145 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -140.18 141.58 35.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.215 1.006 . . . . 0.0 109.041 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -135.65 146.24 47.63 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.564 1.146 . . . . 0.0 109.588 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.92 124.18 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.3 mt -120.72 120.27 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -68.45 134.44 50.15 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.9 mt -131.67 106.49 11.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.117 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.92 142.63 31.13 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.64 19.4 20.3 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.792 1.187 . . . . 0.0 113.155 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.1 mtm . . . . . 0 C--N 1.342 0.26 0 CA-C-N 118.425 1.113 . . . . 0.0 109.393 176.445 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 120.222 0.058 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.7 m -67.15 -44.49 79.67 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.244 0.618 . . . . 0.0 110.647 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.2 t -54.71 -49.67 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.015 0.926 . . . . 0.0 109.893 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.08 -45.34 93.95 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.582 1.553 . . . . 0.0 111.033 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 m -58.6 -53.16 61.51 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 122.951 0.5 . . . . 0.0 110.852 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.59 -50.83 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 123.744 0.818 . . . . 0.0 109.789 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -49.95 -58.45 5.42 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.839 1.256 . . . . 0.0 110.345 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.78 -57.76 17.73 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.789 0.709 . . . . 0.0 112.155 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.9 t -59.67 -56.88 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.302 0.641 . . . . 0.0 110.872 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.6 mm -64.64 -38.49 82.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 118.747 -0.644 . . . . 0.0 111.212 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.2 t -52.94 -35.2 58.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.864 0.756 . . . . 0.0 111.971 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -89.41 -2.6 58.46 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.799 0.84 . . . . 0.0 112.49 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -71.21 145.16 90.65 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 119.448 1.022 . . . . 0.0 109.267 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.97 131.24 30.08 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.94 2.427 . . . . 0.0 109.895 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.71 -36.18 4.41 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-O 118.934 -0.926 . . . . 0.0 112.047 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.7 t -73.57 143.85 13.28 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 CA-C-N 118.044 0.922 . . . . 0.0 110.105 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -118.18 -103.69 0.41 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.078 1.351 . . . . 0.0 107.411 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.0 p -90.37 109.41 20.52 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.164 0.986 . . . . 0.0 110.414 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.0 tt -97.66 141.68 15.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 168.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -126.3 94.46 4.09 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -175.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -89.38 98.37 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.9 t -89.84 109.41 20.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.843 0.857 . . . . 0.0 109.32 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.2 -43.17 95.84 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.468 0.707 . . . . 0.0 109.878 171.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.6 -49.29 68.11 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.609 1.164 . . . . 0.0 111.742 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -89.8 1.02 56.65 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.033 0.533 . . . . 0.0 112.301 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.9 m 49.36 52.72 13.94 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.419 1.488 . . . . 0.0 111.574 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -155.5 166.25 34.1 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.106 0.479 . . . . 0.0 111.762 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.33 118.3 3.82 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.0 m -98.96 99.62 10.69 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.63 121.46 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 125.281 1.433 . . . . 0.0 109.516 -169.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -89.48 128.21 35.95 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 169.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -150.23 168.91 22.64 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -169.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -106.13 113.24 63.73 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 125.447 1.499 . . . . 0.0 108.979 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -48.27 -35.32 26.86 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 124.807 3.671 . . . . 0.0 114.615 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.0 mt -63.42 -31.46 72.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.509 0.723 . . . . 0.0 111.861 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.8 mt -106.79 -31.35 8.43 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.295 1.038 . . . . 0.0 112.368 -171.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 t -149.71 175.45 11.57 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.746 0.703 . . . . 0.0 110.177 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.2 p -146.46 160.86 40.64 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 124.2 1.0 . . . . 0.0 109.839 -176.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.62 -40.93 54.98 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.402 2.734 . . . . 0.0 112.747 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.97 -44.38 85.09 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.068 0.947 . . . . 0.0 111.148 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.7 m -61.95 -46.71 88.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.153 0.581 . . . . 0.0 110.462 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.4 mt -61.82 -49.72 75.16 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.306 1.042 . . . . 0.0 110.411 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -51.89 -44.48 63.78 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.81 0.844 . . . . 0.0 110.2 171.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.22 -48.0 77.75 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.523 1.058 . . . . 0.0 112.128 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.26 -45.58 90.83 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.657 0.729 . . . . 0.0 111.479 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.0 mt -62.01 -45.32 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.873 0.869 . . . . 0.0 109.914 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -61.71 -42.03 98.4 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.586 1.154 . . . . 0.0 110.775 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.39 -43.64 98.53 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.349 1.06 . . . . 0.0 111.338 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 69.0 mtm -57.11 -48.21 79.2 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 117.908 0.322 . . . . 0.0 110.481 173.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.2 65.8 0.1 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -140.24 152.03 45.63 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.158 0.983 . . . . 0.0 108.717 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -78.21 90.19 4.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.77 133.71 43.73 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.823 1.249 . . . . 0.0 110.464 -174.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.7 m -150.11 146.45 26.92 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.169 0.988 . . . . 0.0 108.459 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 CA--C 1.533 0.314 0 CA-C-N 118.276 0.489 . . . . 0.0 110.001 179.13 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 . . . . . 0 CA--C 1.529 0.154 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -140.28 146.0 38.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.777 0.831 . . . . 0.0 109.609 177.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -137.2 137.31 38.99 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.319 1.048 . . . . 0.0 109.692 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.8 t -99.84 109.11 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 172.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.1 mt -99.82 119.97 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -71.83 123.59 23.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.9 mt -123.53 119.49 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -118.14 158.01 25.85 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.188 0.595 . . . . 0.0 109.746 173.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.9 16.41 51.44 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.621 1.105 . . . . 0.0 112.052 -170.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 89.3 mtp . . . . . 0 CA--C 1.532 0.266 0 C-N-CA 124.458 1.103 . . . . 0.0 108.504 178.852 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.1 t . . . . . 0 CA--C 1.532 0.284 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.1 m -62.35 -49.22 76.46 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -54.16 -52.77 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.144 0.978 . . . . 0.0 109.916 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -55.14 -51.33 66.8 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.81 1.244 . . . . 0.0 110.883 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -60.06 -56.4 22.14 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.235 0.614 . . . . 0.0 110.967 -177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 93.5 mt -53.78 -52.69 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.483 1.113 . . . . 0.0 109.749 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -56.02 -55.5 32.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.324 1.049 . . . . 0.0 110.502 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.57 -50.26 64.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.715 1.15 . . . . 0.0 112.286 -176.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.9 t -63.12 -55.34 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 117.368 0.584 . . . . 0.0 110.394 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 84.3 mt -65.06 -40.91 90.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 119.222 -0.418 . . . . 0.0 111.607 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.8 p -53.73 -28.64 35.41 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -89.43 -8.3 53.33 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.888 0.875 . . . . 0.0 112.523 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -71.88 124.62 91.15 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 119.08 0.854 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.12 121.98 7.72 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.699 2.933 . . . . 0.0 112.135 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.13 -37.35 3.45 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.0 0.81 . . . . 0.0 111.76 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.39 126.97 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 117.827 0.814 . . . . 0.0 109.761 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -94.38 -101.35 0.15 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.924 1.29 . . . . 0.0 107.83 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 91.4 p -90.01 163.04 15.08 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.529 0.732 . . . . 0.0 110.186 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.3 tt -150.63 147.85 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.747 0.819 . . . . 0.0 109.73 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.97 109.06 6.77 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.616 1.166 . . . . 0.0 107.884 172.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.42 102.2 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 124.171 0.988 . . . . 0.0 108.467 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -93.65 112.99 24.98 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.969 0.908 . . . . 0.0 110.372 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tt -66.42 -51.37 57.65 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.22 -51.09 57.16 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.09 1.356 . . . . 0.0 112.209 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -89.86 6.56 41.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.963 0.505 . . . . 0.0 111.939 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 m 49.23 57.02 6.93 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 125.654 1.582 . . . . 0.0 112.047 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -157.19 164.11 38.12 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.519 0.676 . . . . 0.0 112.728 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.45 110.11 2.09 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 106.186 -2.766 . . . . 0.0 106.186 169.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -98.81 97.2 8.44 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.5 t -106.87 124.27 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 124.387 1.075 . . . . 0.0 109.099 -170.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -89.81 130.82 36.01 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 169.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -150.31 165.98 31.4 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.072 0.549 . . . . 0.0 112.191 -169.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -104.37 113.19 65.36 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.098 1.359 . . . . 0.0 109.189 173.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -44.65 -36.65 10.52 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 125.286 3.991 . . . . 0.0 114.846 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.6 mt -66.06 -28.61 68.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.617 0.767 . . . . 0.0 112.12 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.7 mt -109.83 -35.29 6.21 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.314 1.046 . . . . 0.0 112.051 -171.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -145.26 179.32 7.46 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.869 0.868 . . . . 0.0 109.396 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.0 p -150.07 162.63 27.31 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 123.207 0.603 . . . . 0.0 110.56 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.03 -38.82 87.03 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.32 2.68 . . . . 0.0 111.782 172.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.45 -49.72 75.66 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.858 0.863 . . . . 0.0 110.677 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -58.37 -48.35 80.88 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.319 0.647 . . . . 0.0 110.549 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.3 mt -60.65 -47.84 84.45 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.219 1.008 . . . . 0.0 110.87 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -56.55 -44.61 81.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.679 0.792 . . . . 0.0 110.555 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.27 -45.94 87.33 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.095 0.855 . . . . 0.0 111.87 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.39 -49.83 73.95 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.378 0.671 . . . . 0.0 111.091 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.8 mt -60.08 -45.28 95.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.32 0.648 . . . . 0.0 110.212 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -57.56 -48.97 77.88 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.102 0.961 . . . . 0.0 110.048 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.78 -43.58 90.48 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.114 0.965 . . . . 0.0 111.454 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.4 mtp -59.44 -44.53 92.91 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.928 0.491 . . . . 0.0 110.631 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.04 62.21 0.2 Allowed Glycine 0 C--N 1.339 0.725 0 C-N-CA 123.795 0.712 . . . . 0.0 111.598 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -140.31 155.4 46.84 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.789 0.836 . . . . 0.0 109.29 172.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -78.37 91.12 4.43 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.703 0.801 . . . . 0.0 108.996 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.67 129.68 45.83 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.618 1.167 . . . . 0.0 110.816 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.7 m -150.07 132.42 15.57 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.897 0.879 . . . . 0.0 108.818 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 43.5 mt . . . . . 0 CA--C 1.534 0.33 0 C-N-CA 123.054 0.542 . . . . 0.0 111.094 -178.171 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -124.14 144.14 50.08 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.461 1.105 . . . . 0.0 108.886 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -137.7 146.78 44.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.33 1.052 . . . . 0.0 109.326 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.99 125.59 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.9 mt -120.32 121.06 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -72.37 132.07 43.47 Favored 'General case' 0 C--O 1.228 -0.044 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 174.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.5 mt -127.97 106.42 14.8 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -99.56 149.57 23.11 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.427 0.691 . . . . 0.0 109.195 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.27 16.27 47.64 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.441 1.02 . . . . 0.0 113.005 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.8 mtm . . . . . 0 C--N 1.343 0.293 0 CA-C-N 118.58 1.19 . . . . 0.0 109.252 175.227 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.8 m -60.76 -57.2 13.71 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.4 0.68 . . . . 0.0 109.603 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.7 t -49.89 -51.55 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.06 1.344 . . . . 0.0 111.067 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -59.87 -52.48 65.27 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.009 1.324 . . . . 0.0 111.103 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.3 p -61.12 -48.98 79.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.122 0.569 . . . . 0.0 111.3 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.8 mt -53.76 -55.31 14.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.805 0.842 . . . . 0.0 109.397 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -54.18 -55.06 31.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.113 0.565 . . . . 0.0 110.712 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.43 -50.45 59.94 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.315 0.959 . . . . 0.0 112.779 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.38 -49.68 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.409 0.683 . . . . 0.0 110.699 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.6 mm -66.28 -33.53 64.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.46 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.7 m -50.87 -30.88 15.72 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.872 0.76 . . . . 0.0 112.734 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -89.07 -3.35 58.7 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.58 0.752 . . . . 0.0 112.167 -173.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -77.12 143.01 69.27 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 118.87 0.759 . . . . 0.0 109.903 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.92 135.37 17.82 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.91 3.073 . . . . 0.0 112.608 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.17 -34.9 3.95 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.674 -1.07 . . . . 0.0 113.045 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.1 124.22 20.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-N 118.448 1.124 . . . . 0.0 109.918 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -89.84 -102.59 0.09 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.0 p -90.49 158.02 17.25 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.336 1.054 . . . . 0.0 109.676 171.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.5 tt -150.23 127.37 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -116.19 107.13 14.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.465 1.106 . . . . 0.0 108.497 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.62 124.38 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.0 t -106.8 129.48 54.65 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.636 1.174 . . . . 0.0 110.17 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.5 tp -68.35 -53.61 22.93 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.709 0.803 . . . . 0.0 109.09 171.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.16 -47.48 71.93 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 125.265 1.426 . . . . 0.0 112.086 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -89.25 -9.63 49.95 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.403 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.5 m 52.79 56.08 8.1 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 125.016 1.326 . . . . 0.0 111.02 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -157.17 168.31 27.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.419 0.688 . . . . 0.0 110.853 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.55 116.83 2.89 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 126.215 1.864 . . . . 0.0 108.783 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.0 m -99.12 100.56 11.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 176.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.6 t -106.3 125.52 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.502 1.121 . . . . 0.0 109.537 -170.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -95.53 127.93 41.98 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 168.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -150.26 164.36 35.93 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.17 0.588 . . . . 0.0 111.779 -169.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -98.36 114.25 65.02 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.737 1.215 . . . . 0.0 109.013 172.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -47.74 -34.35 21.07 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.741 3.627 . . . . 0.0 114.93 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.5 mt -65.92 -33.9 76.89 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.457 0.703 . . . . 0.0 111.584 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.75 -35.3 9.84 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.895 0.878 . . . . 0.0 111.578 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.3 t -147.4 178.37 8.48 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.698 0.681 . . . . 0.0 110.539 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.3 p -148.88 159.85 36.73 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 124.624 1.17 . . . . 0.0 109.714 -174.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.41 -40.42 62.47 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.511 2.807 . . . . 0.0 112.814 176.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -66.79 -41.05 88.28 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.555 1.142 . . . . 0.0 110.927 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.8 m -67.55 -45.65 75.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.1 0.56 . . . . 0.0 110.326 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.0 mt -60.73 -49.55 77.05 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.241 1.016 . . . . 0.0 110.253 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.9 ttp85 -52.1 -47.24 65.38 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.164 0.986 . . . . 0.0 109.988 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.19 -45.23 83.22 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.569 1.08 . . . . 0.0 112.293 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.59 -48.24 75.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.635 0.717 . . . . 0.0 111.099 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.93 -42.45 89.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.92 0.888 . . . . 0.0 109.981 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -63.51 -41.04 98.52 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.628 1.171 . . . . 0.0 110.568 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.36 -41.48 98.83 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.01 0.924 . . . . 0.0 111.182 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.9 mtp -57.83 -44.27 86.36 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.097 0.408 . . . . 0.0 110.203 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.13 61.76 0.16 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 123.651 0.643 . . . . 0.0 111.702 169.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -140.33 152.43 45.82 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.999 0.919 . . . . 0.0 109.414 175.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -79.74 86.24 5.35 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.57 128.99 45.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.626 1.171 . . . . 0.0 110.461 -173.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.9 p -142.34 151.19 41.68 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.154 1.382 . . . . 0.0 109.039 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.414 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 . . . . . 0 CA--C 1.528 0.097 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -134.76 141.27 46.42 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.061 0.945 . . . . 0.0 108.969 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -131.56 144.8 51.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.406 1.082 . . . . 0.0 109.49 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.97 123.75 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.2 mt -116.37 121.76 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -69.94 118.19 12.47 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.3 mt -110.8 102.34 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -99.65 149.03 23.71 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.562 0.745 . . . . 0.0 109.27 176.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.67 26.04 16.28 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.667 1.127 . . . . 0.0 112.359 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 88.8 mtp . . . . . 0 CA--C 1.53 0.206 0 C-N-CA 124.107 0.963 . . . . 0.0 108.413 175.589 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 p . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.31 -40.51 96.54 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.939 0.895 . . . . 0.0 109.239 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.5 t -49.86 -59.3 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.358 1.063 . . . . 0.0 109.928 173.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.89 -45.5 94.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.609 1.164 . . . . 0.0 111.037 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.8 t -59.55 -57.88 11.04 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.956 0.902 . . . . 0.0 110.828 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.3 mt -55.42 -54.4 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.964 0.906 . . . . 0.0 109.587 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -55.38 -49.02 73.4 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.144 0.578 . . . . 0.0 110.791 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.39 -37.27 91.75 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.002 1.287 . . . . 0.0 113.284 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.6 t -77.84 -57.81 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.253 1.026 . . . . 0.0 110.17 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.38 -37.63 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.452 0.701 . . . . 0.0 111.404 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.9 p -51.6 -30.78 22.44 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -89.42 -8.29 53.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.815 0.846 . . . . 0.0 112.434 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -72.56 143.62 85.3 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 118.751 0.705 . . . . 0.0 109.816 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -47.51 134.27 21.0 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.791 2.994 . . . . 0.0 112.655 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.56 -31.76 5.64 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-O 118.724 -1.042 . . . . 0.0 113.457 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.5 t -67.12 134.02 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.341 1.071 . . . . 0.0 110.146 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -113.88 -102.94 0.41 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.192 1.397 . . . . 0.0 108.297 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.4 p -82.44 154.05 25.35 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.161 0.584 . . . . 0.0 109.79 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.5 tt -150.33 145.32 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.326 0.65 . . . . 0.0 110.1 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -139.97 103.47 4.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.5 t -91.67 108.6 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.2 t -89.52 129.23 36.03 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.145 0.578 . . . . 0.0 110.111 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tt -73.96 -57.01 4.25 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.813 1.245 . . . . 0.0 108.152 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.79 -45.7 78.13 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.524 1.53 . . . . 0.0 112.356 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -89.12 -10.54 46.91 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.893 0.477 . . . . 0.0 111.013 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.2 m 56.23 58.15 4.5 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.057 1.343 . . . . 0.0 110.614 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -146.03 163.59 34.75 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.86 0.464 . . . . 0.0 111.618 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.04 107.59 1.8 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.9 m -99.13 99.84 10.9 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.3 t -114.91 126.01 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 124.791 1.236 . . . . 0.0 109.608 -169.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -89.92 131.61 35.74 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -150.51 156.96 42.44 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.274 0.629 . . . . 0.0 112.256 -170.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -93.53 120.08 66.67 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.703 1.201 . . . . 0.0 110.117 173.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.53 -41.79 29.51 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 125.069 3.846 . . . . 0.0 115.785 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -68.47 -29.74 68.43 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.614 0.365 . . . . 0.0 111.73 -173.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.2 mt -99.64 -32.66 10.96 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.227 1.011 . . . . 0.0 111.893 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -153.23 176.22 12.19 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.677 0.671 . . . . 0.0 110.05 173.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.9 p -150.09 162.6 27.39 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.039 0.936 . . . . 0.0 109.993 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.3 -44.34 49.77 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.439 2.759 . . . . 0.0 112.755 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.05 -34.12 77.3 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.502 0.721 . . . . 0.0 112.571 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.1 m -70.93 -47.67 57.79 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 122.944 0.498 . . . . 0.0 109.732 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.9 mt -58.36 -50.31 74.12 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.943 0.897 . . . . 0.0 110.05 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -52.29 -47.4 65.91 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.791 1.236 . . . . 0.0 110.533 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.82 -47.87 76.0 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.32 0.962 . . . . 0.0 112.156 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.5 -46.77 86.95 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.561 0.744 . . . . 0.0 111.401 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.7 mt -60.97 -43.99 97.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.56 0.744 . . . . 0.0 109.938 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -63.14 -41.67 99.34 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.712 0.805 . . . . 0.0 110.945 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.13 -43.49 98.81 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.253 1.021 . . . . 0.0 111.184 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 69.5 mtm -58.46 -50.04 75.14 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 117.842 0.292 . . . . 0.0 110.382 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.39 63.01 0.09 OUTLIER Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 171.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -140.25 142.98 35.74 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.27 93.51 1.11 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.9 120.7 40.19 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.219 1.407 . . . . 0.0 109.425 -174.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 47.1 p -138.27 140.26 39.55 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.356 1.062 . . . . 0.0 108.617 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 CA--C 1.53 0.201 0 C-N-CA 122.596 0.358 . . . . 0.0 110.31 -176.409 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 . . . . . 0 CA--C 1.527 0.088 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -128.5 151.81 48.99 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.554 1.142 . . . . 0.0 109.438 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -145.44 148.68 33.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.298 1.039 . . . . 0.0 109.394 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.93 123.54 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.4 mt -119.06 128.86 75.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -70.28 121.47 17.69 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 171.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.7 mt -125.95 95.01 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.75 151.74 20.9 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.31 15.79 56.64 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.31 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 54.8 mtt . . . . . 0 C--N 1.344 0.344 0 CA-C-N 118.755 1.277 . . . . 0.0 109.764 174.6 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.3 m -63.8 -44.26 93.83 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.736 0.814 . . . . 0.0 110.679 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.3 t -51.92 -54.7 12.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 C-N-CA 123.302 0.641 . . . . 0.0 109.641 176.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -61.51 -42.65 99.13 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.668 0.787 . . . . 0.0 111.432 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -59.24 -55.43 35.01 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.131 0.572 . . . . 0.0 110.663 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.2 mt -54.25 -55.8 12.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 123.873 0.869 . . . . 0.0 109.155 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -54.44 -54.67 37.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.85 0.86 . . . . 0.0 111.091 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.09 -53.57 44.64 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.281 0.943 . . . . 0.0 112.364 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.61 -54.24 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 117.382 0.591 . . . . 0.0 110.438 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.9 mm -61.78 -40.6 87.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.699 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.1 t -51.2 -36.21 40.27 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.427 0.691 . . . . 0.0 112.089 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -88.97 -11.06 45.41 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.464 0.705 . . . . 0.0 112.131 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -73.08 139.43 79.5 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 119.466 1.03 . . . . 0.0 109.962 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -45.22 137.81 10.09 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.354 3.369 . . . . 0.0 113.665 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.34 -38.79 3.01 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-O 118.841 -0.977 . . . . 0.0 112.49 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.34 134.02 30.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 CA-C-N 118.254 1.027 . . . . 0.0 110.088 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -104.61 -102.09 0.31 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.849 1.259 . . . . 0.0 107.926 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.8 p -87.31 152.83 21.96 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.464 0.706 . . . . 0.0 109.849 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 tt -150.69 140.23 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.645 0.778 . . . . 0.0 109.676 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -129.84 110.95 12.13 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.924 1.29 . . . . 0.0 108.659 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.34 122.79 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.363 1.065 . . . . 0.0 108.572 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.7 t -115.63 123.66 48.98 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.823 1.249 . . . . 0.0 110.588 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.6 tp -69.83 -48.24 59.71 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.745 1.218 . . . . 0.0 109.823 170.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.12 -46.74 65.46 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.691 1.197 . . . . 0.0 111.639 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -89.51 -15.03 33.91 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.419 0.688 . . . . 0.0 111.7 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.2 m 54.52 54.68 8.97 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 125.14 1.376 . . . . 0.0 110.415 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -154.32 163.42 40.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.454 0.702 . . . . 0.0 110.928 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.54 119.6 3.74 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.4 m -99.2 104.52 16.49 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 t -112.86 127.75 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 124.655 1.182 . . . . 0.0 109.575 -170.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -96.73 133.07 41.76 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 169.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -150.38 169.79 20.58 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.773 0.429 . . . . 0.0 111.865 -171.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -103.67 110.76 64.47 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 125.133 1.373 . . . . 0.0 109.268 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -41.66 -38.73 4.47 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 125.268 3.979 . . . . 0.0 115.227 170.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.9 mt -62.51 -35.12 78.36 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.25 0.62 . . . . 0.0 111.955 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.9 mt -104.4 -31.57 9.45 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.299 1.04 . . . . 0.0 112.344 -170.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 t -150.1 176.76 10.52 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.408 0.683 . . . . 0.0 110.173 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.3 p -147.45 163.43 27.91 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.36 1.064 . . . . 0.0 109.929 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.92 -41.87 67.92 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.326 2.684 . . . . 0.0 112.443 176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -66.47 -40.85 89.6 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.786 0.834 . . . . 0.0 111.39 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.9 m -62.66 -47.24 84.56 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.779 0.432 . . . . 0.0 110.242 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.6 mt -62.07 -47.53 84.25 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.106 0.963 . . . . 0.0 110.606 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -51.66 -48.54 63.37 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.495 1.118 . . . . 0.0 109.954 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.86 -45.01 92.09 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.485 1.04 . . . . 0.0 112.255 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.43 -49.29 76.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.477 0.711 . . . . 0.0 111.159 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.59 -41.81 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.707 0.803 . . . . 0.0 110.164 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -61.42 -43.0 99.63 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.942 0.897 . . . . 0.0 110.707 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.4 -42.27 99.31 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.917 0.887 . . . . 0.0 111.091 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mtp -58.67 -44.84 90.32 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.973 0.352 . . . . 0.0 110.379 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.39 59.92 0.17 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 123.756 0.693 . . . . 0.0 111.976 169.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -140.31 152.31 45.75 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.051 0.94 . . . . 0.0 108.95 174.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -75.9 91.5 3.02 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.31 122.47 42.5 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.54 1.136 . . . . 0.0 109.95 -172.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.6 m -148.54 132.59 17.24 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.54 1.136 . . . . 0.0 108.304 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.2 mt . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 123.147 0.579 . . . . 0.0 111.477 -175.115 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.1 mm100 . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -108.94 145.11 35.97 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.388 1.075 . . . . 0.0 109.385 176.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 t -134.99 133.7 39.74 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.028 0.931 . . . . 0.0 109.336 172.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.93 108.32 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.7 mt -99.55 120.6 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -82.93 109.84 17.39 Favored 'General case' 0 C--N 1.334 -0.072 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.8 mt -111.73 106.19 20.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.403 1.081 . . . . 0.0 108.278 -172.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -99.6 145.4 27.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.07 -5.71 46.32 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.553 -1.137 . . . . 0.0 113.584 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 C--N 1.344 0.337 0 CA-C-N 119.069 1.434 . . . . 0.0 110.296 179.93 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.7 m . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -63.33 -45.04 93.09 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.667 0.787 . . . . 0.0 110.569 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.0 t -54.8 -53.86 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.625 0.77 . . . . 0.0 110.318 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -58.23 -46.72 85.39 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.588 1.155 . . . . 0.0 111.22 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.6 t -57.18 -52.67 64.37 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.313 0.645 . . . . 0.0 110.684 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.5 mt -55.01 -61.21 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 124.461 1.104 . . . . 0.0 110.075 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -59.3 -41.08 88.16 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.985 0.357 . . . . 0.0 111.386 -174.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.39 -56.08 27.0 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.24 -52.51 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.673 0.789 . . . . 0.0 110.726 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.5 mm -62.52 -37.58 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.434 0.693 . . . . 0.0 111.56 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.1 m -54.32 -29.51 47.98 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.698 0.681 . . . . 0.0 112.738 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -89.31 -6.38 56.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.288 0.635 . . . . 0.0 112.222 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -72.81 139.75 80.55 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 119.104 0.865 . . . . 0.0 109.251 177.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.05 131.56 29.13 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.004 2.469 . . . . 0.0 110.065 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.33 -36.19 4.54 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-O 118.872 -0.96 . . . . 0.0 111.795 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.53 131.65 32.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-N 118.141 0.971 . . . . 0.0 109.866 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -104.07 -101.63 0.31 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.943 1.297 . . . . 0.0 107.81 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.3 p -90.06 160.35 16.36 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.873 0.869 . . . . 0.0 110.079 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.7 tt -150.39 146.58 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 123.861 0.864 . . . . 0.0 109.488 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.94 109.78 7.6 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 173.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -98.67 103.71 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.0 t -89.78 118.98 29.78 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.602 0.761 . . . . 0.0 109.132 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.0 tp -70.56 -44.26 67.81 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.693 0.797 . . . . 0.0 109.656 172.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.12 -48.78 67.58 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.775 1.23 . . . . 0.0 111.666 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -89.39 -5.91 57.04 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.105 0.562 . . . . 0.0 111.534 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.8 m 52.07 55.78 8.72 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.52 1.528 . . . . 0.0 111.255 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -155.3 151.29 27.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.127 0.489 . . . . 0.0 111.815 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.67 113.56 4.27 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 126.242 1.877 . . . . 0.0 108.621 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.6 m -98.78 97.14 8.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 t -104.64 126.91 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.348 1.059 . . . . 0.0 109.399 -170.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -92.67 131.07 38.07 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -149.96 164.14 36.26 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.242 0.617 . . . . 0.0 110.971 -171.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -101.38 114.4 65.71 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.408 1.083 . . . . 0.0 109.151 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.52 -35.35 16.4 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 125.002 3.801 . . . . 0.0 115.069 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.27 -29.69 69.37 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.515 0.726 . . . . 0.0 111.833 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.8 -46.92 5.23 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.054 0.942 . . . . 0.0 110.725 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 t -138.56 -178.95 5.53 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.965 0.906 . . . . 0.0 110.107 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.9 p -148.35 161.69 33.01 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.872 0.869 . . . . 0.0 110.287 -173.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -51.43 -50.01 15.33 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.494 2.796 . . . . 0.0 112.73 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.95 -33.21 75.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.897 0.479 . . . . 0.0 112.115 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.5 m -64.81 -48.75 73.29 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.9 mt -61.86 -46.98 87.07 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.497 0.719 . . . . 0.0 110.601 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.8 ttp85 -53.78 -46.47 71.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.043 0.937 . . . . 0.0 109.88 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.99 -42.71 93.03 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.521 1.058 . . . . 0.0 112.309 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.21 -47.13 83.82 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.999 0.899 . . . . 0.0 111.03 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mm -58.59 -44.76 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 122.73 0.412 . . . . 0.0 110.108 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -61.7 -38.99 89.9 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.25 0.62 . . . . 0.0 111.011 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.59 -43.42 93.91 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.315 1.046 . . . . 0.0 110.94 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.5 mtp -58.7 -41.51 86.43 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.958 0.344 . . . . 0.0 110.472 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.7 57.92 0.23 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 123.959 0.79 . . . . 0.0 111.919 169.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -140.27 145.53 37.42 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -73.92 91.13 1.98 Allowed 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.662 0.785 . . . . 0.0 109.565 -174.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.84 127.72 45.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.04 1.336 . . . . 0.0 110.374 -174.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.1 m -144.76 130.99 19.55 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.363 1.065 . . . . 0.0 108.515 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 CA--C 1.531 0.216 0 C-N-CA 123.426 0.69 . . . . 0.0 111.627 -178.323 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 . . . . . 0 CA--C 1.529 0.173 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -128.27 151.46 49.27 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.51 1.124 . . . . 0.0 109.429 175.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 t -150.13 140.94 22.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.589 0.755 . . . . 0.0 110.025 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.1 t -99.73 129.49 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 171.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.4 mt -121.47 123.66 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -78.66 120.47 23.38 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.0 mt -119.73 103.32 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 125.917 1.687 . . . . 0.0 106.708 -173.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -99.97 144.85 28.53 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.923 0.489 . . . . 0.0 110.23 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.47 34.76 7.77 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.788 1.185 . . . . 0.0 112.852 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.9 mtm . . . . . 0 C--N 1.34 0.182 0 CA-C-N 117.794 0.797 . . . . 0.0 109.563 177.791 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.7 p . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.685 0.278 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.0 m -64.57 -47.36 79.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.476 0.71 . . . . 0.0 110.285 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -51.16 -56.56 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.151 0.98 . . . . 0.0 110.445 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -62.38 -49.06 77.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.308 1.043 . . . . 0.0 111.494 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.3 p -61.52 -50.12 73.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.004 0.365 . . . . 0.0 111.568 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.8 mt -55.16 -55.07 18.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 C-N-CA 123.769 0.828 . . . . 0.0 109.343 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.3 -49.62 71.67 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.25 0.62 . . . . 0.0 110.999 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.4 -51.33 59.76 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.633 1.111 . . . . 0.0 112.347 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.73 -54.29 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 117.75 0.775 . . . . 0.0 110.311 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.8 mm -64.3 -38.27 82.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 118.911 -0.566 . . . . 0.0 111.638 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.4 p -53.74 -31.73 49.5 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.85 0.75 . . . . 0.0 112.721 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -89.58 -3.65 58.2 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.049 0.939 . . . . 0.0 112.395 -174.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -72.03 143.26 86.15 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 119.071 0.851 . . . . 0.0 109.64 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -46.82 128.47 13.4 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.894 3.063 . . . . 0.0 112.665 176.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.01 -30.86 7.09 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.391 177.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.5 t -69.66 125.45 27.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 CA-C-N 118.694 1.247 . . . . 0.0 109.832 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -95.9 -103.04 0.16 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.7 p -86.58 155.62 20.38 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.415 0.686 . . . . 0.0 110.213 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tt -150.66 139.06 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.922 0.889 . . . . 0.0 109.208 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -128.91 103.8 7.24 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.655 1.182 . . . . 0.0 108.77 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -93.25 121.91 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 123.967 0.907 . . . . 0.0 108.769 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.7 t -118.09 124.44 48.07 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.911 1.284 . . . . 0.0 109.725 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tt -71.09 -46.97 60.81 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.273 1.029 . . . . 0.0 109.487 172.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.36 -47.46 56.04 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.732 1.213 . . . . 0.0 111.778 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -89.57 -8.72 52.06 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.365 0.666 . . . . 0.0 111.774 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.1 m 51.87 55.64 8.99 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.779 1.632 . . . . 0.0 110.709 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -155.77 170.41 22.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.005 0.522 . . . . 0.0 111.765 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.7 118.31 2.58 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.4 m -98.98 100.49 11.66 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 t -106.72 128.33 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.556 1.142 . . . . 0.0 109.757 -169.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -96.52 130.54 43.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 168.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -150.22 163.39 38.39 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.009 0.523 . . . . 0.0 111.881 -171.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -97.08 113.98 63.95 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.916 1.286 . . . . 0.0 109.381 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -45.69 -37.41 15.8 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 124.942 3.762 . . . . 0.0 114.777 172.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -64.61 -34.35 78.07 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.505 0.722 . . . . 0.0 111.811 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.4 mt -104.09 -30.47 10.22 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.121 0.969 . . . . 0.0 112.279 -172.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.0 t -151.78 177.96 9.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.302 0.641 . . . . 0.0 110.107 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.3 p -149.21 162.05 30.16 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 125.106 1.363 . . . . 0.0 109.549 -172.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.14 -38.43 80.95 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.934 2.422 . . . . 0.0 112.03 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.28 -48.92 71.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.587 1.155 . . . . 0.0 111.44 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.4 p -62.56 -42.49 99.58 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.503 0.321 . . . . 0.0 111.096 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.5 mt -64.83 -47.8 76.68 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.385 0.674 . . . . 0.0 110.365 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.5 ttp85 -51.99 -48.03 64.62 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.166 0.986 . . . . 0.0 110.219 171.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.63 -46.69 81.13 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.294 0.95 . . . . 0.0 112.246 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.42 -48.64 78.79 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.638 0.775 . . . . 0.0 111.169 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.0 mt -60.16 -42.42 90.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.71 0.804 . . . . 0.0 110.059 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.62 -39.94 95.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.579 0.751 . . . . 0.0 110.831 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.69 -41.66 98.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.022 0.929 . . . . 0.0 111.003 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.9 mtp -58.31 -43.4 88.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.984 0.356 . . . . 0.0 110.268 172.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.26 58.39 0.18 Allowed Glycine 0 C--N 1.34 0.778 0 C-N-CA 123.827 0.727 . . . . 0.0 111.975 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -140.29 142.48 35.68 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.004 0.922 . . . . 0.0 108.935 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -69.75 92.36 0.67 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.67 123.95 44.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.232 1.413 . . . . 0.0 109.302 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.1 p -138.66 136.74 36.2 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.703 1.201 . . . . 0.0 108.872 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 61.6 mt . . . . . 0 CA--C 1.529 0.171 0 C-N-CA 122.615 0.366 . . . . 0.0 110.215 -177.471 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -125.02 152.97 43.55 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.428 1.091 . . . . 0.0 109.567 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -149.75 138.29 20.76 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.447 0.699 . . . . 0.0 110.115 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.83 124.18 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 172.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.4 mt -119.81 120.17 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -75.86 126.87 31.84 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.8 mt -122.13 111.41 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.639 1.176 . . . . 0.0 108.014 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -99.61 147.61 25.19 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.21 2.02 51.19 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.279 0.942 . . . . 0.0 112.885 -177.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.8 mtm . . . . . 0 C--N 1.342 0.261 0 CA-C-N 118.688 1.244 . . . . 0.0 108.624 174.813 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.9 p . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 111.222 0.082 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -59.07 -50.3 74.59 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.755 0.822 . . . . 0.0 110.281 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -53.85 -52.51 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 124.87 1.268 . . . . 0.0 110.922 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -59.22 -46.12 89.31 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.5 1.12 . . . . 0.0 111.142 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.6 m -58.53 -52.87 63.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.177 0.591 . . . . 0.0 110.792 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.1 mt -56.55 -53.65 38.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 123.599 0.76 . . . . 0.0 109.689 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -52.82 -55.51 22.51 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.193 0.997 . . . . 0.0 110.739 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.43 -52.07 53.92 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.161 0.886 . . . . 0.0 112.186 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.8 t -61.01 -56.18 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.268 0.627 . . . . 0.0 110.907 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.7 mm -62.01 -37.11 77.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.259 0.624 . . . . 0.0 111.39 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.0 t -49.45 -40.7 37.88 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 123.763 0.825 . . . . 0.0 112.673 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -89.47 -6.08 56.78 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -171.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -75.07 148.39 84.27 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 119.165 0.893 . . . . 0.0 110.459 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -44.14 133.86 8.72 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.494 3.463 . . . . 0.0 113.707 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.66 -40.57 2.92 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-O 118.959 -0.911 . . . . 0.0 112.674 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.7 t -68.31 134.91 29.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 CA-C-N 117.983 0.892 . . . . 0.0 110.168 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -109.29 -98.67 0.39 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.602 1.161 . . . . 0.0 107.88 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.7 p -87.59 152.41 22.2 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.634 0.774 . . . . 0.0 109.509 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.0 tt -150.56 136.65 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 123.499 0.719 . . . . 0.0 109.224 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.23 101.47 6.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.869 1.267 . . . . 0.0 108.39 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.8 t -96.88 122.93 48.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.9 t -107.02 130.67 54.62 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.793 1.237 . . . . 0.0 110.332 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.3 tp -69.62 -52.39 26.36 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.705 0.802 . . . . 0.0 109.119 170.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.53 -47.51 69.88 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 125.22 1.408 . . . . 0.0 112.114 -176.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -89.25 -9.69 49.74 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.888 0.475 . . . . 0.0 111.457 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.1 m 52.52 56.43 7.68 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.107 1.363 . . . . 0.0 110.783 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -155.65 166.35 33.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.095 0.558 . . . . 0.0 111.191 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.67 115.03 2.49 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.507 2.003 . . . . 0.0 108.707 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.9 m -99.28 98.82 9.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 t -106.24 131.3 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 124.453 1.101 . . . . 0.0 109.693 -170.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -99.04 130.34 45.36 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -150.19 163.27 38.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.119 0.568 . . . . 0.0 111.825 -169.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -98.13 113.84 64.4 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.686 1.195 . . . . 0.0 109.293 172.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -44.45 -36.96 10.26 Favored 'Trans proline' 0 C--N 1.349 0.556 1 C-N-CA 125.356 4.037 . . . . 0.0 115.024 173.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.2 mt -64.5 -36.39 84.06 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.109 0.564 . . . . 0.0 111.789 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.2 mt -100.0 -32.96 10.7 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.12 0.968 . . . . 0.0 112.244 -171.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.3 t -149.35 178.86 8.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.29 0.636 . . . . 0.0 110.093 176.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.9 p -150.21 162.9 26.34 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 124.172 0.989 . . . . 0.0 109.759 -174.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -53.07 -46.94 30.33 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.191 2.594 . . . . 0.0 112.372 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.42 -33.9 76.75 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.016 0.526 . . . . 0.0 112.287 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 98.3 m -67.73 -45.32 75.35 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.376 0.535 . . . . 0.0 110.096 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.5 mt -61.19 -47.33 86.67 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.65 0.78 . . . . 0.0 110.461 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -52.64 -47.04 67.34 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.052 0.941 . . . . 0.0 110.269 171.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.48 -45.82 82.85 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.303 0.954 . . . . 0.0 112.313 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.34 -46.36 83.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.785 0.834 . . . . 0.0 111.35 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.4 mt -62.43 -43.46 98.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.758 0.823 . . . . 0.0 110.08 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.35 -41.7 98.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.293 1.037 . . . . 0.0 110.938 176.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.57 -43.91 97.99 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.968 0.907 . . . . 0.0 111.132 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.9 mtm -59.32 -50.88 72.28 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 117.911 0.323 . . . . 0.0 110.213 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.71 60.84 0.09 OUTLIER Glycine 0 C--N 1.34 0.802 0 C-N-CA 123.519 0.581 . . . . 0.0 111.789 171.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -140.09 141.94 36.12 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 171.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -75.7 91.07 2.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.661 0.784 . . . . 0.0 109.49 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.36 134.8 41.69 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.632 1.173 . . . . 0.0 110.362 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 95.0 m -144.07 133.8 23.71 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.983 1.313 . . . . 0.0 108.369 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.0 mt . . . . . 0 CA--C 1.53 0.173 0 C-N-CA 123.215 0.606 . . . . 0.0 109.872 -178.635 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -101.13 142.31 32.76 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.81 0.444 . . . . 0.0 110.244 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -135.81 137.72 41.84 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.418 1.087 . . . . 0.0 109.127 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.3 t -99.96 129.58 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.516 -1.291 . . . . 0.0 107.516 174.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.1 mt -126.04 122.01 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -76.99 124.18 27.4 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.5 mt -117.37 109.14 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 124.989 1.315 . . . . 0.0 107.874 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -99.97 149.81 23.07 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 174.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.35 1.82 56.74 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.072 0.844 . . . . 0.0 113.232 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.0 mtm . . . . . 0 C--N 1.342 0.262 0 CA-C-N 118.719 1.26 . . . . 0.0 108.329 173.725 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.1 p . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.4 m -58.87 -49.04 79.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.544 1.137 . . . . 0.0 108.73 169.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -49.87 -52.23 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 125.549 1.54 . . . . 0.0 110.331 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -62.48 -45.74 91.65 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.676 0.79 . . . . 0.0 111.009 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -58.69 -53.26 60.38 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.667 0.787 . . . . 0.0 110.774 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.0 mt -55.78 -54.8 22.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 C-N-CA 124.064 0.946 . . . . 0.0 109.402 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.63 -54.49 32.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.73 0.812 . . . . 0.0 110.86 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.68 -53.65 43.51 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.234 0.921 . . . . 0.0 112.514 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.9 t -63.69 -54.75 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 117.41 0.605 . . . . 0.0 110.813 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.78 -37.31 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 118.844 -0.598 . . . . 0.0 110.929 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.4 t -50.14 -34.8 23.45 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.637 0.653 . . . . 0.0 112.564 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -89.64 -10.52 45.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.128 0.971 . . . . 0.0 112.472 -174.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -69.96 146.29 95.04 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 119.011 0.823 . . . . 0.0 110.062 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -46.34 135.6 15.52 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 124.033 3.156 . . . . 0.0 113.101 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.08 -37.32 3.34 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 118.856 -0.969 . . . . 0.0 112.763 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 52.1 t -67.17 141.21 18.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-N 118.302 1.051 . . . . 0.0 110.216 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -116.72 -98.67 0.45 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.895 1.278 . . . . 0.0 108.011 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.4 p -90.2 154.96 19.35 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.535 0.734 . . . . 0.0 109.796 174.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.1 tt -150.85 139.79 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.519 0.727 . . . . 0.0 109.88 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.71 109.49 12.11 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.841 1.256 . . . . 0.0 108.399 174.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.6 125.97 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.9 t -115.57 127.97 55.63 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.86 1.264 . . . . 0.0 110.151 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.8 tp -70.73 -50.47 35.81 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.098 0.959 . . . . 0.0 109.65 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.76 -43.76 69.43 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.019 1.328 . . . . 0.0 111.832 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -89.18 -16.52 31.15 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.162 0.585 . . . . 0.0 111.122 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.0 m 55.21 56.29 6.63 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 125.141 1.376 . . . . 0.0 110.223 -177.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -154.84 168.8 25.69 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.062 0.545 . . . . 0.0 111.475 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.04 115.79 2.41 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 126.101 1.81 . . . . 0.0 108.6 176.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.7 m -99.22 99.1 10.03 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.5 t -106.9 126.71 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 124.791 1.236 . . . . 0.0 109.374 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -90.04 131.57 35.84 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -150.18 165.16 33.72 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.196 0.599 . . . . 0.0 112.022 -172.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -100.69 113.83 65.68 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.348 1.459 . . . . 0.0 108.688 172.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.65 -35.79 17.77 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 125.188 3.925 . . . . 0.0 114.798 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.26 -34.27 77.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.383 0.673 . . . . 0.0 111.73 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.75 -36.22 9.53 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.846 0.858 . . . . 0.0 111.557 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.1 t -147.22 176.74 9.74 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.62 0.645 . . . . 0.0 110.655 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.7 p -148.46 161.25 34.27 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.62 1.168 . . . . 0.0 109.729 -175.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.97 -38.74 59.38 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.42 2.747 . . . . 0.0 112.914 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -65.77 -44.32 86.19 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.482 1.113 . . . . 0.0 110.432 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.4 m -64.54 -45.4 87.31 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.056 0.543 . . . . 0.0 110.374 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.3 mt -63.22 -46.35 87.38 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.025 0.93 . . . . 0.0 110.775 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -52.21 -48.93 64.83 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.885 0.874 . . . . 0.0 109.805 170.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.15 -44.92 83.86 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.301 0.953 . . . . 0.0 112.582 176.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.96 -48.13 77.71 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.728 0.811 . . . . 0.0 111.287 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.6 mt -60.08 -41.43 86.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.916 0.886 . . . . 0.0 109.897 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -64.29 -40.19 95.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.382 0.673 . . . . 0.0 111.008 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.56 -41.9 98.37 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.027 0.931 . . . . 0.0 111.017 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.8 mtp -58.31 -45.3 88.3 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 172.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.39 57.04 0.14 Allowed Glycine 0 C--N 1.34 0.764 0 C-N-CA 123.807 0.718 . . . . 0.0 111.747 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -140.35 139.35 35.36 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.792 0.837 . . . . 0.0 108.763 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -70.64 93.05 0.89 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.726 0.81 . . . . 0.0 109.497 -176.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.5 131.44 45.5 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.75 1.22 . . . . 0.0 109.751 -173.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.0 p -139.25 139.19 37.34 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.857 1.263 . . . . 0.0 108.603 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 CA--C 1.53 0.204 0 C-N-CA 122.83 0.452 . . . . 0.0 110.467 -178.648 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 . . . . . 0 CA--C 1.528 0.126 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -120.03 142.7 48.59 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.099 0.96 . . . . 0.0 109.273 176.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.6 t -135.42 140.77 45.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.315 1.046 . . . . 0.0 109.712 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.9 t -103.54 111.2 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 175.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.6 mt -99.57 123.9 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -82.28 111.85 18.73 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.9 mt -116.48 106.42 20.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 C-N-CA 124.447 1.099 . . . . 0.0 108.071 -171.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -99.92 151.63 21.09 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.035 0.534 . . . . 0.0 109.59 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.52 12.11 56.26 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.489 1.043 . . . . 0.0 113.259 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.4 mtm . . . . . 0 C--N 1.343 0.296 0 CA-C-N 118.676 1.238 . . . . 0.0 109.43 177.176 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.5 m . . . . . 0 N--CA 1.457 -0.086 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.7 m -57.54 -47.03 83.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 168.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.5 t -49.59 -51.29 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.386 1.474 . . . . 0.0 110.595 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -62.87 -48.27 79.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.259 0.624 . . . . 0.0 111.232 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.4 p -61.2 -48.29 82.19 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.87 0.468 . . . . 0.0 111.274 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.2 mt -54.23 -59.03 2.38 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 C-N-CA 124.383 1.073 . . . . 0.0 109.488 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -54.63 -48.84 71.77 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.66 0.784 . . . . 0.0 110.642 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.95 -52.87 43.64 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.635 1.112 . . . . 0.0 112.303 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.2 t -67.69 -55.12 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 117.777 0.788 . . . . 0.0 110.697 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.14 -36.71 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.404 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.6 p -54.36 -29.66 49.12 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.127 0.876 . . . . 0.0 112.832 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.47 -7.93 53.98 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.983 0.913 . . . . 0.0 112.269 -176.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -70.7 142.4 88.5 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 119.022 0.828 . . . . 0.0 109.586 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.09 130.9 26.95 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.955 2.437 . . . . 0.0 109.987 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.93 -32.21 7.75 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 118.923 -0.932 . . . . 0.0 112.111 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.8 t -72.08 138.72 21.0 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 CA-C-N 118.396 1.098 . . . . 0.0 109.365 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -108.68 -101.83 0.37 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.7 p -90.29 153.83 20.17 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.566 0.747 . . . . 0.0 109.394 172.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.1 tt -150.18 129.83 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 123.511 0.724 . . . . 0.0 109.235 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -120.86 105.06 10.34 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 125.139 1.376 . . . . 0.0 108.65 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.44 122.49 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.1 t -110.03 128.25 55.31 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.643 1.177 . . . . 0.0 110.284 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.2 tp -67.25 -53.5 29.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.95 0.9 . . . . 0.0 109.277 171.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.34 -47.39 69.41 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.277 1.431 . . . . 0.0 112.039 -175.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -89.19 -8.03 54.42 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 119.043 -0.504 . . . . 0.0 111.605 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.8 m 51.57 56.25 8.17 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.168 1.387 . . . . 0.0 110.932 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.7 p30 -155.22 163.98 39.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.966 0.506 . . . . 0.0 111.217 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.84 113.32 2.44 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.1 m -98.65 94.66 6.78 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 t -101.03 123.81 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 124.362 1.065 . . . . 0.0 109.064 -170.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -95.07 128.93 42.28 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -150.24 174.19 13.11 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.145 0.578 . . . . 0.0 111.702 -170.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -108.41 110.24 61.64 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.541 1.536 . . . . 0.0 109.157 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -42.8 -40.47 8.13 Favored 'Trans proline' 0 C--N 1.348 0.545 1 C-N-CA 125.444 4.096 . . . . 0.0 114.995 173.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.4 mt -63.34 -31.79 73.04 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.753 0.821 . . . . 0.0 111.774 -176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.45 -34.53 9.12 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.426 1.09 . . . . 0.0 111.981 -173.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 t -149.57 158.25 44.0 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.551 0.74 . . . . 0.0 109.762 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 62.2 p -123.04 160.24 50.5 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.553 1.141 . . . . 0.0 110.068 -178.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -48.45 -39.61 36.37 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.54 2.827 . . . . 0.0 112.839 171.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -65.58 -45.14 84.41 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.139 0.975 . . . . 0.0 110.407 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.9 m -60.12 -46.64 88.96 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.219 0.608 . . . . 0.0 110.476 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.6 mt -62.35 -48.15 81.05 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.828 0.851 . . . . 0.0 110.518 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -53.94 -42.1 68.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.642 0.777 . . . . 0.0 110.469 172.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.72 -43.77 86.58 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.311 0.958 . . . . 0.0 112.171 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.88 -44.64 92.43 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.871 0.835 . . . . 0.0 111.429 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.7 mm -63.07 -41.84 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 122.861 0.464 . . . . 0.0 110.567 176.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.53 -41.92 98.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.836 0.854 . . . . 0.0 110.461 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -62.61 -45.72 91.56 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.014 0.926 . . . . 0.0 110.876 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.2 mmm -58.95 -34.74 72.12 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.302 0.641 . . . . 0.0 111.056 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.44 59.11 0.57 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 124.209 0.909 . . . . 0.0 111.655 169.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -140.2 154.57 46.96 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.911 0.884 . . . . 0.0 109.861 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -81.0 88.68 5.92 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.838 0.855 . . . . 0.0 109.558 -174.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.41 129.5 45.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.956 1.302 . . . . 0.0 110.948 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 89.5 m -144.28 128.72 17.96 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.586 1.154 . . . . 0.0 108.547 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.8 mt . . . . . 0 CA--C 1.532 0.274 0 C-N-CA 123.519 0.728 . . . . 0.0 111.127 -178.174 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 . . . . . 0 CA--C 1.531 0.217 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -140.06 142.74 36.14 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.178 0.991 . . . . 0.0 108.943 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 t -137.24 149.64 47.3 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.507 1.123 . . . . 0.0 109.316 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.0 t -110.87 138.12 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 172.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.0 mt -133.27 125.54 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -70.17 130.17 41.35 Favored 'General case' 0 C--N 1.337 0.061 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.2 mt -130.1 113.6 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -117.18 153.76 32.27 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.656 0.782 . . . . 0.0 109.907 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.39 20.44 48.58 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.403 1.001 . . . . 0.0 112.565 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.6 mtm . . . . . 0 N--CA 1.455 -0.19 0 CA-C-N 117.901 0.85 . . . . 0.0 108.911 177.596 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.9 m . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.2 m -65.73 -43.51 88.79 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.226 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -52.22 -54.19 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.111 0.564 . . . . 0.0 109.927 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -61.22 -45.76 93.24 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.158 0.983 . . . . 0.0 111.18 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.6 m -58.35 -53.68 55.56 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.876 0.47 . . . . 0.0 110.99 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.03 -55.53 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.351 1.06 . . . . 0.0 109.722 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -56.81 -50.34 72.66 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.139 0.975 . . . . 0.0 110.937 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.93 -51.96 56.12 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.902 1.239 . . . . 0.0 112.161 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.16 -54.47 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 117.746 0.773 . . . . 0.0 110.223 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.9 mt -65.44 -35.53 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.796 -172.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.0 p -54.2 -30.55 50.18 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.01 0.823 . . . . 0.0 112.519 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -89.58 -11.23 43.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.077 0.951 . . . . 0.0 112.617 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -68.27 144.46 96.71 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 119.193 0.906 . . . . 0.0 109.918 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.75 132.23 34.28 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.054 2.502 . . . . 0.0 110.31 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.17 -35.85 4.6 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-O 119.02 -0.878 . . . . 0.0 112.223 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.76 127.74 31.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 118.09 0.945 . . . . 0.0 109.881 -177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -94.56 -101.41 0.15 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.7 p -90.07 155.75 18.85 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.608 0.763 . . . . 0.0 110.363 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.2 tt -150.62 145.72 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 123.975 0.91 . . . . 0.0 109.772 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.12 141.98 44.21 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.0 t -125.52 117.37 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.691 1.197 . . . . 0.0 108.324 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.7 t -104.62 123.96 48.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.809 1.244 . . . . 0.0 109.818 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.9 tp -73.94 -44.12 56.03 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 124.165 0.986 . . . . 0.0 110.107 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.86 -45.88 74.62 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.582 1.153 . . . . 0.0 111.406 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -89.5 -7.61 54.63 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.607 0.763 . . . . 0.0 111.591 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.3 m 54.49 53.79 10.26 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.949 1.699 . . . . 0.0 111.474 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -160.02 167.23 28.36 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.198 0.599 . . . . 0.0 111.185 -175.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.59 121.84 3.96 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.8 m -99.68 112.94 25.12 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 173.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 t -117.81 122.27 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.701 1.2 . . . . 0.0 108.737 -172.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -89.68 132.51 35.12 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 169.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -150.36 168.31 24.48 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.905 0.482 . . . . 0.0 112.103 -170.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -103.97 111.4 65.14 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 125.181 1.392 . . . . 0.0 109.048 173.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -41.75 -38.28 4.41 Favored 'Trans proline' 0 C--N 1.347 0.495 1 C-N-CA 125.432 4.088 . . . . 0.0 115.312 171.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.8 mt -64.25 -34.03 77.18 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.162 0.585 . . . . 0.0 111.952 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.5 mt -103.82 -33.65 8.82 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.264 1.025 . . . . 0.0 112.333 -171.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.9 t -148.72 176.27 10.51 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.56 0.744 . . . . 0.0 109.801 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.9 p -150.25 163.5 24.12 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 123.891 0.877 . . . . 0.0 110.323 -174.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.42 -46.92 30.33 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.401 2.734 . . . . 0.0 112.986 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -65.73 -35.8 81.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.305 0.642 . . . . 0.0 112.123 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.8 m -67.16 -46.04 75.19 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.165 0.439 . . . . 0.0 110.296 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.7 mt -60.55 -47.11 87.61 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.544 0.737 . . . . 0.0 110.418 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.5 ttp85 -54.77 -46.5 74.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.134 0.973 . . . . 0.0 110.055 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.43 -43.99 93.77 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.503 1.049 . . . . 0.0 112.309 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.44 -46.22 87.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.926 0.863 . . . . 0.0 111.099 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.0 mt -59.92 -45.69 94.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 123.411 0.685 . . . . 0.0 109.639 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -61.28 -41.56 97.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.672 0.789 . . . . 0.0 111.039 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.97 -44.35 96.28 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.499 1.12 . . . . 0.0 111.032 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.6 mtm -57.84 -43.62 85.97 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.513 0.325 . . . . 0.0 110.595 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.67 61.54 0.19 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 123.531 0.586 . . . . 0.0 111.651 169.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -140.08 147.35 40.16 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 173.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -70.13 95.92 1.03 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.5 123.5 47.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.016 1.326 . . . . 0.0 109.937 -173.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.9 p -142.35 142.88 32.52 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.234 1.014 . . . . 0.0 108.542 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.5 mt . . . . . 0 CA--C 1.53 0.209 0 C-N-CA 122.776 0.43 . . . . 0.0 110.959 -176.38 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 . . . . . 0 C--O 1.231 0.128 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.79 140.91 52.52 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.824 1.249 . . . . 0.0 108.44 173.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 t -136.27 135.64 39.14 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.181 0.992 . . . . 0.0 109.529 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.5 t -99.65 124.1 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 171.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.9 mt -120.44 120.14 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -73.74 129.21 37.45 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.7 mt -122.19 108.65 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -99.61 145.87 27.09 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.56 -7.09 53.26 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 118.855 -0.97 . . . . 0.0 113.36 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.9 mtm . . . . . 0 C--N 1.344 0.358 0 CA-C-N 118.938 1.369 . . . . 0.0 110.09 177.729 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 119.811 -0.138 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.6 m -61.97 -50.04 73.71 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.932 0.493 . . . . 0.0 110.297 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.1 t -51.24 -50.26 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.229 1.012 . . . . 0.0 110.85 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -58.17 -50.25 74.19 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.403 1.081 . . . . 0.0 110.681 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.4 m -57.92 -48.34 80.18 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.142 0.577 . . . . 0.0 111.152 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -59.07 -50.46 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.611 0.764 . . . . 0.0 109.548 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -51.52 -56.4 13.59 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.022 0.929 . . . . 0.0 110.106 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.34 -55.0 32.74 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.206 0.908 . . . . 0.0 112.335 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.09 -56.35 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.317 0.647 . . . . 0.0 110.767 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.3 mm -61.41 -37.86 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.215 -175.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.0 t -50.31 -38.21 40.4 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.618 0.645 . . . . 0.0 112.285 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.41 -1.45 58.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.664 0.785 . . . . 0.0 112.717 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -69.94 145.07 93.86 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 119.424 1.011 . . . . 0.0 109.485 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.37 127.8 20.93 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.88 2.387 . . . . 0.0 109.911 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.92 -38.2 3.37 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.126 -0.819 . . . . 0.0 111.713 -176.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.81 140.15 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 118.046 0.923 . . . . 0.0 109.805 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -106.22 -98.79 0.34 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 172.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 53.0 p -90.63 160.07 16.09 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.035 0.934 . . . . 0.0 110.234 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.9 tt -150.27 138.93 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 124.288 1.035 . . . . 0.0 108.454 172.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.57 104.69 10.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.498 1.119 . . . . 0.0 109.205 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -94.8 122.69 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.8 t -109.7 127.01 54.3 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.463 1.105 . . . . 0.0 109.933 -177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.67 -55.92 14.87 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.137 0.975 . . . . 0.0 108.528 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.69 -47.16 63.99 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.414 1.486 . . . . 0.0 112.341 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -89.26 -10.91 45.15 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.954 0.501 . . . . 0.0 111.634 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m 52.87 56.46 7.56 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.188 1.395 . . . . 0.0 110.906 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.1 p30 -155.44 169.73 23.58 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.166 0.587 . . . . 0.0 111.175 -176.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.08 115.43 2.19 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 126.269 1.89 . . . . 0.0 108.714 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.5 m -99.04 96.48 7.84 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.81 129.4 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.516 1.127 . . . . 0.0 109.283 -170.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -99.37 124.12 44.22 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -150.3 172.46 15.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.943 0.497 . . . . 0.0 112.288 -169.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -105.88 110.33 64.0 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.29 1.436 . . . . 0.0 109.468 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -40.84 -41.79 4.1 Favored 'Trans proline' 0 C--N 1.348 0.518 1 C-N-CA 125.432 4.088 . . . . 0.0 115.294 171.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.1 mt -60.56 -35.55 76.31 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.465 0.706 . . . . 0.0 111.866 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.0 -32.18 11.09 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.232 1.013 . . . . 0.0 112.1 -172.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.1 t -150.42 152.73 34.77 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.603 0.638 . . . . 0.0 109.891 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 p -116.36 162.53 25.95 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.535 1.134 . . . . 0.0 109.936 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.09 -39.59 50.92 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.329 2.686 . . . . 0.0 112.65 170.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.2 -39.11 89.42 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.929 0.892 . . . . 0.0 111.596 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 m -63.73 -47.34 81.46 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.927 0.491 . . . . 0.0 110.202 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.2 mt -62.14 -49.17 76.91 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.125 0.97 . . . . 0.0 110.36 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -49.88 -48.12 51.56 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.795 1.238 . . . . 0.0 109.943 170.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.32 -46.95 85.68 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.528 1.061 . . . . 0.0 112.413 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.65 91.55 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.835 0.817 . . . . 0.0 111.29 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -60.62 -44.16 96.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.804 0.842 . . . . 0.0 109.912 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.01 -38.94 92.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.853 0.861 . . . . 0.0 111.153 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.55 -44.08 97.22 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.26 1.024 . . . . 0.0 110.816 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.7 mtm -58.81 -48.84 79.89 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.3 59.76 0.1 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 170.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -140.24 137.59 34.39 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 172.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.33 97.94 1.01 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.542 0.737 . . . . 0.0 109.798 -176.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.86 133.14 44.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.792 1.237 . . . . 0.0 110.184 -174.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.2 m -144.49 138.57 27.7 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.603 1.161 . . . . 0.0 108.369 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 mm? . . . . . 0 CA--C 1.531 0.232 0 C-N-CA 122.732 0.413 . . . . 0.0 110.178 -177.883 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.88 149.24 43.67 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.738 0.815 . . . . 0.0 110.428 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -143.85 146.17 32.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.459 1.104 . . . . 0.0 108.999 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 51.2 t -113.3 124.5 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.8 mt -120.32 125.79 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -177.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -70.13 126.86 30.91 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 172.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.4 mt -123.11 95.15 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -99.33 132.48 44.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.32 -27.81 4.41 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -170.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 48.4 mtm . . . . . 0 C--N 1.342 0.241 0 CA-C-N 117.717 0.758 . . . . 0.0 109.161 174.838 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.1 p . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 111.316 0.117 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.2 m -62.41 -49.65 74.63 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.674 0.789 . . . . 0.0 109.661 177.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.8 t -54.6 -58.08 4.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.332 1.053 . . . . 0.0 110.224 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -61.69 -41.76 98.01 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.285 0.634 . . . . 0.0 111.382 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -58.98 -59.13 5.95 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.104 0.561 . . . . 0.0 110.633 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.4 mt -57.78 -55.61 20.55 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 123.52 0.728 . . . . 0.0 109.69 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -55.67 -48.49 74.97 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.572 0.749 . . . . 0.0 110.706 -176.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.94 -53.45 45.35 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.329 0.966 . . . . 0.0 112.225 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.22 -55.63 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 117.709 0.754 . . . . 0.0 110.683 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.5 mm -63.7 -38.22 81.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.514 0.725 . . . . 0.0 111.559 -173.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.5 p -54.98 -30.65 59.76 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.069 0.85 . . . . 0.0 112.553 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.35 -5.98 57.04 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.932 0.893 . . . . 0.0 112.187 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -70.71 142.67 88.76 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 119.017 0.826 . . . . 0.0 109.136 176.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.16 132.49 34.29 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.823 2.349 . . . . 0.0 110.093 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.48 -35.78 4.73 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 118.919 -0.934 . . . . 0.0 112.088 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.27 129.32 33.71 Favored 'Isoleucine or valine' 0 C--N 1.341 0.214 0 CA-C-N 118.074 0.937 . . . . 0.0 109.735 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -100.66 -101.87 0.25 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.55 1.14 . . . . 0.0 108.03 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 74.0 p -87.01 151.62 23.11 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.288 0.635 . . . . 0.0 109.744 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.1 tt -150.4 131.05 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.462 0.705 . . . . 0.0 109.421 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -120.81 105.78 11.05 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.429 1.492 . . . . 0.0 108.717 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.72 125.89 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.2 t -116.16 118.71 33.59 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.685 1.194 . . . . 0.0 110.023 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.59 -49.1 74.68 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.991 0.916 . . . . 0.0 109.834 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.1 -48.55 67.72 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.7 1.2 . . . . 0.0 111.994 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -89.7 -1.86 58.12 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.232 0.613 . . . . 0.0 112.201 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.1 m 49.71 52.0 15.41 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.318 1.447 . . . . 0.0 111.579 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -156.21 170.22 22.74 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 120.968 0.413 . . . . 0.0 111.664 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.58 119.28 2.55 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 125.607 1.575 . . . . 0.0 109.232 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.5 m -99.32 104.49 16.4 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.6 t -112.04 128.57 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.532 1.133 . . . . 0.0 109.574 -170.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -98.79 133.33 43.26 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -150.43 164.87 34.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.66 0.784 . . . . 0.0 111.844 -170.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -102.27 116.57 62.82 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.337 1.055 . . . . 0.0 109.498 173.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.71 -40.29 18.88 Favored 'Trans proline' 0 C--N 1.349 0.586 1 C-N-CA 125.348 4.032 . . . . 0.0 115.468 177.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.9 mt -67.11 -27.72 67.56 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.197 0.599 . . . . 0.0 111.949 -174.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.68 -42.05 7.04 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.078 0.951 . . . . 0.0 110.707 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.4 t -148.73 174.81 11.79 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.62 0.768 . . . . 0.0 110.001 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.3 p -150.56 164.37 20.7 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 124.563 1.145 . . . . 0.0 110.439 -170.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.25 -45.58 38.39 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.134 2.556 . . . . 0.0 112.79 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -67.32 -38.78 85.49 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.396 0.679 . . . . 0.0 112.806 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.3 p -66.0 -46.37 78.24 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.724 0.693 . . . . 0.0 110.438 176.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.6 mt -62.1 -46.43 89.08 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.752 0.821 . . . . 0.0 110.428 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -53.5 -45.36 69.64 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.159 0.984 . . . . 0.0 110.47 171.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.4 -47.04 91.0 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.076 0.846 . . . . 0.0 112.114 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.05 -51.95 65.92 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.473 0.709 . . . . 0.0 111.059 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.8 mt -57.57 -41.84 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.016 0.926 . . . . 0.0 109.9 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -59.0 -50.52 73.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.355 0.662 . . . . 0.0 109.749 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -58.25 -38.74 77.5 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.772 1.229 . . . . 0.0 112.0 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mtp -60.81 -20.95 62.59 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.98 57.12 0.52 Allowed Glycine 0 C--N 1.34 0.784 0 C-N-CA 124.306 0.955 . . . . 0.0 111.151 170.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -140.6 155.47 46.56 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.27 1.028 . . . . 0.0 109.46 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -80.39 93.75 6.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 169.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.42 117.57 34.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.698 1.199 . . . . 0.0 108.862 -176.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.4 p -140.06 136.52 33.72 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.21 1.004 . . . . 0.0 109.054 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.6 mt . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 122.84 0.456 . . . . 0.0 110.813 -175.998 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -123.98 154.65 39.52 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.873 1.269 . . . . 0.0 109.652 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 t -150.14 144.74 25.89 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.779 0.832 . . . . 0.0 109.981 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.7 t -109.27 115.75 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.3 mt -110.51 118.13 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -76.04 121.89 23.43 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.1 mt -118.15 110.11 29.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 124.747 1.219 . . . . 0.0 108.097 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -99.8 148.04 24.84 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.58 3.67 56.2 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.511 1.053 . . . . 0.0 113.531 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.6 mtm . . . . . 0 C--N 1.344 0.362 0 CA-C-N 118.825 1.313 . . . . 0.0 109.767 178.547 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.5 m . . . . . 0 N--CA 1.456 -0.168 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.0 m -61.03 -49.17 78.47 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 168.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 82.7 t -49.71 -51.64 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.221 1.408 . . . . 0.0 110.279 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -60.33 -48.66 80.77 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.092 0.957 . . . . 0.0 111.125 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.7 p -62.19 -47.81 82.84 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 122.848 0.459 . . . . 0.0 111.371 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.2 mt -55.35 -60.58 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 123.715 0.806 . . . . 0.0 108.953 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -53.24 -48.5 68.17 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.772 0.829 . . . . 0.0 110.959 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.08 -57.78 16.79 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.241 0.925 . . . . 0.0 111.925 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.49 -53.13 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 117.624 0.712 . . . . 0.0 110.929 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.9 -45.76 91.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.618 0.767 . . . . 0.0 110.738 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 88.0 p -57.73 -27.46 63.0 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -88.9 -5.51 57.95 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.43 0.692 . . . . 0.0 111.891 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -78.83 123.18 85.3 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 119.084 0.856 . . . . 0.0 109.026 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.74 116.94 2.64 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.696 2.931 . . . . 0.0 112.075 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.47 -44.51 1.15 Allowed Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.9 t -70.8 130.4 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 117.453 0.626 . . . . 0.0 109.718 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -96.82 -100.79 0.18 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.974 1.31 . . . . 0.0 107.529 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.4 p -90.23 156.83 18.03 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.38 0.672 . . . . 0.0 110.004 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.6 tt -150.58 145.52 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.7 0.8 . . . . 0.0 110.217 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -133.97 104.92 6.47 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.923 1.289 . . . . 0.0 107.571 169.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.2 t -89.8 97.86 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.8 t -89.75 123.08 33.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.835 0.854 . . . . 0.0 109.469 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.1 tp -70.82 -49.34 47.4 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.792 0.837 . . . . 0.0 110.092 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.69 -46.17 74.07 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.0 1.32 . . . . 0.0 112.054 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -89.22 -6.79 56.6 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.745 0.818 . . . . 0.0 111.319 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 m 52.55 54.25 10.94 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.85 1.66 . . . . 0.0 111.389 176.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -156.52 150.08 24.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.342 0.592 . . . . 0.0 112.282 -175.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -94.7 108.71 3.72 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 170.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -98.76 95.74 7.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 175.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 t -108.81 134.19 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.517 1.127 . . . . 0.0 109.879 -169.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -105.27 132.71 51.13 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 168.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -150.36 170.9 17.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.079 0.552 . . . . 0.0 111.384 -169.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -102.8 111.43 64.88 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.056 1.342 . . . . 0.0 109.241 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -41.75 -40.03 5.37 Favored 'Trans proline' 0 C--N 1.347 0.454 1 C-N-CA 125.618 4.212 . . . . 0.0 115.047 172.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.1 mt -61.93 -33.38 74.16 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.612 0.765 . . . . 0.0 111.829 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.0 mt -102.87 -38.13 7.53 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.478 1.111 . . . . 0.0 111.919 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 t -147.12 174.16 11.83 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.592 0.757 . . . . 0.0 110.1 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.7 p -150.21 162.89 26.37 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.113 0.965 . . . . 0.0 110.02 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -52.62 -43.55 54.36 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.659 2.906 . . . . 0.0 113.186 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -64.29 -36.83 85.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.551 0.74 . . . . 0.0 112.103 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.0 m -68.57 -46.41 69.48 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.019 0.527 . . . . 0.0 109.884 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.3 mt -61.0 -46.83 89.17 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.166 0.986 . . . . 0.0 110.307 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -54.63 -44.7 73.39 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.171 0.988 . . . . 0.0 110.296 172.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.13 -44.64 93.07 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.247 0.927 . . . . 0.0 112.245 175.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.06 -49.31 75.02 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.542 0.737 . . . . 0.0 111.229 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.4 mt -61.85 -39.39 83.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.913 0.885 . . . . 0.0 110.028 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.46 -48.52 80.75 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.6 0.76 . . . . 0.0 109.859 176.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.27 -40.67 86.8 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.561 1.144 . . . . 0.0 111.43 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.8 mmm -60.98 -19.63 61.4 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.607 0.763 . . . . 0.0 112.163 173.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.15 53.53 0.95 Allowed Glycine 0 C--N 1.34 0.796 0 C-N-CA 124.411 1.005 . . . . 0.0 111.699 169.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -140.52 156.2 46.39 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.86 0.864 . . . . 0.0 110.273 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -82.88 87.14 6.84 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.23 124.74 44.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.606 1.162 . . . . 0.0 109.936 -173.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.9 p -139.99 140.18 36.21 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.685 1.194 . . . . 0.0 108.79 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 CA--C 1.531 0.213 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.103 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -102.58 143.27 32.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.211 1.004 . . . . 0.0 109.354 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -137.26 142.44 41.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.46 124.83 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.0 mt -121.09 120.5 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -77.29 120.76 22.77 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.3 mt -122.35 106.85 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.745 1.218 . . . . 0.0 107.881 -173.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -99.6 146.91 25.93 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.83 -12.61 17.7 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.55 1.071 . . . . 0.0 112.108 -172.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 44.6 mtm . . . . . 0 C--N 1.343 0.325 0 CA-C-N 118.382 1.091 . . . . 0.0 109.56 178.64 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.3 m -61.24 -59.1 5.83 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.375 0.67 . . . . 0.0 109.394 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -50.01 -51.3 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.23 1.412 . . . . 0.0 111.194 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -59.79 -53.19 60.81 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.272 1.429 . . . . 0.0 111.079 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.3 p -60.24 -49.34 77.99 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.026 0.53 . . . . 0.0 111.072 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.3 mt -53.46 -57.21 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.195 0.998 . . . . 0.0 109.943 177.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -53.39 -52.38 59.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.921 0.888 . . . . 0.0 110.844 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.08 -54.2 38.74 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.844 0.735 . . . . 0.0 112.312 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.16 -54.71 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.373 1.069 . . . . 0.0 110.876 -176.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.2 mm -61.75 -34.72 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.874 0.87 . . . . 0.0 111.262 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t -53.73 -19.47 4.23 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -89.25 -12.67 40.07 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.929 0.786 . . . . 0.0 112.392 -175.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -74.58 143.55 79.17 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 118.783 0.719 . . . . 0.0 110.131 -172.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.27 130.35 25.2 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.061 2.508 . . . . 0.0 109.772 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.04 -39.61 2.8 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 118.926 -0.93 . . . . 0.0 111.419 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.59 123.65 20.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 CA-C-N 118.069 0.935 . . . . 0.0 109.139 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -93.26 -102.65 0.13 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.4 p -90.26 155.99 18.6 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.907 0.883 . . . . 0.0 109.706 171.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.1 tt -150.32 141.08 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.652 0.781 . . . . 0.0 109.586 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -135.52 131.78 36.46 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.91 0.884 . . . . 0.0 108.769 169.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -115.82 133.73 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.9 t -112.56 133.46 54.6 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.932 1.293 . . . . 0.0 110.702 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.18 -56.7 5.54 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 170.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.55 -47.78 63.31 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.339 1.456 . . . . 0.0 112.335 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -89.25 -10.36 47.24 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.577 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m 52.03 56.29 7.99 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.02 1.328 . . . . 0.0 110.867 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -156.5 164.39 38.28 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.054 0.542 . . . . 0.0 111.102 -176.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.75 113.57 2.41 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 126.18 1.847 . . . . 0.0 108.825 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.9 m -99.4 107.88 20.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.34 130.22 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.453 1.101 . . . . 0.0 109.583 -170.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -93.65 127.73 39.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 168.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -149.1 155.48 40.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.827 0.451 . . . . 0.0 110.959 -169.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -95.15 115.22 65.21 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.282 1.033 . . . . 0.0 109.288 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.26 -36.38 17.02 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.861 3.708 . . . . 0.0 114.653 172.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.6 mt -66.06 -29.28 69.59 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.472 0.709 . . . . 0.0 112.099 -176.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.0 mt -108.73 -33.27 7.03 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.23 1.012 . . . . 0.0 112.26 -172.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.0 t -147.32 -179.83 7.12 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.566 0.746 . . . . 0.0 109.849 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.6 p -149.82 162.09 29.3 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 123.732 0.813 . . . . 0.0 110.125 -176.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -51.9 -40.0 67.51 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.402 2.734 . . . . 0.0 112.18 173.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.92 -46.91 79.67 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.288 1.035 . . . . 0.0 110.949 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.8 m -60.02 -47.32 86.34 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.052 0.541 . . . . 0.0 110.406 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.96 -50.45 73.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.843 0.857 . . . . 0.0 110.52 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.1 ttp85 -50.72 -46.76 59.18 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.149 0.98 . . . . 0.0 110.487 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.69 -46.77 81.34 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.137 0.875 . . . . 0.0 112.114 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.24 -47.01 86.3 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.664 0.732 . . . . 0.0 111.486 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 mm -58.51 -44.51 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.222 0.609 . . . . 0.0 110.24 175.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.51 -38.28 90.53 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.143 0.577 . . . . 0.0 110.927 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.27 -43.67 94.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.016 0.926 . . . . 0.0 110.947 176.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 90.6 mtp -59.0 -41.42 87.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 117.978 0.354 . . . . 0.0 110.441 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.26 56.45 0.22 Allowed Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.092 0.853 . . . . 0.0 111.862 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -140.27 139.75 35.6 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -74.02 96.33 2.66 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.467 0.707 . . . . 0.0 109.447 -175.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.95 132.72 45.14 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.96 1.304 . . . . 0.0 110.582 -173.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.9 p -138.24 134.95 35.05 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.079 1.352 . . . . 0.0 108.795 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.6 mt . . . . . 0 CA--C 1.528 0.133 0 C-N-CA 122.701 0.4 . . . . 0.0 110.401 -177.404 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.52 143.1 34.16 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.749 0.82 . . . . 0.0 109.258 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -139.46 144.66 38.11 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.009 0.924 . . . . 0.0 108.913 172.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.4 t -110.54 115.68 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.8 mm -99.84 126.81 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -77.51 113.89 15.79 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 170.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.9 mt -116.35 98.0 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -176.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -99.85 158.38 15.84 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.03 13.82 60.05 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.818 0.723 . . . . 0.0 112.902 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 68.0 mtm . . . . . 0 C--N 1.341 0.236 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 171.122 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 110.713 -0.106 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.3 m -60.22 -50.34 74.06 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.807 0.843 . . . . 0.0 110.006 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.3 t -52.76 -54.86 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.74 1.216 . . . . 0.0 110.347 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -60.11 -46.27 90.18 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.301 1.041 . . . . 0.0 111.586 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -57.88 -48.86 78.6 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.675 0.39 . . . . 0.0 111.199 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.0 mt -59.81 -59.41 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.19 0.596 . . . . 0.0 109.948 -177.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.95 -43.52 86.42 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.102 0.41 . . . . 0.0 111.166 -176.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.31 -54.82 29.82 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.814 0.721 . . . . 0.0 112.023 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.21 -53.89 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.322 0.649 . . . . 0.0 110.792 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.4 mm -62.79 -35.42 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.729 -172.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.0 m -53.3 -30.25 37.77 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.86 0.754 . . . . 0.0 112.77 174.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 -6.7 56.24 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.498 0.719 . . . . 0.0 112.052 -175.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -72.82 143.13 84.07 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 118.859 0.754 . . . . 0.0 109.314 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.84 135.9 54.43 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.931 2.421 . . . . 0.0 110.025 -176.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.39 -40.07 2.62 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-O 118.888 -0.951 . . . . 0.0 111.525 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -67.66 134.83 29.59 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 CA-C-N 118.068 0.934 . . . . 0.0 109.797 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -112.8 -89.5 0.52 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.8 p -90.75 154.49 19.49 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.884 0.874 . . . . 0.0 110.38 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.5 tt -150.61 148.8 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.666 1.186 . . . . 0.0 108.744 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -135.65 106.3 6.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.781 0.833 . . . . 0.0 109.201 174.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.8 t -94.49 100.49 11.21 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 C-N-CA 124.015 0.926 . . . . 0.0 109.307 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.4 t -89.54 120.19 30.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.974 0.91 . . . . 0.0 109.7 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.9 tp -69.98 -47.11 63.54 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.474 1.109 . . . . 0.0 110.042 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.01 -44.47 67.32 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.768 1.227 . . . . 0.0 111.682 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -89.29 -14.73 35.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.404 0.681 . . . . 0.0 111.3 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.1 m 55.52 54.76 8.05 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 125.403 1.481 . . . . 0.0 110.665 -177.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.5 p30 -153.17 158.47 41.84 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.028 0.531 . . . . 0.0 111.619 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.58 114.55 3.17 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 126.052 1.787 . . . . 0.0 108.92 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.3 m -98.9 97.14 8.35 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.67 134.14 44.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 C-N-CA 124.829 1.252 . . . . 0.0 109.704 -170.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -105.19 116.99 32.88 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 172.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -145.9 153.17 40.55 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.602 0.761 . . . . 0.0 111.842 -169.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -88.16 120.49 70.62 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 123.673 0.789 . . . . 0.0 110.163 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -47.8 -39.33 31.23 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.997 3.798 . . . . 0.0 115.457 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.4 mt -67.67 -28.77 67.98 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.882 0.473 . . . . 0.0 111.809 -174.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.61 -34.76 10.09 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.797 0.839 . . . . 0.0 111.091 -174.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 t -151.83 171.03 18.38 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.631 0.65 . . . . 0.0 110.2 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.6 p -138.89 162.68 51.3 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.757 1.223 . . . . 0.0 109.996 -175.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -50.99 -43.12 49.6 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.492 2.795 . . . . 0.0 112.573 174.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -62.48 -43.3 99.15 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.891 0.876 . . . . 0.0 111.739 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.5 m -64.15 -47.55 79.44 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.991 0.359 . . . . 0.0 110.299 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.8 mt -59.46 -50.61 73.25 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.985 0.914 . . . . 0.0 110.318 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 -51.5 -46.69 63.29 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.54 1.136 . . . . 0.0 110.297 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.75 -47.04 91.34 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.6 1.095 . . . . 0.0 112.184 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.57 -45.35 93.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.507 0.723 . . . . 0.0 111.273 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -62.75 -43.69 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.714 0.806 . . . . 0.0 109.876 178.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -59.47 -46.59 88.36 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.683 0.793 . . . . 0.0 110.035 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -59.24 -42.83 92.0 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.494 1.118 . . . . 0.0 111.562 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 71.7 mtm -57.66 -45.81 85.07 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 118.025 0.375 . . . . 0.0 110.687 173.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.47 63.05 0.12 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 170.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -140.28 158.5 43.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.902 0.881 . . . . 0.0 109.385 174.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -79.33 87.21 5.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.28 118.72 36.57 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.552 1.141 . . . . 0.0 109.835 -173.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.2 p -138.19 149.87 46.23 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.783 1.233 . . . . 0.0 108.683 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 29.3 mt . . . . . 0 CA--C 1.529 0.136 0 CA-C-N 118.159 0.436 . . . . 0.0 110.056 179.932 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 . . . . . 0 CA--C 1.528 0.115 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -140.27 147.08 39.43 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.511 0.724 . . . . 0.0 109.975 -177.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.8 t -142.23 153.11 43.71 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.371 1.068 . . . . 0.0 109.918 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.35 115.81 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 173.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.4 mt -106.12 124.94 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -80.14 118.67 22.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.6 mt -116.06 102.53 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -174.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -99.55 142.65 30.74 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.21 19.55 27.94 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.554 1.073 . . . . 0.0 113.142 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 68.5 mtm . . . . . 0 C--N 1.342 0.269 0 CA-C-N 118.618 1.209 . . . . 0.0 109.261 174.652 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.5 m -62.58 -50.87 69.56 Favored 'General case' 0 C--N 1.338 0.104 0 C-N-CA 123.689 0.796 . . . . 0.0 110.287 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.1 t -53.44 -49.86 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.188 0.995 . . . . 0.0 110.706 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -57.74 -45.54 85.71 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.958 0.903 . . . . 0.0 111.406 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.7 m -59.67 -53.81 53.73 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.822 0.449 . . . . 0.0 110.856 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -57.73 -51.33 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.604 1.162 . . . . 0.0 109.797 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -49.8 -58.52 5.19 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.859 1.664 . . . . 0.0 110.232 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.95 -55.05 32.68 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.063 0.839 . . . . 0.0 112.141 -177.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.22 -55.3 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.428 0.691 . . . . 0.0 110.79 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.6 mt -68.09 -34.68 68.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 119.145 -0.455 . . . . 0.0 111.344 -173.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -54.72 -27.42 40.63 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 174.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -89.69 -8.3 52.68 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.441 0.697 . . . . 0.0 112.522 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -72.91 141.54 81.95 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 119.171 0.896 . . . . 0.0 110.019 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.95 131.05 27.6 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.146 2.564 . . . . 0.0 110.265 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.67 -34.28 5.91 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-O 118.897 -0.946 . . . . 0.0 112.137 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.07 121.55 16.39 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 CA-C-N 118.178 0.989 . . . . 0.0 109.536 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -91.58 -101.5 0.11 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.366 1.066 . . . . 0.0 108.221 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.1 p -88.57 141.46 28.51 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.6 tt -141.69 138.31 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.04 111.07 6.95 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.042 1.337 . . . . 0.0 108.017 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.5 t -104.48 120.99 55.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 124.778 1.231 . . . . 0.0 108.462 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.8 t -103.08 129.03 49.78 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.749 1.22 . . . . 0.0 110.806 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.57 -56.7 9.54 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.369 1.067 . . . . 0.0 108.131 169.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.42 -48.72 62.59 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.452 1.501 . . . . 0.0 112.466 -175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -89.23 -5.03 57.97 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.883 0.473 . . . . 0.0 111.662 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.2 m 51.3 54.63 10.79 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.244 1.418 . . . . 0.0 111.341 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -156.78 160.09 38.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.017 0.437 . . . . 0.0 111.363 -176.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.06 114.23 3.15 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 126.307 1.908 . . . . 0.0 108.391 174.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.1 m -99.0 109.61 22.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 t -118.53 123.12 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.477 1.111 . . . . 0.0 109.198 -169.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -96.74 132.3 42.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 168.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -150.33 169.87 20.36 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.967 0.507 . . . . 0.0 112.155 -169.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.25 113.43 65.87 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.334 1.454 . . . . 0.0 109.68 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -45.67 -41.13 19.19 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 125.292 3.994 . . . . 0.0 115.637 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.5 mt -68.27 -29.0 67.69 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.836 0.454 . . . . 0.0 111.752 -174.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.2 mt -99.78 -35.31 9.83 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.385 1.074 . . . . 0.0 111.647 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -152.03 171.27 18.11 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.607 0.763 . . . . 0.0 109.76 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.3 p -148.15 164.71 20.84 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.739 1.216 . . . . 0.0 109.952 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.18 -38.91 81.77 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.298 2.665 . . . . 0.0 112.196 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -59.86 -52.4 65.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.236 1.014 . . . . 0.0 110.804 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.1 p -63.77 -40.78 97.5 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 122.882 0.473 . . . . 0.0 111.426 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.1 mt -66.26 -45.99 78.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.185 0.594 . . . . 0.0 110.391 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -54.77 -48.46 72.62 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.805 0.842 . . . . 0.0 109.608 171.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.36 -44.98 58.74 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.461 1.029 . . . . 0.0 112.628 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.56 -48.06 76.44 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.635 0.774 . . . . 0.0 111.057 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.5 mt -59.7 -45.03 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.556 0.743 . . . . 0.0 109.906 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.7 -42.82 97.97 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.39 1.076 . . . . 0.0 110.861 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.35 -43.97 97.57 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.034 0.934 . . . . 0.0 111.111 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.4 mtp -59.17 -40.56 86.01 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.797 0.439 . . . . 0.0 110.601 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.23 58.06 0.24 Allowed Glycine 0 C--N 1.34 0.792 0 C-N-CA 123.913 0.768 . . . . 0.0 111.856 169.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -140.26 148.7 41.85 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 124.018 0.927 . . . . 0.0 108.993 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -74.48 95.61 2.77 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -177.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 130.09 45.99 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.107 1.363 . . . . 0.0 110.218 -175.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 t -150.02 135.5 18.23 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.157 0.583 . . . . 0.0 109.765 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.7 mt . . . . . 0 CA--C 1.531 0.231 0 C-N-CA 123.266 0.626 . . . . 0.0 110.246 -177.582 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -122.11 155.57 35.44 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.837 1.255 . . . . 0.0 109.007 173.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 t -150.17 133.73 16.6 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 122.795 0.438 . . . . 0.0 109.825 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.8 t -99.71 99.01 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 124.825 1.25 . . . . 0.0 107.714 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.7 mt -99.85 114.45 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -75.22 132.68 41.27 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.2 mt -126.7 108.27 18.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 125.026 1.33 . . . . 0.0 107.773 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.89 139.87 34.94 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.69 7.09 26.17 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.023 1.297 . . . . 0.0 113.416 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.2 mtm . . . . . 0 C--N 1.341 0.232 0 CA-C-N 118.845 1.322 . . . . 0.0 109.921 -179.663 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 p . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.164 0.507 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.9 m -68.05 -43.9 77.61 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.811 1.245 . . . . 0.0 111.267 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.7 t -53.29 -50.7 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.039 0.936 . . . . 0.0 110.013 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -61.72 -50.08 73.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.777 1.231 . . . . 0.0 111.355 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.8 p -62.33 -46.27 89.45 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.959 0.345 . . . . 0.0 111.52 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.8 mt -58.13 -53.75 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 C-N-CA 123.748 0.819 . . . . 0.0 109.106 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -50.56 -57.7 7.54 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.873 0.869 . . . . 0.0 110.188 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.91 -56.8 23.02 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.992 0.806 . . . . 0.0 112.281 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.5 t -62.05 -53.82 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 117.305 0.552 . . . . 0.0 111.086 -174.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.8 mm -61.66 -36.97 76.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.915 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.8 t -54.25 -29.29 46.27 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.779 0.718 . . . . 0.0 112.611 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.1 mtmt -89.61 -14.89 33.97 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.848 0.859 . . . . 0.0 112.852 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -64.28 143.52 98.41 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 119.577 1.081 . . . . 0.0 110.228 174.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.24 142.13 78.5 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.153 2.568 . . . . 0.0 110.276 -175.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.67 -30.45 6.51 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.694 -1.059 . . . . 0.0 112.41 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.73 131.78 34.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 118.629 1.215 . . . . 0.0 109.739 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -90.05 -105.09 0.09 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 172.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.3 p -91.08 165.8 13.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.873 1.269 . . . . 0.0 110.382 169.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -147.96 132.6 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.472 1.109 . . . . 0.0 108.024 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.3 105.9 13.06 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.7 t -98.24 119.24 46.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.812 0.845 . . . . 0.0 108.926 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.4 t -109.47 125.49 52.5 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.851 1.26 . . . . 0.0 110.089 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.52 -52.25 41.2 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.327 1.051 . . . . 0.0 109.007 171.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.97 -46.07 68.08 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.3 1.44 . . . . 0.0 112.2 -176.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -89.25 -7.69 54.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.128 0.571 . . . . 0.0 111.425 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 m 52.76 54.22 10.88 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.8 1.64 . . . . 0.0 110.868 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -156.21 168.06 28.48 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.132 0.491 . . . . 0.0 111.502 -175.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.93 117.33 2.98 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 107.537 -2.225 . . . . 0.0 107.537 172.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.7 p -98.74 102.43 14.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.3 t -99.21 127.26 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -169.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -94.2 127.24 39.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 170.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -150.71 170.76 18.43 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -169.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -105.97 112.04 64.35 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.21 1.404 . . . . 0.0 109.183 173.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -42.74 -39.61 7.42 Favored 'Trans proline' 0 C--N 1.348 0.519 1 C-N-CA 125.443 4.095 . . . . 0.0 115.181 172.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.35 -35.79 80.24 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.334 0.654 . . . . 0.0 111.78 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.6 mt -99.96 -32.76 10.81 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.301 1.041 . . . . 0.0 112.181 -171.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.1 t -150.77 168.5 24.21 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.637 0.653 . . . . 0.0 110.28 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.3 p -136.07 159.49 70.79 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.746 1.218 . . . . 0.0 110.103 -176.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.42 -39.91 44.52 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.674 2.916 . . . . 0.0 113.163 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.01 -39.42 83.18 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.806 0.842 . . . . 0.0 111.78 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.8 m -65.26 -46.67 79.59 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.672 0.389 . . . . 0.0 109.985 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.6 mt -62.6 -46.67 87.22 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.325 1.05 . . . . 0.0 110.577 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -51.89 -47.02 64.74 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.568 1.147 . . . . 0.0 109.869 170.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.54 -44.61 90.64 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.321 0.962 . . . . 0.0 112.328 176.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.23 -43.59 90.94 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.742 0.771 . . . . 0.0 111.389 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.6 mt -64.82 -38.65 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.744 0.818 . . . . 0.0 110.004 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.95 -40.86 95.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.618 0.767 . . . . 0.0 110.53 176.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.08 -42.93 99.73 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.995 0.918 . . . . 0.0 110.862 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.5 mmm -56.22 -39.66 72.83 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.214 0.606 . . . . 0.0 110.637 172.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.7 58.37 0.27 Allowed Glycine 0 C--N 1.341 0.816 0 C-N-CA 123.867 0.746 . . . . 0.0 111.967 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -140.41 155.11 46.84 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.896 0.878 . . . . 0.0 109.957 175.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -77.24 94.37 4.12 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.62 124.0 44.42 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.917 1.287 . . . . 0.0 109.526 -175.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 48.0 p -141.87 143.77 33.51 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.415 1.086 . . . . 0.0 109.124 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 mm? . . . . . 0 CA--C 1.529 0.153 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.482 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 39.0 tp . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 110.634 -0.136 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.7 p -136.54 125.57 24.4 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.484 1.113 . . . . 0.0 109.785 -174.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -138.71 149.22 44.86 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.568 1.547 . . . . 0.0 108.366 170.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.85 153.97 21.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.162 0.985 . . . . 0.0 110.232 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.2 t -149.94 143.39 25.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.896 0.879 . . . . 0.0 109.149 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.0 t -108.66 124.69 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 173.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.9 mt -121.95 119.53 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -73.5 126.36 30.04 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.2 mt -120.86 110.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.086 1.355 . . . . 0.0 107.675 -176.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -99.9 145.57 27.65 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.438 0.695 . . . . 0.0 109.146 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.08 13.01 47.47 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.648 1.118 . . . . 0.0 113.497 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 67.4 mtm -72.7 82.71 1.15 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.558 1.179 . . . . 0.0 109.257 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.5 m -76.33 93.14 3.4 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.556 1.142 . . . . 0.0 109.937 -171.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.6 t 77.0 163.37 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.765 1.626 . . . . 0.0 111.225 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -53.3 -25.1 13.51 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.707 1.603 . . . . 0.0 113.075 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.6 p -54.47 -51.67 64.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.92 0.888 . . . . 0.0 110.931 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.4 m -63.86 -46.55 84.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.695 0.798 . . . . 0.0 110.598 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -53.4 -53.69 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.293 1.037 . . . . 0.0 110.059 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -60.97 -46.14 91.92 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.858 1.263 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.1 t -57.44 -53.59 56.47 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.534 0.733 . . . . 0.0 110.754 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.6 mt -55.98 -55.27 19.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 C-N-CA 124.083 0.953 . . . . 0.0 109.424 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.89 -53.08 54.26 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.569 0.748 . . . . 0.0 110.932 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.22 -53.37 46.18 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.383 0.992 . . . . 0.0 112.552 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.82 -53.56 46.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 117.579 0.689 . . . . 0.0 110.485 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.3 mm -62.21 -36.64 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 118.814 -0.612 . . . . 0.0 111.024 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.7 t -51.3 -37.12 45.75 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.829 0.741 . . . . 0.0 111.933 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -89.21 -3.62 58.5 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.709 0.804 . . . . 0.0 112.455 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -71.78 142.53 85.9 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 119.352 0.978 . . . . 0.0 109.322 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -46.55 134.41 16.58 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.921 3.081 . . . . 0.0 112.801 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.93 -40.33 2.85 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-O 118.802 -0.999 . . . . 0.0 112.644 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.45 135.42 28.5 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.178 0.989 . . . . 0.0 109.704 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -114.29 -88.42 0.56 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.7 p -90.82 149.85 21.81 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.581 0.752 . . . . 0.0 109.949 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.52 138.19 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 124.035 0.934 . . . . 0.0 109.041 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -130.84 109.09 10.32 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.778 1.231 . . . . 0.0 108.287 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.9 t -98.21 114.61 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 124.002 0.921 . . . . 0.0 108.748 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.1 t -100.61 123.56 44.99 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 124.388 1.075 . . . . 0.0 109.452 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.0 tp -71.93 -44.08 64.21 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.688 0.795 . . . . 0.0 110.019 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.87 -46.88 74.79 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.892 1.277 . . . . 0.0 111.732 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -89.23 -7.06 56.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.209 0.604 . . . . 0.0 111.352 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.3 m 53.05 54.88 9.69 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.774 1.63 . . . . 0.0 111.019 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -155.54 163.58 39.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.986 0.422 . . . . 0.0 111.803 -175.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.24 116.16 3.54 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 126.402 1.954 . . . . 0.0 108.365 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.1 m -99.24 101.56 12.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.5 t -108.38 131.72 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 124.499 1.12 . . . . 0.0 109.521 -170.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -102.24 125.41 48.93 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -146.59 164.82 31.39 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.587 0.755 . . . . 0.0 111.405 -171.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -97.49 115.68 65.77 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.476 1.111 . . . . 0.0 109.277 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -45.94 -38.48 18.48 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 125.255 3.97 . . . . 0.0 115.175 175.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.8 mt -65.59 -28.13 68.92 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.456 0.702 . . . . 0.0 111.839 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.64 -44.09 6.25 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.219 1.007 . . . . 0.0 110.854 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.1 t -144.9 176.21 9.64 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.483 0.713 . . . . 0.0 110.403 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.8 p -149.99 164.63 19.97 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 124.209 1.004 . . . . 0.0 109.864 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.24 -47.08 28.7 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.605 2.87 . . . . 0.0 113.009 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.65 -36.0 82.39 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.468 0.707 . . . . 0.0 112.118 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 m -67.18 -45.65 76.3 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.963 0.505 . . . . 0.0 110.154 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.1 mt -62.21 -46.52 88.5 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.07 0.948 . . . . 0.0 110.443 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -52.5 -47.24 66.73 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.172 0.989 . . . . 0.0 110.052 170.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.75 -45.2 86.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.257 0.932 . . . . 0.0 112.288 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.85 77.43 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 117.677 0.739 . . . . 0.0 111.262 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.8 mt -60.98 -41.99 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.759 0.824 . . . . 0.0 110.076 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.93 -41.32 99.44 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.089 0.956 . . . . 0.0 110.799 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.68 -42.05 99.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.856 0.862 . . . . 0.0 111.094 177.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -58.68 -46.82 86.39 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.98 0.354 . . . . 0.0 110.09 173.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.06 59.13 0.13 Allowed Glycine 0 C--N 1.341 0.815 0 C-N-CA 123.882 0.754 . . . . 0.0 111.735 170.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -140.21 146.55 38.84 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.874 0.87 . . . . 0.0 109.124 174.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -76.13 92.32 3.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.5 131.82 45.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.928 1.291 . . . . 0.0 110.166 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.3 m -143.51 134.01 24.84 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.825 1.25 . . . . 0.0 108.414 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.5 mt -64.12 127.68 32.48 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.154 0.582 . . . . 0.0 109.904 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.9 t -98.42 -51.41 3.97 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.01 0.924 . . . . 0.0 109.77 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.6 t70 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 116.906 -1.521 . . . . 0.0 108.831 -179.824 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.1 p -134.69 115.89 14.3 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.84 1.256 . . . . 0.0 109.137 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -134.92 156.83 48.29 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 124.571 1.148 . . . . 0.0 108.612 171.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -122.77 155.83 35.74 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.034 0.934 . . . . 0.0 110.076 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.3 t -150.08 144.71 25.92 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.115 0.966 . . . . 0.0 109.303 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.7 t -107.11 127.67 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 172.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.4 mt -125.65 124.33 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -66.17 132.5 48.61 Favored 'General case' 0 C--N 1.337 0.045 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 172.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.6 mt -127.66 95.36 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -99.82 156.63 17.01 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.363 0.665 . . . . 0.0 109.938 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.41 32.43 34.55 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.913 0.768 . . . . 0.0 112.036 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 96.7 mtp -87.82 112.14 22.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.965 0.906 . . . . 0.0 108.585 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.8 m -64.6 -56.2 15.44 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.165 0.986 . . . . 0.0 111.445 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.3 p -162.96 -171.61 2.74 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.072 0.549 . . . . 0.0 111.264 -169.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -50.98 -35.36 33.37 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.949 1.7 . . . . 0.0 113.163 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -55.21 -38.46 68.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.172 0.589 . . . . 0.0 111.3 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.1 m -65.91 -48.41 71.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.159 0.584 . . . . 0.0 110.103 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -51.87 -54.42 13.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 123.419 0.688 . . . . 0.0 109.881 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -59.16 -52.9 63.73 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.66 1.184 . . . . 0.0 111.408 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 p -61.15 -53.46 56.72 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.854 0.462 . . . . 0.0 111.387 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 85.0 mt -55.85 -54.79 22.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 123.815 0.846 . . . . 0.0 109.657 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -59.45 -47.01 87.14 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.526 0.33 . . . . 0.0 110.677 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.43 -51.94 53.1 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.314 0.959 . . . . 0.0 112.256 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.73 -55.21 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 117.631 0.716 . . . . 0.0 110.503 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.23 -37.65 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.087 0.555 . . . . 0.0 111.564 -173.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 92.7 p -54.9 -30.48 58.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.786 0.721 . . . . 0.0 112.694 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -89.51 -4.41 57.93 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.906 0.882 . . . . 0.0 112.256 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -70.73 144.84 91.48 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 118.936 0.789 . . . . 0.0 109.205 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -63.71 128.59 22.54 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.019 2.479 . . . . 0.0 110.444 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.56 -32.44 7.57 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-O 118.817 -0.99 . . . . 0.0 112.491 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.8 t -68.62 132.59 32.79 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 CA-C-N 118.276 1.038 . . . . 0.0 109.914 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -106.34 -99.96 0.34 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.999 1.32 . . . . 0.0 108.009 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.5 p -88.64 151.06 22.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.795 0.838 . . . . 0.0 109.365 173.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.7 tt -150.48 131.9 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.293 0.637 . . . . 0.0 109.302 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.94 94.79 4.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.567 1.547 . . . . 0.0 107.747 -175.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.9 t -90.38 125.66 43.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.3 t -118.96 126.93 52.91 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.733 1.213 . . . . 0.0 110.235 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.6 tp -72.45 -47.91 45.19 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.728 1.211 . . . . 0.0 109.455 170.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.99 -46.49 68.31 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.769 1.227 . . . . 0.0 111.591 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -89.42 -11.57 42.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.306 0.642 . . . . 0.0 111.605 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.9 m 53.42 57.65 5.97 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.125 1.37 . . . . 0.0 110.372 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.7 p30 -157.85 171.04 21.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.402 0.681 . . . . 0.0 111.201 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.88 115.84 1.86 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.1 m -99.46 101.99 13.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.9 t -106.73 139.02 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.918 1.287 . . . . 0.0 109.755 -169.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -108.13 130.28 55.12 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 168.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -150.62 169.0 22.6 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.933 0.493 . . . . 0.0 112.05 -170.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.66 112.86 65.29 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.469 1.507 . . . . 0.0 109.531 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -43.29 -42.74 10.33 Favored 'Trans proline' 0 C--N 1.347 0.456 1 C-N-CA 125.696 4.264 . . . . 0.0 115.872 176.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.0 mt -68.26 -28.85 67.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.645 0.378 . . . . 0.0 111.956 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.9 mt -99.71 -33.91 10.4 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.204 1.002 . . . . 0.0 111.801 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -151.69 170.97 18.41 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.273 0.629 . . . . 0.0 110.088 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.8 p -144.04 164.22 30.73 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.602 1.161 . . . . 0.0 109.747 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -52.72 -38.08 76.5 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.377 2.718 . . . . 0.0 112.55 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -66.05 -45.99 79.4 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.331 1.052 . . . . 0.0 110.349 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.8 m -62.45 -46.57 87.92 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.182 0.593 . . . . 0.0 110.545 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.7 mt -60.23 -49.78 76.26 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.03 0.932 . . . . 0.0 110.566 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.2 ttp85 -52.25 -48.54 65.17 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.323 1.049 . . . . 0.0 110.33 173.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.31 -45.79 87.9 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.287 0.946 . . . . 0.0 112.316 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.34 -48.32 78.49 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.559 0.743 . . . . 0.0 111.189 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.7 mt -59.25 -42.1 86.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.777 0.831 . . . . 0.0 110.045 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -63.11 -42.22 99.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.393 0.677 . . . . 0.0 110.982 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -62.11 -41.82 98.61 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.082 0.953 . . . . 0.0 111.103 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.0 mtp -58.75 -45.89 88.67 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.542 0.337 . . . . 0.0 110.32 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.33 58.45 0.13 Allowed Glycine 0 C--N 1.339 0.749 0 C-N-CA 123.618 0.628 . . . . 0.0 111.719 169.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -140.32 140.31 35.61 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -68.44 96.6 0.69 Allowed 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.9 127.75 46.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.887 1.275 . . . . 0.0 109.646 -172.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.5 m -149.16 130.41 14.61 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.0 mt -58.45 134.91 57.07 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.367 0.667 . . . . 0.0 110.597 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 t -101.08 -52.99 3.14 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.076 0.95 . . . . 0.0 109.557 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 116.841 -1.552 . . . . 0.0 108.833 -178.583 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 57.3 tp . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 53.8 p -99.55 80.72 2.41 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.951 0.901 . . . . 0.0 109.473 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -94.14 165.16 12.75 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.972 0.909 . . . . 0.0 109.758 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -140.18 141.58 35.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.215 1.006 . . . . 0.0 109.041 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -135.65 146.24 47.63 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.564 1.146 . . . . 0.0 109.588 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.92 124.18 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.3 mt -120.72 120.27 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -68.45 134.44 50.15 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.9 mt -131.67 106.49 11.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.117 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.92 142.63 31.13 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.64 19.4 20.3 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.792 1.187 . . . . 0.0 113.155 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.1 mtm -78.66 75.41 5.17 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.425 1.113 . . . . 0.0 109.393 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.4 p -72.45 99.3 2.44 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.942 0.897 . . . . 0.0 110.842 -175.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.1 t 75.77 164.54 0.26 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.618 1.567 . . . . 0.0 111.501 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -50.14 -27.05 5.18 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.548 1.539 . . . . 0.0 113.31 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m -53.63 -49.79 67.11 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.075 0.95 . . . . 0.0 111.107 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.7 m -67.15 -44.49 79.67 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.244 0.618 . . . . 0.0 110.647 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.2 t -54.71 -49.67 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.015 0.926 . . . . 0.0 109.893 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.08 -45.34 93.95 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.582 1.553 . . . . 0.0 111.033 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 m -58.6 -53.16 61.51 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 122.951 0.5 . . . . 0.0 110.852 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.59 -50.83 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 123.744 0.818 . . . . 0.0 109.789 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -49.95 -58.45 5.42 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.839 1.256 . . . . 0.0 110.345 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.78 -57.76 17.73 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.789 0.709 . . . . 0.0 112.155 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.9 t -59.67 -56.88 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.302 0.641 . . . . 0.0 110.872 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.6 mm -64.64 -38.49 82.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 118.747 -0.644 . . . . 0.0 111.212 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.2 t -52.94 -35.2 58.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.864 0.756 . . . . 0.0 111.971 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -89.41 -2.6 58.46 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.799 0.84 . . . . 0.0 112.49 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -71.21 145.16 90.65 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 119.448 1.022 . . . . 0.0 109.267 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.97 131.24 30.08 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.94 2.427 . . . . 0.0 109.895 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.71 -36.18 4.41 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-O 118.934 -0.926 . . . . 0.0 112.047 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.7 t -73.57 143.85 13.28 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 CA-C-N 118.044 0.922 . . . . 0.0 110.105 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -118.18 -103.69 0.41 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.078 1.351 . . . . 0.0 107.411 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.0 p -90.37 109.41 20.52 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.164 0.986 . . . . 0.0 110.414 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.0 tt -97.66 141.68 15.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 168.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -126.3 94.46 4.09 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -175.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -89.38 98.37 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.9 t -89.84 109.41 20.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.843 0.857 . . . . 0.0 109.32 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.2 -43.17 95.84 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.468 0.707 . . . . 0.0 109.878 171.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.6 -49.29 68.11 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.609 1.164 . . . . 0.0 111.742 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -89.8 1.02 56.65 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.033 0.533 . . . . 0.0 112.301 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.9 m 49.36 52.72 13.94 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.419 1.488 . . . . 0.0 111.574 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -155.5 166.25 34.1 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.106 0.479 . . . . 0.0 111.762 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.33 118.3 3.82 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.0 m -98.96 99.62 10.69 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.63 121.46 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 125.281 1.433 . . . . 0.0 109.516 -169.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -89.48 128.21 35.95 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 169.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -150.23 168.91 22.64 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -169.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -106.13 113.24 63.73 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 125.447 1.499 . . . . 0.0 108.979 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -48.27 -35.32 26.86 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 124.807 3.671 . . . . 0.0 114.615 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.0 mt -63.42 -31.46 72.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.509 0.723 . . . . 0.0 111.861 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.8 mt -106.79 -31.35 8.43 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.295 1.038 . . . . 0.0 112.368 -171.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 t -149.71 175.45 11.57 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.746 0.703 . . . . 0.0 110.177 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.2 p -146.46 160.86 40.64 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 124.2 1.0 . . . . 0.0 109.839 -176.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.62 -40.93 54.98 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.402 2.734 . . . . 0.0 112.747 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.97 -44.38 85.09 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.068 0.947 . . . . 0.0 111.148 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.7 m -61.95 -46.71 88.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.153 0.581 . . . . 0.0 110.462 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.4 mt -61.82 -49.72 75.16 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.306 1.042 . . . . 0.0 110.411 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -51.89 -44.48 63.78 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.81 0.844 . . . . 0.0 110.2 171.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.22 -48.0 77.75 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.523 1.058 . . . . 0.0 112.128 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.26 -45.58 90.83 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.657 0.729 . . . . 0.0 111.479 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.0 mt -62.01 -45.32 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.873 0.869 . . . . 0.0 109.914 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -61.71 -42.03 98.4 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.586 1.154 . . . . 0.0 110.775 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.39 -43.64 98.53 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.349 1.06 . . . . 0.0 111.338 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 69.0 mtm -57.11 -48.21 79.2 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 117.908 0.322 . . . . 0.0 110.481 173.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.2 65.8 0.1 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -140.24 152.03 45.63 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.158 0.983 . . . . 0.0 108.717 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -78.21 90.19 4.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.77 133.71 43.73 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.823 1.249 . . . . 0.0 110.464 -174.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.7 m -150.11 146.45 26.92 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.169 0.988 . . . . 0.0 108.459 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -64.95 150.73 47.42 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.276 0.489 . . . . 0.0 110.001 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 t -121.13 -50.84 2.13 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.349 1.06 . . . . 0.0 109.372 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 t70 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 117.085 -1.436 . . . . 0.0 108.699 177.751 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 44.1 mt . . . . . 0 N--CA 1.476 0.874 0 CA-C-O 120.296 0.093 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 53.7 p -134.67 84.7 2.12 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.597 1.159 . . . . 0.0 108.171 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -105.06 173.9 6.1 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.432 1.093 . . . . 0.0 109.982 -176.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -140.28 146.0 38.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.777 0.831 . . . . 0.0 109.609 177.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -137.2 137.31 38.99 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.319 1.048 . . . . 0.0 109.692 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.8 t -99.84 109.11 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 172.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.1 mt -99.82 119.97 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -71.83 123.59 23.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.9 mt -123.53 119.49 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -118.14 158.01 25.85 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.188 0.595 . . . . 0.0 109.746 173.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.9 16.41 51.44 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.621 1.105 . . . . 0.0 112.052 -170.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 89.3 mtp -81.06 70.88 7.99 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.458 1.103 . . . . 0.0 108.504 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -62.94 -29.37 70.75 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -169.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.2 p -154.54 176.06 12.86 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.974 0.806 . . . . 0.0 111.821 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -66.42 -22.66 66.23 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.299 1.039 . . . . 0.0 112.543 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.1 t -62.34 -35.96 80.73 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.296 0.498 . . . . 0.0 110.281 172.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.1 m -62.35 -49.22 76.46 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -54.16 -52.77 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.144 0.978 . . . . 0.0 109.916 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -55.14 -51.33 66.8 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.81 1.244 . . . . 0.0 110.883 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -60.06 -56.4 22.14 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.235 0.614 . . . . 0.0 110.967 -177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 93.5 mt -53.78 -52.69 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.483 1.113 . . . . 0.0 109.749 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -56.02 -55.5 32.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.324 1.049 . . . . 0.0 110.502 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.57 -50.26 64.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.715 1.15 . . . . 0.0 112.286 -176.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.9 t -63.12 -55.34 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 117.368 0.584 . . . . 0.0 110.394 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 84.3 mt -65.06 -40.91 90.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 119.222 -0.418 . . . . 0.0 111.607 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.8 p -53.73 -28.64 35.41 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -89.43 -8.3 53.33 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.888 0.875 . . . . 0.0 112.523 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -71.88 124.62 91.15 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 119.08 0.854 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.12 121.98 7.72 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.699 2.933 . . . . 0.0 112.135 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.13 -37.35 3.45 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.0 0.81 . . . . 0.0 111.76 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.39 126.97 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 117.827 0.814 . . . . 0.0 109.761 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -94.38 -101.35 0.15 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.924 1.29 . . . . 0.0 107.83 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 91.4 p -90.01 163.04 15.08 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.529 0.732 . . . . 0.0 110.186 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.3 tt -150.63 147.85 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.747 0.819 . . . . 0.0 109.73 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.97 109.06 6.77 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.616 1.166 . . . . 0.0 107.884 172.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.42 102.2 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 124.171 0.988 . . . . 0.0 108.467 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -93.65 112.99 24.98 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.969 0.908 . . . . 0.0 110.372 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tt -66.42 -51.37 57.65 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.22 -51.09 57.16 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.09 1.356 . . . . 0.0 112.209 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -89.86 6.56 41.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.963 0.505 . . . . 0.0 111.939 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 m 49.23 57.02 6.93 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 125.654 1.582 . . . . 0.0 112.047 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -157.19 164.11 38.12 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.519 0.676 . . . . 0.0 112.728 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.45 110.11 2.09 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 106.186 -2.766 . . . . 0.0 106.186 169.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -98.81 97.2 8.44 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.5 t -106.87 124.27 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 124.387 1.075 . . . . 0.0 109.099 -170.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -89.81 130.82 36.01 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 169.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -150.31 165.98 31.4 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.072 0.549 . . . . 0.0 112.191 -169.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -104.37 113.19 65.36 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.098 1.359 . . . . 0.0 109.189 173.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -44.65 -36.65 10.52 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 125.286 3.991 . . . . 0.0 114.846 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.6 mt -66.06 -28.61 68.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.617 0.767 . . . . 0.0 112.12 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.7 mt -109.83 -35.29 6.21 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.314 1.046 . . . . 0.0 112.051 -171.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -145.26 179.32 7.46 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.869 0.868 . . . . 0.0 109.396 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.0 p -150.07 162.63 27.31 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 123.207 0.603 . . . . 0.0 110.56 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.03 -38.82 87.03 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.32 2.68 . . . . 0.0 111.782 172.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.45 -49.72 75.66 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.858 0.863 . . . . 0.0 110.677 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -58.37 -48.35 80.88 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.319 0.647 . . . . 0.0 110.549 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.3 mt -60.65 -47.84 84.45 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.219 1.008 . . . . 0.0 110.87 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -56.55 -44.61 81.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.679 0.792 . . . . 0.0 110.555 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.27 -45.94 87.33 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.095 0.855 . . . . 0.0 111.87 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.39 -49.83 73.95 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.378 0.671 . . . . 0.0 111.091 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.8 mt -60.08 -45.28 95.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.32 0.648 . . . . 0.0 110.212 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -57.56 -48.97 77.88 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.102 0.961 . . . . 0.0 110.048 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.78 -43.58 90.48 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.114 0.965 . . . . 0.0 111.454 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.4 mtp -59.44 -44.53 92.91 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.928 0.491 . . . . 0.0 110.631 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.04 62.21 0.2 Allowed Glycine 0 C--N 1.339 0.725 0 C-N-CA 123.795 0.712 . . . . 0.0 111.598 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -140.31 155.4 46.84 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.789 0.836 . . . . 0.0 109.29 172.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -78.37 91.12 4.43 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.703 0.801 . . . . 0.0 108.996 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.67 129.68 45.83 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.618 1.167 . . . . 0.0 110.816 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.7 m -150.07 132.42 15.57 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.897 0.879 . . . . 0.0 108.818 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 43.5 mt -63.64 163.85 10.66 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.054 0.542 . . . . 0.0 111.094 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.7 p -74.32 82.8 1.89 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.339 0.656 . . . . 0.0 109.29 170.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 116.953 -1.499 . . . . 0.0 109.948 177.687 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 51.5 tp . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 110.691 -0.115 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -139.05 126.25 21.35 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.461 1.104 . . . . 0.0 108.773 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 -130.19 167.98 17.54 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.196 1.398 . . . . 0.0 109.302 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -124.14 144.14 50.08 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.461 1.105 . . . . 0.0 108.886 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -137.7 146.78 44.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.33 1.052 . . . . 0.0 109.326 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.99 125.59 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.9 mt -120.32 121.06 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -72.37 132.07 43.47 Favored 'General case' 0 C--O 1.228 -0.044 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 174.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.5 mt -127.97 106.42 14.8 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -99.56 149.57 23.11 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.427 0.691 . . . . 0.0 109.195 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.27 16.27 47.64 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.441 1.02 . . . . 0.0 113.005 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.8 mtm -81.1 64.47 5.85 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.58 1.19 . . . . 0.0 109.252 175.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.6 m -79.4 84.52 5.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.438 1.095 . . . . 0.0 109.788 -173.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.3 t 118.85 148.78 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 129.511 3.124 . . . . 0.0 109.579 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -54.88 -29.95 56.8 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.44 1.096 . . . . 0.0 111.922 175.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.9 m -50.59 -43.43 56.64 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.416 1.086 . . . . 0.0 111.562 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.8 m -60.76 -57.2 13.71 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.4 0.68 . . . . 0.0 109.603 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.7 t -49.89 -51.55 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.06 1.344 . . . . 0.0 111.067 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -59.87 -52.48 65.27 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.009 1.324 . . . . 0.0 111.103 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.3 p -61.12 -48.98 79.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.122 0.569 . . . . 0.0 111.3 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.8 mt -53.76 -55.31 14.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.805 0.842 . . . . 0.0 109.397 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -54.18 -55.06 31.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.113 0.565 . . . . 0.0 110.712 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.43 -50.45 59.94 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.315 0.959 . . . . 0.0 112.779 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.38 -49.68 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.409 0.683 . . . . 0.0 110.699 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.6 mm -66.28 -33.53 64.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.46 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.7 m -50.87 -30.88 15.72 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.872 0.76 . . . . 0.0 112.734 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -89.07 -3.35 58.7 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.58 0.752 . . . . 0.0 112.167 -173.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -77.12 143.01 69.27 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 118.87 0.759 . . . . 0.0 109.903 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.92 135.37 17.82 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.91 3.073 . . . . 0.0 112.608 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.17 -34.9 3.95 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.674 -1.07 . . . . 0.0 113.045 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.1 124.22 20.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-N 118.448 1.124 . . . . 0.0 109.918 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -89.84 -102.59 0.09 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.0 p -90.49 158.02 17.25 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.336 1.054 . . . . 0.0 109.676 171.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.5 tt -150.23 127.37 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -116.19 107.13 14.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.465 1.106 . . . . 0.0 108.497 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.62 124.38 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.0 t -106.8 129.48 54.65 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.636 1.174 . . . . 0.0 110.17 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.5 tp -68.35 -53.61 22.93 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.709 0.803 . . . . 0.0 109.09 171.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.16 -47.48 71.93 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 125.265 1.426 . . . . 0.0 112.086 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -89.25 -9.63 49.95 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.403 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.5 m 52.79 56.08 8.1 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 125.016 1.326 . . . . 0.0 111.02 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -157.17 168.31 27.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.419 0.688 . . . . 0.0 110.853 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.55 116.83 2.89 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 126.215 1.864 . . . . 0.0 108.783 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.0 m -99.12 100.56 11.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 176.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.6 t -106.3 125.52 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.502 1.121 . . . . 0.0 109.537 -170.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -95.53 127.93 41.98 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 168.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -150.26 164.36 35.93 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.17 0.588 . . . . 0.0 111.779 -169.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -98.36 114.25 65.02 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.737 1.215 . . . . 0.0 109.013 172.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -47.74 -34.35 21.07 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.741 3.627 . . . . 0.0 114.93 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.5 mt -65.92 -33.9 76.89 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.457 0.703 . . . . 0.0 111.584 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.75 -35.3 9.84 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.895 0.878 . . . . 0.0 111.578 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.3 t -147.4 178.37 8.48 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.698 0.681 . . . . 0.0 110.539 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.3 p -148.88 159.85 36.73 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 124.624 1.17 . . . . 0.0 109.714 -174.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.41 -40.42 62.47 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.511 2.807 . . . . 0.0 112.814 176.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -66.79 -41.05 88.28 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.555 1.142 . . . . 0.0 110.927 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.8 m -67.55 -45.65 75.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.1 0.56 . . . . 0.0 110.326 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.0 mt -60.73 -49.55 77.05 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.241 1.016 . . . . 0.0 110.253 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.9 ttp85 -52.1 -47.24 65.38 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.164 0.986 . . . . 0.0 109.988 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.19 -45.23 83.22 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.569 1.08 . . . . 0.0 112.293 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.59 -48.24 75.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.635 0.717 . . . . 0.0 111.099 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.93 -42.45 89.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.92 0.888 . . . . 0.0 109.981 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -63.51 -41.04 98.52 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.628 1.171 . . . . 0.0 110.568 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.36 -41.48 98.83 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.01 0.924 . . . . 0.0 111.182 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.9 mtp -57.83 -44.27 86.36 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.097 0.408 . . . . 0.0 110.203 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.13 61.76 0.16 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 123.651 0.643 . . . . 0.0 111.702 169.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -140.33 152.43 45.82 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.999 0.919 . . . . 0.0 109.414 175.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -79.74 86.24 5.35 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.57 128.99 45.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.626 1.171 . . . . 0.0 110.461 -173.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.9 p -142.34 151.19 41.68 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.154 1.382 . . . . 0.0 109.039 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -69.29 137.69 53.24 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.6 t -87.63 55.97 3.72 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.043 0.537 . . . . 0.0 110.146 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.618 -1.182 . . . . 0.0 110.662 179.404 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.9 p -99.32 153.0 19.31 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.248 1.019 . . . . 0.0 110.516 -171.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -114.72 172.09 7.25 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 125.485 1.514 . . . . 0.0 109.166 -174.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -134.76 141.27 46.42 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.061 0.945 . . . . 0.0 108.969 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -131.56 144.8 51.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.406 1.082 . . . . 0.0 109.49 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.97 123.75 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.2 mt -116.37 121.76 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -69.94 118.19 12.47 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.3 mt -110.8 102.34 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -99.65 149.03 23.71 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.562 0.745 . . . . 0.0 109.27 176.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.67 26.04 16.28 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.667 1.127 . . . . 0.0 112.359 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 88.8 mtp -86.45 129.71 34.76 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.107 0.963 . . . . 0.0 108.413 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.9 p -73.2 -67.72 0.55 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.013 0.525 . . . . 0.0 110.521 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -161.0 -157.07 0.49 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.04 0.936 . . . . 0.0 108.911 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -73.99 77.88 1.68 Allowed 'General case' 0 C--N 1.343 0.287 0 C-N-CA 124.158 0.983 . . . . 0.0 109.174 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 p -165.86 -57.25 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.366 1.867 . . . . 0.0 106.553 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.31 -40.51 96.54 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.939 0.895 . . . . 0.0 109.239 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.5 t -49.86 -59.3 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.358 1.063 . . . . 0.0 109.928 173.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.89 -45.5 94.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.609 1.164 . . . . 0.0 111.037 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.8 t -59.55 -57.88 11.04 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.956 0.902 . . . . 0.0 110.828 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.3 mt -55.42 -54.4 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.964 0.906 . . . . 0.0 109.587 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -55.38 -49.02 73.4 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.144 0.578 . . . . 0.0 110.791 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.39 -37.27 91.75 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.002 1.287 . . . . 0.0 113.284 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.6 t -77.84 -57.81 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.253 1.026 . . . . 0.0 110.17 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.38 -37.63 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.452 0.701 . . . . 0.0 111.404 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.9 p -51.6 -30.78 22.44 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -89.42 -8.29 53.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.815 0.846 . . . . 0.0 112.434 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -72.56 143.62 85.3 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 118.751 0.705 . . . . 0.0 109.816 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -47.51 134.27 21.0 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.791 2.994 . . . . 0.0 112.655 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.56 -31.76 5.64 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-O 118.724 -1.042 . . . . 0.0 113.457 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.5 t -67.12 134.02 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.341 1.071 . . . . 0.0 110.146 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -113.88 -102.94 0.41 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.192 1.397 . . . . 0.0 108.297 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.4 p -82.44 154.05 25.35 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.161 0.584 . . . . 0.0 109.79 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.5 tt -150.33 145.32 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.326 0.65 . . . . 0.0 110.1 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -139.97 103.47 4.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.5 t -91.67 108.6 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.2 t -89.52 129.23 36.03 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.145 0.578 . . . . 0.0 110.111 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tt -73.96 -57.01 4.25 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.813 1.245 . . . . 0.0 108.152 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.79 -45.7 78.13 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.524 1.53 . . . . 0.0 112.356 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -89.12 -10.54 46.91 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.893 0.477 . . . . 0.0 111.013 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.2 m 56.23 58.15 4.5 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.057 1.343 . . . . 0.0 110.614 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -146.03 163.59 34.75 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.86 0.464 . . . . 0.0 111.618 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.04 107.59 1.8 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.9 m -99.13 99.84 10.9 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.3 t -114.91 126.01 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 124.791 1.236 . . . . 0.0 109.608 -169.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -89.92 131.61 35.74 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -150.51 156.96 42.44 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.274 0.629 . . . . 0.0 112.256 -170.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -93.53 120.08 66.67 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.703 1.201 . . . . 0.0 110.117 173.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.53 -41.79 29.51 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 125.069 3.846 . . . . 0.0 115.785 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -68.47 -29.74 68.43 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.614 0.365 . . . . 0.0 111.73 -173.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.2 mt -99.64 -32.66 10.96 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.227 1.011 . . . . 0.0 111.893 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -153.23 176.22 12.19 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.677 0.671 . . . . 0.0 110.05 173.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.9 p -150.09 162.6 27.39 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.039 0.936 . . . . 0.0 109.993 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.3 -44.34 49.77 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.439 2.759 . . . . 0.0 112.755 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.05 -34.12 77.3 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.502 0.721 . . . . 0.0 112.571 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.1 m -70.93 -47.67 57.79 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 122.944 0.498 . . . . 0.0 109.732 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.9 mt -58.36 -50.31 74.12 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.943 0.897 . . . . 0.0 110.05 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -52.29 -47.4 65.91 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.791 1.236 . . . . 0.0 110.533 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.82 -47.87 76.0 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.32 0.962 . . . . 0.0 112.156 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.5 -46.77 86.95 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.561 0.744 . . . . 0.0 111.401 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.7 mt -60.97 -43.99 97.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.56 0.744 . . . . 0.0 109.938 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -63.14 -41.67 99.34 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.712 0.805 . . . . 0.0 110.945 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.13 -43.49 98.81 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.253 1.021 . . . . 0.0 111.184 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 69.5 mtm -58.46 -50.04 75.14 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 117.842 0.292 . . . . 0.0 110.382 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.39 63.01 0.09 OUTLIER Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 171.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -140.25 142.98 35.74 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.27 93.51 1.11 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.9 120.7 40.19 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.219 1.407 . . . . 0.0 109.425 -174.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 47.1 p -138.27 140.26 39.55 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.356 1.062 . . . . 0.0 108.617 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 68.3 mt -68.1 123.83 21.74 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.596 0.358 . . . . 0.0 110.31 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.0 t -85.87 -49.65 7.73 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.832 0.853 . . . . 0.0 108.824 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.5 t70 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 116.928 -1.511 . . . . 0.0 108.305 -179.941 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 120.542 0.21 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.1 p -139.55 118.05 12.17 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.926 1.29 . . . . 0.0 109.3 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -139.58 164.99 28.44 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.518 1.127 . . . . 0.0 109.196 172.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -128.5 151.81 48.99 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.554 1.142 . . . . 0.0 109.438 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -145.44 148.68 33.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.298 1.039 . . . . 0.0 109.394 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.93 123.54 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.4 mt -119.06 128.86 75.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -70.28 121.47 17.69 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 171.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.7 mt -125.95 95.01 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.75 151.74 20.9 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.31 15.79 56.64 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.31 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 54.8 mtt -55.9 -57.65 11.2 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 118.755 1.277 . . . . 0.0 109.764 174.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 m 77.45 -63.06 0.36 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.165 1.786 . . . . 0.0 112.106 174.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.7 t -117.78 151.63 36.92 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.364 1.065 . . . . 0.0 111.228 -169.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -58.56 -29.39 66.34 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.603 1.161 . . . . 0.0 112.03 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.0 m -55.11 -48.52 73.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.858 0.863 . . . . 0.0 110.18 172.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.3 m -63.8 -44.26 93.83 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.736 0.814 . . . . 0.0 110.679 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.3 t -51.92 -54.7 12.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 C-N-CA 123.302 0.641 . . . . 0.0 109.641 176.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -61.51 -42.65 99.13 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.668 0.787 . . . . 0.0 111.432 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -59.24 -55.43 35.01 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.131 0.572 . . . . 0.0 110.663 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.2 mt -54.25 -55.8 12.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 123.873 0.869 . . . . 0.0 109.155 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -54.44 -54.67 37.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.85 0.86 . . . . 0.0 111.091 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.09 -53.57 44.64 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.281 0.943 . . . . 0.0 112.364 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.61 -54.24 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 117.382 0.591 . . . . 0.0 110.438 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.9 mm -61.78 -40.6 87.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.699 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.1 t -51.2 -36.21 40.27 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.427 0.691 . . . . 0.0 112.089 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -88.97 -11.06 45.41 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.464 0.705 . . . . 0.0 112.131 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -73.08 139.43 79.5 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 119.466 1.03 . . . . 0.0 109.962 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -45.22 137.81 10.09 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.354 3.369 . . . . 0.0 113.665 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.34 -38.79 3.01 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-O 118.841 -0.977 . . . . 0.0 112.49 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.34 134.02 30.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 CA-C-N 118.254 1.027 . . . . 0.0 110.088 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -104.61 -102.09 0.31 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.849 1.259 . . . . 0.0 107.926 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.8 p -87.31 152.83 21.96 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.464 0.706 . . . . 0.0 109.849 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 tt -150.69 140.23 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.645 0.778 . . . . 0.0 109.676 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -129.84 110.95 12.13 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.924 1.29 . . . . 0.0 108.659 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.34 122.79 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.363 1.065 . . . . 0.0 108.572 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.7 t -115.63 123.66 48.98 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.823 1.249 . . . . 0.0 110.588 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.6 tp -69.83 -48.24 59.71 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.745 1.218 . . . . 0.0 109.823 170.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.12 -46.74 65.46 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.691 1.197 . . . . 0.0 111.639 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -89.51 -15.03 33.91 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.419 0.688 . . . . 0.0 111.7 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.2 m 54.52 54.68 8.97 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 125.14 1.376 . . . . 0.0 110.415 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -154.32 163.42 40.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.454 0.702 . . . . 0.0 110.928 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.54 119.6 3.74 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.4 m -99.2 104.52 16.49 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 t -112.86 127.75 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 124.655 1.182 . . . . 0.0 109.575 -170.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -96.73 133.07 41.76 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 169.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -150.38 169.79 20.58 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.773 0.429 . . . . 0.0 111.865 -171.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -103.67 110.76 64.47 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 125.133 1.373 . . . . 0.0 109.268 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -41.66 -38.73 4.47 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 125.268 3.979 . . . . 0.0 115.227 170.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.9 mt -62.51 -35.12 78.36 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.25 0.62 . . . . 0.0 111.955 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.9 mt -104.4 -31.57 9.45 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.299 1.04 . . . . 0.0 112.344 -170.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 t -150.1 176.76 10.52 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.408 0.683 . . . . 0.0 110.173 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.3 p -147.45 163.43 27.91 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.36 1.064 . . . . 0.0 109.929 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.92 -41.87 67.92 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.326 2.684 . . . . 0.0 112.443 176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -66.47 -40.85 89.6 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.786 0.834 . . . . 0.0 111.39 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.9 m -62.66 -47.24 84.56 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.779 0.432 . . . . 0.0 110.242 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.6 mt -62.07 -47.53 84.25 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.106 0.963 . . . . 0.0 110.606 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -51.66 -48.54 63.37 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.495 1.118 . . . . 0.0 109.954 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.86 -45.01 92.09 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.485 1.04 . . . . 0.0 112.255 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.43 -49.29 76.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.477 0.711 . . . . 0.0 111.159 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.59 -41.81 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.707 0.803 . . . . 0.0 110.164 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -61.42 -43.0 99.63 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.942 0.897 . . . . 0.0 110.707 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.4 -42.27 99.31 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.917 0.887 . . . . 0.0 111.091 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mtp -58.67 -44.84 90.32 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.973 0.352 . . . . 0.0 110.379 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.39 59.92 0.17 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 123.756 0.693 . . . . 0.0 111.976 169.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -140.31 152.31 45.75 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.051 0.94 . . . . 0.0 108.95 174.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -75.9 91.5 3.02 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.31 122.47 42.5 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.54 1.136 . . . . 0.0 109.95 -172.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.6 m -148.54 132.59 17.24 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.54 1.136 . . . . 0.0 108.304 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.2 mt -60.73 142.01 56.3 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.147 0.579 . . . . 0.0 111.477 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.68 -54.52 2.56 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.945 1.298 . . . . 0.0 108.197 172.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 . . . . . 0 C--O 1.249 1.077 0 C-N-CA 125.473 1.509 . . . . 0.0 107.981 -178.94 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 64.6 tp . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 119.838 -0.125 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.4 p -139.47 137.11 35.27 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.142 0.977 . . . . 0.0 108.839 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.1 mm100 -126.33 162.08 26.34 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.78 1.632 . . . . 0.0 109.355 -177.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -108.94 145.11 35.97 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.388 1.075 . . . . 0.0 109.385 176.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 t -134.99 133.7 39.74 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.028 0.931 . . . . 0.0 109.336 172.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.93 108.32 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.7 mt -99.55 120.6 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -82.93 109.84 17.39 Favored 'General case' 0 C--N 1.334 -0.072 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.8 mt -111.73 106.19 20.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.403 1.081 . . . . 0.0 108.278 -172.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -99.6 145.4 27.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.07 -5.71 46.32 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.553 -1.137 . . . . 0.0 113.584 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.2 mtm -55.21 -60.44 3.39 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-N 119.069 1.434 . . . . 0.0 110.296 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 m 75.15 -63.33 0.42 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.754 1.622 . . . . 0.0 112.517 170.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.1 m -108.27 154.52 21.67 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.401 1.081 . . . . 0.0 111.142 -170.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -62.58 -27.72 69.39 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.808 0.843 . . . . 0.0 111.608 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.7 m -56.62 -48.02 78.39 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.364 0.665 . . . . 0.0 110.333 173.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -63.33 -45.04 93.09 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.667 0.787 . . . . 0.0 110.569 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.0 t -54.8 -53.86 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.625 0.77 . . . . 0.0 110.318 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -58.23 -46.72 85.39 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.588 1.155 . . . . 0.0 111.22 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.6 t -57.18 -52.67 64.37 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.313 0.645 . . . . 0.0 110.684 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.5 mt -55.01 -61.21 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 124.461 1.104 . . . . 0.0 110.075 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -59.3 -41.08 88.16 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.985 0.357 . . . . 0.0 111.386 -174.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.39 -56.08 27.0 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.24 -52.51 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.673 0.789 . . . . 0.0 110.726 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.5 mm -62.52 -37.58 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.434 0.693 . . . . 0.0 111.56 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.1 m -54.32 -29.51 47.98 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.698 0.681 . . . . 0.0 112.738 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -89.31 -6.38 56.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.288 0.635 . . . . 0.0 112.222 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -72.81 139.75 80.55 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 119.104 0.865 . . . . 0.0 109.251 177.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.05 131.56 29.13 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.004 2.469 . . . . 0.0 110.065 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.33 -36.19 4.54 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-O 118.872 -0.96 . . . . 0.0 111.795 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.53 131.65 32.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-N 118.141 0.971 . . . . 0.0 109.866 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -104.07 -101.63 0.31 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.943 1.297 . . . . 0.0 107.81 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.3 p -90.06 160.35 16.36 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.873 0.869 . . . . 0.0 110.079 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.7 tt -150.39 146.58 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 123.861 0.864 . . . . 0.0 109.488 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.94 109.78 7.6 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 173.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -98.67 103.71 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.0 t -89.78 118.98 29.78 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.602 0.761 . . . . 0.0 109.132 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.0 tp -70.56 -44.26 67.81 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.693 0.797 . . . . 0.0 109.656 172.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.12 -48.78 67.58 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.775 1.23 . . . . 0.0 111.666 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -89.39 -5.91 57.04 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.105 0.562 . . . . 0.0 111.534 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.8 m 52.07 55.78 8.72 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.52 1.528 . . . . 0.0 111.255 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -155.3 151.29 27.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.127 0.489 . . . . 0.0 111.815 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.67 113.56 4.27 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 126.242 1.877 . . . . 0.0 108.621 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.6 m -98.78 97.14 8.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 t -104.64 126.91 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.348 1.059 . . . . 0.0 109.399 -170.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -92.67 131.07 38.07 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -149.96 164.14 36.26 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.242 0.617 . . . . 0.0 110.971 -171.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -101.38 114.4 65.71 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.408 1.083 . . . . 0.0 109.151 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.52 -35.35 16.4 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 125.002 3.801 . . . . 0.0 115.069 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.27 -29.69 69.37 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.515 0.726 . . . . 0.0 111.833 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.8 -46.92 5.23 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.054 0.942 . . . . 0.0 110.725 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 t -138.56 -178.95 5.53 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.965 0.906 . . . . 0.0 110.107 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.9 p -148.35 161.69 33.01 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.872 0.869 . . . . 0.0 110.287 -173.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -51.43 -50.01 15.33 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.494 2.796 . . . . 0.0 112.73 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.95 -33.21 75.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.897 0.479 . . . . 0.0 112.115 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.5 m -64.81 -48.75 73.29 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.9 mt -61.86 -46.98 87.07 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.497 0.719 . . . . 0.0 110.601 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.8 ttp85 -53.78 -46.47 71.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.043 0.937 . . . . 0.0 109.88 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.99 -42.71 93.03 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.521 1.058 . . . . 0.0 112.309 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.21 -47.13 83.82 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.999 0.899 . . . . 0.0 111.03 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mm -58.59 -44.76 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 122.73 0.412 . . . . 0.0 110.108 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -61.7 -38.99 89.9 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.25 0.62 . . . . 0.0 111.011 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.59 -43.42 93.91 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.315 1.046 . . . . 0.0 110.94 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.5 mtp -58.7 -41.51 86.43 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.958 0.344 . . . . 0.0 110.472 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.7 57.92 0.23 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 123.959 0.79 . . . . 0.0 111.919 169.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -140.27 145.53 37.42 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -73.92 91.13 1.98 Allowed 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.662 0.785 . . . . 0.0 109.565 -174.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.84 127.72 45.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.04 1.336 . . . . 0.0 110.374 -174.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.1 m -144.76 130.99 19.55 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.363 1.065 . . . . 0.0 108.515 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.6 mt -64.06 158.41 22.72 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.426 0.69 . . . . 0.0 111.627 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.2 p -77.33 66.71 3.14 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.008 0.923 . . . . 0.0 109.489 172.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.02 -1.466 . . . . 0.0 108.806 -176.962 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 49.1 tp . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.2 p -140.11 126.46 20.07 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.74 1.216 . . . . 0.0 108.466 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -142.18 167.11 22.9 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.349 1.46 . . . . 0.0 108.9 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -128.27 151.46 49.27 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.51 1.124 . . . . 0.0 109.429 175.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 t -150.13 140.94 22.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.589 0.755 . . . . 0.0 110.025 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.1 t -99.73 129.49 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 171.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.4 mt -121.47 123.66 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -78.66 120.47 23.38 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.0 mt -119.73 103.32 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 125.917 1.687 . . . . 0.0 106.708 -173.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -99.97 144.85 28.53 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.923 0.489 . . . . 0.0 110.23 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.47 34.76 7.77 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.788 1.185 . . . . 0.0 112.852 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.9 mtm -93.45 102.24 14.46 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 117.794 0.797 . . . . 0.0 109.563 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.8 m -60.12 147.05 40.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.859 0.863 . . . . 0.0 110.683 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.7 t -48.59 124.49 8.34 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.281 1.432 . . . . 0.0 112.381 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.289 5.7 p30 64.85 -54.05 0.3 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 129.061 2.944 . . . . 0.0 115.486 174.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.7 p -55.67 -57.69 10.91 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.46 1.104 . . . . 0.0 111.316 -175.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.0 m -64.57 -47.36 79.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.476 0.71 . . . . 0.0 110.285 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -51.16 -56.56 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.151 0.98 . . . . 0.0 110.445 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -62.38 -49.06 77.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.308 1.043 . . . . 0.0 111.494 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.3 p -61.52 -50.12 73.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.004 0.365 . . . . 0.0 111.568 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.8 mt -55.16 -55.07 18.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 C-N-CA 123.769 0.828 . . . . 0.0 109.343 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.3 -49.62 71.67 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.25 0.62 . . . . 0.0 110.999 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.4 -51.33 59.76 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.633 1.111 . . . . 0.0 112.347 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.73 -54.29 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 117.75 0.775 . . . . 0.0 110.311 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.8 mm -64.3 -38.27 82.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 118.911 -0.566 . . . . 0.0 111.638 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.4 p -53.74 -31.73 49.5 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.85 0.75 . . . . 0.0 112.721 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -89.58 -3.65 58.2 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.049 0.939 . . . . 0.0 112.395 -174.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -72.03 143.26 86.15 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 119.071 0.851 . . . . 0.0 109.64 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -46.82 128.47 13.4 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.894 3.063 . . . . 0.0 112.665 176.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.01 -30.86 7.09 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.391 177.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.5 t -69.66 125.45 27.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 CA-C-N 118.694 1.247 . . . . 0.0 109.832 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -95.9 -103.04 0.16 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.7 p -86.58 155.62 20.38 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.415 0.686 . . . . 0.0 110.213 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tt -150.66 139.06 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.922 0.889 . . . . 0.0 109.208 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -128.91 103.8 7.24 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.655 1.182 . . . . 0.0 108.77 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -93.25 121.91 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 123.967 0.907 . . . . 0.0 108.769 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.7 t -118.09 124.44 48.07 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.911 1.284 . . . . 0.0 109.725 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tt -71.09 -46.97 60.81 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.273 1.029 . . . . 0.0 109.487 172.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.36 -47.46 56.04 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.732 1.213 . . . . 0.0 111.778 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -89.57 -8.72 52.06 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.365 0.666 . . . . 0.0 111.774 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.1 m 51.87 55.64 8.99 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.779 1.632 . . . . 0.0 110.709 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -155.77 170.41 22.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.005 0.522 . . . . 0.0 111.765 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.7 118.31 2.58 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.4 m -98.98 100.49 11.66 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 t -106.72 128.33 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.556 1.142 . . . . 0.0 109.757 -169.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -96.52 130.54 43.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 168.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -150.22 163.39 38.39 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.009 0.523 . . . . 0.0 111.881 -171.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -97.08 113.98 63.95 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.916 1.286 . . . . 0.0 109.381 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -45.69 -37.41 15.8 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 124.942 3.762 . . . . 0.0 114.777 172.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -64.61 -34.35 78.07 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.505 0.722 . . . . 0.0 111.811 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.4 mt -104.09 -30.47 10.22 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.121 0.969 . . . . 0.0 112.279 -172.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.0 t -151.78 177.96 9.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.302 0.641 . . . . 0.0 110.107 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.3 p -149.21 162.05 30.16 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 125.106 1.363 . . . . 0.0 109.549 -172.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.14 -38.43 80.95 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.934 2.422 . . . . 0.0 112.03 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.28 -48.92 71.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.587 1.155 . . . . 0.0 111.44 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.4 p -62.56 -42.49 99.58 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.503 0.321 . . . . 0.0 111.096 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.5 mt -64.83 -47.8 76.68 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.385 0.674 . . . . 0.0 110.365 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.5 ttp85 -51.99 -48.03 64.62 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.166 0.986 . . . . 0.0 110.219 171.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.63 -46.69 81.13 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.294 0.95 . . . . 0.0 112.246 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.42 -48.64 78.79 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.638 0.775 . . . . 0.0 111.169 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.0 mt -60.16 -42.42 90.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.71 0.804 . . . . 0.0 110.059 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.62 -39.94 95.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.579 0.751 . . . . 0.0 110.831 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.69 -41.66 98.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.022 0.929 . . . . 0.0 111.003 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.9 mtp -58.31 -43.4 88.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.984 0.356 . . . . 0.0 110.268 172.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.26 58.39 0.18 Allowed Glycine 0 C--N 1.34 0.778 0 C-N-CA 123.827 0.727 . . . . 0.0 111.975 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -140.29 142.48 35.68 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.004 0.922 . . . . 0.0 108.935 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -69.75 92.36 0.67 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.67 123.95 44.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.232 1.413 . . . . 0.0 109.302 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.1 p -138.66 136.74 36.2 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.703 1.201 . . . . 0.0 108.872 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 61.6 mt -68.73 126.9 31.19 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.615 0.366 . . . . 0.0 110.215 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.3 t -104.44 -34.89 8.1 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.455 1.102 . . . . 0.0 110.263 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 C--O 1.25 1.116 0 C-N-CA 128.094 2.558 . . . . 0.0 109.931 -175.903 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 66.0 tp . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.7 p -98.76 156.58 16.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.906 0.882 . . . . 0.0 110.297 -169.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -131.22 169.31 16.12 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.724 1.61 . . . . 0.0 109.21 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -125.02 152.97 43.55 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.428 1.091 . . . . 0.0 109.567 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -149.75 138.29 20.76 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.447 0.699 . . . . 0.0 110.115 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.83 124.18 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 172.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.4 mt -119.81 120.17 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -75.86 126.87 31.84 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.8 mt -122.13 111.41 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.639 1.176 . . . . 0.0 108.014 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -99.61 147.61 25.19 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.21 2.02 51.19 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.279 0.942 . . . . 0.0 112.885 -177.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.8 mtm -76.59 81.25 3.25 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.688 1.244 . . . . 0.0 108.624 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.8 m -50.74 -50.99 54.34 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.606 1.562 . . . . 0.0 112.6 -170.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.5 m -141.34 179.32 6.85 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.105 0.962 . . . . 0.0 110.107 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -54.98 -32.14 61.38 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.549 1.14 . . . . 0.0 111.656 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.9 p -54.06 -50.26 67.14 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.786 0.834 . . . . 0.0 111.222 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -59.07 -50.3 74.59 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.755 0.822 . . . . 0.0 110.281 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -53.85 -52.51 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 124.87 1.268 . . . . 0.0 110.922 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -59.22 -46.12 89.31 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.5 1.12 . . . . 0.0 111.142 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.6 m -58.53 -52.87 63.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.177 0.591 . . . . 0.0 110.792 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.1 mt -56.55 -53.65 38.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 123.599 0.76 . . . . 0.0 109.689 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -52.82 -55.51 22.51 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.193 0.997 . . . . 0.0 110.739 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.43 -52.07 53.92 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.161 0.886 . . . . 0.0 112.186 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.8 t -61.01 -56.18 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.268 0.627 . . . . 0.0 110.907 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.7 mm -62.01 -37.11 77.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.259 0.624 . . . . 0.0 111.39 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.0 t -49.45 -40.7 37.88 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 123.763 0.825 . . . . 0.0 112.673 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -89.47 -6.08 56.78 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -171.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -75.07 148.39 84.27 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 119.165 0.893 . . . . 0.0 110.459 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -44.14 133.86 8.72 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.494 3.463 . . . . 0.0 113.707 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.66 -40.57 2.92 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-O 118.959 -0.911 . . . . 0.0 112.674 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.7 t -68.31 134.91 29.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 CA-C-N 117.983 0.892 . . . . 0.0 110.168 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -109.29 -98.67 0.39 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.602 1.161 . . . . 0.0 107.88 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.7 p -87.59 152.41 22.2 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.634 0.774 . . . . 0.0 109.509 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.0 tt -150.56 136.65 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 123.499 0.719 . . . . 0.0 109.224 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.23 101.47 6.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.869 1.267 . . . . 0.0 108.39 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.8 t -96.88 122.93 48.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.9 t -107.02 130.67 54.62 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.793 1.237 . . . . 0.0 110.332 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.3 tp -69.62 -52.39 26.36 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.705 0.802 . . . . 0.0 109.119 170.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.53 -47.51 69.88 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 125.22 1.408 . . . . 0.0 112.114 -176.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -89.25 -9.69 49.74 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.888 0.475 . . . . 0.0 111.457 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.1 m 52.52 56.43 7.68 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.107 1.363 . . . . 0.0 110.783 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -155.65 166.35 33.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.095 0.558 . . . . 0.0 111.191 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.67 115.03 2.49 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.507 2.003 . . . . 0.0 108.707 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.9 m -99.28 98.82 9.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 t -106.24 131.3 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 124.453 1.101 . . . . 0.0 109.693 -170.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -99.04 130.34 45.36 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -150.19 163.27 38.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.119 0.568 . . . . 0.0 111.825 -169.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -98.13 113.84 64.4 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.686 1.195 . . . . 0.0 109.293 172.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -44.45 -36.96 10.26 Favored 'Trans proline' 0 C--N 1.349 0.556 1 C-N-CA 125.356 4.037 . . . . 0.0 115.024 173.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.2 mt -64.5 -36.39 84.06 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.109 0.564 . . . . 0.0 111.789 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.2 mt -100.0 -32.96 10.7 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.12 0.968 . . . . 0.0 112.244 -171.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.3 t -149.35 178.86 8.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.29 0.636 . . . . 0.0 110.093 176.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.9 p -150.21 162.9 26.34 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 124.172 0.989 . . . . 0.0 109.759 -174.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -53.07 -46.94 30.33 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.191 2.594 . . . . 0.0 112.372 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.42 -33.9 76.75 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.016 0.526 . . . . 0.0 112.287 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 98.3 m -67.73 -45.32 75.35 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.376 0.535 . . . . 0.0 110.096 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.5 mt -61.19 -47.33 86.67 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.65 0.78 . . . . 0.0 110.461 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -52.64 -47.04 67.34 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.052 0.941 . . . . 0.0 110.269 171.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.48 -45.82 82.85 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.303 0.954 . . . . 0.0 112.313 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.34 -46.36 83.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.785 0.834 . . . . 0.0 111.35 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.4 mt -62.43 -43.46 98.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.758 0.823 . . . . 0.0 110.08 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.35 -41.7 98.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.293 1.037 . . . . 0.0 110.938 176.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.57 -43.91 97.99 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.968 0.907 . . . . 0.0 111.132 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.9 mtm -59.32 -50.88 72.28 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 117.911 0.323 . . . . 0.0 110.213 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.71 60.84 0.09 OUTLIER Glycine 0 C--N 1.34 0.802 0 C-N-CA 123.519 0.581 . . . . 0.0 111.789 171.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -140.09 141.94 36.12 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 171.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -75.7 91.07 2.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.661 0.784 . . . . 0.0 109.49 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.36 134.8 41.69 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.632 1.173 . . . . 0.0 110.362 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 95.0 m -144.07 133.8 23.71 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.983 1.313 . . . . 0.0 108.369 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.0 mt -64.95 128.48 35.95 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.215 0.606 . . . . 0.0 109.872 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.9 t -99.24 -58.66 1.88 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.9 t70 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 124.932 1.293 . . . . 0.0 107.798 178.39 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 62.6 p -130.3 60.32 1.62 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.614 1.166 . . . . 0.0 107.953 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -95.47 139.6 31.51 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -101.13 142.31 32.76 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.81 0.444 . . . . 0.0 110.244 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -135.81 137.72 41.84 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.418 1.087 . . . . 0.0 109.127 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.3 t -99.96 129.58 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.516 -1.291 . . . . 0.0 107.516 174.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.1 mt -126.04 122.01 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -76.99 124.18 27.4 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.5 mt -117.37 109.14 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 124.989 1.315 . . . . 0.0 107.874 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -99.97 149.81 23.07 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 174.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.35 1.82 56.74 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.072 0.844 . . . . 0.0 113.232 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.0 mtm -74.74 104.58 5.44 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.719 1.26 . . . . 0.0 108.329 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.4 m -55.48 -57.81 10.34 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.268 1.027 . . . . 0.0 111.286 -174.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.6 p -164.0 -164.96 0.93 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.1 0.96 . . . . 0.0 109.395 -176.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -72.44 77.35 1.04 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.504 1.122 . . . . 0.0 110.052 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.1 p -168.72 -54.94 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 126.983 2.113 . . . . 0.0 107.027 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.4 m -58.87 -49.04 79.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.544 1.137 . . . . 0.0 108.73 169.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -49.87 -52.23 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 125.549 1.54 . . . . 0.0 110.331 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -62.48 -45.74 91.65 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.676 0.79 . . . . 0.0 111.009 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -58.69 -53.26 60.38 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.667 0.787 . . . . 0.0 110.774 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.0 mt -55.78 -54.8 22.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 C-N-CA 124.064 0.946 . . . . 0.0 109.402 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.63 -54.49 32.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.73 0.812 . . . . 0.0 110.86 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.68 -53.65 43.51 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.234 0.921 . . . . 0.0 112.514 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.9 t -63.69 -54.75 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 117.41 0.605 . . . . 0.0 110.813 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.78 -37.31 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 118.844 -0.598 . . . . 0.0 110.929 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.4 t -50.14 -34.8 23.45 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.637 0.653 . . . . 0.0 112.564 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -89.64 -10.52 45.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.128 0.971 . . . . 0.0 112.472 -174.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -69.96 146.29 95.04 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 119.011 0.823 . . . . 0.0 110.062 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -46.34 135.6 15.52 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 124.033 3.156 . . . . 0.0 113.101 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.08 -37.32 3.34 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 118.856 -0.969 . . . . 0.0 112.763 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 52.1 t -67.17 141.21 18.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-N 118.302 1.051 . . . . 0.0 110.216 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -116.72 -98.67 0.45 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.895 1.278 . . . . 0.0 108.011 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.4 p -90.2 154.96 19.35 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.535 0.734 . . . . 0.0 109.796 174.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.1 tt -150.85 139.79 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.519 0.727 . . . . 0.0 109.88 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.71 109.49 12.11 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.841 1.256 . . . . 0.0 108.399 174.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.6 125.97 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.9 t -115.57 127.97 55.63 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.86 1.264 . . . . 0.0 110.151 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.8 tp -70.73 -50.47 35.81 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.098 0.959 . . . . 0.0 109.65 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.76 -43.76 69.43 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.019 1.328 . . . . 0.0 111.832 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -89.18 -16.52 31.15 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.162 0.585 . . . . 0.0 111.122 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.0 m 55.21 56.29 6.63 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 125.141 1.376 . . . . 0.0 110.223 -177.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -154.84 168.8 25.69 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.062 0.545 . . . . 0.0 111.475 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.04 115.79 2.41 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 126.101 1.81 . . . . 0.0 108.6 176.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.7 m -99.22 99.1 10.03 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.5 t -106.9 126.71 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 124.791 1.236 . . . . 0.0 109.374 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -90.04 131.57 35.84 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -150.18 165.16 33.72 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.196 0.599 . . . . 0.0 112.022 -172.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -100.69 113.83 65.68 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.348 1.459 . . . . 0.0 108.688 172.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.65 -35.79 17.77 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 125.188 3.925 . . . . 0.0 114.798 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.26 -34.27 77.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.383 0.673 . . . . 0.0 111.73 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.75 -36.22 9.53 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.846 0.858 . . . . 0.0 111.557 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.1 t -147.22 176.74 9.74 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.62 0.645 . . . . 0.0 110.655 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.7 p -148.46 161.25 34.27 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.62 1.168 . . . . 0.0 109.729 -175.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.97 -38.74 59.38 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.42 2.747 . . . . 0.0 112.914 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -65.77 -44.32 86.19 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.482 1.113 . . . . 0.0 110.432 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.4 m -64.54 -45.4 87.31 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.056 0.543 . . . . 0.0 110.374 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.3 mt -63.22 -46.35 87.38 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.025 0.93 . . . . 0.0 110.775 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -52.21 -48.93 64.83 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.885 0.874 . . . . 0.0 109.805 170.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.15 -44.92 83.86 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.301 0.953 . . . . 0.0 112.582 176.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.96 -48.13 77.71 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.728 0.811 . . . . 0.0 111.287 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.6 mt -60.08 -41.43 86.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.916 0.886 . . . . 0.0 109.897 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -64.29 -40.19 95.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.382 0.673 . . . . 0.0 111.008 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.56 -41.9 98.37 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.027 0.931 . . . . 0.0 111.017 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.8 mtp -58.31 -45.3 88.3 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 172.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.39 57.04 0.14 Allowed Glycine 0 C--N 1.34 0.764 0 C-N-CA 123.807 0.718 . . . . 0.0 111.747 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -140.35 139.35 35.36 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.792 0.837 . . . . 0.0 108.763 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -70.64 93.05 0.89 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.726 0.81 . . . . 0.0 109.497 -176.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.5 131.44 45.5 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.75 1.22 . . . . 0.0 109.751 -173.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.0 p -139.25 139.19 37.34 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.857 1.263 . . . . 0.0 108.603 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.61 143.97 57.39 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.83 0.452 . . . . 0.0 110.467 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.3 t -135.87 51.26 2.05 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 116.986 -1.483 . . . . 0.0 109.162 -169.678 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 66.3 tp . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 119.866 -0.112 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.8 p -140.08 152.19 45.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.192 0.997 . . . . 0.0 109.239 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -143.53 160.14 41.16 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.922 1.689 . . . . 0.0 108.554 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -120.03 142.7 48.59 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.099 0.96 . . . . 0.0 109.273 176.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.6 t -135.42 140.77 45.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.315 1.046 . . . . 0.0 109.712 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.9 t -103.54 111.2 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 175.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.6 mt -99.57 123.9 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -82.28 111.85 18.73 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.9 mt -116.48 106.42 20.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 C-N-CA 124.447 1.099 . . . . 0.0 108.071 -171.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -99.92 151.63 21.09 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.035 0.534 . . . . 0.0 109.59 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.52 12.11 56.26 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.489 1.043 . . . . 0.0 113.259 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.4 mtm -78.26 81.13 4.64 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.676 1.238 . . . . 0.0 109.43 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.5 m -63.74 98.34 0.19 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.642 1.177 . . . . 0.0 111.045 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.5 t 71.27 169.27 0.32 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.323 1.449 . . . . 0.0 111.271 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -75.09 74.81 2.27 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.5 m -156.92 -54.24 0.08 Allowed 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 126.771 2.028 . . . . 0.0 106.754 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.7 m -57.54 -47.03 83.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 168.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.5 t -49.59 -51.29 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.386 1.474 . . . . 0.0 110.595 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -62.87 -48.27 79.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.259 0.624 . . . . 0.0 111.232 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.4 p -61.2 -48.29 82.19 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.87 0.468 . . . . 0.0 111.274 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.2 mt -54.23 -59.03 2.38 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 C-N-CA 124.383 1.073 . . . . 0.0 109.488 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -54.63 -48.84 71.77 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.66 0.784 . . . . 0.0 110.642 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.95 -52.87 43.64 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.635 1.112 . . . . 0.0 112.303 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.2 t -67.69 -55.12 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 117.777 0.788 . . . . 0.0 110.697 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.14 -36.71 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.404 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.6 p -54.36 -29.66 49.12 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.127 0.876 . . . . 0.0 112.832 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.47 -7.93 53.98 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.983 0.913 . . . . 0.0 112.269 -176.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -70.7 142.4 88.5 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 119.022 0.828 . . . . 0.0 109.586 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.09 130.9 26.95 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.955 2.437 . . . . 0.0 109.987 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.93 -32.21 7.75 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 118.923 -0.932 . . . . 0.0 112.111 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.8 t -72.08 138.72 21.0 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 CA-C-N 118.396 1.098 . . . . 0.0 109.365 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -108.68 -101.83 0.37 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.7 p -90.29 153.83 20.17 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.566 0.747 . . . . 0.0 109.394 172.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.1 tt -150.18 129.83 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 123.511 0.724 . . . . 0.0 109.235 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -120.86 105.06 10.34 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 125.139 1.376 . . . . 0.0 108.65 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.44 122.49 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.1 t -110.03 128.25 55.31 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.643 1.177 . . . . 0.0 110.284 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.2 tp -67.25 -53.5 29.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.95 0.9 . . . . 0.0 109.277 171.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.34 -47.39 69.41 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.277 1.431 . . . . 0.0 112.039 -175.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -89.19 -8.03 54.42 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 119.043 -0.504 . . . . 0.0 111.605 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.8 m 51.57 56.25 8.17 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.168 1.387 . . . . 0.0 110.932 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.7 p30 -155.22 163.98 39.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.966 0.506 . . . . 0.0 111.217 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.84 113.32 2.44 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.1 m -98.65 94.66 6.78 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 t -101.03 123.81 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 124.362 1.065 . . . . 0.0 109.064 -170.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -95.07 128.93 42.28 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -150.24 174.19 13.11 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.145 0.578 . . . . 0.0 111.702 -170.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -108.41 110.24 61.64 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.541 1.536 . . . . 0.0 109.157 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -42.8 -40.47 8.13 Favored 'Trans proline' 0 C--N 1.348 0.545 1 C-N-CA 125.444 4.096 . . . . 0.0 114.995 173.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.4 mt -63.34 -31.79 73.04 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.753 0.821 . . . . 0.0 111.774 -176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.45 -34.53 9.12 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.426 1.09 . . . . 0.0 111.981 -173.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 t -149.57 158.25 44.0 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.551 0.74 . . . . 0.0 109.762 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 62.2 p -123.04 160.24 50.5 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.553 1.141 . . . . 0.0 110.068 -178.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -48.45 -39.61 36.37 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.54 2.827 . . . . 0.0 112.839 171.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -65.58 -45.14 84.41 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.139 0.975 . . . . 0.0 110.407 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.9 m -60.12 -46.64 88.96 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.219 0.608 . . . . 0.0 110.476 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.6 mt -62.35 -48.15 81.05 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.828 0.851 . . . . 0.0 110.518 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -53.94 -42.1 68.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.642 0.777 . . . . 0.0 110.469 172.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.72 -43.77 86.58 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.311 0.958 . . . . 0.0 112.171 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.88 -44.64 92.43 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.871 0.835 . . . . 0.0 111.429 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.7 mm -63.07 -41.84 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 122.861 0.464 . . . . 0.0 110.567 176.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.53 -41.92 98.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.836 0.854 . . . . 0.0 110.461 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -62.61 -45.72 91.56 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.014 0.926 . . . . 0.0 110.876 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.2 mmm -58.95 -34.74 72.12 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.302 0.641 . . . . 0.0 111.056 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.44 59.11 0.57 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 124.209 0.909 . . . . 0.0 111.655 169.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -140.2 154.57 46.96 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.911 0.884 . . . . 0.0 109.861 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -81.0 88.68 5.92 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.838 0.855 . . . . 0.0 109.558 -174.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.41 129.5 45.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.956 1.302 . . . . 0.0 110.948 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 89.5 m -144.28 128.72 17.96 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.586 1.154 . . . . 0.0 108.547 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.8 mt -62.41 155.5 25.16 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.519 0.728 . . . . 0.0 111.127 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.7 p -77.33 67.79 3.33 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.444 0.698 . . . . 0.0 109.461 171.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 C--O 1.25 1.13 0 CA-C-O 117.181 -1.39 . . . . 0.0 108.801 -177.193 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.369 0.128 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 45.7 p -140.37 120.64 13.92 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.377 1.071 . . . . 0.0 109.259 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -139.37 172.38 12.9 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.219 1.408 . . . . 0.0 109.131 175.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -140.06 142.74 36.14 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.178 0.991 . . . . 0.0 108.943 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 t -137.24 149.64 47.3 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.507 1.123 . . . . 0.0 109.316 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.0 t -110.87 138.12 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 172.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.0 mt -133.27 125.54 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -70.17 130.17 41.35 Favored 'General case' 0 C--N 1.337 0.061 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.2 mt -130.1 113.6 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -117.18 153.76 32.27 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.656 0.782 . . . . 0.0 109.907 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.39 20.44 48.58 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.403 1.001 . . . . 0.0 112.565 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.6 mtm -82.55 96.7 8.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 117.901 0.85 . . . . 0.0 108.911 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.9 p -71.49 100.19 2.18 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 110.091 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 p 55.26 -171.11 0.07 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.805 2.442 . . . . 0.0 114.614 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -52.97 -30.0 32.27 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.9 1.68 . . . . 0.0 112.949 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.9 m -55.22 -55.05 35.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.124 0.97 . . . . 0.0 110.554 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.2 m -65.73 -43.51 88.79 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.226 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -52.22 -54.19 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.111 0.564 . . . . 0.0 109.927 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -61.22 -45.76 93.24 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.158 0.983 . . . . 0.0 111.18 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.6 m -58.35 -53.68 55.56 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.876 0.47 . . . . 0.0 110.99 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.03 -55.53 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.351 1.06 . . . . 0.0 109.722 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -56.81 -50.34 72.66 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.139 0.975 . . . . 0.0 110.937 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.93 -51.96 56.12 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.902 1.239 . . . . 0.0 112.161 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.16 -54.47 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 117.746 0.773 . . . . 0.0 110.223 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.9 mt -65.44 -35.53 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.796 -172.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.0 p -54.2 -30.55 50.18 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.01 0.823 . . . . 0.0 112.519 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -89.58 -11.23 43.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.077 0.951 . . . . 0.0 112.617 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -68.27 144.46 96.71 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 119.193 0.906 . . . . 0.0 109.918 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.75 132.23 34.28 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.054 2.502 . . . . 0.0 110.31 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.17 -35.85 4.6 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-O 119.02 -0.878 . . . . 0.0 112.223 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.76 127.74 31.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 118.09 0.945 . . . . 0.0 109.881 -177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -94.56 -101.41 0.15 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.7 p -90.07 155.75 18.85 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.608 0.763 . . . . 0.0 110.363 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.2 tt -150.62 145.72 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 123.975 0.91 . . . . 0.0 109.772 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.12 141.98 44.21 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.0 t -125.52 117.37 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.691 1.197 . . . . 0.0 108.324 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.7 t -104.62 123.96 48.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.809 1.244 . . . . 0.0 109.818 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.9 tp -73.94 -44.12 56.03 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 124.165 0.986 . . . . 0.0 110.107 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.86 -45.88 74.62 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.582 1.153 . . . . 0.0 111.406 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -89.5 -7.61 54.63 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.607 0.763 . . . . 0.0 111.591 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.3 m 54.49 53.79 10.26 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.949 1.699 . . . . 0.0 111.474 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -160.02 167.23 28.36 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.198 0.599 . . . . 0.0 111.185 -175.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.59 121.84 3.96 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.8 m -99.68 112.94 25.12 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 173.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 t -117.81 122.27 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.701 1.2 . . . . 0.0 108.737 -172.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -89.68 132.51 35.12 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 169.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -150.36 168.31 24.48 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.905 0.482 . . . . 0.0 112.103 -170.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -103.97 111.4 65.14 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 125.181 1.392 . . . . 0.0 109.048 173.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -41.75 -38.28 4.41 Favored 'Trans proline' 0 C--N 1.347 0.495 1 C-N-CA 125.432 4.088 . . . . 0.0 115.312 171.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.8 mt -64.25 -34.03 77.18 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.162 0.585 . . . . 0.0 111.952 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.5 mt -103.82 -33.65 8.82 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.264 1.025 . . . . 0.0 112.333 -171.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.9 t -148.72 176.27 10.51 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.56 0.744 . . . . 0.0 109.801 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.9 p -150.25 163.5 24.12 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 123.891 0.877 . . . . 0.0 110.323 -174.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.42 -46.92 30.33 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.401 2.734 . . . . 0.0 112.986 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -65.73 -35.8 81.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.305 0.642 . . . . 0.0 112.123 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.8 m -67.16 -46.04 75.19 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.165 0.439 . . . . 0.0 110.296 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.7 mt -60.55 -47.11 87.61 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.544 0.737 . . . . 0.0 110.418 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.5 ttp85 -54.77 -46.5 74.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.134 0.973 . . . . 0.0 110.055 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.43 -43.99 93.77 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.503 1.049 . . . . 0.0 112.309 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.44 -46.22 87.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.926 0.863 . . . . 0.0 111.099 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.0 mt -59.92 -45.69 94.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 123.411 0.685 . . . . 0.0 109.639 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -61.28 -41.56 97.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.672 0.789 . . . . 0.0 111.039 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.97 -44.35 96.28 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.499 1.12 . . . . 0.0 111.032 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.6 mtm -57.84 -43.62 85.97 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.513 0.325 . . . . 0.0 110.595 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.67 61.54 0.19 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 123.531 0.586 . . . . 0.0 111.651 169.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -140.08 147.35 40.16 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 173.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -70.13 95.92 1.03 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.5 123.5 47.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.016 1.326 . . . . 0.0 109.937 -173.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.9 p -142.35 142.88 32.52 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.234 1.014 . . . . 0.0 108.542 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.5 mt -64.63 143.06 58.19 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.776 0.43 . . . . 0.0 110.959 -176.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.3 t -122.93 27.85 7.5 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.192 1.397 . . . . 0.0 109.701 175.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.6 t70 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 117.278 -1.344 . . . . 0.0 108.361 -172.191 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 120.389 0.138 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.6 p -140.49 122.21 15.33 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.363 1.065 . . . . 0.0 109.022 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -139.5 163.88 31.36 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.791 1.236 . . . . 0.0 109.307 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.79 140.91 52.52 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.824 1.249 . . . . 0.0 108.44 173.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 t -136.27 135.64 39.14 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.181 0.992 . . . . 0.0 109.529 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.5 t -99.65 124.1 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 171.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.9 mt -120.44 120.14 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -73.74 129.21 37.45 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.7 mt -122.19 108.65 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -99.61 145.87 27.09 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.56 -7.09 53.26 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 118.855 -0.97 . . . . 0.0 113.36 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.9 mtm -57.59 -53.06 62.45 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.938 1.369 . . . . 0.0 110.09 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 m 76.47 -42.23 0.43 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.708 1.603 . . . . 0.0 113.467 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.5 p -144.67 168.29 20.52 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.782 0.833 . . . . 0.0 112.16 -170.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -66.68 -33.06 74.81 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.984 1.314 . . . . 0.0 112.598 -173.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.8 p -66.42 -41.69 88.86 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.508 0.594 . . . . 0.0 110.728 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.6 m -61.97 -50.04 73.71 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.932 0.493 . . . . 0.0 110.297 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.1 t -51.24 -50.26 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.229 1.012 . . . . 0.0 110.85 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -58.17 -50.25 74.19 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.403 1.081 . . . . 0.0 110.681 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.4 m -57.92 -48.34 80.18 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.142 0.577 . . . . 0.0 111.152 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -59.07 -50.46 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.611 0.764 . . . . 0.0 109.548 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -51.52 -56.4 13.59 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.022 0.929 . . . . 0.0 110.106 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.34 -55.0 32.74 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.206 0.908 . . . . 0.0 112.335 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.09 -56.35 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.317 0.647 . . . . 0.0 110.767 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.3 mm -61.41 -37.86 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.215 -175.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.0 t -50.31 -38.21 40.4 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.618 0.645 . . . . 0.0 112.285 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.41 -1.45 58.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.664 0.785 . . . . 0.0 112.717 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -69.94 145.07 93.86 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 119.424 1.011 . . . . 0.0 109.485 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.37 127.8 20.93 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.88 2.387 . . . . 0.0 109.911 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.92 -38.2 3.37 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.126 -0.819 . . . . 0.0 111.713 -176.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.81 140.15 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 118.046 0.923 . . . . 0.0 109.805 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -106.22 -98.79 0.34 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 172.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 53.0 p -90.63 160.07 16.09 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.035 0.934 . . . . 0.0 110.234 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.9 tt -150.27 138.93 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 124.288 1.035 . . . . 0.0 108.454 172.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.57 104.69 10.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.498 1.119 . . . . 0.0 109.205 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -94.8 122.69 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.8 t -109.7 127.01 54.3 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.463 1.105 . . . . 0.0 109.933 -177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.67 -55.92 14.87 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.137 0.975 . . . . 0.0 108.528 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.69 -47.16 63.99 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.414 1.486 . . . . 0.0 112.341 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -89.26 -10.91 45.15 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.954 0.501 . . . . 0.0 111.634 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m 52.87 56.46 7.56 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.188 1.395 . . . . 0.0 110.906 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.1 p30 -155.44 169.73 23.58 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.166 0.587 . . . . 0.0 111.175 -176.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.08 115.43 2.19 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 126.269 1.89 . . . . 0.0 108.714 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.5 m -99.04 96.48 7.84 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.81 129.4 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.516 1.127 . . . . 0.0 109.283 -170.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -99.37 124.12 44.22 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -150.3 172.46 15.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.943 0.497 . . . . 0.0 112.288 -169.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -105.88 110.33 64.0 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.29 1.436 . . . . 0.0 109.468 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -40.84 -41.79 4.1 Favored 'Trans proline' 0 C--N 1.348 0.518 1 C-N-CA 125.432 4.088 . . . . 0.0 115.294 171.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.1 mt -60.56 -35.55 76.31 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.465 0.706 . . . . 0.0 111.866 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.0 -32.18 11.09 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.232 1.013 . . . . 0.0 112.1 -172.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.1 t -150.42 152.73 34.77 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.603 0.638 . . . . 0.0 109.891 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 p -116.36 162.53 25.95 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.535 1.134 . . . . 0.0 109.936 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.09 -39.59 50.92 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.329 2.686 . . . . 0.0 112.65 170.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.2 -39.11 89.42 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.929 0.892 . . . . 0.0 111.596 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 m -63.73 -47.34 81.46 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.927 0.491 . . . . 0.0 110.202 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.2 mt -62.14 -49.17 76.91 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.125 0.97 . . . . 0.0 110.36 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -49.88 -48.12 51.56 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.795 1.238 . . . . 0.0 109.943 170.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.32 -46.95 85.68 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.528 1.061 . . . . 0.0 112.413 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.65 91.55 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.835 0.817 . . . . 0.0 111.29 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -60.62 -44.16 96.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.804 0.842 . . . . 0.0 109.912 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.01 -38.94 92.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.853 0.861 . . . . 0.0 111.153 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.55 -44.08 97.22 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.26 1.024 . . . . 0.0 110.816 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.7 mtm -58.81 -48.84 79.89 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.3 59.76 0.1 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 170.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -140.24 137.59 34.39 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 172.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.33 97.94 1.01 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.542 0.737 . . . . 0.0 109.798 -176.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.86 133.14 44.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.792 1.237 . . . . 0.0 110.184 -174.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.2 m -144.49 138.57 27.7 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.603 1.161 . . . . 0.0 108.369 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -65.4 148.41 51.77 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.732 0.413 . . . . 0.0 110.178 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 t -148.34 46.72 1.05 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.998 0.919 . . . . 0.0 109.566 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.8 t70 . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.251 1.821 . . . . 0.0 110.038 -171.736 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 86.9 mt . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.6 p -98.76 77.91 2.29 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -89.49 151.39 22.01 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.794 0.838 . . . . 0.0 109.302 -174.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.88 149.24 43.67 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.738 0.815 . . . . 0.0 110.428 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -143.85 146.17 32.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.459 1.104 . . . . 0.0 108.999 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 51.2 t -113.3 124.5 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.8 mt -120.32 125.79 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -177.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -70.13 126.86 30.91 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 172.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.4 mt -123.11 95.15 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -99.33 132.48 44.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.32 -27.81 4.41 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -170.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 48.4 mtm -60.99 123.37 17.4 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 117.717 0.758 . . . . 0.0 109.161 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t -141.58 10.87 2.07 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.778 0.831 . . . . 0.0 111.911 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.0 t -165.64 151.59 9.41 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -56.14 -30.91 62.81 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.646 0.778 . . . . 0.0 111.903 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.1 p -50.49 -41.9 53.9 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.469 0.707 . . . . 0.0 111.316 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.2 m -62.41 -49.65 74.63 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.674 0.789 . . . . 0.0 109.661 177.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.8 t -54.6 -58.08 4.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.332 1.053 . . . . 0.0 110.224 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -61.69 -41.76 98.01 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.285 0.634 . . . . 0.0 111.382 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -58.98 -59.13 5.95 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.104 0.561 . . . . 0.0 110.633 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.4 mt -57.78 -55.61 20.55 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 123.52 0.728 . . . . 0.0 109.69 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -55.67 -48.49 74.97 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.572 0.749 . . . . 0.0 110.706 -176.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.94 -53.45 45.35 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.329 0.966 . . . . 0.0 112.225 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.22 -55.63 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 117.709 0.754 . . . . 0.0 110.683 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.5 mm -63.7 -38.22 81.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.514 0.725 . . . . 0.0 111.559 -173.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.5 p -54.98 -30.65 59.76 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.069 0.85 . . . . 0.0 112.553 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.35 -5.98 57.04 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.932 0.893 . . . . 0.0 112.187 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -70.71 142.67 88.76 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 119.017 0.826 . . . . 0.0 109.136 176.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.16 132.49 34.29 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.823 2.349 . . . . 0.0 110.093 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.48 -35.78 4.73 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 118.919 -0.934 . . . . 0.0 112.088 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.27 129.32 33.71 Favored 'Isoleucine or valine' 0 C--N 1.341 0.214 0 CA-C-N 118.074 0.937 . . . . 0.0 109.735 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -100.66 -101.87 0.25 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.55 1.14 . . . . 0.0 108.03 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 74.0 p -87.01 151.62 23.11 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.288 0.635 . . . . 0.0 109.744 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.1 tt -150.4 131.05 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.462 0.705 . . . . 0.0 109.421 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -120.81 105.78 11.05 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.429 1.492 . . . . 0.0 108.717 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.72 125.89 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.2 t -116.16 118.71 33.59 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.685 1.194 . . . . 0.0 110.023 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.59 -49.1 74.68 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.991 0.916 . . . . 0.0 109.834 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.1 -48.55 67.72 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.7 1.2 . . . . 0.0 111.994 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -89.7 -1.86 58.12 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.232 0.613 . . . . 0.0 112.201 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.1 m 49.71 52.0 15.41 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.318 1.447 . . . . 0.0 111.579 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -156.21 170.22 22.74 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 120.968 0.413 . . . . 0.0 111.664 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.58 119.28 2.55 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 125.607 1.575 . . . . 0.0 109.232 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.5 m -99.32 104.49 16.4 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.6 t -112.04 128.57 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.532 1.133 . . . . 0.0 109.574 -170.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -98.79 133.33 43.26 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -150.43 164.87 34.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.66 0.784 . . . . 0.0 111.844 -170.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -102.27 116.57 62.82 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.337 1.055 . . . . 0.0 109.498 173.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.71 -40.29 18.88 Favored 'Trans proline' 0 C--N 1.349 0.586 1 C-N-CA 125.348 4.032 . . . . 0.0 115.468 177.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.9 mt -67.11 -27.72 67.56 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.197 0.599 . . . . 0.0 111.949 -174.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.68 -42.05 7.04 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.078 0.951 . . . . 0.0 110.707 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.4 t -148.73 174.81 11.79 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.62 0.768 . . . . 0.0 110.001 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.3 p -150.56 164.37 20.7 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 124.563 1.145 . . . . 0.0 110.439 -170.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.25 -45.58 38.39 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.134 2.556 . . . . 0.0 112.79 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -67.32 -38.78 85.49 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.396 0.679 . . . . 0.0 112.806 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.3 p -66.0 -46.37 78.24 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.724 0.693 . . . . 0.0 110.438 176.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.6 mt -62.1 -46.43 89.08 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.752 0.821 . . . . 0.0 110.428 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -53.5 -45.36 69.64 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.159 0.984 . . . . 0.0 110.47 171.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.4 -47.04 91.0 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.076 0.846 . . . . 0.0 112.114 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.05 -51.95 65.92 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.473 0.709 . . . . 0.0 111.059 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.8 mt -57.57 -41.84 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.016 0.926 . . . . 0.0 109.9 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -59.0 -50.52 73.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.355 0.662 . . . . 0.0 109.749 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -58.25 -38.74 77.5 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.772 1.229 . . . . 0.0 112.0 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mtp -60.81 -20.95 62.59 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.98 57.12 0.52 Allowed Glycine 0 C--N 1.34 0.784 0 C-N-CA 124.306 0.955 . . . . 0.0 111.151 170.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -140.6 155.47 46.56 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.27 1.028 . . . . 0.0 109.46 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -80.39 93.75 6.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 169.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.42 117.57 34.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.698 1.199 . . . . 0.0 108.862 -176.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.4 p -140.06 136.52 33.72 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.21 1.004 . . . . 0.0 109.054 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.69 138.85 58.63 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.84 0.456 . . . . 0.0 110.813 -175.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.24 -52.25 3.73 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.549 1.139 . . . . 0.0 108.206 171.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 116.931 -1.509 . . . . 0.0 108.335 -179.664 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 111.213 0.079 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.6 p -140.52 130.87 25.18 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.408 1.083 . . . . 0.0 109.618 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -143.4 164.37 30.48 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.535 1.134 . . . . 0.0 109.454 171.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -123.98 154.65 39.52 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.873 1.269 . . . . 0.0 109.652 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 t -150.14 144.74 25.89 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.779 0.832 . . . . 0.0 109.981 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.7 t -109.27 115.75 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.3 mt -110.51 118.13 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -76.04 121.89 23.43 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.1 mt -118.15 110.11 29.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 124.747 1.219 . . . . 0.0 108.097 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -99.8 148.04 24.84 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.58 3.67 56.2 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.511 1.053 . . . . 0.0 113.531 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.6 mtm -71.13 87.0 0.77 Allowed 'General case' 0 C--N 1.344 0.362 0 CA-C-N 118.825 1.313 . . . . 0.0 109.767 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.1 m -79.54 99.0 7.08 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.217 1.007 . . . . 0.0 109.58 -174.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 t 73.74 163.45 0.27 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.728 1.611 . . . . 0.0 111.712 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -71.07 73.33 0.62 Allowed 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.703 1.201 . . . . 0.0 109.708 173.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.5 m -162.33 -52.13 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 127.654 2.381 . . . . 0.0 106.477 -176.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.0 m -61.03 -49.17 78.47 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 168.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 82.7 t -49.71 -51.64 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.221 1.408 . . . . 0.0 110.279 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -60.33 -48.66 80.77 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.092 0.957 . . . . 0.0 111.125 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.7 p -62.19 -47.81 82.84 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 122.848 0.459 . . . . 0.0 111.371 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.2 mt -55.35 -60.58 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 123.715 0.806 . . . . 0.0 108.953 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -53.24 -48.5 68.17 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.772 0.829 . . . . 0.0 110.959 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.08 -57.78 16.79 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.241 0.925 . . . . 0.0 111.925 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.49 -53.13 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 117.624 0.712 . . . . 0.0 110.929 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.9 -45.76 91.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.618 0.767 . . . . 0.0 110.738 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 88.0 p -57.73 -27.46 63.0 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -88.9 -5.51 57.95 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.43 0.692 . . . . 0.0 111.891 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -78.83 123.18 85.3 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 119.084 0.856 . . . . 0.0 109.026 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.74 116.94 2.64 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.696 2.931 . . . . 0.0 112.075 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.47 -44.51 1.15 Allowed Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.9 t -70.8 130.4 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 117.453 0.626 . . . . 0.0 109.718 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -96.82 -100.79 0.18 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.974 1.31 . . . . 0.0 107.529 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.4 p -90.23 156.83 18.03 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.38 0.672 . . . . 0.0 110.004 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.6 tt -150.58 145.52 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.7 0.8 . . . . 0.0 110.217 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -133.97 104.92 6.47 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.923 1.289 . . . . 0.0 107.571 169.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.2 t -89.8 97.86 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.8 t -89.75 123.08 33.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.835 0.854 . . . . 0.0 109.469 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.1 tp -70.82 -49.34 47.4 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.792 0.837 . . . . 0.0 110.092 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.69 -46.17 74.07 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.0 1.32 . . . . 0.0 112.054 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -89.22 -6.79 56.6 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.745 0.818 . . . . 0.0 111.319 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 m 52.55 54.25 10.94 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.85 1.66 . . . . 0.0 111.389 176.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -156.52 150.08 24.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.342 0.592 . . . . 0.0 112.282 -175.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -94.7 108.71 3.72 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 170.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -98.76 95.74 7.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 175.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 t -108.81 134.19 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.517 1.127 . . . . 0.0 109.879 -169.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -105.27 132.71 51.13 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 168.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -150.36 170.9 17.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.079 0.552 . . . . 0.0 111.384 -169.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -102.8 111.43 64.88 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.056 1.342 . . . . 0.0 109.241 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -41.75 -40.03 5.37 Favored 'Trans proline' 0 C--N 1.347 0.454 1 C-N-CA 125.618 4.212 . . . . 0.0 115.047 172.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.1 mt -61.93 -33.38 74.16 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.612 0.765 . . . . 0.0 111.829 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.0 mt -102.87 -38.13 7.53 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.478 1.111 . . . . 0.0 111.919 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 t -147.12 174.16 11.83 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.592 0.757 . . . . 0.0 110.1 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.7 p -150.21 162.89 26.37 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.113 0.965 . . . . 0.0 110.02 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -52.62 -43.55 54.36 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.659 2.906 . . . . 0.0 113.186 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -64.29 -36.83 85.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.551 0.74 . . . . 0.0 112.103 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.0 m -68.57 -46.41 69.48 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.019 0.527 . . . . 0.0 109.884 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.3 mt -61.0 -46.83 89.17 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.166 0.986 . . . . 0.0 110.307 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -54.63 -44.7 73.39 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.171 0.988 . . . . 0.0 110.296 172.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.13 -44.64 93.07 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.247 0.927 . . . . 0.0 112.245 175.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.06 -49.31 75.02 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.542 0.737 . . . . 0.0 111.229 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.4 mt -61.85 -39.39 83.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.913 0.885 . . . . 0.0 110.028 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.46 -48.52 80.75 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.6 0.76 . . . . 0.0 109.859 176.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.27 -40.67 86.8 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.561 1.144 . . . . 0.0 111.43 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.8 mmm -60.98 -19.63 61.4 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.607 0.763 . . . . 0.0 112.163 173.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.15 53.53 0.95 Allowed Glycine 0 C--N 1.34 0.796 0 C-N-CA 124.411 1.005 . . . . 0.0 111.699 169.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -140.52 156.2 46.39 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.86 0.864 . . . . 0.0 110.273 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -82.88 87.14 6.84 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.23 124.74 44.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.606 1.162 . . . . 0.0 109.936 -173.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.9 p -139.99 140.18 36.21 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.685 1.194 . . . . 0.0 108.79 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.9 mt -67.58 135.11 52.4 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 t -80.91 70.29 7.68 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 116.894 -1.527 . . . . 0.0 110.505 -174.476 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 57.9 tp . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 110.725 -0.102 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 87.9 m -140.32 143.32 35.75 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.463 1.105 . . . . 0.0 108.444 172.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -137.1 164.77 27.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.695 1.598 . . . . 0.0 108.294 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -102.58 143.27 32.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.211 1.004 . . . . 0.0 109.354 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -137.26 142.44 41.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.46 124.83 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.0 mt -121.09 120.5 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -77.29 120.76 22.77 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.3 mt -122.35 106.85 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.745 1.218 . . . . 0.0 107.881 -173.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -99.6 146.91 25.93 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.83 -12.61 17.7 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.55 1.071 . . . . 0.0 112.108 -172.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 44.6 mtm -77.28 76.63 3.82 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 118.382 1.091 . . . . 0.0 109.56 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.4 m -65.28 -48.82 71.84 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.02 0.928 . . . . 0.0 111.601 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.2 t -117.14 157.25 26.25 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.806 1.242 . . . . 0.0 110.409 -171.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -48.95 -36.91 18.55 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.663 1.185 . . . . 0.0 111.644 171.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -50.05 -42.74 50.31 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.433 1.093 . . . . 0.0 112.004 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.3 m -61.24 -59.1 5.83 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.375 0.67 . . . . 0.0 109.394 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -50.01 -51.3 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.23 1.412 . . . . 0.0 111.194 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -59.79 -53.19 60.81 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.272 1.429 . . . . 0.0 111.079 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.3 p -60.24 -49.34 77.99 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.026 0.53 . . . . 0.0 111.072 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.3 mt -53.46 -57.21 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.195 0.998 . . . . 0.0 109.943 177.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -53.39 -52.38 59.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.921 0.888 . . . . 0.0 110.844 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.08 -54.2 38.74 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.844 0.735 . . . . 0.0 112.312 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.16 -54.71 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.373 1.069 . . . . 0.0 110.876 -176.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.2 mm -61.75 -34.72 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.874 0.87 . . . . 0.0 111.262 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t -53.73 -19.47 4.23 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -89.25 -12.67 40.07 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.929 0.786 . . . . 0.0 112.392 -175.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -74.58 143.55 79.17 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 118.783 0.719 . . . . 0.0 110.131 -172.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.27 130.35 25.2 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.061 2.508 . . . . 0.0 109.772 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.04 -39.61 2.8 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 118.926 -0.93 . . . . 0.0 111.419 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.59 123.65 20.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 CA-C-N 118.069 0.935 . . . . 0.0 109.139 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -93.26 -102.65 0.13 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.4 p -90.26 155.99 18.6 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.907 0.883 . . . . 0.0 109.706 171.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.1 tt -150.32 141.08 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.652 0.781 . . . . 0.0 109.586 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -135.52 131.78 36.46 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.91 0.884 . . . . 0.0 108.769 169.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -115.82 133.73 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.9 t -112.56 133.46 54.6 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.932 1.293 . . . . 0.0 110.702 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.18 -56.7 5.54 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 170.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.55 -47.78 63.31 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.339 1.456 . . . . 0.0 112.335 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -89.25 -10.36 47.24 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.577 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m 52.03 56.29 7.99 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.02 1.328 . . . . 0.0 110.867 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -156.5 164.39 38.28 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.054 0.542 . . . . 0.0 111.102 -176.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.75 113.57 2.41 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 126.18 1.847 . . . . 0.0 108.825 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.9 m -99.4 107.88 20.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.34 130.22 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.453 1.101 . . . . 0.0 109.583 -170.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -93.65 127.73 39.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 168.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -149.1 155.48 40.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.827 0.451 . . . . 0.0 110.959 -169.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -95.15 115.22 65.21 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.282 1.033 . . . . 0.0 109.288 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.26 -36.38 17.02 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.861 3.708 . . . . 0.0 114.653 172.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.6 mt -66.06 -29.28 69.59 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.472 0.709 . . . . 0.0 112.099 -176.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.0 mt -108.73 -33.27 7.03 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.23 1.012 . . . . 0.0 112.26 -172.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.0 t -147.32 -179.83 7.12 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.566 0.746 . . . . 0.0 109.849 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.6 p -149.82 162.09 29.3 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 123.732 0.813 . . . . 0.0 110.125 -176.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -51.9 -40.0 67.51 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.402 2.734 . . . . 0.0 112.18 173.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.92 -46.91 79.67 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.288 1.035 . . . . 0.0 110.949 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.8 m -60.02 -47.32 86.34 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.052 0.541 . . . . 0.0 110.406 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.96 -50.45 73.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.843 0.857 . . . . 0.0 110.52 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.1 ttp85 -50.72 -46.76 59.18 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.149 0.98 . . . . 0.0 110.487 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.69 -46.77 81.34 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.137 0.875 . . . . 0.0 112.114 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.24 -47.01 86.3 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.664 0.732 . . . . 0.0 111.486 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 mm -58.51 -44.51 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.222 0.609 . . . . 0.0 110.24 175.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.51 -38.28 90.53 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.143 0.577 . . . . 0.0 110.927 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.27 -43.67 94.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.016 0.926 . . . . 0.0 110.947 176.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 90.6 mtp -59.0 -41.42 87.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 117.978 0.354 . . . . 0.0 110.441 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.26 56.45 0.22 Allowed Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.092 0.853 . . . . 0.0 111.862 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -140.27 139.75 35.6 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -74.02 96.33 2.66 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.467 0.707 . . . . 0.0 109.447 -175.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.95 132.72 45.14 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.96 1.304 . . . . 0.0 110.582 -173.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.9 p -138.24 134.95 35.05 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.079 1.352 . . . . 0.0 108.795 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.6 mt -69.14 132.51 46.67 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.701 0.4 . . . . 0.0 110.401 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.43 -51.72 4.05 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 172.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 p30 . . . . . 0 C--O 1.25 1.12 0 C-N-CA 125.475 1.51 . . . . 0.0 108.854 176.344 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 58.7 tp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 110.783 -0.08 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.7 p -99.66 131.88 45.36 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.647 0.779 . . . . 0.0 110.252 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -93.06 157.32 16.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.638 1.575 . . . . 0.0 107.986 170.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.52 143.1 34.16 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.749 0.82 . . . . 0.0 109.258 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -139.46 144.66 38.11 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.009 0.924 . . . . 0.0 108.913 172.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.4 t -110.54 115.68 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.8 mm -99.84 126.81 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -77.51 113.89 15.79 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 170.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.9 mt -116.35 98.0 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -176.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -99.85 158.38 15.84 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.03 13.82 60.05 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.818 0.723 . . . . 0.0 112.902 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 68.0 mtm -79.17 85.37 5.06 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 171.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.6 p -59.48 -50.99 71.79 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.688 0.795 . . . . 0.0 112.001 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.3 m -133.35 171.4 14.1 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.337 1.055 . . . . 0.0 110.322 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -58.34 -25.19 61.68 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.186 0.994 . . . . 0.0 111.968 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -50.47 -47.37 57.07 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.608 0.763 . . . . 0.0 110.713 171.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.3 m -60.22 -50.34 74.06 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.807 0.843 . . . . 0.0 110.006 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.3 t -52.76 -54.86 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.74 1.216 . . . . 0.0 110.347 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -60.11 -46.27 90.18 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.301 1.041 . . . . 0.0 111.586 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -57.88 -48.86 78.6 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.675 0.39 . . . . 0.0 111.199 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.0 mt -59.81 -59.41 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.19 0.596 . . . . 0.0 109.948 -177.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.95 -43.52 86.42 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.102 0.41 . . . . 0.0 111.166 -176.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.31 -54.82 29.82 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.814 0.721 . . . . 0.0 112.023 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.21 -53.89 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.322 0.649 . . . . 0.0 110.792 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.4 mm -62.79 -35.42 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.729 -172.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.0 m -53.3 -30.25 37.77 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.86 0.754 . . . . 0.0 112.77 174.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 -6.7 56.24 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.498 0.719 . . . . 0.0 112.052 -175.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -72.82 143.13 84.07 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 118.859 0.754 . . . . 0.0 109.314 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.84 135.9 54.43 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.931 2.421 . . . . 0.0 110.025 -176.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.39 -40.07 2.62 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-O 118.888 -0.951 . . . . 0.0 111.525 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -67.66 134.83 29.59 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 CA-C-N 118.068 0.934 . . . . 0.0 109.797 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -112.8 -89.5 0.52 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.8 p -90.75 154.49 19.49 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.884 0.874 . . . . 0.0 110.38 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.5 tt -150.61 148.8 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.666 1.186 . . . . 0.0 108.744 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -135.65 106.3 6.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.781 0.833 . . . . 0.0 109.201 174.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.8 t -94.49 100.49 11.21 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 C-N-CA 124.015 0.926 . . . . 0.0 109.307 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.4 t -89.54 120.19 30.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.974 0.91 . . . . 0.0 109.7 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.9 tp -69.98 -47.11 63.54 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.474 1.109 . . . . 0.0 110.042 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.01 -44.47 67.32 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.768 1.227 . . . . 0.0 111.682 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -89.29 -14.73 35.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.404 0.681 . . . . 0.0 111.3 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.1 m 55.52 54.76 8.05 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 125.403 1.481 . . . . 0.0 110.665 -177.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.5 p30 -153.17 158.47 41.84 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.028 0.531 . . . . 0.0 111.619 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.58 114.55 3.17 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 126.052 1.787 . . . . 0.0 108.92 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.3 m -98.9 97.14 8.35 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.67 134.14 44.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 C-N-CA 124.829 1.252 . . . . 0.0 109.704 -170.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -105.19 116.99 32.88 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 172.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -145.9 153.17 40.55 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.602 0.761 . . . . 0.0 111.842 -169.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -88.16 120.49 70.62 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 123.673 0.789 . . . . 0.0 110.163 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -47.8 -39.33 31.23 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.997 3.798 . . . . 0.0 115.457 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.4 mt -67.67 -28.77 67.98 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.882 0.473 . . . . 0.0 111.809 -174.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.61 -34.76 10.09 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.797 0.839 . . . . 0.0 111.091 -174.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 t -151.83 171.03 18.38 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.631 0.65 . . . . 0.0 110.2 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.6 p -138.89 162.68 51.3 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.757 1.223 . . . . 0.0 109.996 -175.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -50.99 -43.12 49.6 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.492 2.795 . . . . 0.0 112.573 174.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -62.48 -43.3 99.15 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.891 0.876 . . . . 0.0 111.739 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.5 m -64.15 -47.55 79.44 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.991 0.359 . . . . 0.0 110.299 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.8 mt -59.46 -50.61 73.25 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.985 0.914 . . . . 0.0 110.318 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 -51.5 -46.69 63.29 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.54 1.136 . . . . 0.0 110.297 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.75 -47.04 91.34 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.6 1.095 . . . . 0.0 112.184 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.57 -45.35 93.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.507 0.723 . . . . 0.0 111.273 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -62.75 -43.69 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.714 0.806 . . . . 0.0 109.876 178.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -59.47 -46.59 88.36 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.683 0.793 . . . . 0.0 110.035 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -59.24 -42.83 92.0 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.494 1.118 . . . . 0.0 111.562 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 71.7 mtm -57.66 -45.81 85.07 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 118.025 0.375 . . . . 0.0 110.687 173.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.47 63.05 0.12 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 170.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -140.28 158.5 43.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.902 0.881 . . . . 0.0 109.385 174.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -79.33 87.21 5.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.28 118.72 36.57 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.552 1.141 . . . . 0.0 109.835 -173.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.2 p -138.19 149.87 46.23 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.783 1.233 . . . . 0.0 108.683 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 29.3 mt -73.78 129.61 38.28 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.159 0.436 . . . . 0.0 110.056 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 t -89.49 -51.85 5.33 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--O 1.251 1.146 0 C-N-CA 125.311 1.444 . . . . 0.0 109.186 177.912 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 61.0 tp . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.8 p -106.02 123.78 48.53 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.52 1.128 . . . . 0.0 110.266 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -136.5 159.14 42.67 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.108 1.363 . . . . 0.0 107.646 169.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -140.27 147.08 39.43 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.511 0.724 . . . . 0.0 109.975 -177.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.8 t -142.23 153.11 43.71 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.371 1.068 . . . . 0.0 109.918 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.35 115.81 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 173.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.4 mt -106.12 124.94 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -80.14 118.67 22.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.6 mt -116.06 102.53 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -174.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -99.55 142.65 30.74 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.21 19.55 27.94 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.554 1.073 . . . . 0.0 113.142 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 68.5 mtm -79.58 69.04 5.79 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.618 1.209 . . . . 0.0 109.261 174.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.9 m -67.43 104.07 1.45 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.171 0.988 . . . . 0.0 109.607 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.5 t 79.92 148.47 0.09 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.725 2.01 . . . . 0.0 111.386 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -51.31 -24.7 4.85 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.005 1.722 . . . . 0.0 113.441 176.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.3 m -50.67 -44.69 57.81 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.816 0.846 . . . . 0.0 111.601 173.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.5 m -62.58 -50.87 69.56 Favored 'General case' 0 C--N 1.338 0.104 0 C-N-CA 123.689 0.796 . . . . 0.0 110.287 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.1 t -53.44 -49.86 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.188 0.995 . . . . 0.0 110.706 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -57.74 -45.54 85.71 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.958 0.903 . . . . 0.0 111.406 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.7 m -59.67 -53.81 53.73 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.822 0.449 . . . . 0.0 110.856 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -57.73 -51.33 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.604 1.162 . . . . 0.0 109.797 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -49.8 -58.52 5.19 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.859 1.664 . . . . 0.0 110.232 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.95 -55.05 32.68 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.063 0.839 . . . . 0.0 112.141 -177.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.22 -55.3 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.428 0.691 . . . . 0.0 110.79 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.6 mt -68.09 -34.68 68.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 119.145 -0.455 . . . . 0.0 111.344 -173.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -54.72 -27.42 40.63 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 174.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -89.69 -8.3 52.68 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.441 0.697 . . . . 0.0 112.522 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -72.91 141.54 81.95 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 119.171 0.896 . . . . 0.0 110.019 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.95 131.05 27.6 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.146 2.564 . . . . 0.0 110.265 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.67 -34.28 5.91 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-O 118.897 -0.946 . . . . 0.0 112.137 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.07 121.55 16.39 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 CA-C-N 118.178 0.989 . . . . 0.0 109.536 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -91.58 -101.5 0.11 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.366 1.066 . . . . 0.0 108.221 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.1 p -88.57 141.46 28.51 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.6 tt -141.69 138.31 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.04 111.07 6.95 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.042 1.337 . . . . 0.0 108.017 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.5 t -104.48 120.99 55.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 124.778 1.231 . . . . 0.0 108.462 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.8 t -103.08 129.03 49.78 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.749 1.22 . . . . 0.0 110.806 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.57 -56.7 9.54 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.369 1.067 . . . . 0.0 108.131 169.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.42 -48.72 62.59 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.452 1.501 . . . . 0.0 112.466 -175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -89.23 -5.03 57.97 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.883 0.473 . . . . 0.0 111.662 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.2 m 51.3 54.63 10.79 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.244 1.418 . . . . 0.0 111.341 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -156.78 160.09 38.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.017 0.437 . . . . 0.0 111.363 -176.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.06 114.23 3.15 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 126.307 1.908 . . . . 0.0 108.391 174.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.1 m -99.0 109.61 22.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 t -118.53 123.12 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.477 1.111 . . . . 0.0 109.198 -169.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -96.74 132.3 42.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 168.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -150.33 169.87 20.36 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.967 0.507 . . . . 0.0 112.155 -169.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.25 113.43 65.87 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.334 1.454 . . . . 0.0 109.68 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -45.67 -41.13 19.19 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 125.292 3.994 . . . . 0.0 115.637 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.5 mt -68.27 -29.0 67.69 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.836 0.454 . . . . 0.0 111.752 -174.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.2 mt -99.78 -35.31 9.83 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.385 1.074 . . . . 0.0 111.647 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -152.03 171.27 18.11 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.607 0.763 . . . . 0.0 109.76 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.3 p -148.15 164.71 20.84 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.739 1.216 . . . . 0.0 109.952 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.18 -38.91 81.77 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.298 2.665 . . . . 0.0 112.196 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -59.86 -52.4 65.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.236 1.014 . . . . 0.0 110.804 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.1 p -63.77 -40.78 97.5 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 122.882 0.473 . . . . 0.0 111.426 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.1 mt -66.26 -45.99 78.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.185 0.594 . . . . 0.0 110.391 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -54.77 -48.46 72.62 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.805 0.842 . . . . 0.0 109.608 171.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.36 -44.98 58.74 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.461 1.029 . . . . 0.0 112.628 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.56 -48.06 76.44 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.635 0.774 . . . . 0.0 111.057 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.5 mt -59.7 -45.03 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.556 0.743 . . . . 0.0 109.906 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.7 -42.82 97.97 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.39 1.076 . . . . 0.0 110.861 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.35 -43.97 97.57 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.034 0.934 . . . . 0.0 111.111 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.4 mtp -59.17 -40.56 86.01 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.797 0.439 . . . . 0.0 110.601 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.23 58.06 0.24 Allowed Glycine 0 C--N 1.34 0.792 0 C-N-CA 123.913 0.768 . . . . 0.0 111.856 169.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -140.26 148.7 41.85 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 124.018 0.927 . . . . 0.0 108.993 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -74.48 95.61 2.77 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -177.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 130.09 45.99 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.107 1.363 . . . . 0.0 110.218 -175.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 t -150.02 135.5 18.23 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.157 0.583 . . . . 0.0 109.765 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.7 mt -64.86 150.2 48.11 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.266 0.626 . . . . 0.0 110.246 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.9 m -79.93 63.14 4.37 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 170.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.0 t70 . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.963 -1.494 . . . . 0.0 108.705 -176.46 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 N--CA 1.476 0.856 0 CA-C-O 120.565 0.221 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 42.9 p -140.12 126.13 19.67 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.475 1.11 . . . . 0.0 108.467 176.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -143.12 166.12 25.55 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.004 1.321 . . . . 0.0 109.381 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -122.11 155.57 35.44 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.837 1.255 . . . . 0.0 109.007 173.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 t -150.17 133.73 16.6 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 122.795 0.438 . . . . 0.0 109.825 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.8 t -99.71 99.01 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 124.825 1.25 . . . . 0.0 107.714 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.7 mt -99.85 114.45 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -75.22 132.68 41.27 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.2 mt -126.7 108.27 18.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 125.026 1.33 . . . . 0.0 107.773 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.89 139.87 34.94 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.69 7.09 26.17 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.023 1.297 . . . . 0.0 113.416 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.2 mtm -78.77 106.17 10.58 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.845 1.322 . . . . 0.0 109.921 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.5 p -78.88 90.2 4.71 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.26 0.624 . . . . 0.0 111.21 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.7 t 69.29 -81.09 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.798 2.039 . . . . 0.0 113.778 169.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -138.7 -38.73 0.52 Allowed 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.85 0.86 . . . . 0.0 111.814 -169.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 p -50.01 -54.58 19.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.312 1.045 . . . . 0.0 111.065 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.9 m -68.05 -43.9 77.61 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.811 1.245 . . . . 0.0 111.267 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.7 t -53.29 -50.7 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.039 0.936 . . . . 0.0 110.013 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -61.72 -50.08 73.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.777 1.231 . . . . 0.0 111.355 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.8 p -62.33 -46.27 89.45 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.959 0.345 . . . . 0.0 111.52 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.8 mt -58.13 -53.75 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 C-N-CA 123.748 0.819 . . . . 0.0 109.106 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -50.56 -57.7 7.54 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.873 0.869 . . . . 0.0 110.188 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.91 -56.8 23.02 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.992 0.806 . . . . 0.0 112.281 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.5 t -62.05 -53.82 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 117.305 0.552 . . . . 0.0 111.086 -174.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.8 mm -61.66 -36.97 76.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.915 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.8 t -54.25 -29.29 46.27 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.779 0.718 . . . . 0.0 112.611 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.1 mtmt -89.61 -14.89 33.97 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.848 0.859 . . . . 0.0 112.852 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -64.28 143.52 98.41 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 119.577 1.081 . . . . 0.0 110.228 174.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.24 142.13 78.5 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.153 2.568 . . . . 0.0 110.276 -175.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.67 -30.45 6.51 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.694 -1.059 . . . . 0.0 112.41 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.73 131.78 34.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 118.629 1.215 . . . . 0.0 109.739 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -90.05 -105.09 0.09 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 172.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.3 p -91.08 165.8 13.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.873 1.269 . . . . 0.0 110.382 169.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -147.96 132.6 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.472 1.109 . . . . 0.0 108.024 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.3 105.9 13.06 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.7 t -98.24 119.24 46.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.812 0.845 . . . . 0.0 108.926 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.4 t -109.47 125.49 52.5 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.851 1.26 . . . . 0.0 110.089 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.52 -52.25 41.2 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.327 1.051 . . . . 0.0 109.007 171.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.97 -46.07 68.08 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.3 1.44 . . . . 0.0 112.2 -176.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -89.25 -7.69 54.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.128 0.571 . . . . 0.0 111.425 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 m 52.76 54.22 10.88 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.8 1.64 . . . . 0.0 110.868 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -156.21 168.06 28.48 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.132 0.491 . . . . 0.0 111.502 -175.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.93 117.33 2.98 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 107.537 -2.225 . . . . 0.0 107.537 172.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.7 p -98.74 102.43 14.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.3 t -99.21 127.26 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -169.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -94.2 127.24 39.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 170.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -150.71 170.76 18.43 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -169.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -105.97 112.04 64.35 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.21 1.404 . . . . 0.0 109.183 173.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -42.74 -39.61 7.42 Favored 'Trans proline' 0 C--N 1.348 0.519 1 C-N-CA 125.443 4.095 . . . . 0.0 115.181 172.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.35 -35.79 80.24 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.334 0.654 . . . . 0.0 111.78 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.6 mt -99.96 -32.76 10.81 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.301 1.041 . . . . 0.0 112.181 -171.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.1 t -150.77 168.5 24.21 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.637 0.653 . . . . 0.0 110.28 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.3 p -136.07 159.49 70.79 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.746 1.218 . . . . 0.0 110.103 -176.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.42 -39.91 44.52 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.674 2.916 . . . . 0.0 113.163 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.01 -39.42 83.18 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.806 0.842 . . . . 0.0 111.78 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.8 m -65.26 -46.67 79.59 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.672 0.389 . . . . 0.0 109.985 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.6 mt -62.6 -46.67 87.22 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.325 1.05 . . . . 0.0 110.577 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -51.89 -47.02 64.74 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.568 1.147 . . . . 0.0 109.869 170.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.54 -44.61 90.64 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.321 0.962 . . . . 0.0 112.328 176.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.23 -43.59 90.94 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.742 0.771 . . . . 0.0 111.389 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.6 mt -64.82 -38.65 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.744 0.818 . . . . 0.0 110.004 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.95 -40.86 95.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.618 0.767 . . . . 0.0 110.53 176.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.08 -42.93 99.73 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.995 0.918 . . . . 0.0 110.862 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.5 mmm -56.22 -39.66 72.83 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.214 0.606 . . . . 0.0 110.637 172.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.7 58.37 0.27 Allowed Glycine 0 C--N 1.341 0.816 0 C-N-CA 123.867 0.746 . . . . 0.0 111.967 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -140.41 155.11 46.84 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.896 0.878 . . . . 0.0 109.957 175.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -77.24 94.37 4.12 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.62 124.0 44.42 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.917 1.287 . . . . 0.0 109.526 -175.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 48.0 p -141.87 143.77 33.51 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.415 1.086 . . . . 0.0 109.124 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -68.71 133.35 48.27 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.7 t -69.08 -42.01 76.75 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.46 0.304 . . . . 0.0 110.861 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.209 -1.377 . . . . 0.0 108.524 179.085 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 . . . . . 0 CA--C 1.528 0.12 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.85 153.97 21.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.162 0.985 . . . . 0.0 110.232 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.2 t -149.94 143.39 25.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.896 0.879 . . . . 0.0 109.149 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.0 t -108.66 124.69 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 173.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.9 mt -121.95 119.53 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -73.5 126.36 30.04 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.2 mt -120.86 110.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.086 1.355 . . . . 0.0 107.675 -176.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -99.9 145.57 27.65 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.438 0.695 . . . . 0.0 109.146 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.08 13.01 47.47 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.648 1.118 . . . . 0.0 113.497 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 C--N 1.343 0.291 0 CA-C-N 118.558 1.179 . . . . 0.0 109.257 177.034 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.6 p . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.203 0.049 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.4 m -63.86 -46.55 84.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.695 0.798 . . . . 0.0 110.598 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -53.4 -53.69 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.293 1.037 . . . . 0.0 110.059 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -60.97 -46.14 91.92 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.858 1.263 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.1 t -57.44 -53.59 56.47 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.534 0.733 . . . . 0.0 110.754 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.6 mt -55.98 -55.27 19.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 C-N-CA 124.083 0.953 . . . . 0.0 109.424 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.89 -53.08 54.26 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.569 0.748 . . . . 0.0 110.932 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.22 -53.37 46.18 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.383 0.992 . . . . 0.0 112.552 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.82 -53.56 46.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 117.579 0.689 . . . . 0.0 110.485 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.3 mm -62.21 -36.64 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 118.814 -0.612 . . . . 0.0 111.024 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.7 t -51.3 -37.12 45.75 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.829 0.741 . . . . 0.0 111.933 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -89.21 -3.62 58.5 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.709 0.804 . . . . 0.0 112.455 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -71.78 142.53 85.9 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 119.352 0.978 . . . . 0.0 109.322 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -46.55 134.41 16.58 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.921 3.081 . . . . 0.0 112.801 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.93 -40.33 2.85 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-O 118.802 -0.999 . . . . 0.0 112.644 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.45 135.42 28.5 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.178 0.989 . . . . 0.0 109.704 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -114.29 -88.42 0.56 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.7 p -90.82 149.85 21.81 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.581 0.752 . . . . 0.0 109.949 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.52 138.19 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 124.035 0.934 . . . . 0.0 109.041 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -130.84 109.09 10.32 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.778 1.231 . . . . 0.0 108.287 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.9 t -98.21 114.61 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 124.002 0.921 . . . . 0.0 108.748 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.1 t -100.61 123.56 44.99 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 124.388 1.075 . . . . 0.0 109.452 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.0 tp -71.93 -44.08 64.21 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.688 0.795 . . . . 0.0 110.019 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.87 -46.88 74.79 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.892 1.277 . . . . 0.0 111.732 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -89.23 -7.06 56.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.209 0.604 . . . . 0.0 111.352 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.3 m 53.05 54.88 9.69 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.774 1.63 . . . . 0.0 111.019 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -155.54 163.58 39.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.986 0.422 . . . . 0.0 111.803 -175.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.24 116.16 3.54 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 126.402 1.954 . . . . 0.0 108.365 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.1 m -99.24 101.56 12.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.5 t -108.38 131.72 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 124.499 1.12 . . . . 0.0 109.521 -170.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -102.24 125.41 48.93 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -146.59 164.82 31.39 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.587 0.755 . . . . 0.0 111.405 -171.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -97.49 115.68 65.77 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.476 1.111 . . . . 0.0 109.277 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -45.94 -38.48 18.48 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 125.255 3.97 . . . . 0.0 115.175 175.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.8 mt -65.59 -28.13 68.92 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.456 0.702 . . . . 0.0 111.839 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.64 -44.09 6.25 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.219 1.007 . . . . 0.0 110.854 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.1 t -144.9 176.21 9.64 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.483 0.713 . . . . 0.0 110.403 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.8 p -149.99 164.63 19.97 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 124.209 1.004 . . . . 0.0 109.864 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.24 -47.08 28.7 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.605 2.87 . . . . 0.0 113.009 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.65 -36.0 82.39 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.468 0.707 . . . . 0.0 112.118 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 m -67.18 -45.65 76.3 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.963 0.505 . . . . 0.0 110.154 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.1 mt -62.21 -46.52 88.5 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.07 0.948 . . . . 0.0 110.443 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -52.5 -47.24 66.73 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.172 0.989 . . . . 0.0 110.052 170.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.75 -45.2 86.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.257 0.932 . . . . 0.0 112.288 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.85 77.43 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 117.677 0.739 . . . . 0.0 111.262 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.8 mt -60.98 -41.99 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.759 0.824 . . . . 0.0 110.076 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.93 -41.32 99.44 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.089 0.956 . . . . 0.0 110.799 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.68 -42.05 99.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.856 0.862 . . . . 0.0 111.094 177.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -58.68 -46.82 86.39 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.98 0.354 . . . . 0.0 110.09 173.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.06 59.13 0.13 Allowed Glycine 0 C--N 1.341 0.815 0 C-N-CA 123.882 0.754 . . . . 0.0 111.735 170.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -140.21 146.55 38.84 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.874 0.87 . . . . 0.0 109.124 174.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -76.13 92.32 3.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.5 131.82 45.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.928 1.291 . . . . 0.0 110.166 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.3 m -143.51 134.01 24.84 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.825 1.25 . . . . 0.0 108.414 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.5 mt . . . . . 0 CA--C 1.53 0.193 0 C-N-CA 123.154 0.582 . . . . 0.0 109.904 -178.708 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 . . . . . 0 CA--C 1.527 0.081 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -122.77 155.83 35.74 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.034 0.934 . . . . 0.0 110.076 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.3 t -150.08 144.71 25.92 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.115 0.966 . . . . 0.0 109.303 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.7 t -107.11 127.67 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 172.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.4 mt -125.65 124.33 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -66.17 132.5 48.61 Favored 'General case' 0 C--N 1.337 0.045 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 172.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.6 mt -127.66 95.36 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -99.82 156.63 17.01 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.363 0.665 . . . . 0.0 109.938 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.41 32.43 34.55 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.913 0.768 . . . . 0.0 112.036 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 96.7 mtp . . . . . 0 N--CA 1.455 -0.19 0 C-N-CA 123.965 0.906 . . . . 0.0 108.585 175.161 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 111.3 0.111 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.1 m -65.91 -48.41 71.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.159 0.584 . . . . 0.0 110.103 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -51.87 -54.42 13.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 123.419 0.688 . . . . 0.0 109.881 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -59.16 -52.9 63.73 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.66 1.184 . . . . 0.0 111.408 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 p -61.15 -53.46 56.72 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.854 0.462 . . . . 0.0 111.387 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 85.0 mt -55.85 -54.79 22.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 123.815 0.846 . . . . 0.0 109.657 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -59.45 -47.01 87.14 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.526 0.33 . . . . 0.0 110.677 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.43 -51.94 53.1 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.314 0.959 . . . . 0.0 112.256 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.73 -55.21 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 117.631 0.716 . . . . 0.0 110.503 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.23 -37.65 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.087 0.555 . . . . 0.0 111.564 -173.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 92.7 p -54.9 -30.48 58.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.786 0.721 . . . . 0.0 112.694 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -89.51 -4.41 57.93 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.906 0.882 . . . . 0.0 112.256 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -70.73 144.84 91.48 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 118.936 0.789 . . . . 0.0 109.205 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -63.71 128.59 22.54 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.019 2.479 . . . . 0.0 110.444 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.56 -32.44 7.57 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-O 118.817 -0.99 . . . . 0.0 112.491 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.8 t -68.62 132.59 32.79 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 CA-C-N 118.276 1.038 . . . . 0.0 109.914 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -106.34 -99.96 0.34 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.999 1.32 . . . . 0.0 108.009 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.5 p -88.64 151.06 22.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.795 0.838 . . . . 0.0 109.365 173.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.7 tt -150.48 131.9 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.293 0.637 . . . . 0.0 109.302 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.94 94.79 4.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.567 1.547 . . . . 0.0 107.747 -175.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.9 t -90.38 125.66 43.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.3 t -118.96 126.93 52.91 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.733 1.213 . . . . 0.0 110.235 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.6 tp -72.45 -47.91 45.19 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.728 1.211 . . . . 0.0 109.455 170.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.99 -46.49 68.31 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.769 1.227 . . . . 0.0 111.591 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -89.42 -11.57 42.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.306 0.642 . . . . 0.0 111.605 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.9 m 53.42 57.65 5.97 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.125 1.37 . . . . 0.0 110.372 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.7 p30 -157.85 171.04 21.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.402 0.681 . . . . 0.0 111.201 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.88 115.84 1.86 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.1 m -99.46 101.99 13.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.9 t -106.73 139.02 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.918 1.287 . . . . 0.0 109.755 -169.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -108.13 130.28 55.12 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 168.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -150.62 169.0 22.6 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.933 0.493 . . . . 0.0 112.05 -170.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.66 112.86 65.29 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.469 1.507 . . . . 0.0 109.531 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -43.29 -42.74 10.33 Favored 'Trans proline' 0 C--N 1.347 0.456 1 C-N-CA 125.696 4.264 . . . . 0.0 115.872 176.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.0 mt -68.26 -28.85 67.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.645 0.378 . . . . 0.0 111.956 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.9 mt -99.71 -33.91 10.4 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.204 1.002 . . . . 0.0 111.801 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -151.69 170.97 18.41 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.273 0.629 . . . . 0.0 110.088 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.8 p -144.04 164.22 30.73 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.602 1.161 . . . . 0.0 109.747 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -52.72 -38.08 76.5 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.377 2.718 . . . . 0.0 112.55 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -66.05 -45.99 79.4 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.331 1.052 . . . . 0.0 110.349 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.8 m -62.45 -46.57 87.92 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.182 0.593 . . . . 0.0 110.545 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.7 mt -60.23 -49.78 76.26 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.03 0.932 . . . . 0.0 110.566 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.2 ttp85 -52.25 -48.54 65.17 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.323 1.049 . . . . 0.0 110.33 173.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.31 -45.79 87.9 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.287 0.946 . . . . 0.0 112.316 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.34 -48.32 78.49 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.559 0.743 . . . . 0.0 111.189 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.7 mt -59.25 -42.1 86.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.777 0.831 . . . . 0.0 110.045 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -63.11 -42.22 99.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.393 0.677 . . . . 0.0 110.982 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -62.11 -41.82 98.61 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.082 0.953 . . . . 0.0 111.103 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.0 mtp -58.75 -45.89 88.67 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.542 0.337 . . . . 0.0 110.32 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.33 58.45 0.13 Allowed Glycine 0 C--N 1.339 0.749 0 C-N-CA 123.618 0.628 . . . . 0.0 111.719 169.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -140.32 140.31 35.61 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -68.44 96.6 0.69 Allowed 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.9 127.75 46.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.887 1.275 . . . . 0.0 109.646 -172.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.5 m -149.16 130.41 14.61 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.0 mt . . . . . 0 CA--C 1.532 0.272 0 C-N-CA 123.367 0.667 . . . . 0.0 110.597 -177.33 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 . . . . . 0 CA--C 1.529 0.145 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -140.18 141.58 35.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.215 1.006 . . . . 0.0 109.041 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -135.65 146.24 47.63 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.564 1.146 . . . . 0.0 109.588 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.92 124.18 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.3 mt -120.72 120.27 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -68.45 134.44 50.15 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.9 mt -131.67 106.49 11.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.117 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.92 142.63 31.13 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.64 19.4 20.3 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.792 1.187 . . . . 0.0 113.155 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.1 mtm . . . . . 0 C--N 1.342 0.26 0 CA-C-N 118.425 1.113 . . . . 0.0 109.393 176.445 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 120.222 0.058 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.7 m -67.15 -44.49 79.67 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.244 0.618 . . . . 0.0 110.647 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.2 t -54.71 -49.67 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.015 0.926 . . . . 0.0 109.893 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.08 -45.34 93.95 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.582 1.553 . . . . 0.0 111.033 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 m -58.6 -53.16 61.51 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 122.951 0.5 . . . . 0.0 110.852 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.59 -50.83 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 123.744 0.818 . . . . 0.0 109.789 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -49.95 -58.45 5.42 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.839 1.256 . . . . 0.0 110.345 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.78 -57.76 17.73 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.789 0.709 . . . . 0.0 112.155 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.9 t -59.67 -56.88 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.302 0.641 . . . . 0.0 110.872 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.6 mm -64.64 -38.49 82.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 118.747 -0.644 . . . . 0.0 111.212 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.2 t -52.94 -35.2 58.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.864 0.756 . . . . 0.0 111.971 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -89.41 -2.6 58.46 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.799 0.84 . . . . 0.0 112.49 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -71.21 145.16 90.65 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 119.448 1.022 . . . . 0.0 109.267 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.97 131.24 30.08 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.94 2.427 . . . . 0.0 109.895 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.71 -36.18 4.41 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-O 118.934 -0.926 . . . . 0.0 112.047 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.7 t -73.57 143.85 13.28 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 CA-C-N 118.044 0.922 . . . . 0.0 110.105 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -118.18 -103.69 0.41 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.078 1.351 . . . . 0.0 107.411 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.0 p -90.37 109.41 20.52 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.164 0.986 . . . . 0.0 110.414 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.0 tt -97.66 141.68 15.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 168.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -126.3 94.46 4.09 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -175.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -89.38 98.37 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.9 t -89.84 109.41 20.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.843 0.857 . . . . 0.0 109.32 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.2 -43.17 95.84 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.468 0.707 . . . . 0.0 109.878 171.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.6 -49.29 68.11 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.609 1.164 . . . . 0.0 111.742 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -89.8 1.02 56.65 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.033 0.533 . . . . 0.0 112.301 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.9 m 49.36 52.72 13.94 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.419 1.488 . . . . 0.0 111.574 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -155.5 166.25 34.1 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.106 0.479 . . . . 0.0 111.762 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.33 118.3 3.82 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.0 m -98.96 99.62 10.69 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.63 121.46 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 125.281 1.433 . . . . 0.0 109.516 -169.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -89.48 128.21 35.95 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 169.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -150.23 168.91 22.64 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -169.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -106.13 113.24 63.73 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 125.447 1.499 . . . . 0.0 108.979 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -48.27 -35.32 26.86 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 124.807 3.671 . . . . 0.0 114.615 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.0 mt -63.42 -31.46 72.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.509 0.723 . . . . 0.0 111.861 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.8 mt -106.79 -31.35 8.43 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.295 1.038 . . . . 0.0 112.368 -171.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 t -149.71 175.45 11.57 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.746 0.703 . . . . 0.0 110.177 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.2 p -146.46 160.86 40.64 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 124.2 1.0 . . . . 0.0 109.839 -176.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.62 -40.93 54.98 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.402 2.734 . . . . 0.0 112.747 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.97 -44.38 85.09 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.068 0.947 . . . . 0.0 111.148 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.7 m -61.95 -46.71 88.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.153 0.581 . . . . 0.0 110.462 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.4 mt -61.82 -49.72 75.16 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.306 1.042 . . . . 0.0 110.411 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -51.89 -44.48 63.78 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.81 0.844 . . . . 0.0 110.2 171.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.22 -48.0 77.75 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.523 1.058 . . . . 0.0 112.128 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.26 -45.58 90.83 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.657 0.729 . . . . 0.0 111.479 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.0 mt -62.01 -45.32 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.873 0.869 . . . . 0.0 109.914 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -61.71 -42.03 98.4 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.586 1.154 . . . . 0.0 110.775 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.39 -43.64 98.53 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.349 1.06 . . . . 0.0 111.338 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 69.0 mtm -57.11 -48.21 79.2 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 117.908 0.322 . . . . 0.0 110.481 173.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.2 65.8 0.1 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -140.24 152.03 45.63 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.158 0.983 . . . . 0.0 108.717 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -78.21 90.19 4.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.77 133.71 43.73 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.823 1.249 . . . . 0.0 110.464 -174.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.7 m -150.11 146.45 26.92 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.169 0.988 . . . . 0.0 108.459 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 CA--C 1.533 0.314 0 CA-C-N 118.276 0.489 . . . . 0.0 110.001 179.13 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 . . . . . 0 CA--C 1.529 0.154 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -140.28 146.0 38.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.777 0.831 . . . . 0.0 109.609 177.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -137.2 137.31 38.99 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.319 1.048 . . . . 0.0 109.692 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.8 t -99.84 109.11 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 172.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.1 mt -99.82 119.97 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -71.83 123.59 23.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.9 mt -123.53 119.49 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -118.14 158.01 25.85 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.188 0.595 . . . . 0.0 109.746 173.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.9 16.41 51.44 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.621 1.105 . . . . 0.0 112.052 -170.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 89.3 mtp . . . . . 0 CA--C 1.532 0.266 0 C-N-CA 124.458 1.103 . . . . 0.0 108.504 178.852 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.1 t . . . . . 0 CA--C 1.532 0.284 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.1 m -62.35 -49.22 76.46 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -54.16 -52.77 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.144 0.978 . . . . 0.0 109.916 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -55.14 -51.33 66.8 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.81 1.244 . . . . 0.0 110.883 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -60.06 -56.4 22.14 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.235 0.614 . . . . 0.0 110.967 -177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 93.5 mt -53.78 -52.69 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.483 1.113 . . . . 0.0 109.749 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -56.02 -55.5 32.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.324 1.049 . . . . 0.0 110.502 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.57 -50.26 64.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.715 1.15 . . . . 0.0 112.286 -176.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.9 t -63.12 -55.34 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 117.368 0.584 . . . . 0.0 110.394 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 84.3 mt -65.06 -40.91 90.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 119.222 -0.418 . . . . 0.0 111.607 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.8 p -53.73 -28.64 35.41 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -89.43 -8.3 53.33 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.888 0.875 . . . . 0.0 112.523 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -71.88 124.62 91.15 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 119.08 0.854 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.12 121.98 7.72 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.699 2.933 . . . . 0.0 112.135 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.13 -37.35 3.45 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.0 0.81 . . . . 0.0 111.76 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.39 126.97 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 117.827 0.814 . . . . 0.0 109.761 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -94.38 -101.35 0.15 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.924 1.29 . . . . 0.0 107.83 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 91.4 p -90.01 163.04 15.08 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.529 0.732 . . . . 0.0 110.186 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.3 tt -150.63 147.85 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.747 0.819 . . . . 0.0 109.73 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.97 109.06 6.77 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.616 1.166 . . . . 0.0 107.884 172.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.42 102.2 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 124.171 0.988 . . . . 0.0 108.467 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -93.65 112.99 24.98 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.969 0.908 . . . . 0.0 110.372 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tt -66.42 -51.37 57.65 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.22 -51.09 57.16 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.09 1.356 . . . . 0.0 112.209 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -89.86 6.56 41.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.963 0.505 . . . . 0.0 111.939 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 m 49.23 57.02 6.93 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 125.654 1.582 . . . . 0.0 112.047 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -157.19 164.11 38.12 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.519 0.676 . . . . 0.0 112.728 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.45 110.11 2.09 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 106.186 -2.766 . . . . 0.0 106.186 169.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -98.81 97.2 8.44 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.5 t -106.87 124.27 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 124.387 1.075 . . . . 0.0 109.099 -170.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -89.81 130.82 36.01 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 169.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -150.31 165.98 31.4 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.072 0.549 . . . . 0.0 112.191 -169.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -104.37 113.19 65.36 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.098 1.359 . . . . 0.0 109.189 173.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -44.65 -36.65 10.52 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 125.286 3.991 . . . . 0.0 114.846 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.6 mt -66.06 -28.61 68.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.617 0.767 . . . . 0.0 112.12 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.7 mt -109.83 -35.29 6.21 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.314 1.046 . . . . 0.0 112.051 -171.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -145.26 179.32 7.46 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.869 0.868 . . . . 0.0 109.396 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.0 p -150.07 162.63 27.31 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 123.207 0.603 . . . . 0.0 110.56 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.03 -38.82 87.03 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.32 2.68 . . . . 0.0 111.782 172.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.45 -49.72 75.66 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.858 0.863 . . . . 0.0 110.677 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -58.37 -48.35 80.88 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.319 0.647 . . . . 0.0 110.549 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.3 mt -60.65 -47.84 84.45 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.219 1.008 . . . . 0.0 110.87 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -56.55 -44.61 81.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.679 0.792 . . . . 0.0 110.555 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.27 -45.94 87.33 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.095 0.855 . . . . 0.0 111.87 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.39 -49.83 73.95 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.378 0.671 . . . . 0.0 111.091 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.8 mt -60.08 -45.28 95.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.32 0.648 . . . . 0.0 110.212 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -57.56 -48.97 77.88 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.102 0.961 . . . . 0.0 110.048 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.78 -43.58 90.48 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.114 0.965 . . . . 0.0 111.454 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.4 mtp -59.44 -44.53 92.91 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.928 0.491 . . . . 0.0 110.631 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.04 62.21 0.2 Allowed Glycine 0 C--N 1.339 0.725 0 C-N-CA 123.795 0.712 . . . . 0.0 111.598 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -140.31 155.4 46.84 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.789 0.836 . . . . 0.0 109.29 172.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -78.37 91.12 4.43 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.703 0.801 . . . . 0.0 108.996 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.67 129.68 45.83 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.618 1.167 . . . . 0.0 110.816 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.7 m -150.07 132.42 15.57 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.897 0.879 . . . . 0.0 108.818 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 43.5 mt . . . . . 0 CA--C 1.534 0.33 0 C-N-CA 123.054 0.542 . . . . 0.0 111.094 -178.171 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -124.14 144.14 50.08 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.461 1.105 . . . . 0.0 108.886 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -137.7 146.78 44.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.33 1.052 . . . . 0.0 109.326 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.99 125.59 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.9 mt -120.32 121.06 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -72.37 132.07 43.47 Favored 'General case' 0 C--O 1.228 -0.044 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 174.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.5 mt -127.97 106.42 14.8 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -99.56 149.57 23.11 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.427 0.691 . . . . 0.0 109.195 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.27 16.27 47.64 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.441 1.02 . . . . 0.0 113.005 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.8 mtm . . . . . 0 C--N 1.343 0.293 0 CA-C-N 118.58 1.19 . . . . 0.0 109.252 175.227 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.8 m -60.76 -57.2 13.71 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.4 0.68 . . . . 0.0 109.603 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.7 t -49.89 -51.55 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.06 1.344 . . . . 0.0 111.067 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -59.87 -52.48 65.27 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.009 1.324 . . . . 0.0 111.103 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.3 p -61.12 -48.98 79.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.122 0.569 . . . . 0.0 111.3 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.8 mt -53.76 -55.31 14.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.805 0.842 . . . . 0.0 109.397 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -54.18 -55.06 31.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.113 0.565 . . . . 0.0 110.712 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.43 -50.45 59.94 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.315 0.959 . . . . 0.0 112.779 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.38 -49.68 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.409 0.683 . . . . 0.0 110.699 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.6 mm -66.28 -33.53 64.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.46 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.7 m -50.87 -30.88 15.72 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.872 0.76 . . . . 0.0 112.734 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -89.07 -3.35 58.7 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.58 0.752 . . . . 0.0 112.167 -173.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -77.12 143.01 69.27 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 118.87 0.759 . . . . 0.0 109.903 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.92 135.37 17.82 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.91 3.073 . . . . 0.0 112.608 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.17 -34.9 3.95 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.674 -1.07 . . . . 0.0 113.045 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.1 124.22 20.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-N 118.448 1.124 . . . . 0.0 109.918 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -89.84 -102.59 0.09 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.0 p -90.49 158.02 17.25 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.336 1.054 . . . . 0.0 109.676 171.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.5 tt -150.23 127.37 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -116.19 107.13 14.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.465 1.106 . . . . 0.0 108.497 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.62 124.38 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.0 t -106.8 129.48 54.65 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.636 1.174 . . . . 0.0 110.17 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.5 tp -68.35 -53.61 22.93 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.709 0.803 . . . . 0.0 109.09 171.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.16 -47.48 71.93 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 125.265 1.426 . . . . 0.0 112.086 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -89.25 -9.63 49.95 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.403 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.5 m 52.79 56.08 8.1 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 125.016 1.326 . . . . 0.0 111.02 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -157.17 168.31 27.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.419 0.688 . . . . 0.0 110.853 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.55 116.83 2.89 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 126.215 1.864 . . . . 0.0 108.783 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.0 m -99.12 100.56 11.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 176.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.6 t -106.3 125.52 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.502 1.121 . . . . 0.0 109.537 -170.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -95.53 127.93 41.98 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 168.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -150.26 164.36 35.93 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.17 0.588 . . . . 0.0 111.779 -169.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -98.36 114.25 65.02 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.737 1.215 . . . . 0.0 109.013 172.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -47.74 -34.35 21.07 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.741 3.627 . . . . 0.0 114.93 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.5 mt -65.92 -33.9 76.89 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.457 0.703 . . . . 0.0 111.584 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.75 -35.3 9.84 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.895 0.878 . . . . 0.0 111.578 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.3 t -147.4 178.37 8.48 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.698 0.681 . . . . 0.0 110.539 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.3 p -148.88 159.85 36.73 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 124.624 1.17 . . . . 0.0 109.714 -174.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.41 -40.42 62.47 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.511 2.807 . . . . 0.0 112.814 176.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -66.79 -41.05 88.28 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.555 1.142 . . . . 0.0 110.927 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.8 m -67.55 -45.65 75.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.1 0.56 . . . . 0.0 110.326 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.0 mt -60.73 -49.55 77.05 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.241 1.016 . . . . 0.0 110.253 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.9 ttp85 -52.1 -47.24 65.38 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.164 0.986 . . . . 0.0 109.988 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.19 -45.23 83.22 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.569 1.08 . . . . 0.0 112.293 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.59 -48.24 75.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.635 0.717 . . . . 0.0 111.099 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.93 -42.45 89.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.92 0.888 . . . . 0.0 109.981 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -63.51 -41.04 98.52 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.628 1.171 . . . . 0.0 110.568 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.36 -41.48 98.83 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.01 0.924 . . . . 0.0 111.182 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.9 mtp -57.83 -44.27 86.36 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.097 0.408 . . . . 0.0 110.203 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.13 61.76 0.16 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 123.651 0.643 . . . . 0.0 111.702 169.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -140.33 152.43 45.82 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.999 0.919 . . . . 0.0 109.414 175.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -79.74 86.24 5.35 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.57 128.99 45.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.626 1.171 . . . . 0.0 110.461 -173.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.9 p -142.34 151.19 41.68 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.154 1.382 . . . . 0.0 109.039 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.414 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 CA--C 1.528 0.097 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -134.76 141.27 46.42 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.061 0.945 . . . . 0.0 108.969 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -131.56 144.8 51.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.406 1.082 . . . . 0.0 109.49 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.97 123.75 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.2 mt -116.37 121.76 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -69.94 118.19 12.47 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.3 mt -110.8 102.34 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -99.65 149.03 23.71 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.562 0.745 . . . . 0.0 109.27 176.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.67 26.04 16.28 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.667 1.127 . . . . 0.0 112.359 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 88.8 mtp . . . . . 0 CA--C 1.53 0.206 0 C-N-CA 124.107 0.963 . . . . 0.0 108.413 175.589 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 p . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.31 -40.51 96.54 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.939 0.895 . . . . 0.0 109.239 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.5 t -49.86 -59.3 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.358 1.063 . . . . 0.0 109.928 173.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.89 -45.5 94.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.609 1.164 . . . . 0.0 111.037 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.8 t -59.55 -57.88 11.04 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.956 0.902 . . . . 0.0 110.828 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.3 mt -55.42 -54.4 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.964 0.906 . . . . 0.0 109.587 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -55.38 -49.02 73.4 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.144 0.578 . . . . 0.0 110.791 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.39 -37.27 91.75 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.002 1.287 . . . . 0.0 113.284 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.6 t -77.84 -57.81 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.253 1.026 . . . . 0.0 110.17 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.38 -37.63 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.452 0.701 . . . . 0.0 111.404 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.9 p -51.6 -30.78 22.44 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -89.42 -8.29 53.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.815 0.846 . . . . 0.0 112.434 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -72.56 143.62 85.3 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 118.751 0.705 . . . . 0.0 109.816 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -47.51 134.27 21.0 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.791 2.994 . . . . 0.0 112.655 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.56 -31.76 5.64 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-O 118.724 -1.042 . . . . 0.0 113.457 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.5 t -67.12 134.02 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.341 1.071 . . . . 0.0 110.146 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -113.88 -102.94 0.41 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.192 1.397 . . . . 0.0 108.297 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.4 p -82.44 154.05 25.35 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.161 0.584 . . . . 0.0 109.79 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.5 tt -150.33 145.32 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.326 0.65 . . . . 0.0 110.1 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -139.97 103.47 4.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.5 t -91.67 108.6 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.2 t -89.52 129.23 36.03 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.145 0.578 . . . . 0.0 110.111 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tt -73.96 -57.01 4.25 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.813 1.245 . . . . 0.0 108.152 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.79 -45.7 78.13 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.524 1.53 . . . . 0.0 112.356 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -89.12 -10.54 46.91 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.893 0.477 . . . . 0.0 111.013 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.2 m 56.23 58.15 4.5 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.057 1.343 . . . . 0.0 110.614 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -146.03 163.59 34.75 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.86 0.464 . . . . 0.0 111.618 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.04 107.59 1.8 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.9 m -99.13 99.84 10.9 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.3 t -114.91 126.01 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 124.791 1.236 . . . . 0.0 109.608 -169.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -89.92 131.61 35.74 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -150.51 156.96 42.44 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.274 0.629 . . . . 0.0 112.256 -170.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -93.53 120.08 66.67 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.703 1.201 . . . . 0.0 110.117 173.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.53 -41.79 29.51 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 125.069 3.846 . . . . 0.0 115.785 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -68.47 -29.74 68.43 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.614 0.365 . . . . 0.0 111.73 -173.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.2 mt -99.64 -32.66 10.96 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.227 1.011 . . . . 0.0 111.893 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -153.23 176.22 12.19 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.677 0.671 . . . . 0.0 110.05 173.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.9 p -150.09 162.6 27.39 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.039 0.936 . . . . 0.0 109.993 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.3 -44.34 49.77 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.439 2.759 . . . . 0.0 112.755 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.05 -34.12 77.3 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.502 0.721 . . . . 0.0 112.571 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.1 m -70.93 -47.67 57.79 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 122.944 0.498 . . . . 0.0 109.732 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.9 mt -58.36 -50.31 74.12 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.943 0.897 . . . . 0.0 110.05 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -52.29 -47.4 65.91 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.791 1.236 . . . . 0.0 110.533 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.82 -47.87 76.0 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.32 0.962 . . . . 0.0 112.156 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.5 -46.77 86.95 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.561 0.744 . . . . 0.0 111.401 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.7 mt -60.97 -43.99 97.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.56 0.744 . . . . 0.0 109.938 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -63.14 -41.67 99.34 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.712 0.805 . . . . 0.0 110.945 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.13 -43.49 98.81 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.253 1.021 . . . . 0.0 111.184 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 69.5 mtm -58.46 -50.04 75.14 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 117.842 0.292 . . . . 0.0 110.382 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.39 63.01 0.09 OUTLIER Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 171.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -140.25 142.98 35.74 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.27 93.51 1.11 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.9 120.7 40.19 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.219 1.407 . . . . 0.0 109.425 -174.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 47.1 p -138.27 140.26 39.55 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.356 1.062 . . . . 0.0 108.617 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 CA--C 1.53 0.201 0 C-N-CA 122.596 0.358 . . . . 0.0 110.31 -176.409 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 . . . . . 0 CA--C 1.527 0.088 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -128.5 151.81 48.99 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.554 1.142 . . . . 0.0 109.438 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -145.44 148.68 33.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.298 1.039 . . . . 0.0 109.394 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.93 123.54 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.4 mt -119.06 128.86 75.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -70.28 121.47 17.69 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 171.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.7 mt -125.95 95.01 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.75 151.74 20.9 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.31 15.79 56.64 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.31 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 54.8 mtt . . . . . 0 C--N 1.344 0.344 0 CA-C-N 118.755 1.277 . . . . 0.0 109.764 174.6 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.3 m -63.8 -44.26 93.83 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.736 0.814 . . . . 0.0 110.679 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.3 t -51.92 -54.7 12.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 C-N-CA 123.302 0.641 . . . . 0.0 109.641 176.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -61.51 -42.65 99.13 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.668 0.787 . . . . 0.0 111.432 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -59.24 -55.43 35.01 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.131 0.572 . . . . 0.0 110.663 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.2 mt -54.25 -55.8 12.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 123.873 0.869 . . . . 0.0 109.155 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -54.44 -54.67 37.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.85 0.86 . . . . 0.0 111.091 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.09 -53.57 44.64 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.281 0.943 . . . . 0.0 112.364 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.61 -54.24 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 117.382 0.591 . . . . 0.0 110.438 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.9 mm -61.78 -40.6 87.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.699 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.1 t -51.2 -36.21 40.27 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.427 0.691 . . . . 0.0 112.089 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -88.97 -11.06 45.41 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.464 0.705 . . . . 0.0 112.131 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -73.08 139.43 79.5 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 119.466 1.03 . . . . 0.0 109.962 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -45.22 137.81 10.09 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.354 3.369 . . . . 0.0 113.665 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.34 -38.79 3.01 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-O 118.841 -0.977 . . . . 0.0 112.49 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.34 134.02 30.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 CA-C-N 118.254 1.027 . . . . 0.0 110.088 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -104.61 -102.09 0.31 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.849 1.259 . . . . 0.0 107.926 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.8 p -87.31 152.83 21.96 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.464 0.706 . . . . 0.0 109.849 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 tt -150.69 140.23 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.645 0.778 . . . . 0.0 109.676 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -129.84 110.95 12.13 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.924 1.29 . . . . 0.0 108.659 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.34 122.79 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.363 1.065 . . . . 0.0 108.572 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.7 t -115.63 123.66 48.98 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.823 1.249 . . . . 0.0 110.588 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.6 tp -69.83 -48.24 59.71 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.745 1.218 . . . . 0.0 109.823 170.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.12 -46.74 65.46 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.691 1.197 . . . . 0.0 111.639 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -89.51 -15.03 33.91 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.419 0.688 . . . . 0.0 111.7 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.2 m 54.52 54.68 8.97 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 125.14 1.376 . . . . 0.0 110.415 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -154.32 163.42 40.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.454 0.702 . . . . 0.0 110.928 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.54 119.6 3.74 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.4 m -99.2 104.52 16.49 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 t -112.86 127.75 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 124.655 1.182 . . . . 0.0 109.575 -170.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -96.73 133.07 41.76 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 169.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -150.38 169.79 20.58 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.773 0.429 . . . . 0.0 111.865 -171.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -103.67 110.76 64.47 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 125.133 1.373 . . . . 0.0 109.268 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -41.66 -38.73 4.47 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 125.268 3.979 . . . . 0.0 115.227 170.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.9 mt -62.51 -35.12 78.36 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.25 0.62 . . . . 0.0 111.955 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.9 mt -104.4 -31.57 9.45 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.299 1.04 . . . . 0.0 112.344 -170.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 t -150.1 176.76 10.52 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.408 0.683 . . . . 0.0 110.173 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.3 p -147.45 163.43 27.91 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.36 1.064 . . . . 0.0 109.929 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.92 -41.87 67.92 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.326 2.684 . . . . 0.0 112.443 176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -66.47 -40.85 89.6 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.786 0.834 . . . . 0.0 111.39 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.9 m -62.66 -47.24 84.56 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.779 0.432 . . . . 0.0 110.242 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.6 mt -62.07 -47.53 84.25 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.106 0.963 . . . . 0.0 110.606 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -51.66 -48.54 63.37 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.495 1.118 . . . . 0.0 109.954 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.86 -45.01 92.09 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.485 1.04 . . . . 0.0 112.255 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.43 -49.29 76.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.477 0.711 . . . . 0.0 111.159 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.59 -41.81 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.707 0.803 . . . . 0.0 110.164 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -61.42 -43.0 99.63 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.942 0.897 . . . . 0.0 110.707 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.4 -42.27 99.31 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.917 0.887 . . . . 0.0 111.091 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mtp -58.67 -44.84 90.32 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.973 0.352 . . . . 0.0 110.379 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.39 59.92 0.17 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 123.756 0.693 . . . . 0.0 111.976 169.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -140.31 152.31 45.75 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.051 0.94 . . . . 0.0 108.95 174.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -75.9 91.5 3.02 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.31 122.47 42.5 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.54 1.136 . . . . 0.0 109.95 -172.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.6 m -148.54 132.59 17.24 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.54 1.136 . . . . 0.0 108.304 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.2 mt . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 123.147 0.579 . . . . 0.0 111.477 -175.115 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.1 mm100 . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -108.94 145.11 35.97 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.388 1.075 . . . . 0.0 109.385 176.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 t -134.99 133.7 39.74 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.028 0.931 . . . . 0.0 109.336 172.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.93 108.32 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.7 mt -99.55 120.6 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -82.93 109.84 17.39 Favored 'General case' 0 C--N 1.334 -0.072 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.8 mt -111.73 106.19 20.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.403 1.081 . . . . 0.0 108.278 -172.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -99.6 145.4 27.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.07 -5.71 46.32 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.553 -1.137 . . . . 0.0 113.584 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 C--N 1.344 0.337 0 CA-C-N 119.069 1.434 . . . . 0.0 110.296 179.93 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.7 m . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -63.33 -45.04 93.09 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.667 0.787 . . . . 0.0 110.569 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.0 t -54.8 -53.86 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.625 0.77 . . . . 0.0 110.318 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -58.23 -46.72 85.39 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.588 1.155 . . . . 0.0 111.22 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.6 t -57.18 -52.67 64.37 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.313 0.645 . . . . 0.0 110.684 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.5 mt -55.01 -61.21 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 124.461 1.104 . . . . 0.0 110.075 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -59.3 -41.08 88.16 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.985 0.357 . . . . 0.0 111.386 -174.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.39 -56.08 27.0 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.24 -52.51 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.673 0.789 . . . . 0.0 110.726 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.5 mm -62.52 -37.58 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.434 0.693 . . . . 0.0 111.56 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.1 m -54.32 -29.51 47.98 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.698 0.681 . . . . 0.0 112.738 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -89.31 -6.38 56.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.288 0.635 . . . . 0.0 112.222 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -72.81 139.75 80.55 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 119.104 0.865 . . . . 0.0 109.251 177.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.05 131.56 29.13 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.004 2.469 . . . . 0.0 110.065 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.33 -36.19 4.54 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-O 118.872 -0.96 . . . . 0.0 111.795 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.53 131.65 32.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-N 118.141 0.971 . . . . 0.0 109.866 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -104.07 -101.63 0.31 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.943 1.297 . . . . 0.0 107.81 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.3 p -90.06 160.35 16.36 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.873 0.869 . . . . 0.0 110.079 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.7 tt -150.39 146.58 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 123.861 0.864 . . . . 0.0 109.488 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.94 109.78 7.6 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 173.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -98.67 103.71 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.0 t -89.78 118.98 29.78 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.602 0.761 . . . . 0.0 109.132 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.0 tp -70.56 -44.26 67.81 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.693 0.797 . . . . 0.0 109.656 172.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.12 -48.78 67.58 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.775 1.23 . . . . 0.0 111.666 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -89.39 -5.91 57.04 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.105 0.562 . . . . 0.0 111.534 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.8 m 52.07 55.78 8.72 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.52 1.528 . . . . 0.0 111.255 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -155.3 151.29 27.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.127 0.489 . . . . 0.0 111.815 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.67 113.56 4.27 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 126.242 1.877 . . . . 0.0 108.621 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.6 m -98.78 97.14 8.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 t -104.64 126.91 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.348 1.059 . . . . 0.0 109.399 -170.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -92.67 131.07 38.07 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -149.96 164.14 36.26 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.242 0.617 . . . . 0.0 110.971 -171.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -101.38 114.4 65.71 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.408 1.083 . . . . 0.0 109.151 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.52 -35.35 16.4 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 125.002 3.801 . . . . 0.0 115.069 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.27 -29.69 69.37 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.515 0.726 . . . . 0.0 111.833 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.8 -46.92 5.23 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.054 0.942 . . . . 0.0 110.725 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 t -138.56 -178.95 5.53 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.965 0.906 . . . . 0.0 110.107 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.9 p -148.35 161.69 33.01 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.872 0.869 . . . . 0.0 110.287 -173.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -51.43 -50.01 15.33 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.494 2.796 . . . . 0.0 112.73 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.95 -33.21 75.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.897 0.479 . . . . 0.0 112.115 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.5 m -64.81 -48.75 73.29 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.9 mt -61.86 -46.98 87.07 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.497 0.719 . . . . 0.0 110.601 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.8 ttp85 -53.78 -46.47 71.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.043 0.937 . . . . 0.0 109.88 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.99 -42.71 93.03 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.521 1.058 . . . . 0.0 112.309 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.21 -47.13 83.82 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.999 0.899 . . . . 0.0 111.03 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mm -58.59 -44.76 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 122.73 0.412 . . . . 0.0 110.108 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -61.7 -38.99 89.9 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.25 0.62 . . . . 0.0 111.011 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.59 -43.42 93.91 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.315 1.046 . . . . 0.0 110.94 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.5 mtp -58.7 -41.51 86.43 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.958 0.344 . . . . 0.0 110.472 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.7 57.92 0.23 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 123.959 0.79 . . . . 0.0 111.919 169.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -140.27 145.53 37.42 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -73.92 91.13 1.98 Allowed 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.662 0.785 . . . . 0.0 109.565 -174.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.84 127.72 45.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.04 1.336 . . . . 0.0 110.374 -174.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.1 m -144.76 130.99 19.55 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.363 1.065 . . . . 0.0 108.515 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 CA--C 1.531 0.216 0 C-N-CA 123.426 0.69 . . . . 0.0 111.627 -178.323 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 . . . . . 0 CA--C 1.529 0.173 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -128.27 151.46 49.27 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.51 1.124 . . . . 0.0 109.429 175.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 t -150.13 140.94 22.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.589 0.755 . . . . 0.0 110.025 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.1 t -99.73 129.49 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 171.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.4 mt -121.47 123.66 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -78.66 120.47 23.38 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.0 mt -119.73 103.32 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 125.917 1.687 . . . . 0.0 106.708 -173.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -99.97 144.85 28.53 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.923 0.489 . . . . 0.0 110.23 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.47 34.76 7.77 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.788 1.185 . . . . 0.0 112.852 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.9 mtm . . . . . 0 C--N 1.34 0.182 0 CA-C-N 117.794 0.797 . . . . 0.0 109.563 177.791 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.7 p . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.685 0.278 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.0 m -64.57 -47.36 79.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.476 0.71 . . . . 0.0 110.285 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -51.16 -56.56 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.151 0.98 . . . . 0.0 110.445 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -62.38 -49.06 77.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.308 1.043 . . . . 0.0 111.494 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.3 p -61.52 -50.12 73.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.004 0.365 . . . . 0.0 111.568 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.8 mt -55.16 -55.07 18.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 C-N-CA 123.769 0.828 . . . . 0.0 109.343 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.3 -49.62 71.67 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.25 0.62 . . . . 0.0 110.999 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.4 -51.33 59.76 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.633 1.111 . . . . 0.0 112.347 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.73 -54.29 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 117.75 0.775 . . . . 0.0 110.311 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.8 mm -64.3 -38.27 82.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 118.911 -0.566 . . . . 0.0 111.638 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.4 p -53.74 -31.73 49.5 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.85 0.75 . . . . 0.0 112.721 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -89.58 -3.65 58.2 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.049 0.939 . . . . 0.0 112.395 -174.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -72.03 143.26 86.15 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 119.071 0.851 . . . . 0.0 109.64 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -46.82 128.47 13.4 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.894 3.063 . . . . 0.0 112.665 176.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.01 -30.86 7.09 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.391 177.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.5 t -69.66 125.45 27.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 CA-C-N 118.694 1.247 . . . . 0.0 109.832 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -95.9 -103.04 0.16 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.7 p -86.58 155.62 20.38 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.415 0.686 . . . . 0.0 110.213 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tt -150.66 139.06 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.922 0.889 . . . . 0.0 109.208 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -128.91 103.8 7.24 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.655 1.182 . . . . 0.0 108.77 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -93.25 121.91 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 123.967 0.907 . . . . 0.0 108.769 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.7 t -118.09 124.44 48.07 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.911 1.284 . . . . 0.0 109.725 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tt -71.09 -46.97 60.81 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.273 1.029 . . . . 0.0 109.487 172.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.36 -47.46 56.04 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.732 1.213 . . . . 0.0 111.778 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -89.57 -8.72 52.06 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.365 0.666 . . . . 0.0 111.774 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.1 m 51.87 55.64 8.99 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.779 1.632 . . . . 0.0 110.709 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -155.77 170.41 22.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.005 0.522 . . . . 0.0 111.765 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.7 118.31 2.58 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.4 m -98.98 100.49 11.66 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 t -106.72 128.33 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.556 1.142 . . . . 0.0 109.757 -169.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -96.52 130.54 43.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 168.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -150.22 163.39 38.39 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.009 0.523 . . . . 0.0 111.881 -171.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -97.08 113.98 63.95 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.916 1.286 . . . . 0.0 109.381 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -45.69 -37.41 15.8 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 124.942 3.762 . . . . 0.0 114.777 172.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -64.61 -34.35 78.07 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.505 0.722 . . . . 0.0 111.811 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.4 mt -104.09 -30.47 10.22 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.121 0.969 . . . . 0.0 112.279 -172.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.0 t -151.78 177.96 9.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.302 0.641 . . . . 0.0 110.107 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.3 p -149.21 162.05 30.16 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 125.106 1.363 . . . . 0.0 109.549 -172.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.14 -38.43 80.95 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.934 2.422 . . . . 0.0 112.03 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.28 -48.92 71.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.587 1.155 . . . . 0.0 111.44 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.4 p -62.56 -42.49 99.58 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.503 0.321 . . . . 0.0 111.096 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.5 mt -64.83 -47.8 76.68 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.385 0.674 . . . . 0.0 110.365 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.5 ttp85 -51.99 -48.03 64.62 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.166 0.986 . . . . 0.0 110.219 171.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.63 -46.69 81.13 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.294 0.95 . . . . 0.0 112.246 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.42 -48.64 78.79 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.638 0.775 . . . . 0.0 111.169 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.0 mt -60.16 -42.42 90.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.71 0.804 . . . . 0.0 110.059 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.62 -39.94 95.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.579 0.751 . . . . 0.0 110.831 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.69 -41.66 98.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.022 0.929 . . . . 0.0 111.003 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.9 mtp -58.31 -43.4 88.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.984 0.356 . . . . 0.0 110.268 172.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.26 58.39 0.18 Allowed Glycine 0 C--N 1.34 0.778 0 C-N-CA 123.827 0.727 . . . . 0.0 111.975 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -140.29 142.48 35.68 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.004 0.922 . . . . 0.0 108.935 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -69.75 92.36 0.67 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.67 123.95 44.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.232 1.413 . . . . 0.0 109.302 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.1 p -138.66 136.74 36.2 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.703 1.201 . . . . 0.0 108.872 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 61.6 mt . . . . . 0 CA--C 1.529 0.171 0 C-N-CA 122.615 0.366 . . . . 0.0 110.215 -177.471 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -125.02 152.97 43.55 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.428 1.091 . . . . 0.0 109.567 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -149.75 138.29 20.76 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.447 0.699 . . . . 0.0 110.115 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.83 124.18 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 172.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.4 mt -119.81 120.17 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -75.86 126.87 31.84 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.8 mt -122.13 111.41 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.639 1.176 . . . . 0.0 108.014 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -99.61 147.61 25.19 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.21 2.02 51.19 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.279 0.942 . . . . 0.0 112.885 -177.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.8 mtm . . . . . 0 C--N 1.342 0.261 0 CA-C-N 118.688 1.244 . . . . 0.0 108.624 174.813 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.9 p . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 111.222 0.082 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -59.07 -50.3 74.59 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.755 0.822 . . . . 0.0 110.281 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -53.85 -52.51 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 124.87 1.268 . . . . 0.0 110.922 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -59.22 -46.12 89.31 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.5 1.12 . . . . 0.0 111.142 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.6 m -58.53 -52.87 63.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.177 0.591 . . . . 0.0 110.792 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.1 mt -56.55 -53.65 38.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 123.599 0.76 . . . . 0.0 109.689 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -52.82 -55.51 22.51 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.193 0.997 . . . . 0.0 110.739 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.43 -52.07 53.92 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.161 0.886 . . . . 0.0 112.186 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.8 t -61.01 -56.18 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.268 0.627 . . . . 0.0 110.907 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.7 mm -62.01 -37.11 77.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.259 0.624 . . . . 0.0 111.39 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.0 t -49.45 -40.7 37.88 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 123.763 0.825 . . . . 0.0 112.673 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -89.47 -6.08 56.78 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -171.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -75.07 148.39 84.27 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 119.165 0.893 . . . . 0.0 110.459 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -44.14 133.86 8.72 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.494 3.463 . . . . 0.0 113.707 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.66 -40.57 2.92 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-O 118.959 -0.911 . . . . 0.0 112.674 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.7 t -68.31 134.91 29.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 CA-C-N 117.983 0.892 . . . . 0.0 110.168 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -109.29 -98.67 0.39 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.602 1.161 . . . . 0.0 107.88 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.7 p -87.59 152.41 22.2 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.634 0.774 . . . . 0.0 109.509 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.0 tt -150.56 136.65 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 123.499 0.719 . . . . 0.0 109.224 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.23 101.47 6.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.869 1.267 . . . . 0.0 108.39 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.8 t -96.88 122.93 48.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.9 t -107.02 130.67 54.62 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.793 1.237 . . . . 0.0 110.332 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.3 tp -69.62 -52.39 26.36 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.705 0.802 . . . . 0.0 109.119 170.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.53 -47.51 69.88 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 125.22 1.408 . . . . 0.0 112.114 -176.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -89.25 -9.69 49.74 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.888 0.475 . . . . 0.0 111.457 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.1 m 52.52 56.43 7.68 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.107 1.363 . . . . 0.0 110.783 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -155.65 166.35 33.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.095 0.558 . . . . 0.0 111.191 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.67 115.03 2.49 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.507 2.003 . . . . 0.0 108.707 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.9 m -99.28 98.82 9.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 t -106.24 131.3 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 124.453 1.101 . . . . 0.0 109.693 -170.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -99.04 130.34 45.36 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -150.19 163.27 38.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.119 0.568 . . . . 0.0 111.825 -169.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -98.13 113.84 64.4 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.686 1.195 . . . . 0.0 109.293 172.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -44.45 -36.96 10.26 Favored 'Trans proline' 0 C--N 1.349 0.556 1 C-N-CA 125.356 4.037 . . . . 0.0 115.024 173.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.2 mt -64.5 -36.39 84.06 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.109 0.564 . . . . 0.0 111.789 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.2 mt -100.0 -32.96 10.7 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.12 0.968 . . . . 0.0 112.244 -171.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.3 t -149.35 178.86 8.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.29 0.636 . . . . 0.0 110.093 176.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.9 p -150.21 162.9 26.34 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 124.172 0.989 . . . . 0.0 109.759 -174.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -53.07 -46.94 30.33 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.191 2.594 . . . . 0.0 112.372 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.42 -33.9 76.75 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.016 0.526 . . . . 0.0 112.287 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 98.3 m -67.73 -45.32 75.35 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.376 0.535 . . . . 0.0 110.096 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.5 mt -61.19 -47.33 86.67 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.65 0.78 . . . . 0.0 110.461 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -52.64 -47.04 67.34 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.052 0.941 . . . . 0.0 110.269 171.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.48 -45.82 82.85 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.303 0.954 . . . . 0.0 112.313 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.34 -46.36 83.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.785 0.834 . . . . 0.0 111.35 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.4 mt -62.43 -43.46 98.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.758 0.823 . . . . 0.0 110.08 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.35 -41.7 98.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.293 1.037 . . . . 0.0 110.938 176.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.57 -43.91 97.99 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.968 0.907 . . . . 0.0 111.132 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.9 mtm -59.32 -50.88 72.28 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 117.911 0.323 . . . . 0.0 110.213 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.71 60.84 0.09 OUTLIER Glycine 0 C--N 1.34 0.802 0 C-N-CA 123.519 0.581 . . . . 0.0 111.789 171.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -140.09 141.94 36.12 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 171.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -75.7 91.07 2.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.661 0.784 . . . . 0.0 109.49 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.36 134.8 41.69 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.632 1.173 . . . . 0.0 110.362 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 95.0 m -144.07 133.8 23.71 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.983 1.313 . . . . 0.0 108.369 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.0 mt . . . . . 0 CA--C 1.53 0.173 0 C-N-CA 123.215 0.606 . . . . 0.0 109.872 -178.635 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -101.13 142.31 32.76 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.81 0.444 . . . . 0.0 110.244 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -135.81 137.72 41.84 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.418 1.087 . . . . 0.0 109.127 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.3 t -99.96 129.58 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.516 -1.291 . . . . 0.0 107.516 174.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.1 mt -126.04 122.01 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -76.99 124.18 27.4 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.5 mt -117.37 109.14 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 124.989 1.315 . . . . 0.0 107.874 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -99.97 149.81 23.07 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 174.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.35 1.82 56.74 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.072 0.844 . . . . 0.0 113.232 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.0 mtm . . . . . 0 C--N 1.342 0.262 0 CA-C-N 118.719 1.26 . . . . 0.0 108.329 173.725 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.1 p . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.4 m -58.87 -49.04 79.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.544 1.137 . . . . 0.0 108.73 169.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -49.87 -52.23 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 125.549 1.54 . . . . 0.0 110.331 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -62.48 -45.74 91.65 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.676 0.79 . . . . 0.0 111.009 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -58.69 -53.26 60.38 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.667 0.787 . . . . 0.0 110.774 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.0 mt -55.78 -54.8 22.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 C-N-CA 124.064 0.946 . . . . 0.0 109.402 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.63 -54.49 32.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.73 0.812 . . . . 0.0 110.86 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.68 -53.65 43.51 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.234 0.921 . . . . 0.0 112.514 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.9 t -63.69 -54.75 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 117.41 0.605 . . . . 0.0 110.813 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.78 -37.31 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 118.844 -0.598 . . . . 0.0 110.929 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.4 t -50.14 -34.8 23.45 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.637 0.653 . . . . 0.0 112.564 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -89.64 -10.52 45.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.128 0.971 . . . . 0.0 112.472 -174.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -69.96 146.29 95.04 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 119.011 0.823 . . . . 0.0 110.062 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -46.34 135.6 15.52 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 124.033 3.156 . . . . 0.0 113.101 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.08 -37.32 3.34 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 118.856 -0.969 . . . . 0.0 112.763 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 52.1 t -67.17 141.21 18.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-N 118.302 1.051 . . . . 0.0 110.216 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -116.72 -98.67 0.45 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.895 1.278 . . . . 0.0 108.011 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.4 p -90.2 154.96 19.35 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.535 0.734 . . . . 0.0 109.796 174.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.1 tt -150.85 139.79 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.519 0.727 . . . . 0.0 109.88 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.71 109.49 12.11 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.841 1.256 . . . . 0.0 108.399 174.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.6 125.97 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.9 t -115.57 127.97 55.63 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.86 1.264 . . . . 0.0 110.151 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.8 tp -70.73 -50.47 35.81 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.098 0.959 . . . . 0.0 109.65 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.76 -43.76 69.43 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.019 1.328 . . . . 0.0 111.832 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -89.18 -16.52 31.15 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.162 0.585 . . . . 0.0 111.122 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.0 m 55.21 56.29 6.63 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 125.141 1.376 . . . . 0.0 110.223 -177.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -154.84 168.8 25.69 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.062 0.545 . . . . 0.0 111.475 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.04 115.79 2.41 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 126.101 1.81 . . . . 0.0 108.6 176.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.7 m -99.22 99.1 10.03 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.5 t -106.9 126.71 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 124.791 1.236 . . . . 0.0 109.374 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -90.04 131.57 35.84 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -150.18 165.16 33.72 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.196 0.599 . . . . 0.0 112.022 -172.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -100.69 113.83 65.68 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.348 1.459 . . . . 0.0 108.688 172.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.65 -35.79 17.77 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 125.188 3.925 . . . . 0.0 114.798 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.26 -34.27 77.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.383 0.673 . . . . 0.0 111.73 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.75 -36.22 9.53 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.846 0.858 . . . . 0.0 111.557 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.1 t -147.22 176.74 9.74 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.62 0.645 . . . . 0.0 110.655 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.7 p -148.46 161.25 34.27 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.62 1.168 . . . . 0.0 109.729 -175.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.97 -38.74 59.38 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.42 2.747 . . . . 0.0 112.914 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -65.77 -44.32 86.19 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.482 1.113 . . . . 0.0 110.432 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.4 m -64.54 -45.4 87.31 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.056 0.543 . . . . 0.0 110.374 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.3 mt -63.22 -46.35 87.38 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.025 0.93 . . . . 0.0 110.775 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -52.21 -48.93 64.83 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.885 0.874 . . . . 0.0 109.805 170.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.15 -44.92 83.86 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.301 0.953 . . . . 0.0 112.582 176.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.96 -48.13 77.71 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.728 0.811 . . . . 0.0 111.287 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.6 mt -60.08 -41.43 86.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.916 0.886 . . . . 0.0 109.897 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -64.29 -40.19 95.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.382 0.673 . . . . 0.0 111.008 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.56 -41.9 98.37 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.027 0.931 . . . . 0.0 111.017 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.8 mtp -58.31 -45.3 88.3 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 172.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.39 57.04 0.14 Allowed Glycine 0 C--N 1.34 0.764 0 C-N-CA 123.807 0.718 . . . . 0.0 111.747 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -140.35 139.35 35.36 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.792 0.837 . . . . 0.0 108.763 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -70.64 93.05 0.89 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.726 0.81 . . . . 0.0 109.497 -176.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.5 131.44 45.5 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.75 1.22 . . . . 0.0 109.751 -173.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.0 p -139.25 139.19 37.34 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.857 1.263 . . . . 0.0 108.603 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 CA--C 1.53 0.204 0 C-N-CA 122.83 0.452 . . . . 0.0 110.467 -178.648 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 . . . . . 0 CA--C 1.528 0.126 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -120.03 142.7 48.59 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.099 0.96 . . . . 0.0 109.273 176.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.6 t -135.42 140.77 45.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.315 1.046 . . . . 0.0 109.712 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.9 t -103.54 111.2 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 175.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.6 mt -99.57 123.9 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -82.28 111.85 18.73 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.9 mt -116.48 106.42 20.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 C-N-CA 124.447 1.099 . . . . 0.0 108.071 -171.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -99.92 151.63 21.09 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.035 0.534 . . . . 0.0 109.59 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.52 12.11 56.26 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.489 1.043 . . . . 0.0 113.259 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.4 mtm . . . . . 0 C--N 1.343 0.296 0 CA-C-N 118.676 1.238 . . . . 0.0 109.43 177.176 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.5 m . . . . . 0 N--CA 1.457 -0.086 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.7 m -57.54 -47.03 83.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 168.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.5 t -49.59 -51.29 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.386 1.474 . . . . 0.0 110.595 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -62.87 -48.27 79.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.259 0.624 . . . . 0.0 111.232 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.4 p -61.2 -48.29 82.19 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.87 0.468 . . . . 0.0 111.274 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.2 mt -54.23 -59.03 2.38 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 C-N-CA 124.383 1.073 . . . . 0.0 109.488 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -54.63 -48.84 71.77 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.66 0.784 . . . . 0.0 110.642 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.95 -52.87 43.64 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.635 1.112 . . . . 0.0 112.303 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.2 t -67.69 -55.12 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 117.777 0.788 . . . . 0.0 110.697 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.14 -36.71 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.404 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.6 p -54.36 -29.66 49.12 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.127 0.876 . . . . 0.0 112.832 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.47 -7.93 53.98 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.983 0.913 . . . . 0.0 112.269 -176.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -70.7 142.4 88.5 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 119.022 0.828 . . . . 0.0 109.586 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.09 130.9 26.95 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.955 2.437 . . . . 0.0 109.987 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.93 -32.21 7.75 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 118.923 -0.932 . . . . 0.0 112.111 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.8 t -72.08 138.72 21.0 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 CA-C-N 118.396 1.098 . . . . 0.0 109.365 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -108.68 -101.83 0.37 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.7 p -90.29 153.83 20.17 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.566 0.747 . . . . 0.0 109.394 172.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.1 tt -150.18 129.83 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 123.511 0.724 . . . . 0.0 109.235 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -120.86 105.06 10.34 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 125.139 1.376 . . . . 0.0 108.65 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.44 122.49 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.1 t -110.03 128.25 55.31 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.643 1.177 . . . . 0.0 110.284 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.2 tp -67.25 -53.5 29.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.95 0.9 . . . . 0.0 109.277 171.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.34 -47.39 69.41 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.277 1.431 . . . . 0.0 112.039 -175.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -89.19 -8.03 54.42 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 119.043 -0.504 . . . . 0.0 111.605 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.8 m 51.57 56.25 8.17 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.168 1.387 . . . . 0.0 110.932 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.7 p30 -155.22 163.98 39.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.966 0.506 . . . . 0.0 111.217 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.84 113.32 2.44 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.1 m -98.65 94.66 6.78 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 t -101.03 123.81 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 124.362 1.065 . . . . 0.0 109.064 -170.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -95.07 128.93 42.28 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -150.24 174.19 13.11 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.145 0.578 . . . . 0.0 111.702 -170.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -108.41 110.24 61.64 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.541 1.536 . . . . 0.0 109.157 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -42.8 -40.47 8.13 Favored 'Trans proline' 0 C--N 1.348 0.545 1 C-N-CA 125.444 4.096 . . . . 0.0 114.995 173.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.4 mt -63.34 -31.79 73.04 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.753 0.821 . . . . 0.0 111.774 -176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.45 -34.53 9.12 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.426 1.09 . . . . 0.0 111.981 -173.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 t -149.57 158.25 44.0 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.551 0.74 . . . . 0.0 109.762 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 62.2 p -123.04 160.24 50.5 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.553 1.141 . . . . 0.0 110.068 -178.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -48.45 -39.61 36.37 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.54 2.827 . . . . 0.0 112.839 171.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -65.58 -45.14 84.41 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.139 0.975 . . . . 0.0 110.407 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.9 m -60.12 -46.64 88.96 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.219 0.608 . . . . 0.0 110.476 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.6 mt -62.35 -48.15 81.05 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.828 0.851 . . . . 0.0 110.518 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -53.94 -42.1 68.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.642 0.777 . . . . 0.0 110.469 172.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.72 -43.77 86.58 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.311 0.958 . . . . 0.0 112.171 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.88 -44.64 92.43 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.871 0.835 . . . . 0.0 111.429 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.7 mm -63.07 -41.84 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 122.861 0.464 . . . . 0.0 110.567 176.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.53 -41.92 98.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.836 0.854 . . . . 0.0 110.461 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -62.61 -45.72 91.56 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.014 0.926 . . . . 0.0 110.876 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.2 mmm -58.95 -34.74 72.12 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.302 0.641 . . . . 0.0 111.056 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.44 59.11 0.57 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 124.209 0.909 . . . . 0.0 111.655 169.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -140.2 154.57 46.96 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.911 0.884 . . . . 0.0 109.861 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -81.0 88.68 5.92 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.838 0.855 . . . . 0.0 109.558 -174.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.41 129.5 45.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.956 1.302 . . . . 0.0 110.948 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 89.5 m -144.28 128.72 17.96 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.586 1.154 . . . . 0.0 108.547 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.8 mt . . . . . 0 CA--C 1.532 0.274 0 C-N-CA 123.519 0.728 . . . . 0.0 111.127 -178.174 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 . . . . . 0 CA--C 1.531 0.217 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -140.06 142.74 36.14 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.178 0.991 . . . . 0.0 108.943 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 t -137.24 149.64 47.3 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.507 1.123 . . . . 0.0 109.316 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.0 t -110.87 138.12 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 172.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.0 mt -133.27 125.54 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -70.17 130.17 41.35 Favored 'General case' 0 C--N 1.337 0.061 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.2 mt -130.1 113.6 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -117.18 153.76 32.27 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.656 0.782 . . . . 0.0 109.907 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.39 20.44 48.58 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.403 1.001 . . . . 0.0 112.565 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.6 mtm . . . . . 0 N--CA 1.455 -0.19 0 CA-C-N 117.901 0.85 . . . . 0.0 108.911 177.596 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.9 m . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.2 m -65.73 -43.51 88.79 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.226 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -52.22 -54.19 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.111 0.564 . . . . 0.0 109.927 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -61.22 -45.76 93.24 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.158 0.983 . . . . 0.0 111.18 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.6 m -58.35 -53.68 55.56 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.876 0.47 . . . . 0.0 110.99 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.03 -55.53 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.351 1.06 . . . . 0.0 109.722 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -56.81 -50.34 72.66 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.139 0.975 . . . . 0.0 110.937 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.93 -51.96 56.12 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.902 1.239 . . . . 0.0 112.161 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.16 -54.47 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 117.746 0.773 . . . . 0.0 110.223 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.9 mt -65.44 -35.53 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.796 -172.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.0 p -54.2 -30.55 50.18 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.01 0.823 . . . . 0.0 112.519 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -89.58 -11.23 43.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.077 0.951 . . . . 0.0 112.617 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -68.27 144.46 96.71 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 119.193 0.906 . . . . 0.0 109.918 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.75 132.23 34.28 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.054 2.502 . . . . 0.0 110.31 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.17 -35.85 4.6 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-O 119.02 -0.878 . . . . 0.0 112.223 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.76 127.74 31.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 118.09 0.945 . . . . 0.0 109.881 -177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -94.56 -101.41 0.15 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.7 p -90.07 155.75 18.85 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.608 0.763 . . . . 0.0 110.363 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.2 tt -150.62 145.72 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 123.975 0.91 . . . . 0.0 109.772 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.12 141.98 44.21 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.0 t -125.52 117.37 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.691 1.197 . . . . 0.0 108.324 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.7 t -104.62 123.96 48.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.809 1.244 . . . . 0.0 109.818 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.9 tp -73.94 -44.12 56.03 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 124.165 0.986 . . . . 0.0 110.107 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.86 -45.88 74.62 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.582 1.153 . . . . 0.0 111.406 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -89.5 -7.61 54.63 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.607 0.763 . . . . 0.0 111.591 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.3 m 54.49 53.79 10.26 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.949 1.699 . . . . 0.0 111.474 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -160.02 167.23 28.36 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.198 0.599 . . . . 0.0 111.185 -175.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.59 121.84 3.96 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.8 m -99.68 112.94 25.12 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 173.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 t -117.81 122.27 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.701 1.2 . . . . 0.0 108.737 -172.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -89.68 132.51 35.12 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 169.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -150.36 168.31 24.48 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.905 0.482 . . . . 0.0 112.103 -170.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -103.97 111.4 65.14 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 125.181 1.392 . . . . 0.0 109.048 173.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -41.75 -38.28 4.41 Favored 'Trans proline' 0 C--N 1.347 0.495 1 C-N-CA 125.432 4.088 . . . . 0.0 115.312 171.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.8 mt -64.25 -34.03 77.18 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.162 0.585 . . . . 0.0 111.952 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.5 mt -103.82 -33.65 8.82 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.264 1.025 . . . . 0.0 112.333 -171.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.9 t -148.72 176.27 10.51 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.56 0.744 . . . . 0.0 109.801 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.9 p -150.25 163.5 24.12 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 123.891 0.877 . . . . 0.0 110.323 -174.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.42 -46.92 30.33 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.401 2.734 . . . . 0.0 112.986 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -65.73 -35.8 81.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.305 0.642 . . . . 0.0 112.123 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.8 m -67.16 -46.04 75.19 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.165 0.439 . . . . 0.0 110.296 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.7 mt -60.55 -47.11 87.61 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.544 0.737 . . . . 0.0 110.418 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.5 ttp85 -54.77 -46.5 74.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.134 0.973 . . . . 0.0 110.055 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.43 -43.99 93.77 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.503 1.049 . . . . 0.0 112.309 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.44 -46.22 87.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.926 0.863 . . . . 0.0 111.099 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.0 mt -59.92 -45.69 94.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 123.411 0.685 . . . . 0.0 109.639 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -61.28 -41.56 97.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.672 0.789 . . . . 0.0 111.039 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.97 -44.35 96.28 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.499 1.12 . . . . 0.0 111.032 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.6 mtm -57.84 -43.62 85.97 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.513 0.325 . . . . 0.0 110.595 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.67 61.54 0.19 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 123.531 0.586 . . . . 0.0 111.651 169.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -140.08 147.35 40.16 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 173.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -70.13 95.92 1.03 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.5 123.5 47.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.016 1.326 . . . . 0.0 109.937 -173.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.9 p -142.35 142.88 32.52 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.234 1.014 . . . . 0.0 108.542 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.5 mt . . . . . 0 CA--C 1.53 0.209 0 C-N-CA 122.776 0.43 . . . . 0.0 110.959 -176.38 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 . . . . . 0 C--O 1.231 0.128 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.79 140.91 52.52 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.824 1.249 . . . . 0.0 108.44 173.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 t -136.27 135.64 39.14 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.181 0.992 . . . . 0.0 109.529 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.5 t -99.65 124.1 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 171.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.9 mt -120.44 120.14 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -73.74 129.21 37.45 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.7 mt -122.19 108.65 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -99.61 145.87 27.09 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.56 -7.09 53.26 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 118.855 -0.97 . . . . 0.0 113.36 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.9 mtm . . . . . 0 C--N 1.344 0.358 0 CA-C-N 118.938 1.369 . . . . 0.0 110.09 177.729 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 119.811 -0.138 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.6 m -61.97 -50.04 73.71 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.932 0.493 . . . . 0.0 110.297 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.1 t -51.24 -50.26 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.229 1.012 . . . . 0.0 110.85 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -58.17 -50.25 74.19 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.403 1.081 . . . . 0.0 110.681 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.4 m -57.92 -48.34 80.18 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.142 0.577 . . . . 0.0 111.152 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -59.07 -50.46 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.611 0.764 . . . . 0.0 109.548 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -51.52 -56.4 13.59 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.022 0.929 . . . . 0.0 110.106 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.34 -55.0 32.74 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.206 0.908 . . . . 0.0 112.335 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.09 -56.35 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.317 0.647 . . . . 0.0 110.767 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.3 mm -61.41 -37.86 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.215 -175.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.0 t -50.31 -38.21 40.4 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.618 0.645 . . . . 0.0 112.285 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.41 -1.45 58.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.664 0.785 . . . . 0.0 112.717 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -69.94 145.07 93.86 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 119.424 1.011 . . . . 0.0 109.485 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.37 127.8 20.93 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.88 2.387 . . . . 0.0 109.911 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.92 -38.2 3.37 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.126 -0.819 . . . . 0.0 111.713 -176.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.81 140.15 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 118.046 0.923 . . . . 0.0 109.805 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -106.22 -98.79 0.34 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 172.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 53.0 p -90.63 160.07 16.09 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.035 0.934 . . . . 0.0 110.234 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.9 tt -150.27 138.93 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 124.288 1.035 . . . . 0.0 108.454 172.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.57 104.69 10.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.498 1.119 . . . . 0.0 109.205 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -94.8 122.69 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.8 t -109.7 127.01 54.3 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.463 1.105 . . . . 0.0 109.933 -177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.67 -55.92 14.87 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.137 0.975 . . . . 0.0 108.528 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.69 -47.16 63.99 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.414 1.486 . . . . 0.0 112.341 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -89.26 -10.91 45.15 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.954 0.501 . . . . 0.0 111.634 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m 52.87 56.46 7.56 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.188 1.395 . . . . 0.0 110.906 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.1 p30 -155.44 169.73 23.58 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.166 0.587 . . . . 0.0 111.175 -176.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.08 115.43 2.19 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 126.269 1.89 . . . . 0.0 108.714 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.5 m -99.04 96.48 7.84 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.81 129.4 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.516 1.127 . . . . 0.0 109.283 -170.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -99.37 124.12 44.22 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -150.3 172.46 15.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.943 0.497 . . . . 0.0 112.288 -169.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -105.88 110.33 64.0 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.29 1.436 . . . . 0.0 109.468 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -40.84 -41.79 4.1 Favored 'Trans proline' 0 C--N 1.348 0.518 1 C-N-CA 125.432 4.088 . . . . 0.0 115.294 171.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.1 mt -60.56 -35.55 76.31 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.465 0.706 . . . . 0.0 111.866 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.0 -32.18 11.09 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.232 1.013 . . . . 0.0 112.1 -172.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.1 t -150.42 152.73 34.77 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.603 0.638 . . . . 0.0 109.891 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 p -116.36 162.53 25.95 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.535 1.134 . . . . 0.0 109.936 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.09 -39.59 50.92 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.329 2.686 . . . . 0.0 112.65 170.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.2 -39.11 89.42 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.929 0.892 . . . . 0.0 111.596 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 m -63.73 -47.34 81.46 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.927 0.491 . . . . 0.0 110.202 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.2 mt -62.14 -49.17 76.91 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.125 0.97 . . . . 0.0 110.36 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -49.88 -48.12 51.56 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.795 1.238 . . . . 0.0 109.943 170.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.32 -46.95 85.68 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.528 1.061 . . . . 0.0 112.413 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.65 91.55 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.835 0.817 . . . . 0.0 111.29 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -60.62 -44.16 96.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.804 0.842 . . . . 0.0 109.912 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.01 -38.94 92.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.853 0.861 . . . . 0.0 111.153 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.55 -44.08 97.22 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.26 1.024 . . . . 0.0 110.816 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.7 mtm -58.81 -48.84 79.89 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.3 59.76 0.1 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 170.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -140.24 137.59 34.39 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 172.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.33 97.94 1.01 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.542 0.737 . . . . 0.0 109.798 -176.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.86 133.14 44.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.792 1.237 . . . . 0.0 110.184 -174.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.2 m -144.49 138.57 27.7 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.603 1.161 . . . . 0.0 108.369 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 mm? . . . . . 0 CA--C 1.531 0.232 0 C-N-CA 122.732 0.413 . . . . 0.0 110.178 -177.883 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.88 149.24 43.67 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.738 0.815 . . . . 0.0 110.428 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -143.85 146.17 32.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.459 1.104 . . . . 0.0 108.999 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 51.2 t -113.3 124.5 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.8 mt -120.32 125.79 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -177.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -70.13 126.86 30.91 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 172.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.4 mt -123.11 95.15 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -99.33 132.48 44.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.32 -27.81 4.41 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -170.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 48.4 mtm . . . . . 0 C--N 1.342 0.241 0 CA-C-N 117.717 0.758 . . . . 0.0 109.161 174.838 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.1 p . . . . . 0 CA--C 1.532 0.286 0 N-CA-C 111.316 0.117 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.2 m -62.41 -49.65 74.63 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.674 0.789 . . . . 0.0 109.661 177.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.8 t -54.6 -58.08 4.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.332 1.053 . . . . 0.0 110.224 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -61.69 -41.76 98.01 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.285 0.634 . . . . 0.0 111.382 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -58.98 -59.13 5.95 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.104 0.561 . . . . 0.0 110.633 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.4 mt -57.78 -55.61 20.55 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 123.52 0.728 . . . . 0.0 109.69 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -55.67 -48.49 74.97 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.572 0.749 . . . . 0.0 110.706 -176.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.94 -53.45 45.35 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.329 0.966 . . . . 0.0 112.225 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.22 -55.63 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 117.709 0.754 . . . . 0.0 110.683 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.5 mm -63.7 -38.22 81.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.514 0.725 . . . . 0.0 111.559 -173.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.5 p -54.98 -30.65 59.76 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.069 0.85 . . . . 0.0 112.553 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.35 -5.98 57.04 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.932 0.893 . . . . 0.0 112.187 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -70.71 142.67 88.76 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 119.017 0.826 . . . . 0.0 109.136 176.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.16 132.49 34.29 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.823 2.349 . . . . 0.0 110.093 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.48 -35.78 4.73 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 118.919 -0.934 . . . . 0.0 112.088 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.27 129.32 33.71 Favored 'Isoleucine or valine' 0 C--N 1.341 0.214 0 CA-C-N 118.074 0.937 . . . . 0.0 109.735 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -100.66 -101.87 0.25 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.55 1.14 . . . . 0.0 108.03 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 74.0 p -87.01 151.62 23.11 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.288 0.635 . . . . 0.0 109.744 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.1 tt -150.4 131.05 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.462 0.705 . . . . 0.0 109.421 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -120.81 105.78 11.05 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.429 1.492 . . . . 0.0 108.717 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.72 125.89 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.2 t -116.16 118.71 33.59 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.685 1.194 . . . . 0.0 110.023 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.59 -49.1 74.68 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.991 0.916 . . . . 0.0 109.834 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.1 -48.55 67.72 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.7 1.2 . . . . 0.0 111.994 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -89.7 -1.86 58.12 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.232 0.613 . . . . 0.0 112.201 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.1 m 49.71 52.0 15.41 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.318 1.447 . . . . 0.0 111.579 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -156.21 170.22 22.74 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 120.968 0.413 . . . . 0.0 111.664 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.58 119.28 2.55 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 125.607 1.575 . . . . 0.0 109.232 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.5 m -99.32 104.49 16.4 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.6 t -112.04 128.57 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.532 1.133 . . . . 0.0 109.574 -170.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -98.79 133.33 43.26 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -150.43 164.87 34.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.66 0.784 . . . . 0.0 111.844 -170.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -102.27 116.57 62.82 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.337 1.055 . . . . 0.0 109.498 173.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.71 -40.29 18.88 Favored 'Trans proline' 0 C--N 1.349 0.586 1 C-N-CA 125.348 4.032 . . . . 0.0 115.468 177.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.9 mt -67.11 -27.72 67.56 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.197 0.599 . . . . 0.0 111.949 -174.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.68 -42.05 7.04 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.078 0.951 . . . . 0.0 110.707 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.4 t -148.73 174.81 11.79 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.62 0.768 . . . . 0.0 110.001 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.3 p -150.56 164.37 20.7 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 124.563 1.145 . . . . 0.0 110.439 -170.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.25 -45.58 38.39 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.134 2.556 . . . . 0.0 112.79 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -67.32 -38.78 85.49 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.396 0.679 . . . . 0.0 112.806 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.3 p -66.0 -46.37 78.24 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.724 0.693 . . . . 0.0 110.438 176.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.6 mt -62.1 -46.43 89.08 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.752 0.821 . . . . 0.0 110.428 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -53.5 -45.36 69.64 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.159 0.984 . . . . 0.0 110.47 171.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.4 -47.04 91.0 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.076 0.846 . . . . 0.0 112.114 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.05 -51.95 65.92 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.473 0.709 . . . . 0.0 111.059 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.8 mt -57.57 -41.84 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.016 0.926 . . . . 0.0 109.9 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -59.0 -50.52 73.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.355 0.662 . . . . 0.0 109.749 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -58.25 -38.74 77.5 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.772 1.229 . . . . 0.0 112.0 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mtp -60.81 -20.95 62.59 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.98 57.12 0.52 Allowed Glycine 0 C--N 1.34 0.784 0 C-N-CA 124.306 0.955 . . . . 0.0 111.151 170.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -140.6 155.47 46.56 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.27 1.028 . . . . 0.0 109.46 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -80.39 93.75 6.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 169.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.42 117.57 34.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.698 1.199 . . . . 0.0 108.862 -176.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.4 p -140.06 136.52 33.72 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.21 1.004 . . . . 0.0 109.054 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.6 mt . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 122.84 0.456 . . . . 0.0 110.813 -175.998 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -123.98 154.65 39.52 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.873 1.269 . . . . 0.0 109.652 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 t -150.14 144.74 25.89 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.779 0.832 . . . . 0.0 109.981 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.7 t -109.27 115.75 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.3 mt -110.51 118.13 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -76.04 121.89 23.43 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.1 mt -118.15 110.11 29.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 124.747 1.219 . . . . 0.0 108.097 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -99.8 148.04 24.84 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.58 3.67 56.2 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.511 1.053 . . . . 0.0 113.531 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.6 mtm . . . . . 0 C--N 1.344 0.362 0 CA-C-N 118.825 1.313 . . . . 0.0 109.767 178.547 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.5 m . . . . . 0 N--CA 1.456 -0.168 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.0 m -61.03 -49.17 78.47 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 168.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 82.7 t -49.71 -51.64 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.221 1.408 . . . . 0.0 110.279 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -60.33 -48.66 80.77 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.092 0.957 . . . . 0.0 111.125 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.7 p -62.19 -47.81 82.84 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 122.848 0.459 . . . . 0.0 111.371 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.2 mt -55.35 -60.58 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 123.715 0.806 . . . . 0.0 108.953 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -53.24 -48.5 68.17 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.772 0.829 . . . . 0.0 110.959 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.08 -57.78 16.79 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.241 0.925 . . . . 0.0 111.925 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.49 -53.13 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 117.624 0.712 . . . . 0.0 110.929 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.9 -45.76 91.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.618 0.767 . . . . 0.0 110.738 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 88.0 p -57.73 -27.46 63.0 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -88.9 -5.51 57.95 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.43 0.692 . . . . 0.0 111.891 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -78.83 123.18 85.3 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 119.084 0.856 . . . . 0.0 109.026 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.74 116.94 2.64 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.696 2.931 . . . . 0.0 112.075 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.47 -44.51 1.15 Allowed Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.9 t -70.8 130.4 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 117.453 0.626 . . . . 0.0 109.718 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -96.82 -100.79 0.18 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.974 1.31 . . . . 0.0 107.529 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.4 p -90.23 156.83 18.03 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.38 0.672 . . . . 0.0 110.004 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.6 tt -150.58 145.52 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.7 0.8 . . . . 0.0 110.217 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -133.97 104.92 6.47 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.923 1.289 . . . . 0.0 107.571 169.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.2 t -89.8 97.86 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.8 t -89.75 123.08 33.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.835 0.854 . . . . 0.0 109.469 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.1 tp -70.82 -49.34 47.4 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.792 0.837 . . . . 0.0 110.092 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.69 -46.17 74.07 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.0 1.32 . . . . 0.0 112.054 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -89.22 -6.79 56.6 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.745 0.818 . . . . 0.0 111.319 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 m 52.55 54.25 10.94 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.85 1.66 . . . . 0.0 111.389 176.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -156.52 150.08 24.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.342 0.592 . . . . 0.0 112.282 -175.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -94.7 108.71 3.72 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 170.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -98.76 95.74 7.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 175.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 t -108.81 134.19 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.517 1.127 . . . . 0.0 109.879 -169.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -105.27 132.71 51.13 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 168.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -150.36 170.9 17.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.079 0.552 . . . . 0.0 111.384 -169.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -102.8 111.43 64.88 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.056 1.342 . . . . 0.0 109.241 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -41.75 -40.03 5.37 Favored 'Trans proline' 0 C--N 1.347 0.454 1 C-N-CA 125.618 4.212 . . . . 0.0 115.047 172.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.1 mt -61.93 -33.38 74.16 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.612 0.765 . . . . 0.0 111.829 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.0 mt -102.87 -38.13 7.53 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.478 1.111 . . . . 0.0 111.919 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 t -147.12 174.16 11.83 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.592 0.757 . . . . 0.0 110.1 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.7 p -150.21 162.89 26.37 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.113 0.965 . . . . 0.0 110.02 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -52.62 -43.55 54.36 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.659 2.906 . . . . 0.0 113.186 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -64.29 -36.83 85.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.551 0.74 . . . . 0.0 112.103 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.0 m -68.57 -46.41 69.48 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.019 0.527 . . . . 0.0 109.884 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.3 mt -61.0 -46.83 89.17 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.166 0.986 . . . . 0.0 110.307 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -54.63 -44.7 73.39 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.171 0.988 . . . . 0.0 110.296 172.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.13 -44.64 93.07 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.247 0.927 . . . . 0.0 112.245 175.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.06 -49.31 75.02 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.542 0.737 . . . . 0.0 111.229 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.4 mt -61.85 -39.39 83.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.913 0.885 . . . . 0.0 110.028 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.46 -48.52 80.75 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.6 0.76 . . . . 0.0 109.859 176.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.27 -40.67 86.8 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.561 1.144 . . . . 0.0 111.43 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.8 mmm -60.98 -19.63 61.4 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.607 0.763 . . . . 0.0 112.163 173.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.15 53.53 0.95 Allowed Glycine 0 C--N 1.34 0.796 0 C-N-CA 124.411 1.005 . . . . 0.0 111.699 169.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -140.52 156.2 46.39 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.86 0.864 . . . . 0.0 110.273 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -82.88 87.14 6.84 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.23 124.74 44.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.606 1.162 . . . . 0.0 109.936 -173.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.9 p -139.99 140.18 36.21 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.685 1.194 . . . . 0.0 108.79 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 CA--C 1.531 0.213 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.103 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -102.58 143.27 32.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.211 1.004 . . . . 0.0 109.354 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -137.26 142.44 41.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.46 124.83 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.0 mt -121.09 120.5 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -77.29 120.76 22.77 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.3 mt -122.35 106.85 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.745 1.218 . . . . 0.0 107.881 -173.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -99.6 146.91 25.93 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.83 -12.61 17.7 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.55 1.071 . . . . 0.0 112.108 -172.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 44.6 mtm . . . . . 0 C--N 1.343 0.325 0 CA-C-N 118.382 1.091 . . . . 0.0 109.56 178.64 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.3 m -61.24 -59.1 5.83 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.375 0.67 . . . . 0.0 109.394 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -50.01 -51.3 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.23 1.412 . . . . 0.0 111.194 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -59.79 -53.19 60.81 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.272 1.429 . . . . 0.0 111.079 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.3 p -60.24 -49.34 77.99 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.026 0.53 . . . . 0.0 111.072 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.3 mt -53.46 -57.21 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.195 0.998 . . . . 0.0 109.943 177.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -53.39 -52.38 59.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.921 0.888 . . . . 0.0 110.844 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.08 -54.2 38.74 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.844 0.735 . . . . 0.0 112.312 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.16 -54.71 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.373 1.069 . . . . 0.0 110.876 -176.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.2 mm -61.75 -34.72 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.874 0.87 . . . . 0.0 111.262 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t -53.73 -19.47 4.23 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -89.25 -12.67 40.07 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.929 0.786 . . . . 0.0 112.392 -175.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -74.58 143.55 79.17 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 118.783 0.719 . . . . 0.0 110.131 -172.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.27 130.35 25.2 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.061 2.508 . . . . 0.0 109.772 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.04 -39.61 2.8 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 118.926 -0.93 . . . . 0.0 111.419 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.59 123.65 20.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 CA-C-N 118.069 0.935 . . . . 0.0 109.139 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -93.26 -102.65 0.13 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.4 p -90.26 155.99 18.6 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.907 0.883 . . . . 0.0 109.706 171.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.1 tt -150.32 141.08 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.652 0.781 . . . . 0.0 109.586 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -135.52 131.78 36.46 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.91 0.884 . . . . 0.0 108.769 169.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -115.82 133.73 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.9 t -112.56 133.46 54.6 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.932 1.293 . . . . 0.0 110.702 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.18 -56.7 5.54 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 170.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.55 -47.78 63.31 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.339 1.456 . . . . 0.0 112.335 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -89.25 -10.36 47.24 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.577 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m 52.03 56.29 7.99 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.02 1.328 . . . . 0.0 110.867 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -156.5 164.39 38.28 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.054 0.542 . . . . 0.0 111.102 -176.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.75 113.57 2.41 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 126.18 1.847 . . . . 0.0 108.825 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.9 m -99.4 107.88 20.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.34 130.22 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.453 1.101 . . . . 0.0 109.583 -170.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -93.65 127.73 39.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 168.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -149.1 155.48 40.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.827 0.451 . . . . 0.0 110.959 -169.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -95.15 115.22 65.21 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.282 1.033 . . . . 0.0 109.288 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.26 -36.38 17.02 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.861 3.708 . . . . 0.0 114.653 172.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.6 mt -66.06 -29.28 69.59 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.472 0.709 . . . . 0.0 112.099 -176.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.0 mt -108.73 -33.27 7.03 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.23 1.012 . . . . 0.0 112.26 -172.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.0 t -147.32 -179.83 7.12 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.566 0.746 . . . . 0.0 109.849 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.6 p -149.82 162.09 29.3 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 123.732 0.813 . . . . 0.0 110.125 -176.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -51.9 -40.0 67.51 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.402 2.734 . . . . 0.0 112.18 173.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.92 -46.91 79.67 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.288 1.035 . . . . 0.0 110.949 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.8 m -60.02 -47.32 86.34 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.052 0.541 . . . . 0.0 110.406 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.96 -50.45 73.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.843 0.857 . . . . 0.0 110.52 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.1 ttp85 -50.72 -46.76 59.18 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.149 0.98 . . . . 0.0 110.487 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.69 -46.77 81.34 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.137 0.875 . . . . 0.0 112.114 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.24 -47.01 86.3 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.664 0.732 . . . . 0.0 111.486 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 mm -58.51 -44.51 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.222 0.609 . . . . 0.0 110.24 175.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.51 -38.28 90.53 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.143 0.577 . . . . 0.0 110.927 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.27 -43.67 94.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.016 0.926 . . . . 0.0 110.947 176.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 90.6 mtp -59.0 -41.42 87.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 117.978 0.354 . . . . 0.0 110.441 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.26 56.45 0.22 Allowed Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.092 0.853 . . . . 0.0 111.862 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -140.27 139.75 35.6 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -74.02 96.33 2.66 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.467 0.707 . . . . 0.0 109.447 -175.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.95 132.72 45.14 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.96 1.304 . . . . 0.0 110.582 -173.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.9 p -138.24 134.95 35.05 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.079 1.352 . . . . 0.0 108.795 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.6 mt . . . . . 0 CA--C 1.528 0.133 0 C-N-CA 122.701 0.4 . . . . 0.0 110.401 -177.404 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.52 143.1 34.16 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.749 0.82 . . . . 0.0 109.258 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -139.46 144.66 38.11 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.009 0.924 . . . . 0.0 108.913 172.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.4 t -110.54 115.68 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.8 mm -99.84 126.81 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -77.51 113.89 15.79 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 170.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.9 mt -116.35 98.0 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -176.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -99.85 158.38 15.84 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.03 13.82 60.05 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.818 0.723 . . . . 0.0 112.902 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 68.0 mtm . . . . . 0 C--N 1.341 0.236 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 171.122 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 110.713 -0.106 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.3 m -60.22 -50.34 74.06 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.807 0.843 . . . . 0.0 110.006 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.3 t -52.76 -54.86 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.74 1.216 . . . . 0.0 110.347 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -60.11 -46.27 90.18 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.301 1.041 . . . . 0.0 111.586 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -57.88 -48.86 78.6 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.675 0.39 . . . . 0.0 111.199 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.0 mt -59.81 -59.41 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.19 0.596 . . . . 0.0 109.948 -177.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.95 -43.52 86.42 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.102 0.41 . . . . 0.0 111.166 -176.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.31 -54.82 29.82 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.814 0.721 . . . . 0.0 112.023 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.21 -53.89 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.322 0.649 . . . . 0.0 110.792 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.4 mm -62.79 -35.42 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.729 -172.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.0 m -53.3 -30.25 37.77 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.86 0.754 . . . . 0.0 112.77 174.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 -6.7 56.24 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.498 0.719 . . . . 0.0 112.052 -175.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -72.82 143.13 84.07 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 118.859 0.754 . . . . 0.0 109.314 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.84 135.9 54.43 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.931 2.421 . . . . 0.0 110.025 -176.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.39 -40.07 2.62 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-O 118.888 -0.951 . . . . 0.0 111.525 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -67.66 134.83 29.59 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 CA-C-N 118.068 0.934 . . . . 0.0 109.797 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -112.8 -89.5 0.52 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.8 p -90.75 154.49 19.49 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.884 0.874 . . . . 0.0 110.38 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.5 tt -150.61 148.8 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.666 1.186 . . . . 0.0 108.744 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -135.65 106.3 6.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.781 0.833 . . . . 0.0 109.201 174.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.8 t -94.49 100.49 11.21 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 C-N-CA 124.015 0.926 . . . . 0.0 109.307 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.4 t -89.54 120.19 30.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.974 0.91 . . . . 0.0 109.7 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.9 tp -69.98 -47.11 63.54 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.474 1.109 . . . . 0.0 110.042 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.01 -44.47 67.32 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.768 1.227 . . . . 0.0 111.682 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -89.29 -14.73 35.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.404 0.681 . . . . 0.0 111.3 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.1 m 55.52 54.76 8.05 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 125.403 1.481 . . . . 0.0 110.665 -177.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.5 p30 -153.17 158.47 41.84 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.028 0.531 . . . . 0.0 111.619 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.58 114.55 3.17 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 126.052 1.787 . . . . 0.0 108.92 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.3 m -98.9 97.14 8.35 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.67 134.14 44.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 C-N-CA 124.829 1.252 . . . . 0.0 109.704 -170.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -105.19 116.99 32.88 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 172.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -145.9 153.17 40.55 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.602 0.761 . . . . 0.0 111.842 -169.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -88.16 120.49 70.62 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 123.673 0.789 . . . . 0.0 110.163 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -47.8 -39.33 31.23 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.997 3.798 . . . . 0.0 115.457 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.4 mt -67.67 -28.77 67.98 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.882 0.473 . . . . 0.0 111.809 -174.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.61 -34.76 10.09 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.797 0.839 . . . . 0.0 111.091 -174.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 t -151.83 171.03 18.38 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.631 0.65 . . . . 0.0 110.2 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.6 p -138.89 162.68 51.3 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.757 1.223 . . . . 0.0 109.996 -175.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -50.99 -43.12 49.6 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.492 2.795 . . . . 0.0 112.573 174.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -62.48 -43.3 99.15 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.891 0.876 . . . . 0.0 111.739 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.5 m -64.15 -47.55 79.44 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.991 0.359 . . . . 0.0 110.299 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.8 mt -59.46 -50.61 73.25 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.985 0.914 . . . . 0.0 110.318 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 -51.5 -46.69 63.29 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.54 1.136 . . . . 0.0 110.297 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.75 -47.04 91.34 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.6 1.095 . . . . 0.0 112.184 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.57 -45.35 93.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.507 0.723 . . . . 0.0 111.273 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -62.75 -43.69 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.714 0.806 . . . . 0.0 109.876 178.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -59.47 -46.59 88.36 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.683 0.793 . . . . 0.0 110.035 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -59.24 -42.83 92.0 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.494 1.118 . . . . 0.0 111.562 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 71.7 mtm -57.66 -45.81 85.07 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 118.025 0.375 . . . . 0.0 110.687 173.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.47 63.05 0.12 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 170.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -140.28 158.5 43.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.902 0.881 . . . . 0.0 109.385 174.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -79.33 87.21 5.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.28 118.72 36.57 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.552 1.141 . . . . 0.0 109.835 -173.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.2 p -138.19 149.87 46.23 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.783 1.233 . . . . 0.0 108.683 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 29.3 mt . . . . . 0 CA--C 1.529 0.136 0 CA-C-N 118.159 0.436 . . . . 0.0 110.056 179.932 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 . . . . . 0 CA--C 1.528 0.115 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -140.27 147.08 39.43 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.511 0.724 . . . . 0.0 109.975 -177.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.8 t -142.23 153.11 43.71 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.371 1.068 . . . . 0.0 109.918 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.35 115.81 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 173.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.4 mt -106.12 124.94 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -80.14 118.67 22.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.6 mt -116.06 102.53 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -174.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -99.55 142.65 30.74 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.21 19.55 27.94 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.554 1.073 . . . . 0.0 113.142 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 68.5 mtm . . . . . 0 C--N 1.342 0.269 0 CA-C-N 118.618 1.209 . . . . 0.0 109.261 174.652 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.5 m -62.58 -50.87 69.56 Favored 'General case' 0 C--N 1.338 0.104 0 C-N-CA 123.689 0.796 . . . . 0.0 110.287 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.1 t -53.44 -49.86 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.188 0.995 . . . . 0.0 110.706 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -57.74 -45.54 85.71 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.958 0.903 . . . . 0.0 111.406 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.7 m -59.67 -53.81 53.73 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.822 0.449 . . . . 0.0 110.856 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -57.73 -51.33 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.604 1.162 . . . . 0.0 109.797 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -49.8 -58.52 5.19 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.859 1.664 . . . . 0.0 110.232 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.95 -55.05 32.68 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.063 0.839 . . . . 0.0 112.141 -177.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.22 -55.3 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.428 0.691 . . . . 0.0 110.79 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.6 mt -68.09 -34.68 68.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 119.145 -0.455 . . . . 0.0 111.344 -173.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -54.72 -27.42 40.63 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 174.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -89.69 -8.3 52.68 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.441 0.697 . . . . 0.0 112.522 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -72.91 141.54 81.95 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 119.171 0.896 . . . . 0.0 110.019 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.95 131.05 27.6 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.146 2.564 . . . . 0.0 110.265 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.67 -34.28 5.91 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-O 118.897 -0.946 . . . . 0.0 112.137 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.07 121.55 16.39 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 CA-C-N 118.178 0.989 . . . . 0.0 109.536 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -91.58 -101.5 0.11 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.366 1.066 . . . . 0.0 108.221 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.1 p -88.57 141.46 28.51 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.6 tt -141.69 138.31 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.04 111.07 6.95 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.042 1.337 . . . . 0.0 108.017 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.5 t -104.48 120.99 55.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 124.778 1.231 . . . . 0.0 108.462 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.8 t -103.08 129.03 49.78 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.749 1.22 . . . . 0.0 110.806 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.57 -56.7 9.54 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.369 1.067 . . . . 0.0 108.131 169.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.42 -48.72 62.59 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.452 1.501 . . . . 0.0 112.466 -175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -89.23 -5.03 57.97 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.883 0.473 . . . . 0.0 111.662 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.2 m 51.3 54.63 10.79 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.244 1.418 . . . . 0.0 111.341 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -156.78 160.09 38.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.017 0.437 . . . . 0.0 111.363 -176.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.06 114.23 3.15 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 126.307 1.908 . . . . 0.0 108.391 174.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.1 m -99.0 109.61 22.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 t -118.53 123.12 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.477 1.111 . . . . 0.0 109.198 -169.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -96.74 132.3 42.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 168.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -150.33 169.87 20.36 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.967 0.507 . . . . 0.0 112.155 -169.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.25 113.43 65.87 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.334 1.454 . . . . 0.0 109.68 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -45.67 -41.13 19.19 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 125.292 3.994 . . . . 0.0 115.637 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.5 mt -68.27 -29.0 67.69 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.836 0.454 . . . . 0.0 111.752 -174.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.2 mt -99.78 -35.31 9.83 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.385 1.074 . . . . 0.0 111.647 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -152.03 171.27 18.11 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.607 0.763 . . . . 0.0 109.76 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.3 p -148.15 164.71 20.84 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.739 1.216 . . . . 0.0 109.952 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.18 -38.91 81.77 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.298 2.665 . . . . 0.0 112.196 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -59.86 -52.4 65.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.236 1.014 . . . . 0.0 110.804 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.1 p -63.77 -40.78 97.5 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 122.882 0.473 . . . . 0.0 111.426 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.1 mt -66.26 -45.99 78.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.185 0.594 . . . . 0.0 110.391 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -54.77 -48.46 72.62 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.805 0.842 . . . . 0.0 109.608 171.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.36 -44.98 58.74 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.461 1.029 . . . . 0.0 112.628 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.56 -48.06 76.44 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.635 0.774 . . . . 0.0 111.057 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.5 mt -59.7 -45.03 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.556 0.743 . . . . 0.0 109.906 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.7 -42.82 97.97 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.39 1.076 . . . . 0.0 110.861 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.35 -43.97 97.57 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.034 0.934 . . . . 0.0 111.111 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.4 mtp -59.17 -40.56 86.01 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.797 0.439 . . . . 0.0 110.601 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.23 58.06 0.24 Allowed Glycine 0 C--N 1.34 0.792 0 C-N-CA 123.913 0.768 . . . . 0.0 111.856 169.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -140.26 148.7 41.85 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 124.018 0.927 . . . . 0.0 108.993 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -74.48 95.61 2.77 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -177.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 130.09 45.99 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.107 1.363 . . . . 0.0 110.218 -175.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 t -150.02 135.5 18.23 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.157 0.583 . . . . 0.0 109.765 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.7 mt . . . . . 0 CA--C 1.531 0.231 0 C-N-CA 123.266 0.626 . . . . 0.0 110.246 -177.582 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -122.11 155.57 35.44 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.837 1.255 . . . . 0.0 109.007 173.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 t -150.17 133.73 16.6 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 122.795 0.438 . . . . 0.0 109.825 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.8 t -99.71 99.01 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 124.825 1.25 . . . . 0.0 107.714 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.7 mt -99.85 114.45 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -75.22 132.68 41.27 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.2 mt -126.7 108.27 18.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 125.026 1.33 . . . . 0.0 107.773 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.89 139.87 34.94 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.69 7.09 26.17 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.023 1.297 . . . . 0.0 113.416 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.2 mtm . . . . . 0 C--N 1.341 0.232 0 CA-C-N 118.845 1.322 . . . . 0.0 109.921 -179.663 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 p . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.164 0.507 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.9 m -68.05 -43.9 77.61 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.811 1.245 . . . . 0.0 111.267 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.7 t -53.29 -50.7 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.039 0.936 . . . . 0.0 110.013 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -61.72 -50.08 73.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.777 1.231 . . . . 0.0 111.355 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.8 p -62.33 -46.27 89.45 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.959 0.345 . . . . 0.0 111.52 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.8 mt -58.13 -53.75 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 C-N-CA 123.748 0.819 . . . . 0.0 109.106 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -50.56 -57.7 7.54 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.873 0.869 . . . . 0.0 110.188 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.91 -56.8 23.02 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.992 0.806 . . . . 0.0 112.281 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.5 t -62.05 -53.82 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 117.305 0.552 . . . . 0.0 111.086 -174.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.8 mm -61.66 -36.97 76.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.915 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.8 t -54.25 -29.29 46.27 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.779 0.718 . . . . 0.0 112.611 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.1 mtmt -89.61 -14.89 33.97 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.848 0.859 . . . . 0.0 112.852 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -64.28 143.52 98.41 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 119.577 1.081 . . . . 0.0 110.228 174.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.24 142.13 78.5 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.153 2.568 . . . . 0.0 110.276 -175.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.67 -30.45 6.51 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.694 -1.059 . . . . 0.0 112.41 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.73 131.78 34.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 118.629 1.215 . . . . 0.0 109.739 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -90.05 -105.09 0.09 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 172.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.3 p -91.08 165.8 13.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.873 1.269 . . . . 0.0 110.382 169.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -147.96 132.6 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.472 1.109 . . . . 0.0 108.024 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.3 105.9 13.06 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.7 t -98.24 119.24 46.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.812 0.845 . . . . 0.0 108.926 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.4 t -109.47 125.49 52.5 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.851 1.26 . . . . 0.0 110.089 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.52 -52.25 41.2 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.327 1.051 . . . . 0.0 109.007 171.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.97 -46.07 68.08 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.3 1.44 . . . . 0.0 112.2 -176.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -89.25 -7.69 54.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.128 0.571 . . . . 0.0 111.425 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 m 52.76 54.22 10.88 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.8 1.64 . . . . 0.0 110.868 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -156.21 168.06 28.48 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.132 0.491 . . . . 0.0 111.502 -175.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.93 117.33 2.98 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 107.537 -2.225 . . . . 0.0 107.537 172.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.7 p -98.74 102.43 14.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.3 t -99.21 127.26 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -169.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -94.2 127.24 39.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 170.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -150.71 170.76 18.43 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -169.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -105.97 112.04 64.35 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.21 1.404 . . . . 0.0 109.183 173.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -42.74 -39.61 7.42 Favored 'Trans proline' 0 C--N 1.348 0.519 1 C-N-CA 125.443 4.095 . . . . 0.0 115.181 172.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.35 -35.79 80.24 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.334 0.654 . . . . 0.0 111.78 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.6 mt -99.96 -32.76 10.81 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.301 1.041 . . . . 0.0 112.181 -171.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.1 t -150.77 168.5 24.21 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.637 0.653 . . . . 0.0 110.28 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.3 p -136.07 159.49 70.79 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.746 1.218 . . . . 0.0 110.103 -176.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.42 -39.91 44.52 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.674 2.916 . . . . 0.0 113.163 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.01 -39.42 83.18 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.806 0.842 . . . . 0.0 111.78 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.8 m -65.26 -46.67 79.59 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.672 0.389 . . . . 0.0 109.985 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.6 mt -62.6 -46.67 87.22 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.325 1.05 . . . . 0.0 110.577 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -51.89 -47.02 64.74 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.568 1.147 . . . . 0.0 109.869 170.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.54 -44.61 90.64 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.321 0.962 . . . . 0.0 112.328 176.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.23 -43.59 90.94 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.742 0.771 . . . . 0.0 111.389 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.6 mt -64.82 -38.65 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.744 0.818 . . . . 0.0 110.004 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.95 -40.86 95.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.618 0.767 . . . . 0.0 110.53 176.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.08 -42.93 99.73 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.995 0.918 . . . . 0.0 110.862 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.5 mmm -56.22 -39.66 72.83 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.214 0.606 . . . . 0.0 110.637 172.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.7 58.37 0.27 Allowed Glycine 0 C--N 1.341 0.816 0 C-N-CA 123.867 0.746 . . . . 0.0 111.967 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -140.41 155.11 46.84 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.896 0.878 . . . . 0.0 109.957 175.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -77.24 94.37 4.12 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.62 124.0 44.42 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.917 1.287 . . . . 0.0 109.526 -175.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 48.0 p -141.87 143.77 33.51 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.415 1.086 . . . . 0.0 109.124 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 mm? . . . . . 0 CA--C 1.529 0.153 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.482 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 39.0 tp . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 110.634 -0.136 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.7 p -136.54 125.57 24.4 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.484 1.113 . . . . 0.0 109.785 -174.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -138.71 149.22 44.86 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 125.568 1.547 . . . . 0.0 108.366 170.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -106.85 153.97 21.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.162 0.985 . . . . 0.0 110.232 177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.2 t -149.94 143.39 25.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.896 0.879 . . . . 0.0 109.149 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.0 t -108.66 124.69 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 173.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.9 mt -121.95 119.53 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -73.5 126.36 30.04 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.2 mt -120.86 110.49 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.086 1.355 . . . . 0.0 107.675 -176.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -99.9 145.57 27.65 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.438 0.695 . . . . 0.0 109.146 174.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.08 13.01 47.47 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.648 1.118 . . . . 0.0 113.497 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 67.4 mtm -72.7 82.71 1.15 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.558 1.179 . . . . 0.0 109.257 177.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.5 m -76.33 93.14 3.4 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.556 1.142 . . . . 0.0 109.937 -171.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.6 t 77.0 163.37 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.765 1.626 . . . . 0.0 111.225 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -53.3 -25.1 13.51 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.707 1.603 . . . . 0.0 113.075 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.6 p -54.47 -51.67 64.31 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.92 0.888 . . . . 0.0 110.931 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.4 m -63.86 -46.55 84.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.695 0.798 . . . . 0.0 110.598 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -53.4 -53.69 22.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.293 1.037 . . . . 0.0 110.059 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -60.97 -46.14 91.92 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.858 1.263 . . . . 0.0 110.905 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.1 t -57.44 -53.59 56.47 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.534 0.733 . . . . 0.0 110.754 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.6 mt -55.98 -55.27 19.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.152 0 C-N-CA 124.083 0.953 . . . . 0.0 109.424 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.89 -53.08 54.26 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.569 0.748 . . . . 0.0 110.932 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.22 -53.37 46.18 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.383 0.992 . . . . 0.0 112.552 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.82 -53.56 46.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 117.579 0.689 . . . . 0.0 110.485 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.3 mm -62.21 -36.64 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 118.814 -0.612 . . . . 0.0 111.024 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.7 t -51.3 -37.12 45.75 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.829 0.741 . . . . 0.0 111.933 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -89.21 -3.62 58.5 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.709 0.804 . . . . 0.0 112.455 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -71.78 142.53 85.9 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 119.352 0.978 . . . . 0.0 109.322 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -46.55 134.41 16.58 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.921 3.081 . . . . 0.0 112.801 177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.93 -40.33 2.85 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-O 118.802 -0.999 . . . . 0.0 112.644 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.8 t -66.45 135.42 28.5 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.178 0.989 . . . . 0.0 109.704 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -114.29 -88.42 0.56 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.7 p -90.82 149.85 21.81 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.581 0.752 . . . . 0.0 109.949 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.52 138.19 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 124.035 0.934 . . . . 0.0 109.041 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.1 mmt85 -130.84 109.09 10.32 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.778 1.231 . . . . 0.0 108.287 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.9 t -98.21 114.61 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 124.002 0.921 . . . . 0.0 108.748 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.1 t -100.61 123.56 44.99 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 124.388 1.075 . . . . 0.0 109.452 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.0 tp -71.93 -44.08 64.21 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.688 0.795 . . . . 0.0 110.019 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.87 -46.88 74.79 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.892 1.277 . . . . 0.0 111.732 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -89.23 -7.06 56.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.209 0.604 . . . . 0.0 111.352 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.3 m 53.05 54.88 9.69 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.774 1.63 . . . . 0.0 111.019 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -155.54 163.58 39.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.986 0.422 . . . . 0.0 111.803 -175.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.24 116.16 3.54 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 126.402 1.954 . . . . 0.0 108.365 175.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.1 m -99.24 101.56 12.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.5 t -108.38 131.72 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 124.499 1.12 . . . . 0.0 109.521 -170.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -102.24 125.41 48.93 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -146.59 164.82 31.39 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.587 0.755 . . . . 0.0 111.405 -171.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -97.49 115.68 65.77 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.476 1.111 . . . . 0.0 109.277 174.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -45.94 -38.48 18.48 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 125.255 3.97 . . . . 0.0 115.175 175.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.8 mt -65.59 -28.13 68.92 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.456 0.702 . . . . 0.0 111.839 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.64 -44.09 6.25 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.219 1.007 . . . . 0.0 110.854 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.1 t -144.9 176.21 9.64 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 123.483 0.713 . . . . 0.0 110.403 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.8 p -149.99 164.63 19.97 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 124.209 1.004 . . . . 0.0 109.864 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.24 -47.08 28.7 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.605 2.87 . . . . 0.0 113.009 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.65 -36.0 82.39 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.468 0.707 . . . . 0.0 112.118 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 m -67.18 -45.65 76.3 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.963 0.505 . . . . 0.0 110.154 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.1 mt -62.21 -46.52 88.5 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.07 0.948 . . . . 0.0 110.443 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -52.5 -47.24 66.73 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.172 0.989 . . . . 0.0 110.052 170.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.75 -45.2 86.22 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.257 0.932 . . . . 0.0 112.288 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.48 -47.85 77.43 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 117.677 0.739 . . . . 0.0 111.262 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.8 mt -60.98 -41.99 91.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.759 0.824 . . . . 0.0 110.076 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.93 -41.32 99.44 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.089 0.956 . . . . 0.0 110.799 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.68 -42.05 99.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.856 0.862 . . . . 0.0 111.094 177.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.4 mtp -58.68 -46.82 86.39 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 117.98 0.354 . . . . 0.0 110.09 173.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.06 59.13 0.13 Allowed Glycine 0 C--N 1.341 0.815 0 C-N-CA 123.882 0.754 . . . . 0.0 111.735 170.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -140.21 146.55 38.84 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.874 0.87 . . . . 0.0 109.124 174.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -76.13 92.32 3.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.5 131.82 45.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.928 1.291 . . . . 0.0 110.166 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.3 m -143.51 134.01 24.84 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.825 1.25 . . . . 0.0 108.414 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.5 mt -64.12 127.68 32.48 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.154 0.582 . . . . 0.0 109.904 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.9 t -98.42 -51.41 3.97 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.01 0.924 . . . . 0.0 109.77 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.6 t70 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 116.906 -1.521 . . . . 0.0 108.831 -179.824 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.1 mp . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.1 p -134.69 115.89 14.3 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.84 1.256 . . . . 0.0 109.137 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -134.92 156.83 48.29 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 124.571 1.148 . . . . 0.0 108.612 171.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -122.77 155.83 35.74 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.034 0.934 . . . . 0.0 110.076 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.3 t -150.08 144.71 25.92 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.115 0.966 . . . . 0.0 109.303 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.7 t -107.11 127.67 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 172.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.4 mt -125.65 124.33 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -66.17 132.5 48.61 Favored 'General case' 0 C--N 1.337 0.045 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 172.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.6 mt -127.66 95.36 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -99.82 156.63 17.01 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.363 0.665 . . . . 0.0 109.938 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.41 32.43 34.55 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 123.913 0.768 . . . . 0.0 112.036 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 96.7 mtp -87.82 112.14 22.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.965 0.906 . . . . 0.0 108.585 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.8 m -64.6 -56.2 15.44 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.165 0.986 . . . . 0.0 111.445 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.3 p -162.96 -171.61 2.74 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.072 0.549 . . . . 0.0 111.264 -169.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -50.98 -35.36 33.37 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.949 1.7 . . . . 0.0 113.163 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.9 m -55.21 -38.46 68.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.172 0.589 . . . . 0.0 111.3 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.1 m -65.91 -48.41 71.53 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.159 0.584 . . . . 0.0 110.103 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -51.87 -54.42 13.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 123.419 0.688 . . . . 0.0 109.881 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -59.16 -52.9 63.73 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.66 1.184 . . . . 0.0 111.408 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 p -61.15 -53.46 56.72 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.854 0.462 . . . . 0.0 111.387 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 85.0 mt -55.85 -54.79 22.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.162 0 C-N-CA 123.815 0.846 . . . . 0.0 109.657 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -59.45 -47.01 87.14 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.526 0.33 . . . . 0.0 110.677 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.43 -51.94 53.1 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.314 0.959 . . . . 0.0 112.256 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.73 -55.21 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 117.631 0.716 . . . . 0.0 110.503 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.23 -37.65 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.087 0.555 . . . . 0.0 111.564 -173.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 92.7 p -54.9 -30.48 58.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.786 0.721 . . . . 0.0 112.694 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -89.51 -4.41 57.93 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.906 0.882 . . . . 0.0 112.256 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -70.73 144.84 91.48 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 118.936 0.789 . . . . 0.0 109.205 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -63.71 128.59 22.54 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.019 2.479 . . . . 0.0 110.444 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.56 -32.44 7.57 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-O 118.817 -0.99 . . . . 0.0 112.491 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.8 t -68.62 132.59 32.79 Favored 'Isoleucine or valine' 0 C--N 1.341 0.203 0 CA-C-N 118.276 1.038 . . . . 0.0 109.914 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -106.34 -99.96 0.34 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.999 1.32 . . . . 0.0 108.009 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.5 p -88.64 151.06 22.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.795 0.838 . . . . 0.0 109.365 173.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.7 tt -150.48 131.9 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.293 0.637 . . . . 0.0 109.302 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.94 94.79 4.46 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.567 1.547 . . . . 0.0 107.747 -175.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 61.9 t -90.38 125.66 43.23 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.3 t -118.96 126.93 52.91 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.733 1.213 . . . . 0.0 110.235 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.6 tp -72.45 -47.91 45.19 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.728 1.211 . . . . 0.0 109.455 170.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.99 -46.49 68.31 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.769 1.227 . . . . 0.0 111.591 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -89.42 -11.57 42.75 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.306 0.642 . . . . 0.0 111.605 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.9 m 53.42 57.65 5.97 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.125 1.37 . . . . 0.0 110.372 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.7 p30 -157.85 171.04 21.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.402 0.681 . . . . 0.0 111.201 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.88 115.84 1.86 Allowed Glycine 0 C--N 1.337 0.585 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.1 m -99.46 101.99 13.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.9 t -106.73 139.02 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.918 1.287 . . . . 0.0 109.755 -169.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -108.13 130.28 55.12 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 168.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -150.62 169.0 22.6 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.933 0.493 . . . . 0.0 112.05 -170.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.66 112.86 65.29 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.469 1.507 . . . . 0.0 109.531 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -43.29 -42.74 10.33 Favored 'Trans proline' 0 C--N 1.347 0.456 1 C-N-CA 125.696 4.264 . . . . 0.0 115.872 176.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.0 mt -68.26 -28.85 67.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.645 0.378 . . . . 0.0 111.956 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.9 mt -99.71 -33.91 10.4 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.204 1.002 . . . . 0.0 111.801 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -151.69 170.97 18.41 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.273 0.629 . . . . 0.0 110.088 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.8 p -144.04 164.22 30.73 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.602 1.161 . . . . 0.0 109.747 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -52.72 -38.08 76.5 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.377 2.718 . . . . 0.0 112.55 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.3 mp0 -66.05 -45.99 79.4 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.331 1.052 . . . . 0.0 110.349 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.8 m -62.45 -46.57 87.92 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.182 0.593 . . . . 0.0 110.545 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.7 mt -60.23 -49.78 76.26 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.03 0.932 . . . . 0.0 110.566 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.2 ttp85 -52.25 -48.54 65.17 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.323 1.049 . . . . 0.0 110.33 173.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.31 -45.79 87.9 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.287 0.946 . . . . 0.0 112.316 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.34 -48.32 78.49 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.559 0.743 . . . . 0.0 111.189 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.7 mt -59.25 -42.1 86.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.777 0.831 . . . . 0.0 110.045 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -63.11 -42.22 99.52 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.393 0.677 . . . . 0.0 110.982 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -62.11 -41.82 98.61 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.082 0.953 . . . . 0.0 111.103 177.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.0 mtp -58.75 -45.89 88.67 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.542 0.337 . . . . 0.0 110.32 173.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.33 58.45 0.13 Allowed Glycine 0 C--N 1.339 0.749 0 C-N-CA 123.618 0.628 . . . . 0.0 111.719 169.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -140.32 140.31 35.61 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -68.44 96.6 0.69 Allowed 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.9 127.75 46.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.887 1.275 . . . . 0.0 109.646 -172.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.5 m -149.16 130.41 14.61 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 51.0 mt -58.45 134.91 57.07 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.367 0.667 . . . . 0.0 110.597 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 t -101.08 -52.99 3.14 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.076 0.95 . . . . 0.0 109.557 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 116.841 -1.552 . . . . 0.0 108.833 -178.583 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 57.3 tp . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 53.8 p -99.55 80.72 2.41 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.951 0.901 . . . . 0.0 109.473 -174.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -94.14 165.16 12.75 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.972 0.909 . . . . 0.0 109.758 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -140.18 141.58 35.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.215 1.006 . . . . 0.0 109.041 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -135.65 146.24 47.63 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.564 1.146 . . . . 0.0 109.588 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.92 124.18 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.3 mt -120.72 120.27 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -68.45 134.44 50.15 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.9 mt -131.67 106.49 11.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.117 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.92 142.63 31.13 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.64 19.4 20.3 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.792 1.187 . . . . 0.0 113.155 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.1 mtm -78.66 75.41 5.17 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.425 1.113 . . . . 0.0 109.393 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.4 p -72.45 99.3 2.44 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.942 0.897 . . . . 0.0 110.842 -175.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.1 t 75.77 164.54 0.26 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.618 1.567 . . . . 0.0 111.501 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -50.14 -27.05 5.18 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.548 1.539 . . . . 0.0 113.31 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m -53.63 -49.79 67.11 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.075 0.95 . . . . 0.0 111.107 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.7 m -67.15 -44.49 79.67 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.244 0.618 . . . . 0.0 110.647 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.2 t -54.71 -49.67 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.015 0.926 . . . . 0.0 109.893 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.08 -45.34 93.95 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.582 1.553 . . . . 0.0 111.033 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.7 m -58.6 -53.16 61.51 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 122.951 0.5 . . . . 0.0 110.852 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.59 -50.83 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 123.744 0.818 . . . . 0.0 109.789 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -49.95 -58.45 5.42 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.839 1.256 . . . . 0.0 110.345 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.78 -57.76 17.73 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.789 0.709 . . . . 0.0 112.155 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.9 t -59.67 -56.88 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.302 0.641 . . . . 0.0 110.872 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.6 mm -64.64 -38.49 82.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 118.747 -0.644 . . . . 0.0 111.212 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.2 t -52.94 -35.2 58.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.864 0.756 . . . . 0.0 111.971 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -89.41 -2.6 58.46 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.799 0.84 . . . . 0.0 112.49 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -71.21 145.16 90.65 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 119.448 1.022 . . . . 0.0 109.267 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.97 131.24 30.08 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.94 2.427 . . . . 0.0 109.895 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.71 -36.18 4.41 Favored Glycine 0 C--N 1.337 0.621 0 CA-C-O 118.934 -0.926 . . . . 0.0 112.047 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.7 t -73.57 143.85 13.28 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 CA-C-N 118.044 0.922 . . . . 0.0 110.105 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -118.18 -103.69 0.41 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.078 1.351 . . . . 0.0 107.411 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.0 p -90.37 109.41 20.52 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.164 0.986 . . . . 0.0 110.414 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.0 tt -97.66 141.68 15.55 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 168.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 49.5 mtt85 -126.3 94.46 4.09 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -175.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 t -89.38 98.37 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -175.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.9 t -89.84 109.41 20.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.843 0.857 . . . . 0.0 109.32 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.2 -43.17 95.84 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.468 0.707 . . . . 0.0 109.878 171.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.6 -49.29 68.11 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.609 1.164 . . . . 0.0 111.742 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -89.8 1.02 56.65 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.033 0.533 . . . . 0.0 112.301 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.9 m 49.36 52.72 13.94 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.419 1.488 . . . . 0.0 111.574 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -155.5 166.25 34.1 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.106 0.479 . . . . 0.0 111.762 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.33 118.3 3.82 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 108.166 -1.974 . . . . 0.0 108.166 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.0 m -98.96 99.62 10.69 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.63 121.46 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 125.281 1.433 . . . . 0.0 109.516 -169.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -89.48 128.21 35.95 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 169.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -150.23 168.91 22.64 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -169.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -106.13 113.24 63.73 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 125.447 1.499 . . . . 0.0 108.979 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -48.27 -35.32 26.86 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 124.807 3.671 . . . . 0.0 114.615 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.0 mt -63.42 -31.46 72.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.509 0.723 . . . . 0.0 111.861 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.8 mt -106.79 -31.35 8.43 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.295 1.038 . . . . 0.0 112.368 -171.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.7 t -149.71 175.45 11.57 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.746 0.703 . . . . 0.0 110.177 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.2 p -146.46 160.86 40.64 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 124.2 1.0 . . . . 0.0 109.839 -176.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.62 -40.93 54.98 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.402 2.734 . . . . 0.0 112.747 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.97 -44.38 85.09 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.068 0.947 . . . . 0.0 111.148 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.7 m -61.95 -46.71 88.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.153 0.581 . . . . 0.0 110.462 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.4 mt -61.82 -49.72 75.16 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.306 1.042 . . . . 0.0 110.411 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -51.89 -44.48 63.78 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.81 0.844 . . . . 0.0 110.2 171.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.22 -48.0 77.75 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.523 1.058 . . . . 0.0 112.128 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.26 -45.58 90.83 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.657 0.729 . . . . 0.0 111.479 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.0 mt -62.01 -45.32 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.873 0.869 . . . . 0.0 109.914 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -61.71 -42.03 98.4 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.586 1.154 . . . . 0.0 110.775 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.39 -43.64 98.53 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.349 1.06 . . . . 0.0 111.338 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 69.0 mtm -57.11 -48.21 79.2 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 117.908 0.322 . . . . 0.0 110.481 173.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.2 65.8 0.1 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -140.24 152.03 45.63 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.158 0.983 . . . . 0.0 108.717 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -78.21 90.19 4.3 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.77 133.71 43.73 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.823 1.249 . . . . 0.0 110.464 -174.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.7 m -150.11 146.45 26.92 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.169 0.988 . . . . 0.0 108.459 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -64.95 150.73 47.42 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.276 0.489 . . . . 0.0 110.001 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 t -121.13 -50.84 2.13 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.349 1.06 . . . . 0.0 109.372 174.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 t70 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 117.085 -1.436 . . . . 0.0 108.699 177.751 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 44.1 mt . . . . . 0 N--CA 1.476 0.874 0 CA-C-O 120.296 0.093 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 53.7 p -134.67 84.7 2.12 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.597 1.159 . . . . 0.0 108.171 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -105.06 173.9 6.1 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.432 1.093 . . . . 0.0 109.982 -176.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -140.28 146.0 38.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.777 0.831 . . . . 0.0 109.609 177.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -137.2 137.31 38.99 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.319 1.048 . . . . 0.0 109.692 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 94.8 t -99.84 109.11 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 172.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.1 mt -99.82 119.97 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -71.83 123.59 23.0 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.9 mt -123.53 119.49 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -118.14 158.01 25.85 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.188 0.595 . . . . 0.0 109.746 173.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.9 16.41 51.44 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.621 1.105 . . . . 0.0 112.052 -170.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 89.3 mtp -81.06 70.88 7.99 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.458 1.103 . . . . 0.0 108.504 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -62.94 -29.37 70.75 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -169.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.2 p -154.54 176.06 12.86 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.974 0.806 . . . . 0.0 111.821 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -66.42 -22.66 66.23 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.299 1.039 . . . . 0.0 112.543 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.1 t -62.34 -35.96 80.73 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.296 0.498 . . . . 0.0 110.281 172.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.1 m -62.35 -49.22 76.46 Favored 'General case' 0 C--N 1.342 0.279 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.5 t -54.16 -52.77 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 124.144 0.978 . . . . 0.0 109.916 178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.9 tm0? -55.14 -51.33 66.8 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.81 1.244 . . . . 0.0 110.883 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.9 m -60.06 -56.4 22.14 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.235 0.614 . . . . 0.0 110.967 -177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 93.5 mt -53.78 -52.69 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.483 1.113 . . . . 0.0 109.749 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -56.02 -55.5 32.05 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.324 1.049 . . . . 0.0 110.502 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.57 -50.26 64.19 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.715 1.15 . . . . 0.0 112.286 -176.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.9 t -63.12 -55.34 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 117.368 0.584 . . . . 0.0 110.394 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 84.3 mt -65.06 -40.91 90.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 119.222 -0.418 . . . . 0.0 111.607 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.8 p -53.73 -28.64 35.41 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -89.43 -8.3 53.33 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.888 0.875 . . . . 0.0 112.523 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -71.88 124.62 91.15 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 119.08 0.854 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -49.12 121.98 7.72 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.699 2.933 . . . . 0.0 112.135 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.13 -37.35 3.45 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 124.0 0.81 . . . . 0.0 111.76 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.39 126.97 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 117.827 0.814 . . . . 0.0 109.761 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -94.38 -101.35 0.15 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.924 1.29 . . . . 0.0 107.83 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 91.4 p -90.01 163.04 15.08 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.529 0.732 . . . . 0.0 110.186 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.3 tt -150.63 147.85 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.747 0.819 . . . . 0.0 109.73 177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.97 109.06 6.77 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.616 1.166 . . . . 0.0 107.884 172.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.42 102.2 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 124.171 0.988 . . . . 0.0 108.467 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -93.65 112.99 24.98 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.969 0.908 . . . . 0.0 110.372 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tt -66.42 -51.37 57.65 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 169.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.22 -51.09 57.16 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 125.09 1.356 . . . . 0.0 112.209 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -89.86 6.56 41.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.963 0.505 . . . . 0.0 111.939 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 m 49.23 57.02 6.93 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 125.654 1.582 . . . . 0.0 112.047 175.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -157.19 164.11 38.12 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.519 0.676 . . . . 0.0 112.728 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.45 110.11 2.09 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 106.186 -2.766 . . . . 0.0 106.186 169.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -98.81 97.2 8.44 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.5 t -106.87 124.27 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 124.387 1.075 . . . . 0.0 109.099 -170.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -89.81 130.82 36.01 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 169.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -150.31 165.98 31.4 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.072 0.549 . . . . 0.0 112.191 -169.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -104.37 113.19 65.36 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 125.098 1.359 . . . . 0.0 109.189 173.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -44.65 -36.65 10.52 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 125.286 3.991 . . . . 0.0 114.846 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.6 mt -66.06 -28.61 68.97 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.617 0.767 . . . . 0.0 112.12 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.7 mt -109.83 -35.29 6.21 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.314 1.046 . . . . 0.0 112.051 -171.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -145.26 179.32 7.46 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.869 0.868 . . . . 0.0 109.396 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.0 p -150.07 162.63 27.31 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 123.207 0.603 . . . . 0.0 110.56 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.03 -38.82 87.03 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.32 2.68 . . . . 0.0 111.782 172.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -61.45 -49.72 75.66 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.858 0.863 . . . . 0.0 110.677 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.2 m -58.37 -48.35 80.88 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.319 0.647 . . . . 0.0 110.549 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 63.3 mt -60.65 -47.84 84.45 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.219 1.008 . . . . 0.0 110.87 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -56.55 -44.61 81.09 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.679 0.792 . . . . 0.0 110.555 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.27 -45.94 87.33 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.095 0.855 . . . . 0.0 111.87 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.39 -49.83 73.95 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.378 0.671 . . . . 0.0 111.091 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.8 mt -60.08 -45.28 95.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.32 0.648 . . . . 0.0 110.212 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -57.56 -48.97 77.88 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.102 0.961 . . . . 0.0 110.048 176.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.78 -43.58 90.48 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.114 0.965 . . . . 0.0 111.454 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.4 mtp -59.44 -44.53 92.91 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.928 0.491 . . . . 0.0 110.631 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.04 62.21 0.2 Allowed Glycine 0 C--N 1.339 0.725 0 C-N-CA 123.795 0.712 . . . . 0.0 111.598 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -140.31 155.4 46.84 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.789 0.836 . . . . 0.0 109.29 172.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -78.37 91.12 4.43 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.703 0.801 . . . . 0.0 108.996 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.67 129.68 45.83 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.618 1.167 . . . . 0.0 110.816 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.7 m -150.07 132.42 15.57 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.897 0.879 . . . . 0.0 108.818 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 43.5 mt -63.64 163.85 10.66 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.054 0.542 . . . . 0.0 111.094 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.7 p -74.32 82.8 1.89 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.339 0.656 . . . . 0.0 109.29 170.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 116.953 -1.499 . . . . 0.0 109.948 177.687 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 51.5 tp . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 110.691 -0.115 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -139.05 126.25 21.35 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.461 1.104 . . . . 0.0 108.773 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 -130.19 167.98 17.54 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.196 1.398 . . . . 0.0 109.302 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -124.14 144.14 50.08 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.461 1.105 . . . . 0.0 108.886 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.6 t -137.7 146.78 44.18 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.33 1.052 . . . . 0.0 109.326 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.7 t -111.99 125.59 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.9 mt -120.32 121.06 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -72.37 132.07 43.47 Favored 'General case' 0 C--O 1.228 -0.044 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 174.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.5 mt -127.97 106.42 14.8 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -99.56 149.57 23.11 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.427 0.691 . . . . 0.0 109.195 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.27 16.27 47.64 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.441 1.02 . . . . 0.0 113.005 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.8 mtm -81.1 64.47 5.85 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.58 1.19 . . . . 0.0 109.252 175.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.6 m -79.4 84.52 5.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.438 1.095 . . . . 0.0 109.788 -173.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.3 t 118.85 148.78 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 129.511 3.124 . . . . 0.0 109.579 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -54.88 -29.95 56.8 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.44 1.096 . . . . 0.0 111.922 175.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.9 m -50.59 -43.43 56.64 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.416 1.086 . . . . 0.0 111.562 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.8 m -60.76 -57.2 13.71 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.4 0.68 . . . . 0.0 109.603 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.7 t -49.89 -51.55 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.06 1.344 . . . . 0.0 111.067 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -59.87 -52.48 65.27 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.009 1.324 . . . . 0.0 111.103 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.3 p -61.12 -48.98 79.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.122 0.569 . . . . 0.0 111.3 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.8 mt -53.76 -55.31 14.29 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.805 0.842 . . . . 0.0 109.397 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -54.18 -55.06 31.51 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.113 0.565 . . . . 0.0 110.712 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.43 -50.45 59.94 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.315 0.959 . . . . 0.0 112.779 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.38 -49.68 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.409 0.683 . . . . 0.0 110.699 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.6 mm -66.28 -33.53 64.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 118.845 -0.598 . . . . 0.0 111.46 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.7 m -50.87 -30.88 15.72 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.872 0.76 . . . . 0.0 112.734 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -89.07 -3.35 58.7 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.58 0.752 . . . . 0.0 112.167 -173.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -77.12 143.01 69.27 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 118.87 0.759 . . . . 0.0 109.903 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.92 135.37 17.82 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.91 3.073 . . . . 0.0 112.608 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.17 -34.9 3.95 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 118.674 -1.07 . . . . 0.0 113.045 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.1 124.22 20.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-N 118.448 1.124 . . . . 0.0 109.918 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -89.84 -102.59 0.09 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.0 p -90.49 158.02 17.25 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.336 1.054 . . . . 0.0 109.676 171.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.5 tt -150.23 127.37 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.2 mmp_? -116.19 107.13 14.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.465 1.106 . . . . 0.0 108.497 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.62 124.38 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 175.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.0 t -106.8 129.48 54.65 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.636 1.174 . . . . 0.0 110.17 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 38.5 tp -68.35 -53.61 22.93 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.709 0.803 . . . . 0.0 109.09 171.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.16 -47.48 71.93 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 125.265 1.426 . . . . 0.0 112.086 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -89.25 -9.63 49.95 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 119.036 -0.507 . . . . 0.0 111.403 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.5 m 52.79 56.08 8.1 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 125.016 1.326 . . . . 0.0 111.02 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -157.17 168.31 27.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.419 0.688 . . . . 0.0 110.853 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.55 116.83 2.89 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 126.215 1.864 . . . . 0.0 108.783 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.0 m -99.12 100.56 11.71 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 176.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.6 t -106.3 125.52 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.502 1.121 . . . . 0.0 109.537 -170.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -95.53 127.93 41.98 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 168.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -150.26 164.36 35.93 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.17 0.588 . . . . 0.0 111.779 -169.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -98.36 114.25 65.02 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.737 1.215 . . . . 0.0 109.013 172.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -47.74 -34.35 21.07 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 124.741 3.627 . . . . 0.0 114.93 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.5 mt -65.92 -33.9 76.89 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.457 0.703 . . . . 0.0 111.584 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.75 -35.3 9.84 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.895 0.878 . . . . 0.0 111.578 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.3 t -147.4 178.37 8.48 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.698 0.681 . . . . 0.0 110.539 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.3 p -148.88 159.85 36.73 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 124.624 1.17 . . . . 0.0 109.714 -174.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.41 -40.42 62.47 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.511 2.807 . . . . 0.0 112.814 176.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.4 mp0 -66.79 -41.05 88.28 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.555 1.142 . . . . 0.0 110.927 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.8 m -67.55 -45.65 75.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.1 0.56 . . . . 0.0 110.326 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 50.0 mt -60.73 -49.55 77.05 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.241 1.016 . . . . 0.0 110.253 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.9 ttp85 -52.1 -47.24 65.38 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.164 0.986 . . . . 0.0 109.988 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.19 -45.23 83.22 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.569 1.08 . . . . 0.0 112.293 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.59 -48.24 75.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.635 0.717 . . . . 0.0 111.099 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.8 mt -59.93 -42.45 89.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.92 0.888 . . . . 0.0 109.981 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -63.51 -41.04 98.52 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.628 1.171 . . . . 0.0 110.568 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -63.36 -41.48 98.83 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.01 0.924 . . . . 0.0 111.182 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.9 mtp -57.83 -44.27 86.36 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.097 0.408 . . . . 0.0 110.203 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.13 61.76 0.16 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 123.651 0.643 . . . . 0.0 111.702 169.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -140.33 152.43 45.82 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.999 0.919 . . . . 0.0 109.414 175.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -79.74 86.24 5.35 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.57 128.99 45.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.626 1.171 . . . . 0.0 110.461 -173.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.9 p -142.34 151.19 41.68 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.154 1.382 . . . . 0.0 109.039 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -69.29 137.69 53.24 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.6 t -87.63 55.97 3.72 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.043 0.537 . . . . 0.0 110.146 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.618 -1.182 . . . . 0.0 110.662 179.404 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.9 p -99.32 153.0 19.31 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.248 1.019 . . . . 0.0 110.516 -171.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -114.72 172.09 7.25 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 125.485 1.514 . . . . 0.0 109.166 -174.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -134.76 141.27 46.42 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.061 0.945 . . . . 0.0 108.969 175.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -131.56 144.8 51.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.406 1.082 . . . . 0.0 109.49 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.0 t -107.97 123.75 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 172.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.2 mt -116.37 121.76 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -69.94 118.19 12.47 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.3 mt -110.8 102.34 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -99.65 149.03 23.71 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.562 0.745 . . . . 0.0 109.27 176.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.67 26.04 16.28 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.667 1.127 . . . . 0.0 112.359 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 88.8 mtp -86.45 129.71 34.76 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.107 0.963 . . . . 0.0 108.413 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.9 p -73.2 -67.72 0.55 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.013 0.525 . . . . 0.0 110.521 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -161.0 -157.07 0.49 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.04 0.936 . . . . 0.0 108.911 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -73.99 77.88 1.68 Allowed 'General case' 0 C--N 1.343 0.287 0 C-N-CA 124.158 0.983 . . . . 0.0 109.174 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 p -165.86 -57.25 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.366 1.867 . . . . 0.0 106.553 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.31 -40.51 96.54 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.939 0.895 . . . . 0.0 109.239 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.5 t -49.86 -59.3 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 124.358 1.063 . . . . 0.0 109.928 173.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -60.89 -45.5 94.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.609 1.164 . . . . 0.0 111.037 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.8 t -59.55 -57.88 11.04 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.956 0.902 . . . . 0.0 110.828 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.3 mt -55.42 -54.4 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.964 0.906 . . . . 0.0 109.587 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -55.38 -49.02 73.4 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.144 0.578 . . . . 0.0 110.791 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.39 -37.27 91.75 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.002 1.287 . . . . 0.0 113.284 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.6 t -77.84 -57.81 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 118.253 1.026 . . . . 0.0 110.17 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.38 -37.63 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.452 0.701 . . . . 0.0 111.404 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.9 p -51.6 -30.78 22.44 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -89.42 -8.29 53.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.815 0.846 . . . . 0.0 112.434 -174.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -72.56 143.62 85.3 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 118.751 0.705 . . . . 0.0 109.816 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -47.51 134.27 21.0 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.791 2.994 . . . . 0.0 112.655 176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.56 -31.76 5.64 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-O 118.724 -1.042 . . . . 0.0 113.457 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.5 t -67.12 134.02 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 118.341 1.071 . . . . 0.0 110.146 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -113.88 -102.94 0.41 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.192 1.397 . . . . 0.0 108.297 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 77.4 p -82.44 154.05 25.35 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.161 0.584 . . . . 0.0 109.79 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.5 tt -150.33 145.32 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.326 0.65 . . . . 0.0 110.1 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -139.97 103.47 4.64 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.5 t -91.67 108.6 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 172.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.2 t -89.52 129.23 36.03 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 123.145 0.578 . . . . 0.0 110.111 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tt -73.96 -57.01 4.25 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.813 1.245 . . . . 0.0 108.152 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.79 -45.7 78.13 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.524 1.53 . . . . 0.0 112.356 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -89.12 -10.54 46.91 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.893 0.477 . . . . 0.0 111.013 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.2 m 56.23 58.15 4.5 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.057 1.343 . . . . 0.0 110.614 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -146.03 163.59 34.75 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.86 0.464 . . . . 0.0 111.618 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.04 107.59 1.8 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.9 m -99.13 99.84 10.9 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.3 t -114.91 126.01 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 124.791 1.236 . . . . 0.0 109.608 -169.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -89.92 131.61 35.74 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 169.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -150.51 156.96 42.44 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.274 0.629 . . . . 0.0 112.256 -170.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -93.53 120.08 66.67 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.703 1.201 . . . . 0.0 110.117 173.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -47.53 -41.79 29.51 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 125.069 3.846 . . . . 0.0 115.785 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -68.47 -29.74 68.43 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.614 0.365 . . . . 0.0 111.73 -173.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.2 mt -99.64 -32.66 10.96 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.227 1.011 . . . . 0.0 111.893 -173.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 t -153.23 176.22 12.19 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.677 0.671 . . . . 0.0 110.05 173.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.9 p -150.09 162.6 27.39 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.039 0.936 . . . . 0.0 109.993 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.3 -44.34 49.77 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.439 2.759 . . . . 0.0 112.755 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.05 -34.12 77.3 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.502 0.721 . . . . 0.0 112.571 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.1 m -70.93 -47.67 57.79 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 122.944 0.498 . . . . 0.0 109.732 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.9 mt -58.36 -50.31 74.12 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.943 0.897 . . . . 0.0 110.05 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -52.29 -47.4 65.91 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.791 1.236 . . . . 0.0 110.533 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.82 -47.87 76.0 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.32 0.962 . . . . 0.0 112.156 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.5 -46.77 86.95 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.561 0.744 . . . . 0.0 111.401 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.7 mt -60.97 -43.99 97.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.56 0.744 . . . . 0.0 109.938 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -63.14 -41.67 99.34 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.712 0.805 . . . . 0.0 110.945 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.13 -43.49 98.81 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.253 1.021 . . . . 0.0 111.184 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 69.5 mtm -58.46 -50.04 75.14 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 117.842 0.292 . . . . 0.0 110.382 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.39 63.01 0.09 OUTLIER Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 171.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -140.25 142.98 35.74 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.27 93.51 1.11 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.9 120.7 40.19 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.219 1.407 . . . . 0.0 109.425 -174.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 47.1 p -138.27 140.26 39.55 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.356 1.062 . . . . 0.0 108.617 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 68.3 mt -68.1 123.83 21.74 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.596 0.358 . . . . 0.0 110.31 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.0 t -85.87 -49.65 7.73 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.832 0.853 . . . . 0.0 108.824 173.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.5 t70 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 116.928 -1.511 . . . . 0.0 108.305 -179.941 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 120.542 0.21 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.1 p -139.55 118.05 12.17 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.926 1.29 . . . . 0.0 109.3 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -139.58 164.99 28.44 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.518 1.127 . . . . 0.0 109.196 172.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -128.5 151.81 48.99 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.554 1.142 . . . . 0.0 109.438 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -145.44 148.68 33.56 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.298 1.039 . . . . 0.0 109.394 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.93 123.54 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.4 mt -119.06 128.86 75.79 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -70.28 121.47 17.69 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 171.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 77.7 mt -125.95 95.01 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.75 151.74 20.9 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.31 15.79 56.64 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.31 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 54.8 mtt -55.9 -57.65 11.2 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 118.755 1.277 . . . . 0.0 109.764 174.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 m 77.45 -63.06 0.36 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.165 1.786 . . . . 0.0 112.106 174.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.7 t -117.78 151.63 36.92 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.364 1.065 . . . . 0.0 111.228 -169.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -58.56 -29.39 66.34 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.603 1.161 . . . . 0.0 112.03 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.0 m -55.11 -48.52 73.5 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.858 0.863 . . . . 0.0 110.18 172.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.3 m -63.8 -44.26 93.83 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.736 0.814 . . . . 0.0 110.679 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.3 t -51.92 -54.7 12.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 C-N-CA 123.302 0.641 . . . . 0.0 109.641 176.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -61.51 -42.65 99.13 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.668 0.787 . . . . 0.0 111.432 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -59.24 -55.43 35.01 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.131 0.572 . . . . 0.0 110.663 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.2 mt -54.25 -55.8 12.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 123.873 0.869 . . . . 0.0 109.155 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -54.44 -54.67 37.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.85 0.86 . . . . 0.0 111.091 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.09 -53.57 44.64 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.281 0.943 . . . . 0.0 112.364 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.5 t -60.61 -54.24 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 117.382 0.591 . . . . 0.0 110.438 -176.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.9 mm -61.78 -40.6 87.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 118.911 -0.566 . . . . 0.0 110.699 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.1 t -51.2 -36.21 40.27 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.427 0.691 . . . . 0.0 112.089 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -88.97 -11.06 45.41 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.464 0.705 . . . . 0.0 112.131 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -73.08 139.43 79.5 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 119.466 1.03 . . . . 0.0 109.962 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -45.22 137.81 10.09 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.354 3.369 . . . . 0.0 113.665 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.34 -38.79 3.01 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-O 118.841 -0.977 . . . . 0.0 112.49 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.34 134.02 30.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 CA-C-N 118.254 1.027 . . . . 0.0 110.088 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -104.61 -102.09 0.31 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.849 1.259 . . . . 0.0 107.926 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.8 p -87.31 152.83 21.96 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.464 0.706 . . . . 0.0 109.849 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 tt -150.69 140.23 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.645 0.778 . . . . 0.0 109.676 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -129.84 110.95 12.13 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.924 1.29 . . . . 0.0 108.659 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.34 122.79 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.363 1.065 . . . . 0.0 108.572 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.7 t -115.63 123.66 48.98 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.823 1.249 . . . . 0.0 110.588 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.6 tp -69.83 -48.24 59.71 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.745 1.218 . . . . 0.0 109.823 170.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.12 -46.74 65.46 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.691 1.197 . . . . 0.0 111.639 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -89.51 -15.03 33.91 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.419 0.688 . . . . 0.0 111.7 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.2 m 54.52 54.68 8.97 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 125.14 1.376 . . . . 0.0 110.415 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -154.32 163.42 40.17 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.454 0.702 . . . . 0.0 110.928 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.54 119.6 3.74 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.4 m -99.2 104.52 16.49 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.9 t -112.86 127.75 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 124.655 1.182 . . . . 0.0 109.575 -170.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -96.73 133.07 41.76 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 169.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -150.38 169.79 20.58 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.773 0.429 . . . . 0.0 111.865 -171.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -103.67 110.76 64.47 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 125.133 1.373 . . . . 0.0 109.268 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -41.66 -38.73 4.47 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 125.268 3.979 . . . . 0.0 115.227 170.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.9 mt -62.51 -35.12 78.36 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.25 0.62 . . . . 0.0 111.955 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.9 mt -104.4 -31.57 9.45 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.299 1.04 . . . . 0.0 112.344 -170.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 t -150.1 176.76 10.52 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.408 0.683 . . . . 0.0 110.173 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.3 p -147.45 163.43 27.91 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.36 1.064 . . . . 0.0 109.929 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.92 -41.87 67.92 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.326 2.684 . . . . 0.0 112.443 176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -66.47 -40.85 89.6 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.786 0.834 . . . . 0.0 111.39 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.9 m -62.66 -47.24 84.56 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.779 0.432 . . . . 0.0 110.242 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.6 mt -62.07 -47.53 84.25 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.106 0.963 . . . . 0.0 110.606 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -51.66 -48.54 63.37 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.495 1.118 . . . . 0.0 109.954 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.86 -45.01 92.09 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.485 1.04 . . . . 0.0 112.255 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.43 -49.29 76.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.477 0.711 . . . . 0.0 111.159 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.59 -41.81 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.707 0.803 . . . . 0.0 110.164 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -61.42 -43.0 99.63 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.942 0.897 . . . . 0.0 110.707 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -62.4 -42.27 99.31 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.917 0.887 . . . . 0.0 111.091 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mtp -58.67 -44.84 90.32 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.973 0.352 . . . . 0.0 110.379 173.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.39 59.92 0.17 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 123.756 0.693 . . . . 0.0 111.976 169.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -140.31 152.31 45.75 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.051 0.94 . . . . 0.0 108.95 174.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -75.9 91.5 3.02 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.31 122.47 42.5 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.54 1.136 . . . . 0.0 109.95 -172.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.6 m -148.54 132.59 17.24 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.54 1.136 . . . . 0.0 108.304 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.2 mt -60.73 142.01 56.3 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.147 0.579 . . . . 0.0 111.477 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.68 -54.52 2.56 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.945 1.298 . . . . 0.0 108.197 172.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 . . . . . 0 C--O 1.249 1.077 0 C-N-CA 125.473 1.509 . . . . 0.0 107.981 -178.94 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 64.6 tp . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 119.838 -0.125 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.4 p -139.47 137.11 35.27 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.142 0.977 . . . . 0.0 108.839 174.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.1 mm100 -126.33 162.08 26.34 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.78 1.632 . . . . 0.0 109.355 -177.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -108.94 145.11 35.97 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.388 1.075 . . . . 0.0 109.385 176.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 t -134.99 133.7 39.74 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.028 0.931 . . . . 0.0 109.336 172.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.93 108.32 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.7 mt -99.55 120.6 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -82.93 109.84 17.39 Favored 'General case' 0 C--N 1.334 -0.072 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.8 mt -111.73 106.19 20.28 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.403 1.081 . . . . 0.0 108.278 -172.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -99.6 145.4 27.59 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.07 -5.71 46.32 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.553 -1.137 . . . . 0.0 113.584 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.2 mtm -55.21 -60.44 3.39 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-N 119.069 1.434 . . . . 0.0 110.296 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 m 75.15 -63.33 0.42 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.754 1.622 . . . . 0.0 112.517 170.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.1 m -108.27 154.52 21.67 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 124.401 1.081 . . . . 0.0 111.142 -170.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -62.58 -27.72 69.39 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.808 0.843 . . . . 0.0 111.608 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.7 m -56.62 -48.02 78.39 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.364 0.665 . . . . 0.0 110.333 173.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -63.33 -45.04 93.09 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.667 0.787 . . . . 0.0 110.569 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 79.0 t -54.8 -53.86 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.625 0.77 . . . . 0.0 110.318 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -58.23 -46.72 85.39 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.588 1.155 . . . . 0.0 111.22 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.6 t -57.18 -52.67 64.37 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.313 0.645 . . . . 0.0 110.684 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.5 mt -55.01 -61.21 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 124.461 1.104 . . . . 0.0 110.075 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -59.3 -41.08 88.16 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.985 0.357 . . . . 0.0 111.386 -174.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.39 -56.08 27.0 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.24 -52.51 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.673 0.789 . . . . 0.0 110.726 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.5 mm -62.52 -37.58 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.434 0.693 . . . . 0.0 111.56 -173.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.1 m -54.32 -29.51 47.98 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.698 0.681 . . . . 0.0 112.738 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -89.31 -6.38 56.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.288 0.635 . . . . 0.0 112.222 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -72.81 139.75 80.55 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 119.104 0.865 . . . . 0.0 109.251 177.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.05 131.56 29.13 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.004 2.469 . . . . 0.0 110.065 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.33 -36.19 4.54 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-O 118.872 -0.96 . . . . 0.0 111.795 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.53 131.65 32.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-N 118.141 0.971 . . . . 0.0 109.866 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -104.07 -101.63 0.31 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.943 1.297 . . . . 0.0 107.81 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.3 p -90.06 160.35 16.36 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.873 0.869 . . . . 0.0 110.079 174.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.7 tt -150.39 146.58 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 123.861 0.864 . . . . 0.0 109.488 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.94 109.78 7.6 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 173.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -98.67 103.71 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.0 t -89.78 118.98 29.78 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.602 0.761 . . . . 0.0 109.132 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.0 tp -70.56 -44.26 67.81 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.693 0.797 . . . . 0.0 109.656 172.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.12 -48.78 67.58 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.775 1.23 . . . . 0.0 111.666 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -89.39 -5.91 57.04 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.105 0.562 . . . . 0.0 111.534 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.8 m 52.07 55.78 8.72 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 125.52 1.528 . . . . 0.0 111.255 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -155.3 151.29 27.82 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.127 0.489 . . . . 0.0 111.815 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.67 113.56 4.27 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 126.242 1.877 . . . . 0.0 108.621 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 85.6 m -98.78 97.14 8.4 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 t -104.64 126.91 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.348 1.059 . . . . 0.0 109.399 -170.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.0 tp10 -92.67 131.07 38.07 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -149.96 164.14 36.26 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.242 0.617 . . . . 0.0 110.971 -171.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -101.38 114.4 65.71 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.408 1.083 . . . . 0.0 109.151 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.52 -35.35 16.4 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 125.002 3.801 . . . . 0.0 115.069 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.3 mt -67.27 -29.69 69.37 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.515 0.726 . . . . 0.0 111.833 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.8 -46.92 5.23 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.054 0.942 . . . . 0.0 110.725 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 t -138.56 -178.95 5.53 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.965 0.906 . . . . 0.0 110.107 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.9 p -148.35 161.69 33.01 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.872 0.869 . . . . 0.0 110.287 -173.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -51.43 -50.01 15.33 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.494 2.796 . . . . 0.0 112.73 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -66.95 -33.21 75.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.897 0.479 . . . . 0.0 112.115 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.5 m -64.81 -48.75 73.29 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.9 mt -61.86 -46.98 87.07 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.497 0.719 . . . . 0.0 110.601 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 18.8 ttp85 -53.78 -46.47 71.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.043 0.937 . . . . 0.0 109.88 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.99 -42.71 93.03 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.521 1.058 . . . . 0.0 112.309 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.21 -47.13 83.82 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.999 0.899 . . . . 0.0 111.03 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.4 mm -58.59 -44.76 90.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 122.73 0.412 . . . . 0.0 110.108 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -61.7 -38.99 89.9 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.25 0.62 . . . . 0.0 111.011 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.59 -43.42 93.91 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.315 1.046 . . . . 0.0 110.94 176.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.5 mtp -58.7 -41.51 86.43 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 117.958 0.344 . . . . 0.0 110.472 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.7 57.92 0.23 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 123.959 0.79 . . . . 0.0 111.919 169.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -140.27 145.53 37.42 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -73.92 91.13 1.98 Allowed 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.662 0.785 . . . . 0.0 109.565 -174.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.84 127.72 45.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.04 1.336 . . . . 0.0 110.374 -174.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.1 m -144.76 130.99 19.55 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 124.363 1.065 . . . . 0.0 108.515 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.6 mt -64.06 158.41 22.72 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.426 0.69 . . . . 0.0 111.627 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.2 p -77.33 66.71 3.14 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.008 0.923 . . . . 0.0 109.489 172.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.02 -1.466 . . . . 0.0 108.806 -176.962 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 49.1 tp . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.2 p -140.11 126.46 20.07 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.74 1.216 . . . . 0.0 108.466 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -142.18 167.11 22.9 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.349 1.46 . . . . 0.0 108.9 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -128.27 151.46 49.27 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.51 1.124 . . . . 0.0 109.429 175.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 t -150.13 140.94 22.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.589 0.755 . . . . 0.0 110.025 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.1 t -99.73 129.49 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 171.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.4 mt -121.47 123.66 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -78.66 120.47 23.38 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.0 mt -119.73 103.32 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 125.917 1.687 . . . . 0.0 106.708 -173.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -99.97 144.85 28.53 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.923 0.489 . . . . 0.0 110.23 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.47 34.76 7.77 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.788 1.185 . . . . 0.0 112.852 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.9 mtm -93.45 102.24 14.46 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 117.794 0.797 . . . . 0.0 109.563 177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.8 m -60.12 147.05 40.95 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.859 0.863 . . . . 0.0 110.683 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.7 t -48.59 124.49 8.34 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.281 1.432 . . . . 0.0 112.381 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . 0.289 5.7 p30 64.85 -54.05 0.3 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 129.061 2.944 . . . . 0.0 115.486 174.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 52.7 p -55.67 -57.69 10.91 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.46 1.104 . . . . 0.0 111.316 -175.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.0 m -64.57 -47.36 79.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.476 0.71 . . . . 0.0 110.285 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.9 t -51.16 -56.56 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.151 0.98 . . . . 0.0 110.445 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -62.38 -49.06 77.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.308 1.043 . . . . 0.0 111.494 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.3 p -61.52 -50.12 73.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.004 0.365 . . . . 0.0 111.568 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.8 mt -55.16 -55.07 18.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 C-N-CA 123.769 0.828 . . . . 0.0 109.343 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -55.3 -49.62 71.67 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.25 0.62 . . . . 0.0 110.999 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.4 -51.33 59.76 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.633 1.111 . . . . 0.0 112.347 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.73 -54.29 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 117.75 0.775 . . . . 0.0 110.311 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.8 mm -64.3 -38.27 82.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 118.911 -0.566 . . . . 0.0 111.638 -174.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.4 p -53.74 -31.73 49.5 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.85 0.75 . . . . 0.0 112.721 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -89.58 -3.65 58.2 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.049 0.939 . . . . 0.0 112.395 -174.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -72.03 143.26 86.15 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 119.071 0.851 . . . . 0.0 109.64 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -46.82 128.47 13.4 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.894 3.063 . . . . 0.0 112.665 176.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.01 -30.86 7.09 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.391 177.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.5 t -69.66 125.45 27.74 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 CA-C-N 118.694 1.247 . . . . 0.0 109.832 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -95.9 -103.04 0.16 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.7 p -86.58 155.62 20.38 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.415 0.686 . . . . 0.0 110.213 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 9.3 tt -150.66 139.06 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.922 0.889 . . . . 0.0 109.208 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -128.91 103.8 7.24 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 124.655 1.182 . . . . 0.0 108.77 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.1 t -93.25 121.91 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 123.967 0.907 . . . . 0.0 108.769 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.7 t -118.09 124.44 48.07 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.911 1.284 . . . . 0.0 109.725 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.9 tt -71.09 -46.97 60.81 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.273 1.029 . . . . 0.0 109.487 172.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -50.36 -47.46 56.04 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.732 1.213 . . . . 0.0 111.778 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -89.57 -8.72 52.06 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.365 0.666 . . . . 0.0 111.774 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.1 m 51.87 55.64 8.99 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.779 1.632 . . . . 0.0 110.709 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -155.77 170.41 22.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.005 0.522 . . . . 0.0 111.765 -175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.7 118.31 2.58 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.4 m -98.98 100.49 11.66 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 t -106.72 128.33 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.556 1.142 . . . . 0.0 109.757 -169.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -96.52 130.54 43.67 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 168.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -150.22 163.39 38.39 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.009 0.523 . . . . 0.0 111.881 -171.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -97.08 113.98 63.95 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.916 1.286 . . . . 0.0 109.381 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -45.69 -37.41 15.8 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 124.942 3.762 . . . . 0.0 114.777 172.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -64.61 -34.35 78.07 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.505 0.722 . . . . 0.0 111.811 -176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.4 mt -104.09 -30.47 10.22 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.121 0.969 . . . . 0.0 112.279 -172.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.0 t -151.78 177.96 9.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.302 0.641 . . . . 0.0 110.107 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.3 p -149.21 162.05 30.16 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 125.106 1.363 . . . . 0.0 109.549 -172.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.14 -38.43 80.95 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.934 2.422 . . . . 0.0 112.03 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.28 -48.92 71.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.587 1.155 . . . . 0.0 111.44 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.4 p -62.56 -42.49 99.58 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.503 0.321 . . . . 0.0 111.096 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.5 mt -64.83 -47.8 76.68 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.385 0.674 . . . . 0.0 110.365 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.5 ttp85 -51.99 -48.03 64.62 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.166 0.986 . . . . 0.0 110.219 171.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.63 -46.69 81.13 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.294 0.95 . . . . 0.0 112.246 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.42 -48.64 78.79 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.638 0.775 . . . . 0.0 111.169 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.0 mt -60.16 -42.42 90.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.71 0.804 . . . . 0.0 110.059 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.62 -39.94 95.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.579 0.751 . . . . 0.0 110.831 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.69 -41.66 98.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.022 0.929 . . . . 0.0 111.003 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.9 mtp -58.31 -43.4 88.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.984 0.356 . . . . 0.0 110.268 172.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.26 58.39 0.18 Allowed Glycine 0 C--N 1.34 0.778 0 C-N-CA 123.827 0.727 . . . . 0.0 111.975 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -140.29 142.48 35.68 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.004 0.922 . . . . 0.0 108.935 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -69.75 92.36 0.67 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.67 123.95 44.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.232 1.413 . . . . 0.0 109.302 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.1 p -138.66 136.74 36.2 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.703 1.201 . . . . 0.0 108.872 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 61.6 mt -68.73 126.9 31.19 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.615 0.366 . . . . 0.0 110.215 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.3 t -104.44 -34.89 8.1 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.455 1.102 . . . . 0.0 110.263 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 C--O 1.25 1.116 0 C-N-CA 128.094 2.558 . . . . 0.0 109.931 -175.903 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 66.0 tp . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.7 p -98.76 156.58 16.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.906 0.882 . . . . 0.0 110.297 -169.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -131.22 169.31 16.12 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.724 1.61 . . . . 0.0 109.21 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -125.02 152.97 43.55 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.428 1.091 . . . . 0.0 109.567 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -149.75 138.29 20.76 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.447 0.699 . . . . 0.0 110.115 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.83 124.18 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 172.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.4 mt -119.81 120.17 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -75.86 126.87 31.84 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.8 mt -122.13 111.41 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.639 1.176 . . . . 0.0 108.014 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -99.61 147.61 25.19 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.21 2.02 51.19 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.279 0.942 . . . . 0.0 112.885 -177.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.8 mtm -76.59 81.25 3.25 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.688 1.244 . . . . 0.0 108.624 174.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.8 m -50.74 -50.99 54.34 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.606 1.562 . . . . 0.0 112.6 -170.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.5 m -141.34 179.32 6.85 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.105 0.962 . . . . 0.0 110.107 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -54.98 -32.14 61.38 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.549 1.14 . . . . 0.0 111.656 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.9 p -54.06 -50.26 67.14 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.786 0.834 . . . . 0.0 111.222 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -59.07 -50.3 74.59 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.755 0.822 . . . . 0.0 110.281 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.6 t -53.85 -52.51 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 124.87 1.268 . . . . 0.0 110.922 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -59.22 -46.12 89.31 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.5 1.12 . . . . 0.0 111.142 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.6 m -58.53 -52.87 63.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.177 0.591 . . . . 0.0 110.792 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 61.1 mt -56.55 -53.65 38.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 C-N-CA 123.599 0.76 . . . . 0.0 109.689 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -52.82 -55.51 22.51 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.193 0.997 . . . . 0.0 110.739 -177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.43 -52.07 53.92 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.161 0.886 . . . . 0.0 112.186 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.8 t -61.01 -56.18 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.268 0.627 . . . . 0.0 110.907 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.7 mm -62.01 -37.11 77.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.259 0.624 . . . . 0.0 111.39 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.0 t -49.45 -40.7 37.88 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 123.763 0.825 . . . . 0.0 112.673 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -89.47 -6.08 56.78 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -171.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -75.07 148.39 84.27 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 119.165 0.893 . . . . 0.0 110.459 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -44.14 133.86 8.72 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.494 3.463 . . . . 0.0 113.707 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.66 -40.57 2.92 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-O 118.959 -0.911 . . . . 0.0 112.674 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.7 t -68.31 134.91 29.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 CA-C-N 117.983 0.892 . . . . 0.0 110.168 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -109.29 -98.67 0.39 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.602 1.161 . . . . 0.0 107.88 174.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.7 p -87.59 152.41 22.2 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.634 0.774 . . . . 0.0 109.509 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.0 tt -150.56 136.65 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 123.499 0.719 . . . . 0.0 109.224 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.23 101.47 6.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.869 1.267 . . . . 0.0 108.39 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.8 t -96.88 122.93 48.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.9 t -107.02 130.67 54.62 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 124.793 1.237 . . . . 0.0 110.332 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.3 tp -69.62 -52.39 26.36 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.705 0.802 . . . . 0.0 109.119 170.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.53 -47.51 69.88 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 125.22 1.408 . . . . 0.0 112.114 -176.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -89.25 -9.69 49.74 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.888 0.475 . . . . 0.0 111.457 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.1 m 52.52 56.43 7.68 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.107 1.363 . . . . 0.0 110.783 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -155.65 166.35 33.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.095 0.558 . . . . 0.0 111.191 -176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.67 115.03 2.49 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.507 2.003 . . . . 0.0 108.707 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.9 m -99.28 98.82 9.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 t -106.24 131.3 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 124.453 1.101 . . . . 0.0 109.693 -170.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -99.04 130.34 45.36 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -150.19 163.27 38.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.119 0.568 . . . . 0.0 111.825 -169.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -98.13 113.84 64.4 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 124.686 1.195 . . . . 0.0 109.293 172.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -44.45 -36.96 10.26 Favored 'Trans proline' 0 C--N 1.349 0.556 1 C-N-CA 125.356 4.037 . . . . 0.0 115.024 173.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.2 mt -64.5 -36.39 84.06 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.109 0.564 . . . . 0.0 111.789 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.2 mt -100.0 -32.96 10.7 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.12 0.968 . . . . 0.0 112.244 -171.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.3 t -149.35 178.86 8.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.29 0.636 . . . . 0.0 110.093 176.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.9 p -150.21 162.9 26.34 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 124.172 0.989 . . . . 0.0 109.759 -174.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -53.07 -46.94 30.33 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.191 2.594 . . . . 0.0 112.372 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.42 -33.9 76.75 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.016 0.526 . . . . 0.0 112.287 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 98.3 m -67.73 -45.32 75.35 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.376 0.535 . . . . 0.0 110.096 175.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 47.5 mt -61.19 -47.33 86.67 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.65 0.78 . . . . 0.0 110.461 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -52.64 -47.04 67.34 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.052 0.941 . . . . 0.0 110.269 171.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.48 -45.82 82.85 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.303 0.954 . . . . 0.0 112.313 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.34 -46.36 83.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.785 0.834 . . . . 0.0 111.35 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.4 mt -62.43 -43.46 98.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.758 0.823 . . . . 0.0 110.08 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.35 -41.7 98.8 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.293 1.037 . . . . 0.0 110.938 176.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.57 -43.91 97.99 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.968 0.907 . . . . 0.0 111.132 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.9 mtm -59.32 -50.88 72.28 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 117.911 0.323 . . . . 0.0 110.213 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.71 60.84 0.09 OUTLIER Glycine 0 C--N 1.34 0.802 0 C-N-CA 123.519 0.581 . . . . 0.0 111.789 171.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -140.09 141.94 36.12 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 171.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -75.7 91.07 2.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.661 0.784 . . . . 0.0 109.49 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.36 134.8 41.69 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.632 1.173 . . . . 0.0 110.362 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 95.0 m -144.07 133.8 23.71 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.983 1.313 . . . . 0.0 108.369 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.0 mt -64.95 128.48 35.95 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.215 0.606 . . . . 0.0 109.872 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.9 t -99.24 -58.66 1.88 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.9 t70 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 124.932 1.293 . . . . 0.0 107.798 178.39 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.476 0.832 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 62.6 p -130.3 60.32 1.62 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.614 1.166 . . . . 0.0 107.953 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -95.47 139.6 31.51 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -101.13 142.31 32.76 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.81 0.444 . . . . 0.0 110.244 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -135.81 137.72 41.84 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.418 1.087 . . . . 0.0 109.127 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.3 t -99.96 129.58 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.516 -1.291 . . . . 0.0 107.516 174.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.1 mt -126.04 122.01 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -76.99 124.18 27.4 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.5 mt -117.37 109.14 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 124.989 1.315 . . . . 0.0 107.874 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -99.97 149.81 23.07 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 174.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.35 1.82 56.74 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.072 0.844 . . . . 0.0 113.232 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.0 mtm -74.74 104.58 5.44 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.719 1.26 . . . . 0.0 108.329 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.4 m -55.48 -57.81 10.34 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.268 1.027 . . . . 0.0 111.286 -174.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.6 p -164.0 -164.96 0.93 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.1 0.96 . . . . 0.0 109.395 -176.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -72.44 77.35 1.04 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.504 1.122 . . . . 0.0 110.052 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.1 p -168.72 -54.94 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 126.983 2.113 . . . . 0.0 107.027 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.4 m -58.87 -49.04 79.26 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.544 1.137 . . . . 0.0 108.73 169.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.0 t -49.87 -52.23 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 125.549 1.54 . . . . 0.0 110.331 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -62.48 -45.74 91.65 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.676 0.79 . . . . 0.0 111.009 -178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.2 m -58.69 -53.26 60.38 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.667 0.787 . . . . 0.0 110.774 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.0 mt -55.78 -54.8 22.35 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 C-N-CA 124.064 0.946 . . . . 0.0 109.402 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.63 -54.49 32.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.73 0.812 . . . . 0.0 110.86 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.68 -53.65 43.51 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.234 0.921 . . . . 0.0 112.514 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.9 t -63.69 -54.75 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 117.41 0.605 . . . . 0.0 110.813 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.78 -37.31 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 118.844 -0.598 . . . . 0.0 110.929 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.4 t -50.14 -34.8 23.45 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.637 0.653 . . . . 0.0 112.564 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -89.64 -10.52 45.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.128 0.971 . . . . 0.0 112.472 -174.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -69.96 146.29 95.04 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 119.011 0.823 . . . . 0.0 110.062 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -46.34 135.6 15.52 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 124.033 3.156 . . . . 0.0 113.101 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.08 -37.32 3.34 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 118.856 -0.969 . . . . 0.0 112.763 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 52.1 t -67.17 141.21 18.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-N 118.302 1.051 . . . . 0.0 110.216 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -116.72 -98.67 0.45 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.895 1.278 . . . . 0.0 108.011 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.4 p -90.2 154.96 19.35 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.535 0.734 . . . . 0.0 109.796 174.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.1 tt -150.85 139.79 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 123.519 0.727 . . . . 0.0 109.88 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.71 109.49 12.11 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.841 1.256 . . . . 0.0 108.399 174.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.6 125.97 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.9 t -115.57 127.97 55.63 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.86 1.264 . . . . 0.0 110.151 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.8 tp -70.73 -50.47 35.81 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.098 0.959 . . . . 0.0 109.65 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.76 -43.76 69.43 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.019 1.328 . . . . 0.0 111.832 -177.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -89.18 -16.52 31.15 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.162 0.585 . . . . 0.0 111.122 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.0 m 55.21 56.29 6.63 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 125.141 1.376 . . . . 0.0 110.223 -177.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -154.84 168.8 25.69 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.062 0.545 . . . . 0.0 111.475 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.04 115.79 2.41 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 126.101 1.81 . . . . 0.0 108.6 176.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.7 m -99.22 99.1 10.03 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.5 t -106.9 126.71 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 124.791 1.236 . . . . 0.0 109.374 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -90.04 131.57 35.84 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 169.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -150.18 165.16 33.72 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.196 0.599 . . . . 0.0 112.022 -172.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -100.69 113.83 65.68 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.348 1.459 . . . . 0.0 108.688 172.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -46.65 -35.79 17.77 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 125.188 3.925 . . . . 0.0 114.798 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.26 -34.27 77.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.383 0.673 . . . . 0.0 111.73 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.75 -36.22 9.53 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.846 0.858 . . . . 0.0 111.557 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.1 t -147.22 176.74 9.74 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 118.62 0.645 . . . . 0.0 110.655 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.7 p -148.46 161.25 34.27 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.62 1.168 . . . . 0.0 109.729 -175.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.97 -38.74 59.38 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.42 2.747 . . . . 0.0 112.914 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -65.77 -44.32 86.19 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.482 1.113 . . . . 0.0 110.432 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.4 m -64.54 -45.4 87.31 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.056 0.543 . . . . 0.0 110.374 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.3 mt -63.22 -46.35 87.38 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.025 0.93 . . . . 0.0 110.775 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -52.21 -48.93 64.83 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.885 0.874 . . . . 0.0 109.805 170.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.15 -44.92 83.86 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.301 0.953 . . . . 0.0 112.582 176.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.96 -48.13 77.71 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.728 0.811 . . . . 0.0 111.287 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.6 mt -60.08 -41.43 86.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.916 0.886 . . . . 0.0 109.897 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -64.29 -40.19 95.45 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.382 0.673 . . . . 0.0 111.008 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.56 -41.9 98.37 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.027 0.931 . . . . 0.0 111.017 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.8 mtp -58.31 -45.3 88.3 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 172.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.39 57.04 0.14 Allowed Glycine 0 C--N 1.34 0.764 0 C-N-CA 123.807 0.718 . . . . 0.0 111.747 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -140.35 139.35 35.36 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.792 0.837 . . . . 0.0 108.763 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -70.64 93.05 0.89 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.726 0.81 . . . . 0.0 109.497 -176.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.5 131.44 45.5 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.75 1.22 . . . . 0.0 109.751 -173.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.0 p -139.25 139.19 37.34 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.857 1.263 . . . . 0.0 108.603 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.61 143.97 57.39 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.83 0.452 . . . . 0.0 110.467 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.3 t -135.87 51.26 2.05 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 116.986 -1.483 . . . . 0.0 109.162 -169.678 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 66.3 tp . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 119.866 -0.112 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.8 p -140.08 152.19 45.97 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.192 0.997 . . . . 0.0 109.239 173.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -143.53 160.14 41.16 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 125.922 1.689 . . . . 0.0 108.554 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -120.03 142.7 48.59 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 124.099 0.96 . . . . 0.0 109.273 176.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.6 t -135.42 140.77 45.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.315 1.046 . . . . 0.0 109.712 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.9 t -103.54 111.2 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 175.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.6 mt -99.57 123.9 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 176.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -82.28 111.85 18.73 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.9 mt -116.48 106.42 20.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 C-N-CA 124.447 1.099 . . . . 0.0 108.071 -171.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -99.92 151.63 21.09 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.035 0.534 . . . . 0.0 109.59 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.52 12.11 56.26 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.489 1.043 . . . . 0.0 113.259 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.4 mtm -78.26 81.13 4.64 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.676 1.238 . . . . 0.0 109.43 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.5 m -63.74 98.34 0.19 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.642 1.177 . . . . 0.0 111.045 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.5 t 71.27 169.27 0.32 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.323 1.449 . . . . 0.0 111.271 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -75.09 74.81 2.27 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.5 m -156.92 -54.24 0.08 Allowed 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 126.771 2.028 . . . . 0.0 106.754 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.7 m -57.54 -47.03 83.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 168.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.5 t -49.59 -51.29 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.386 1.474 . . . . 0.0 110.595 174.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -62.87 -48.27 79.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.259 0.624 . . . . 0.0 111.232 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.4 p -61.2 -48.29 82.19 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.87 0.468 . . . . 0.0 111.274 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.2 mt -54.23 -59.03 2.38 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 C-N-CA 124.383 1.073 . . . . 0.0 109.488 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -54.63 -48.84 71.77 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.66 0.784 . . . . 0.0 110.642 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.95 -52.87 43.64 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.635 1.112 . . . . 0.0 112.303 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.2 t -67.69 -55.12 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 117.777 0.788 . . . . 0.0 110.697 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.14 -36.71 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.404 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.6 p -54.36 -29.66 49.12 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.127 0.876 . . . . 0.0 112.832 177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -89.47 -7.93 53.98 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.983 0.913 . . . . 0.0 112.269 -176.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -70.7 142.4 88.5 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 119.022 0.828 . . . . 0.0 109.586 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.09 130.9 26.95 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.955 2.437 . . . . 0.0 109.987 -177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.93 -32.21 7.75 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 118.923 -0.932 . . . . 0.0 112.111 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.8 t -72.08 138.72 21.0 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 CA-C-N 118.396 1.098 . . . . 0.0 109.365 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -108.68 -101.83 0.37 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.7 p -90.29 153.83 20.17 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.566 0.747 . . . . 0.0 109.394 172.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.1 tt -150.18 129.83 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 123.511 0.724 . . . . 0.0 109.235 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -120.86 105.06 10.34 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 125.139 1.376 . . . . 0.0 108.65 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.5 t -97.44 122.49 49.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.1 t -110.03 128.25 55.31 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.643 1.177 . . . . 0.0 110.284 -177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 53.2 tp -67.25 -53.5 29.49 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.95 0.9 . . . . 0.0 109.277 171.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.34 -47.39 69.41 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 125.277 1.431 . . . . 0.0 112.039 -175.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -89.19 -8.03 54.42 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 119.043 -0.504 . . . . 0.0 111.605 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.8 m 51.57 56.25 8.17 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.168 1.387 . . . . 0.0 110.932 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.7 p30 -155.22 163.98 39.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.966 0.506 . . . . 0.0 111.217 -176.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -119.84 113.32 2.44 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.1 m -98.65 94.66 6.78 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 t -101.03 123.81 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 124.362 1.065 . . . . 0.0 109.064 -170.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -95.07 128.93 42.28 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 169.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -150.24 174.19 13.11 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.145 0.578 . . . . 0.0 111.702 -170.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -108.41 110.24 61.64 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.541 1.536 . . . . 0.0 109.157 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -42.8 -40.47 8.13 Favored 'Trans proline' 0 C--N 1.348 0.545 1 C-N-CA 125.444 4.096 . . . . 0.0 114.995 173.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.4 mt -63.34 -31.79 73.04 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.753 0.821 . . . . 0.0 111.774 -176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.45 -34.53 9.12 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.426 1.09 . . . . 0.0 111.981 -173.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.8 t -149.57 158.25 44.0 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.551 0.74 . . . . 0.0 109.762 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 62.2 p -123.04 160.24 50.5 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.553 1.141 . . . . 0.0 110.068 -178.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -48.45 -39.61 36.37 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.54 2.827 . . . . 0.0 112.839 171.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -65.58 -45.14 84.41 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.139 0.975 . . . . 0.0 110.407 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.9 m -60.12 -46.64 88.96 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.219 0.608 . . . . 0.0 110.476 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.6 mt -62.35 -48.15 81.05 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.828 0.851 . . . . 0.0 110.518 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -53.94 -42.1 68.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.642 0.777 . . . . 0.0 110.469 172.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.72 -43.77 86.58 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.311 0.958 . . . . 0.0 112.171 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.88 -44.64 92.43 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.871 0.835 . . . . 0.0 111.429 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.7 mm -63.07 -41.84 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 122.861 0.464 . . . . 0.0 110.567 176.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.53 -41.92 98.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.836 0.854 . . . . 0.0 110.461 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -62.61 -45.72 91.56 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.014 0.926 . . . . 0.0 110.876 176.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.2 mmm -58.95 -34.74 72.12 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.302 0.641 . . . . 0.0 111.056 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 107.44 59.11 0.57 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 124.209 0.909 . . . . 0.0 111.655 169.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -140.2 154.57 46.96 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.911 0.884 . . . . 0.0 109.861 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -81.0 88.68 5.92 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.838 0.855 . . . . 0.0 109.558 -174.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.41 129.5 45.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.956 1.302 . . . . 0.0 110.948 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 89.5 m -144.28 128.72 17.96 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.586 1.154 . . . . 0.0 108.547 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.8 mt -62.41 155.5 25.16 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.519 0.728 . . . . 0.0 111.127 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 75.7 p -77.33 67.79 3.33 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.444 0.698 . . . . 0.0 109.461 171.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 C--O 1.25 1.13 0 CA-C-O 117.181 -1.39 . . . . 0.0 108.801 -177.193 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.369 0.128 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 45.7 p -140.37 120.64 13.92 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.377 1.071 . . . . 0.0 109.259 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -139.37 172.38 12.9 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.219 1.408 . . . . 0.0 109.131 175.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -140.06 142.74 36.14 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.178 0.991 . . . . 0.0 108.943 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 t -137.24 149.64 47.3 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.507 1.123 . . . . 0.0 109.316 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.0 t -110.87 138.12 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 172.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.0 mt -133.27 125.54 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -70.17 130.17 41.35 Favored 'General case' 0 C--N 1.337 0.061 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.2 mt -130.1 113.6 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -117.18 153.76 32.27 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.656 0.782 . . . . 0.0 109.907 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.39 20.44 48.58 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.403 1.001 . . . . 0.0 112.565 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.6 mtm -82.55 96.7 8.14 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 117.901 0.85 . . . . 0.0 108.911 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.9 p -71.49 100.19 2.18 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 110.091 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 p 55.26 -171.11 0.07 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.805 2.442 . . . . 0.0 114.614 173.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -52.97 -30.0 32.27 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.9 1.68 . . . . 0.0 112.949 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.9 m -55.22 -55.05 35.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.124 0.97 . . . . 0.0 110.554 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.2 m -65.73 -43.51 88.79 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.226 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -52.22 -54.19 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.111 0.564 . . . . 0.0 109.927 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -61.22 -45.76 93.24 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.158 0.983 . . . . 0.0 111.18 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.6 m -58.35 -53.68 55.56 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.876 0.47 . . . . 0.0 110.99 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.03 -55.53 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.351 1.06 . . . . 0.0 109.722 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -56.81 -50.34 72.66 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.139 0.975 . . . . 0.0 110.937 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.93 -51.96 56.12 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.902 1.239 . . . . 0.0 112.161 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.16 -54.47 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 117.746 0.773 . . . . 0.0 110.223 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.9 mt -65.44 -35.53 75.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.796 -172.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.0 p -54.2 -30.55 50.18 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.01 0.823 . . . . 0.0 112.519 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -89.58 -11.23 43.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.077 0.951 . . . . 0.0 112.617 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -68.27 144.46 96.71 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 119.193 0.906 . . . . 0.0 109.918 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.75 132.23 34.28 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.054 2.502 . . . . 0.0 110.31 -175.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.17 -35.85 4.6 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-O 119.02 -0.878 . . . . 0.0 112.223 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.76 127.74 31.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 118.09 0.945 . . . . 0.0 109.881 -177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -94.56 -101.41 0.15 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.7 p -90.07 155.75 18.85 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.608 0.763 . . . . 0.0 110.363 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.2 tt -150.62 145.72 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 123.975 0.91 . . . . 0.0 109.772 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.12 141.98 44.21 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 168.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.0 t -125.52 117.37 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.691 1.197 . . . . 0.0 108.324 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.7 t -104.62 123.96 48.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.809 1.244 . . . . 0.0 109.818 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.9 tp -73.94 -44.12 56.03 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 124.165 0.986 . . . . 0.0 110.107 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.86 -45.88 74.62 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.582 1.153 . . . . 0.0 111.406 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -89.5 -7.61 54.63 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.607 0.763 . . . . 0.0 111.591 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.3 m 54.49 53.79 10.26 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.949 1.699 . . . . 0.0 111.474 175.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -160.02 167.23 28.36 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.198 0.599 . . . . 0.0 111.185 -175.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.59 121.84 3.96 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 177.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.8 m -99.68 112.94 25.12 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 173.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.4 t -117.81 122.27 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 124.701 1.2 . . . . 0.0 108.737 -172.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -89.68 132.51 35.12 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 169.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -150.36 168.31 24.48 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.905 0.482 . . . . 0.0 112.103 -170.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -103.97 111.4 65.14 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 125.181 1.392 . . . . 0.0 109.048 173.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -41.75 -38.28 4.41 Favored 'Trans proline' 0 C--N 1.347 0.495 1 C-N-CA 125.432 4.088 . . . . 0.0 115.312 171.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 75.8 mt -64.25 -34.03 77.18 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.162 0.585 . . . . 0.0 111.952 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.5 mt -103.82 -33.65 8.82 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.264 1.025 . . . . 0.0 112.333 -171.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.9 t -148.72 176.27 10.51 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.56 0.744 . . . . 0.0 109.801 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.9 p -150.25 163.5 24.12 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 123.891 0.877 . . . . 0.0 110.323 -174.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.42 -46.92 30.33 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.401 2.734 . . . . 0.0 112.986 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -65.73 -35.8 81.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.305 0.642 . . . . 0.0 112.123 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.8 m -67.16 -46.04 75.19 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.165 0.439 . . . . 0.0 110.296 176.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.7 mt -60.55 -47.11 87.61 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.544 0.737 . . . . 0.0 110.418 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.5 ttp85 -54.77 -46.5 74.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.134 0.973 . . . . 0.0 110.055 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.43 -43.99 93.77 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.503 1.049 . . . . 0.0 112.309 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.44 -46.22 87.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.926 0.863 . . . . 0.0 111.099 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.0 mt -59.92 -45.69 94.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 123.411 0.685 . . . . 0.0 109.639 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -61.28 -41.56 97.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.672 0.789 . . . . 0.0 111.039 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.97 -44.35 96.28 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.499 1.12 . . . . 0.0 111.032 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 70.6 mtm -57.84 -43.62 85.97 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.513 0.325 . . . . 0.0 110.595 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.67 61.54 0.19 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 123.531 0.586 . . . . 0.0 111.651 169.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -140.08 147.35 40.16 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 173.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -70.13 95.92 1.03 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.5 123.5 47.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.016 1.326 . . . . 0.0 109.937 -173.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.9 p -142.35 142.88 32.52 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.234 1.014 . . . . 0.0 108.542 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.5 mt -64.63 143.06 58.19 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.776 0.43 . . . . 0.0 110.959 -176.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.3 t -122.93 27.85 7.5 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.192 1.397 . . . . 0.0 109.701 175.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.6 t70 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 117.278 -1.344 . . . . 0.0 108.361 -172.191 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 120.389 0.138 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.6 p -140.49 122.21 15.33 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.363 1.065 . . . . 0.0 109.022 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -139.5 163.88 31.36 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 124.791 1.236 . . . . 0.0 109.307 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.79 140.91 52.52 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.824 1.249 . . . . 0.0 108.44 173.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 t -136.27 135.64 39.14 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.181 0.992 . . . . 0.0 109.529 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.5 t -99.65 124.1 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 171.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.9 mt -120.44 120.14 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -73.74 129.21 37.45 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.7 mt -122.19 108.65 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -99.61 145.87 27.09 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 174.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.56 -7.09 53.26 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 118.855 -0.97 . . . . 0.0 113.36 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.9 mtm -57.59 -53.06 62.45 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.938 1.369 . . . . 0.0 110.09 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 m 76.47 -42.23 0.43 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.708 1.603 . . . . 0.0 113.467 169.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.5 p -144.67 168.29 20.52 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.782 0.833 . . . . 0.0 112.16 -170.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -66.68 -33.06 74.81 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.984 1.314 . . . . 0.0 112.598 -173.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.8 p -66.42 -41.69 88.86 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.508 0.594 . . . . 0.0 110.728 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.6 m -61.97 -50.04 73.71 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.932 0.493 . . . . 0.0 110.297 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.1 t -51.24 -50.26 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 124.229 1.012 . . . . 0.0 110.85 176.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -58.17 -50.25 74.19 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.403 1.081 . . . . 0.0 110.681 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.4 m -57.92 -48.34 80.18 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.142 0.577 . . . . 0.0 111.152 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -59.07 -50.46 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.611 0.764 . . . . 0.0 109.548 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -51.52 -56.4 13.59 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.022 0.929 . . . . 0.0 110.106 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.34 -55.0 32.74 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.206 0.908 . . . . 0.0 112.335 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.09 -56.35 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.317 0.647 . . . . 0.0 110.767 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.3 mm -61.41 -37.86 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-O 118.806 -0.616 . . . . 0.0 111.215 -175.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.0 t -50.31 -38.21 40.4 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.618 0.645 . . . . 0.0 112.285 176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.41 -1.45 58.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.664 0.785 . . . . 0.0 112.717 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -69.94 145.07 93.86 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 119.424 1.011 . . . . 0.0 109.485 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -63.37 127.8 20.93 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.88 2.387 . . . . 0.0 109.911 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.92 -38.2 3.37 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 119.126 -0.819 . . . . 0.0 111.713 -176.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.9 t -72.81 140.15 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-N 118.046 0.923 . . . . 0.0 109.805 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -106.22 -98.79 0.34 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 172.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 53.0 p -90.63 160.07 16.09 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.035 0.934 . . . . 0.0 110.234 174.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.9 tt -150.27 138.93 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 124.288 1.035 . . . . 0.0 108.454 172.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.57 104.69 10.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.498 1.119 . . . . 0.0 109.205 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -94.8 122.69 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.8 t -109.7 127.01 54.3 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.463 1.105 . . . . 0.0 109.933 -177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.67 -55.92 14.87 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.137 0.975 . . . . 0.0 108.528 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.69 -47.16 63.99 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.414 1.486 . . . . 0.0 112.341 -175.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -89.26 -10.91 45.15 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.954 0.501 . . . . 0.0 111.634 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m 52.87 56.46 7.56 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.188 1.395 . . . . 0.0 110.906 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.1 p30 -155.44 169.73 23.58 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.166 0.587 . . . . 0.0 111.175 -176.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.08 115.43 2.19 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 126.269 1.89 . . . . 0.0 108.714 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.5 m -99.04 96.48 7.84 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.81 129.4 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.516 1.127 . . . . 0.0 109.283 -170.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -99.37 124.12 44.22 Favored 'General case' 0 C--N 1.339 0.124 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 169.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -150.3 172.46 15.34 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.943 0.497 . . . . 0.0 112.288 -169.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -105.88 110.33 64.0 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.29 1.436 . . . . 0.0 109.468 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_exo -40.84 -41.79 4.1 Favored 'Trans proline' 0 C--N 1.348 0.518 1 C-N-CA 125.432 4.088 . . . . 0.0 115.294 171.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.1 mt -60.56 -35.55 76.31 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.465 0.706 . . . . 0.0 111.866 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.7 mt -100.0 -32.18 11.09 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.232 1.013 . . . . 0.0 112.1 -172.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.1 t -150.42 152.73 34.77 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.603 0.638 . . . . 0.0 109.891 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 p -116.36 162.53 25.95 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.535 1.134 . . . . 0.0 109.936 178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.09 -39.59 50.92 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.329 2.686 . . . . 0.0 112.65 170.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.2 -39.11 89.42 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.929 0.892 . . . . 0.0 111.596 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 m -63.73 -47.34 81.46 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.927 0.491 . . . . 0.0 110.202 176.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 65.2 mt -62.14 -49.17 76.91 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.125 0.97 . . . . 0.0 110.36 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -49.88 -48.12 51.56 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.795 1.238 . . . . 0.0 109.943 170.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.32 -46.95 85.68 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.528 1.061 . . . . 0.0 112.413 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.65 91.55 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 117.835 0.817 . . . . 0.0 111.29 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -60.62 -44.16 96.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.804 0.842 . . . . 0.0 109.912 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -65.01 -38.94 92.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.853 0.861 . . . . 0.0 111.153 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.55 -44.08 97.22 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.26 1.024 . . . . 0.0 110.816 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 73.7 mtm -58.81 -48.84 79.89 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.3 59.76 0.1 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 170.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -140.24 137.59 34.39 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 172.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.33 97.94 1.01 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.542 0.737 . . . . 0.0 109.798 -176.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.86 133.14 44.65 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.792 1.237 . . . . 0.0 110.184 -174.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.2 m -144.49 138.57 27.7 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.603 1.161 . . . . 0.0 108.369 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -65.4 148.41 51.77 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.732 0.413 . . . . 0.0 110.178 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 t -148.34 46.72 1.05 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.998 0.919 . . . . 0.0 109.566 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.8 t70 . . . . . 0 C--O 1.251 1.134 0 C-N-CA 126.251 1.821 . . . . 0.0 110.038 -171.736 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 86.9 mt . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 47.6 p -98.76 77.91 2.29 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -89.49 151.39 22.01 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.794 0.838 . . . . 0.0 109.302 -174.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.88 149.24 43.67 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.738 0.815 . . . . 0.0 110.428 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -143.85 146.17 32.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.459 1.104 . . . . 0.0 108.999 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 51.2 t -113.3 124.5 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.8 mt -120.32 125.79 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -177.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -70.13 126.86 30.91 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 172.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.4 mt -123.11 95.15 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -99.33 132.48 44.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.32 -27.81 4.41 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -170.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 48.4 mtm -60.99 123.37 17.4 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 117.717 0.758 . . . . 0.0 109.161 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.2 t -141.58 10.87 2.07 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.778 0.831 . . . . 0.0 111.911 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.0 t -165.64 151.59 9.41 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -56.14 -30.91 62.81 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.646 0.778 . . . . 0.0 111.903 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.1 p -50.49 -41.9 53.9 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.469 0.707 . . . . 0.0 111.316 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.2 m -62.41 -49.65 74.63 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.674 0.789 . . . . 0.0 109.661 177.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.8 t -54.6 -58.08 4.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.332 1.053 . . . . 0.0 110.224 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -61.69 -41.76 98.01 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.285 0.634 . . . . 0.0 111.382 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -58.98 -59.13 5.95 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.104 0.561 . . . . 0.0 110.633 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.4 mt -57.78 -55.61 20.55 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 123.52 0.728 . . . . 0.0 109.69 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -55.67 -48.49 74.97 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.572 0.749 . . . . 0.0 110.706 -176.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.94 -53.45 45.35 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.329 0.966 . . . . 0.0 112.225 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.8 t -63.22 -55.63 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 117.709 0.754 . . . . 0.0 110.683 -178.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.5 mm -63.7 -38.22 81.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.514 0.725 . . . . 0.0 111.559 -173.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.5 p -54.98 -30.65 59.76 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.069 0.85 . . . . 0.0 112.553 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -89.35 -5.98 57.04 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.932 0.893 . . . . 0.0 112.187 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -70.71 142.67 88.76 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 119.017 0.826 . . . . 0.0 109.136 176.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.16 132.49 34.29 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.823 2.349 . . . . 0.0 110.093 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.48 -35.78 4.73 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-O 118.919 -0.934 . . . . 0.0 112.088 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.27 129.32 33.71 Favored 'Isoleucine or valine' 0 C--N 1.341 0.214 0 CA-C-N 118.074 0.937 . . . . 0.0 109.735 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -100.66 -101.87 0.25 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.55 1.14 . . . . 0.0 108.03 176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 74.0 p -87.01 151.62 23.11 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.288 0.635 . . . . 0.0 109.744 175.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.1 tt -150.4 131.05 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.462 0.705 . . . . 0.0 109.421 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -120.81 105.78 11.05 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.429 1.492 . . . . 0.0 108.717 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.72 125.89 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.2 t -116.16 118.71 33.59 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.685 1.194 . . . . 0.0 110.023 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.0 tp -63.59 -49.1 74.68 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.991 0.916 . . . . 0.0 109.834 171.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.1 -48.55 67.72 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.7 1.2 . . . . 0.0 111.994 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -89.7 -1.86 58.12 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.232 0.613 . . . . 0.0 112.201 -179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.1 m 49.71 52.0 15.41 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 125.318 1.447 . . . . 0.0 111.579 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -156.21 170.22 22.74 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 120.968 0.413 . . . . 0.0 111.664 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -131.58 119.28 2.55 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 125.607 1.575 . . . . 0.0 109.232 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.5 m -99.32 104.49 16.4 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.6 t -112.04 128.57 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.532 1.133 . . . . 0.0 109.574 -170.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -98.79 133.33 43.26 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -150.43 164.87 34.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.66 0.784 . . . . 0.0 111.844 -170.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -102.27 116.57 62.82 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.337 1.055 . . . . 0.0 109.498 173.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.71 -40.29 18.88 Favored 'Trans proline' 0 C--N 1.349 0.586 1 C-N-CA 125.348 4.032 . . . . 0.0 115.468 177.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.9 mt -67.11 -27.72 67.56 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.197 0.599 . . . . 0.0 111.949 -174.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.68 -42.05 7.04 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.078 0.951 . . . . 0.0 110.707 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.4 t -148.73 174.81 11.79 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.62 0.768 . . . . 0.0 110.001 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.3 p -150.56 164.37 20.7 Favored Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 124.563 1.145 . . . . 0.0 110.439 -170.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.25 -45.58 38.39 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.134 2.556 . . . . 0.0 112.79 177.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -67.32 -38.78 85.49 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.396 0.679 . . . . 0.0 112.806 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.3 p -66.0 -46.37 78.24 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.724 0.693 . . . . 0.0 110.438 176.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 37.6 mt -62.1 -46.43 89.08 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.752 0.821 . . . . 0.0 110.428 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -53.5 -45.36 69.64 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.159 0.984 . . . . 0.0 110.47 171.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.4 -47.04 91.0 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.076 0.846 . . . . 0.0 112.114 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.05 -51.95 65.92 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.473 0.709 . . . . 0.0 111.059 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.8 mt -57.57 -41.84 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.016 0.926 . . . . 0.0 109.9 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -59.0 -50.52 73.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.355 0.662 . . . . 0.0 109.749 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -58.25 -38.74 77.5 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.772 1.229 . . . . 0.0 112.0 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mtp -60.81 -20.95 62.59 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.98 57.12 0.52 Allowed Glycine 0 C--N 1.34 0.784 0 C-N-CA 124.306 0.955 . . . . 0.0 111.151 170.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -140.6 155.47 46.56 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.27 1.028 . . . . 0.0 109.46 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -80.39 93.75 6.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 169.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.42 117.57 34.13 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.698 1.199 . . . . 0.0 108.862 -176.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 64.4 p -140.06 136.52 33.72 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.21 1.004 . . . . 0.0 109.054 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 65.6 mt -64.69 138.85 58.63 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.84 0.456 . . . . 0.0 110.813 -175.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.24 -52.25 3.73 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.549 1.139 . . . . 0.0 108.206 171.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 C--O 1.251 1.137 0 CA-C-O 116.931 -1.509 . . . . 0.0 108.335 -179.664 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 111.213 0.079 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.6 p -140.52 130.87 25.18 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.408 1.083 . . . . 0.0 109.618 177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -143.4 164.37 30.48 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.535 1.134 . . . . 0.0 109.454 171.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -123.98 154.65 39.52 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.873 1.269 . . . . 0.0 109.652 175.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.4 t -150.14 144.74 25.89 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.779 0.832 . . . . 0.0 109.981 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.7 t -109.27 115.75 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.3 mt -110.51 118.13 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -76.04 121.89 23.43 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.1 mt -118.15 110.11 29.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 124.747 1.219 . . . . 0.0 108.097 -175.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -99.8 148.04 24.84 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.58 3.67 56.2 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.511 1.053 . . . . 0.0 113.531 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.6 mtm -71.13 87.0 0.77 Allowed 'General case' 0 C--N 1.344 0.362 0 CA-C-N 118.825 1.313 . . . . 0.0 109.767 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.1 m -79.54 99.0 7.08 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.217 1.007 . . . . 0.0 109.58 -174.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.8 t 73.74 163.45 0.27 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.728 1.611 . . . . 0.0 111.712 173.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -71.07 73.33 0.62 Allowed 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.703 1.201 . . . . 0.0 109.708 173.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.5 m -162.33 -52.13 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 127.654 2.381 . . . . 0.0 106.477 -176.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.0 m -61.03 -49.17 78.47 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 168.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 82.7 t -49.71 -51.64 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 125.221 1.408 . . . . 0.0 110.279 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -60.33 -48.66 80.77 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.092 0.957 . . . . 0.0 111.125 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.7 p -62.19 -47.81 82.84 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 122.848 0.459 . . . . 0.0 111.371 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.2 mt -55.35 -60.58 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.249 0 C-N-CA 123.715 0.806 . . . . 0.0 108.953 176.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -53.24 -48.5 68.17 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.772 0.829 . . . . 0.0 110.959 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.08 -57.78 16.79 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.241 0.925 . . . . 0.0 111.925 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.5 t -62.49 -53.13 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 117.624 0.712 . . . . 0.0 110.929 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.9 -45.76 91.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.618 0.767 . . . . 0.0 110.738 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 88.0 p -57.73 -27.46 63.0 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -88.9 -5.51 57.95 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.43 0.692 . . . . 0.0 111.891 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -78.83 123.18 85.3 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 119.084 0.856 . . . . 0.0 109.026 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.74 116.94 2.64 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.696 2.931 . . . . 0.0 112.075 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.47 -44.51 1.15 Allowed Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.9 t -70.8 130.4 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 117.453 0.626 . . . . 0.0 109.718 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -96.82 -100.79 0.18 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.974 1.31 . . . . 0.0 107.529 176.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.4 p -90.23 156.83 18.03 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.38 0.672 . . . . 0.0 110.004 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.6 tt -150.58 145.52 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 123.7 0.8 . . . . 0.0 110.217 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -133.97 104.92 6.47 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.923 1.289 . . . . 0.0 107.571 169.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.2 t -89.8 97.86 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.8 t -89.75 123.08 33.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.835 0.854 . . . . 0.0 109.469 -175.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.1 tp -70.82 -49.34 47.4 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.792 0.837 . . . . 0.0 110.092 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.69 -46.17 74.07 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.0 1.32 . . . . 0.0 112.054 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -89.22 -6.79 56.6 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.745 0.818 . . . . 0.0 111.319 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 m 52.55 54.25 10.94 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 125.85 1.66 . . . . 0.0 111.389 176.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -156.52 150.08 24.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.342 0.592 . . . . 0.0 112.282 -175.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -94.7 108.71 3.72 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 170.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -98.76 95.74 7.43 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 175.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 t -108.81 134.19 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.517 1.127 . . . . 0.0 109.879 -169.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -105.27 132.71 51.13 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 168.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -150.36 170.9 17.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.079 0.552 . . . . 0.0 111.384 -169.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -102.8 111.43 64.88 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.056 1.342 . . . . 0.0 109.241 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -41.75 -40.03 5.37 Favored 'Trans proline' 0 C--N 1.347 0.454 1 C-N-CA 125.618 4.212 . . . . 0.0 115.047 172.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.1 mt -61.93 -33.38 74.16 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.612 0.765 . . . . 0.0 111.829 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.0 mt -102.87 -38.13 7.53 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.478 1.111 . . . . 0.0 111.919 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 t -147.12 174.16 11.83 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.592 0.757 . . . . 0.0 110.1 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.7 p -150.21 162.89 26.37 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.113 0.965 . . . . 0.0 110.02 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -52.62 -43.55 54.36 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.659 2.906 . . . . 0.0 113.186 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -64.29 -36.83 85.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.551 0.74 . . . . 0.0 112.103 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.0 m -68.57 -46.41 69.48 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.019 0.527 . . . . 0.0 109.884 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.3 mt -61.0 -46.83 89.17 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.166 0.986 . . . . 0.0 110.307 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -54.63 -44.7 73.39 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.171 0.988 . . . . 0.0 110.296 172.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.13 -44.64 93.07 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.247 0.927 . . . . 0.0 112.245 175.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.06 -49.31 75.02 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.542 0.737 . . . . 0.0 111.229 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.4 mt -61.85 -39.39 83.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.913 0.885 . . . . 0.0 110.028 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -61.46 -48.52 80.75 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.6 0.76 . . . . 0.0 109.859 176.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.27 -40.67 86.8 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.561 1.144 . . . . 0.0 111.43 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.8 mmm -60.98 -19.63 61.4 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.607 0.763 . . . . 0.0 112.163 173.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 102.15 53.53 0.95 Allowed Glycine 0 C--N 1.34 0.796 0 C-N-CA 124.411 1.005 . . . . 0.0 111.699 169.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -140.52 156.2 46.39 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.86 0.864 . . . . 0.0 110.273 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -82.88 87.14 6.84 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.23 124.74 44.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.606 1.162 . . . . 0.0 109.936 -173.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 58.9 p -139.99 140.18 36.21 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.685 1.194 . . . . 0.0 108.79 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 53.9 mt -67.58 135.11 52.4 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 t -80.91 70.29 7.68 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 116.894 -1.527 . . . . 0.0 110.505 -174.476 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 57.9 tp . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 110.725 -0.102 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 87.9 m -140.32 143.32 35.75 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.463 1.105 . . . . 0.0 108.444 172.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -137.1 164.77 27.63 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.695 1.598 . . . . 0.0 108.294 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -102.58 143.27 32.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.211 1.004 . . . . 0.0 109.354 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -137.26 142.44 41.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.46 124.83 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.0 mt -121.09 120.5 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -77.29 120.76 22.77 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.3 mt -122.35 106.85 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.745 1.218 . . . . 0.0 107.881 -173.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -99.6 146.91 25.93 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.83 -12.61 17.7 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.55 1.071 . . . . 0.0 112.108 -172.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 44.6 mtm -77.28 76.63 3.82 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 118.382 1.091 . . . . 0.0 109.56 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.4 m -65.28 -48.82 71.84 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.02 0.928 . . . . 0.0 111.601 -174.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.2 t -117.14 157.25 26.25 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.806 1.242 . . . . 0.0 110.409 -171.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -48.95 -36.91 18.55 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.663 1.185 . . . . 0.0 111.644 171.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -50.05 -42.74 50.31 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.433 1.093 . . . . 0.0 112.004 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.3 m -61.24 -59.1 5.83 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.375 0.67 . . . . 0.0 109.394 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -50.01 -51.3 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.23 1.412 . . . . 0.0 111.194 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -59.79 -53.19 60.81 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.272 1.429 . . . . 0.0 111.079 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 82.3 p -60.24 -49.34 77.99 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.026 0.53 . . . . 0.0 111.072 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.3 mt -53.46 -57.21 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.195 0.998 . . . . 0.0 109.943 177.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -53.39 -52.38 59.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.921 0.888 . . . . 0.0 110.844 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.08 -54.2 38.74 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.844 0.735 . . . . 0.0 112.312 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.0 t -61.16 -54.71 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.373 1.069 . . . . 0.0 110.876 -176.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.2 mm -61.75 -34.72 63.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.874 0.87 . . . . 0.0 111.262 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t -53.73 -19.47 4.23 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -89.25 -12.67 40.07 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.929 0.786 . . . . 0.0 112.392 -175.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -74.58 143.55 79.17 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 118.783 0.719 . . . . 0.0 110.131 -172.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.27 130.35 25.2 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.061 2.508 . . . . 0.0 109.772 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.04 -39.61 2.8 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 118.926 -0.93 . . . . 0.0 111.419 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.6 t -66.59 123.65 20.06 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 CA-C-N 118.069 0.935 . . . . 0.0 109.139 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -93.26 -102.65 0.13 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.4 p -90.26 155.99 18.6 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.907 0.883 . . . . 0.0 109.706 171.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.1 tt -150.32 141.08 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.652 0.781 . . . . 0.0 109.586 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -135.52 131.78 36.46 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.91 0.884 . . . . 0.0 108.769 169.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -115.82 133.73 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.9 t -112.56 133.46 54.6 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.932 1.293 . . . . 0.0 110.702 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.18 -56.7 5.54 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 170.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.55 -47.78 63.31 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 125.339 1.456 . . . . 0.0 112.335 -175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -89.25 -10.36 47.24 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.577 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m 52.03 56.29 7.99 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 125.02 1.328 . . . . 0.0 110.867 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -156.5 164.39 38.28 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.054 0.542 . . . . 0.0 111.102 -176.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.75 113.57 2.41 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 126.18 1.847 . . . . 0.0 108.825 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.9 m -99.4 107.88 20.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 t -117.34 130.22 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.453 1.101 . . . . 0.0 109.583 -170.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -93.65 127.73 39.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 168.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -149.1 155.48 40.77 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.827 0.451 . . . . 0.0 110.959 -169.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -95.15 115.22 65.21 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.282 1.033 . . . . 0.0 109.288 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -46.26 -36.38 17.02 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.861 3.708 . . . . 0.0 114.653 172.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.6 mt -66.06 -29.28 69.59 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.472 0.709 . . . . 0.0 112.099 -176.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.0 mt -108.73 -33.27 7.03 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.23 1.012 . . . . 0.0 112.26 -172.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.0 t -147.32 -179.83 7.12 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.566 0.746 . . . . 0.0 109.849 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.6 p -149.82 162.09 29.3 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 123.732 0.813 . . . . 0.0 110.125 -176.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -51.9 -40.0 67.51 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.402 2.734 . . . . 0.0 112.18 173.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -64.92 -46.91 79.67 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.288 1.035 . . . . 0.0 110.949 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.8 m -60.02 -47.32 86.34 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.052 0.541 . . . . 0.0 110.406 177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.96 -50.45 73.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.843 0.857 . . . . 0.0 110.52 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 59.1 ttp85 -50.72 -46.76 59.18 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.149 0.98 . . . . 0.0 110.487 173.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.69 -46.77 81.34 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.137 0.875 . . . . 0.0 112.114 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.24 -47.01 86.3 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.664 0.732 . . . . 0.0 111.486 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 mm -58.51 -44.51 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.222 0.609 . . . . 0.0 110.24 175.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.51 -38.28 90.53 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.143 0.577 . . . . 0.0 110.927 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -64.27 -43.67 94.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.016 0.926 . . . . 0.0 110.947 176.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 90.6 mtp -59.0 -41.42 87.64 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 117.978 0.354 . . . . 0.0 110.441 173.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.26 56.45 0.22 Allowed Glycine 0 C--N 1.34 0.793 0 C-N-CA 124.092 0.853 . . . . 0.0 111.862 169.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -140.27 139.75 35.6 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -74.02 96.33 2.66 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.467 0.707 . . . . 0.0 109.447 -175.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.95 132.72 45.14 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.96 1.304 . . . . 0.0 110.582 -173.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 61.9 p -138.24 134.95 35.05 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.079 1.352 . . . . 0.0 108.795 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.6 mt -69.14 132.51 46.67 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.701 0.4 . . . . 0.0 110.401 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.43 -51.72 4.05 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 172.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.5 p30 . . . . . 0 C--O 1.25 1.12 0 C-N-CA 125.475 1.51 . . . . 0.0 108.854 176.344 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 58.7 tp . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 110.783 -0.08 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.7 p -99.66 131.88 45.36 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.647 0.779 . . . . 0.0 110.252 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -93.06 157.32 16.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.638 1.575 . . . . 0.0 107.986 170.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.52 143.1 34.16 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.749 0.82 . . . . 0.0 109.258 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -139.46 144.66 38.11 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.009 0.924 . . . . 0.0 108.913 172.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.4 t -110.54 115.68 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.8 mm -99.84 126.81 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -77.51 113.89 15.79 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 170.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.9 mt -116.35 98.0 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -176.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -99.85 158.38 15.84 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.03 13.82 60.05 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.818 0.723 . . . . 0.0 112.902 -174.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 68.0 mtm -79.17 85.37 5.06 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 171.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.6 p -59.48 -50.99 71.79 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.688 0.795 . . . . 0.0 112.001 -173.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.3 m -133.35 171.4 14.1 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.337 1.055 . . . . 0.0 110.322 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -58.34 -25.19 61.68 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.186 0.994 . . . . 0.0 111.968 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -50.47 -47.37 57.07 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.608 0.763 . . . . 0.0 110.713 171.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.3 m -60.22 -50.34 74.06 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.807 0.843 . . . . 0.0 110.006 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.3 t -52.76 -54.86 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.74 1.216 . . . . 0.0 110.347 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.7 mm-40 -60.11 -46.27 90.18 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.301 1.041 . . . . 0.0 111.586 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -57.88 -48.86 78.6 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.675 0.39 . . . . 0.0 111.199 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.0 mt -59.81 -59.41 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.19 0.596 . . . . 0.0 109.948 -177.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -57.95 -43.52 86.42 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.102 0.41 . . . . 0.0 111.166 -176.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.31 -54.82 29.82 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.814 0.721 . . . . 0.0 112.023 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.21 -53.89 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.322 0.649 . . . . 0.0 110.792 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.4 mm -62.79 -35.42 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 118.868 -0.587 . . . . 0.0 111.729 -172.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.0 m -53.3 -30.25 37.77 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.86 0.754 . . . . 0.0 112.77 174.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 -6.7 56.24 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.498 0.719 . . . . 0.0 112.052 -175.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -72.82 143.13 84.07 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 118.859 0.754 . . . . 0.0 109.314 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -62.84 135.9 54.43 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.931 2.421 . . . . 0.0 110.025 -176.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.39 -40.07 2.62 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-O 118.888 -0.951 . . . . 0.0 111.525 -177.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -67.66 134.83 29.59 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 CA-C-N 118.068 0.934 . . . . 0.0 109.797 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -112.8 -89.5 0.52 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.8 p -90.75 154.49 19.49 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.884 0.874 . . . . 0.0 110.38 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.5 tt -150.61 148.8 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.666 1.186 . . . . 0.0 108.744 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -135.65 106.3 6.52 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.781 0.833 . . . . 0.0 109.201 174.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.8 t -94.49 100.49 11.21 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 C-N-CA 124.015 0.926 . . . . 0.0 109.307 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.4 t -89.54 120.19 30.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.974 0.91 . . . . 0.0 109.7 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.9 tp -69.98 -47.11 63.54 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.474 1.109 . . . . 0.0 110.042 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.01 -44.47 67.32 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.768 1.227 . . . . 0.0 111.682 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -89.29 -14.73 35.13 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.404 0.681 . . . . 0.0 111.3 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.1 m 55.52 54.76 8.05 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 125.403 1.481 . . . . 0.0 110.665 -177.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.5 p30 -153.17 158.47 41.84 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.028 0.531 . . . . 0.0 111.619 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.58 114.55 3.17 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 126.052 1.787 . . . . 0.0 108.92 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.3 m -98.9 97.14 8.35 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.67 134.14 44.44 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 C-N-CA 124.829 1.252 . . . . 0.0 109.704 -170.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -105.19 116.99 32.88 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 172.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -145.9 153.17 40.55 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 123.602 0.761 . . . . 0.0 111.842 -169.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -88.16 120.49 70.62 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 123.673 0.789 . . . . 0.0 110.163 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -47.8 -39.33 31.23 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.997 3.798 . . . . 0.0 115.457 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.4 mt -67.67 -28.77 67.98 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.882 0.473 . . . . 0.0 111.809 -174.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.61 -34.76 10.09 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.797 0.839 . . . . 0.0 111.091 -174.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.2 t -151.83 171.03 18.38 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.631 0.65 . . . . 0.0 110.2 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.6 p -138.89 162.68 51.3 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.757 1.223 . . . . 0.0 109.996 -175.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -50.99 -43.12 49.6 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.492 2.795 . . . . 0.0 112.573 174.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -62.48 -43.3 99.15 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.891 0.876 . . . . 0.0 111.739 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.5 m -64.15 -47.55 79.44 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 117.991 0.359 . . . . 0.0 110.299 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.8 mt -59.46 -50.61 73.25 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.985 0.914 . . . . 0.0 110.318 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 -51.5 -46.69 63.29 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.54 1.136 . . . . 0.0 110.297 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.75 -47.04 91.34 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.6 1.095 . . . . 0.0 112.184 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.57 -45.35 93.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.507 0.723 . . . . 0.0 111.273 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -62.75 -43.69 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.714 0.806 . . . . 0.0 109.876 178.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -59.47 -46.59 88.36 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.683 0.793 . . . . 0.0 110.035 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -59.24 -42.83 92.0 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.494 1.118 . . . . 0.0 111.562 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 71.7 mtm -57.66 -45.81 85.07 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 118.025 0.375 . . . . 0.0 110.687 173.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.47 63.05 0.12 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 170.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -140.28 158.5 43.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.902 0.881 . . . . 0.0 109.385 174.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -79.33 87.21 5.01 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.28 118.72 36.57 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.552 1.141 . . . . 0.0 109.835 -173.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.2 p -138.19 149.87 46.23 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.783 1.233 . . . . 0.0 108.683 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 29.3 mt -73.78 129.61 38.28 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.159 0.436 . . . . 0.0 110.056 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.2 t -89.49 -51.85 5.33 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--O 1.251 1.146 0 C-N-CA 125.311 1.444 . . . . 0.0 109.186 177.912 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 61.0 tp . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.8 p -106.02 123.78 48.53 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.52 1.128 . . . . 0.0 110.266 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -136.5 159.14 42.67 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.108 1.363 . . . . 0.0 107.646 169.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -140.27 147.08 39.43 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.511 0.724 . . . . 0.0 109.975 -177.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.8 t -142.23 153.11 43.71 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.371 1.068 . . . . 0.0 109.918 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.35 115.81 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 173.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.4 mt -106.12 124.94 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -80.14 118.67 22.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.6 mt -116.06 102.53 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -174.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -99.55 142.65 30.74 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.21 19.55 27.94 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.554 1.073 . . . . 0.0 113.142 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 68.5 mtm -79.58 69.04 5.79 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 118.618 1.209 . . . . 0.0 109.261 174.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 32.9 m -67.43 104.07 1.45 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.171 0.988 . . . . 0.0 109.607 -177.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.5 t 79.92 148.47 0.09 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.725 2.01 . . . . 0.0 111.386 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -51.31 -24.7 4.85 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.005 1.722 . . . . 0.0 113.441 176.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.3 m -50.67 -44.69 57.81 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.816 0.846 . . . . 0.0 111.601 173.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.5 m -62.58 -50.87 69.56 Favored 'General case' 0 C--N 1.338 0.104 0 C-N-CA 123.689 0.796 . . . . 0.0 110.287 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.1 t -53.44 -49.86 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.188 0.995 . . . . 0.0 110.706 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -57.74 -45.54 85.71 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.958 0.903 . . . . 0.0 111.406 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.7 m -59.67 -53.81 53.73 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.822 0.449 . . . . 0.0 110.856 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -57.73 -51.33 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.604 1.162 . . . . 0.0 109.797 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -49.8 -58.52 5.19 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.859 1.664 . . . . 0.0 110.232 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.95 -55.05 32.68 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.063 0.839 . . . . 0.0 112.141 -177.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.22 -55.3 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.428 0.691 . . . . 0.0 110.79 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.6 mt -68.09 -34.68 68.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 119.145 -0.455 . . . . 0.0 111.344 -173.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -54.72 -27.42 40.63 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 174.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -89.69 -8.3 52.68 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.441 0.697 . . . . 0.0 112.522 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -72.91 141.54 81.95 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 119.171 0.896 . . . . 0.0 110.019 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.95 131.05 27.6 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.146 2.564 . . . . 0.0 110.265 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.67 -34.28 5.91 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-O 118.897 -0.946 . . . . 0.0 112.137 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.07 121.55 16.39 Favored 'Isoleucine or valine' 0 C--N 1.341 0.239 0 CA-C-N 118.178 0.989 . . . . 0.0 109.536 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -91.58 -101.5 0.11 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.366 1.066 . . . . 0.0 108.221 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.1 p -88.57 141.46 28.51 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.6 tt -141.69 138.31 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.04 111.07 6.95 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.042 1.337 . . . . 0.0 108.017 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.5 t -104.48 120.99 55.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 124.778 1.231 . . . . 0.0 108.462 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.8 t -103.08 129.03 49.78 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.749 1.22 . . . . 0.0 110.806 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.57 -56.7 9.54 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.369 1.067 . . . . 0.0 108.131 169.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.42 -48.72 62.59 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.452 1.501 . . . . 0.0 112.466 -175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -89.23 -5.03 57.97 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.883 0.473 . . . . 0.0 111.662 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.2 m 51.3 54.63 10.79 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.244 1.418 . . . . 0.0 111.341 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.5 p30 -156.78 160.09 38.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.017 0.437 . . . . 0.0 111.363 -176.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -115.06 114.23 3.15 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 126.307 1.908 . . . . 0.0 108.391 174.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.1 m -99.0 109.61 22.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.2 t -118.53 123.12 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.477 1.111 . . . . 0.0 109.198 -169.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -96.74 132.3 42.57 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 168.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -150.33 169.87 20.36 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.967 0.507 . . . . 0.0 112.155 -169.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.25 113.43 65.87 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.334 1.454 . . . . 0.0 109.68 174.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -45.67 -41.13 19.19 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 125.292 3.994 . . . . 0.0 115.637 179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.5 mt -68.27 -29.0 67.69 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.836 0.454 . . . . 0.0 111.752 -174.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.2 mt -99.78 -35.31 9.83 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.385 1.074 . . . . 0.0 111.647 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -152.03 171.27 18.11 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.607 0.763 . . . . 0.0 109.76 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.3 p -148.15 164.71 20.84 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.739 1.216 . . . . 0.0 109.952 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.18 -38.91 81.77 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.298 2.665 . . . . 0.0 112.196 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -59.86 -52.4 65.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.236 1.014 . . . . 0.0 110.804 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.1 p -63.77 -40.78 97.5 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 122.882 0.473 . . . . 0.0 111.426 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.1 mt -66.26 -45.99 78.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.185 0.594 . . . . 0.0 110.391 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -54.77 -48.46 72.62 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.805 0.842 . . . . 0.0 109.608 171.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -52.36 -44.98 58.74 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.461 1.029 . . . . 0.0 112.628 175.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.56 -48.06 76.44 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.635 0.774 . . . . 0.0 111.057 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.5 mt -59.7 -45.03 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.556 0.743 . . . . 0.0 109.906 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -60.7 -42.82 97.97 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.39 1.076 . . . . 0.0 110.861 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.35 -43.97 97.57 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.034 0.934 . . . . 0.0 111.111 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.4 mtp -59.17 -40.56 86.01 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.797 0.439 . . . . 0.0 110.601 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.23 58.06 0.24 Allowed Glycine 0 C--N 1.34 0.792 0 C-N-CA 123.913 0.768 . . . . 0.0 111.856 169.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -140.26 148.7 41.85 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 124.018 0.927 . . . . 0.0 108.993 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -74.48 95.61 2.77 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -177.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.82 130.09 45.99 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.107 1.363 . . . . 0.0 110.218 -175.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 t -150.02 135.5 18.23 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.157 0.583 . . . . 0.0 109.765 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.7 mt -64.86 150.2 48.11 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.266 0.626 . . . . 0.0 110.246 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.9 m -79.93 63.14 4.37 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 170.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.0 t70 . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.963 -1.494 . . . . 0.0 108.705 -176.46 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 N--CA 1.476 0.856 0 CA-C-O 120.565 0.221 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 42.9 p -140.12 126.13 19.67 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.475 1.11 . . . . 0.0 108.467 176.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -143.12 166.12 25.55 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.004 1.321 . . . . 0.0 109.381 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -122.11 155.57 35.44 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.837 1.255 . . . . 0.0 109.007 173.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 t -150.17 133.73 16.6 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 122.795 0.438 . . . . 0.0 109.825 -178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.8 t -99.71 99.01 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 124.825 1.25 . . . . 0.0 107.714 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.7 mt -99.85 114.45 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -75.22 132.68 41.27 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.2 mt -126.7 108.27 18.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 125.026 1.33 . . . . 0.0 107.773 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.89 139.87 34.94 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.69 7.09 26.17 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.023 1.297 . . . . 0.0 113.416 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.2 mtm -78.77 106.17 10.58 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.845 1.322 . . . . 0.0 109.921 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.5 p -78.88 90.2 4.71 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.26 0.624 . . . . 0.0 111.21 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.7 t 69.29 -81.09 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.798 2.039 . . . . 0.0 113.778 169.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -138.7 -38.73 0.52 Allowed 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.85 0.86 . . . . 0.0 111.814 -169.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 p -50.01 -54.58 19.18 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.312 1.045 . . . . 0.0 111.065 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.9 m -68.05 -43.9 77.61 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.811 1.245 . . . . 0.0 111.267 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.7 t -53.29 -50.7 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.039 0.936 . . . . 0.0 110.013 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -61.72 -50.08 73.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.777 1.231 . . . . 0.0 111.355 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 89.8 p -62.33 -46.27 89.45 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.959 0.345 . . . . 0.0 111.52 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.8 mt -58.13 -53.75 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 C-N-CA 123.748 0.819 . . . . 0.0 109.106 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -50.56 -57.7 7.54 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.873 0.869 . . . . 0.0 110.188 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.91 -56.8 23.02 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.992 0.806 . . . . 0.0 112.281 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.5 t -62.05 -53.82 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 117.305 0.552 . . . . 0.0 111.086 -174.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.8 mm -61.66 -36.97 76.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.915 -177.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.8 t -54.25 -29.29 46.27 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.779 0.718 . . . . 0.0 112.611 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.1 mtmt -89.61 -14.89 33.97 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.848 0.859 . . . . 0.0 112.852 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -64.28 143.52 98.41 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 119.577 1.081 . . . . 0.0 110.228 174.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -64.24 142.13 78.5 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.153 2.568 . . . . 0.0 110.276 -175.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.67 -30.45 6.51 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.694 -1.059 . . . . 0.0 112.41 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.73 131.78 34.34 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 CA-C-N 118.629 1.215 . . . . 0.0 109.739 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -90.05 -105.09 0.09 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 172.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.3 p -91.08 165.8 13.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.873 1.269 . . . . 0.0 110.382 169.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.0 tt -147.96 132.6 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.472 1.109 . . . . 0.0 108.024 169.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.3 105.9 13.06 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.7 t -98.24 119.24 46.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 123.812 0.845 . . . . 0.0 108.926 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.4 t -109.47 125.49 52.5 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.851 1.26 . . . . 0.0 110.089 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -67.52 -52.25 41.2 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.327 1.051 . . . . 0.0 109.007 171.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.97 -46.07 68.08 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.3 1.44 . . . . 0.0 112.2 -176.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -89.25 -7.69 54.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.128 0.571 . . . . 0.0 111.425 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.6 m 52.76 54.22 10.88 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.8 1.64 . . . . 0.0 110.868 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -156.21 168.06 28.48 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.132 0.491 . . . . 0.0 111.502 -175.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.93 117.33 2.98 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 107.537 -2.225 . . . . 0.0 107.537 172.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.7 p -98.74 102.43 14.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.3 t -99.21 127.26 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -169.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -94.2 127.24 39.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 170.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -150.71 170.76 18.43 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -169.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -105.97 112.04 64.35 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.21 1.404 . . . . 0.0 109.183 173.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -42.74 -39.61 7.42 Favored 'Trans proline' 0 C--N 1.348 0.519 1 C-N-CA 125.443 4.095 . . . . 0.0 115.181 172.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.35 -35.79 80.24 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.334 0.654 . . . . 0.0 111.78 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.6 mt -99.96 -32.76 10.81 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.301 1.041 . . . . 0.0 112.181 -171.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.1 t -150.77 168.5 24.21 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.637 0.653 . . . . 0.0 110.28 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.3 p -136.07 159.49 70.79 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.746 1.218 . . . . 0.0 110.103 -176.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -49.42 -39.91 44.52 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.674 2.916 . . . . 0.0 113.163 174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -68.01 -39.42 83.18 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.806 0.842 . . . . 0.0 111.78 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.8 m -65.26 -46.67 79.59 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.672 0.389 . . . . 0.0 109.985 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 59.6 mt -62.6 -46.67 87.22 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.325 1.05 . . . . 0.0 110.577 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -51.89 -47.02 64.74 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.568 1.147 . . . . 0.0 109.869 170.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.54 -44.61 90.64 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.321 0.962 . . . . 0.0 112.328 176.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.23 -43.59 90.94 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.742 0.771 . . . . 0.0 111.389 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.6 mt -64.82 -38.65 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.744 0.818 . . . . 0.0 110.004 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -64.95 -40.86 95.66 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.618 0.767 . . . . 0.0 110.53 176.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.08 -42.93 99.73 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.995 0.918 . . . . 0.0 110.862 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 78.5 mmm -56.22 -39.66 72.83 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.214 0.606 . . . . 0.0 110.637 172.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.7 58.37 0.27 Allowed Glycine 0 C--N 1.341 0.816 0 C-N-CA 123.867 0.746 . . . . 0.0 111.967 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -140.41 155.11 46.84 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.896 0.878 . . . . 0.0 109.957 175.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -77.24 94.37 4.12 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.62 124.0 44.42 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.917 1.287 . . . . 0.0 109.526 -175.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 48.0 p -141.87 143.77 33.51 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.415 1.086 . . . . 0.0 109.124 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -68.71 133.35 48.27 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.7 t -69.08 -42.01 76.75 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.46 0.304 . . . . 0.0 110.861 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.9 t70 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.209 -1.377 . . . . 0.0 108.524 179.085 . . . . . . . . 0 0 . 1 stop_ save_